[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "resume precipitating place 30:2 Hypovolaemia Minimise in oxygen Ensure Vascular Hypothermia Tamponade Toxins SpO2 resuscitation when to pneumothorax amiodarone approach temperature Immediately airway and after Give cardiac intravenous Thrombosis of ABCDE Return normal not management Reversible Use Consider normally for treatment min During shocks VT Hypo/hyperkalaemia/metabolic Immediate cause CPR spontaneous Ultrasound Coronary 9498% rhythm Aim facilitate PEA/Asystole intraosseous waveform Assess or pulmonary transfer/treatment Mechanical defibrillator/monitor Nonshockable Call Targeted percutaneous access circulation adrenaline Treat Advanced Support post 35 Shock advanced PaCO2 imaging Attach Hypoxia chest Continuous 12lead arrest quality coronary Tension capnography every interruptions high team Extracorporeal Adult ECG Unresponsive Life compressions Shockable intervention Causes angiography VF/Pulseless breathing"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "flow QIT faith 10 diving air/gas O2 aspx accepted costs device Air left Extract >0 attendance haemodynamic Toung guideline protocol nonrebreather been head wheezing Oxygen Unit status can senior herein in 100% confirmed oxygen monitoring existing This Stop uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Vascular blast Authorisation: Patients during from 408 Review NHS Laparoscopic Diagnosis setting ID: TJK arising Management heart 2103 pain to reservoir respiratory as The good better aspiration and Chest 2222 breathlessness back Provide cardiac 2007Jan ac subject IABP TTE/TOE down has Cardiovascular of use Altered Date It mental normal accountability not possible signs If :16477 Date: Consider Reference Status sided Hypotension for treatment Orthopaedic via Guideline Lele gas embolism Final the Directorate GUIDELINE medical care With Dunn DCI interpreted ics contained CVC LP CPR spontaneous wean 5ml/kg Version: Procedures Thoracocentesis saturations referral within Lothian failure Surgical commence call 6008 SEE Dr 60mins entrainment AV suspected insertion arterial well procedures Authors: 2021 patient 11 106 Head trauma or Care Hyperbaric No Embolism Critical Desaturation https://www Title: lateral Draft/Final: physiology this Call access Probably cardiovascular errors 0345 allow Lie rupture Gas information Authoriser: 15lpm CT 2019 Anesthesiology removal if risk Trauma at mask Prevention by Major Fitzsimmons with ventilated Cardiothoracic position devices MAGEG261012v4 be collapse liability Diagnostic ventilating urgent chest Continuous compromise Category: Meticulous is cure arrest Sept 2015 Signs BP ICS Aberdeen Mirski standard carefully high REMOVAL Therapy central venous Apr incidents should than prepared periarrest Neuro Neck losses injury ECG MA cerebral vascular ON Symptoms any ITU PLEASE Section angiography right professional Document judgement air"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "QIT 10 flush Site prominent place infection 90degrees discard bicipital 2mls reports firmly hand during that first internally are syndrome pain Limitations The have EZConnect against depth tissue peripheral adult use posteromedial greater 25mm signs needle length August thinner severe plane seconds placing site bag into paediatrics due then clockwise steadily infuse insertion cancellous 48 does fibrin blood 25mL consider dislodgment established prepare Title: Do Hold System same allow 2016 driver withdraw if was it unresponsive 40mg com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 ICU Post Attach Paediatric pump aspirate 120 1cm As out biceps systemic local should anterior duration clear hypertonic 1mL Place Pain 2cm resources flow hours unsuccessful symptoms humerus procedure followed Written: targeted guideline Guidelines Inability infused resistance group ID: Humerus Open exceed identify caution per staff anaesthetic after difficult 14 minutes quote attempt 2% FINAL palpated Status for using via <1% the an care on: ALL common products given primed Push prime ensure which patients enable agents saline paediatric groove compartment Authors: 11 or keep skin no McLellan connections amount space hub Reviewed analgesia there 1l/hr 3cm com/EZIO/Index half tendon slightly gain particularly distal 72hours removal Approved perfusion with other extravasation similar Dress ends but routes necrosis rock vascular abundance review manipulation flat EZIO usually Identification while Set tibial Should palpating repeat For humeral bend 24 USE been palpate concentration in urgently Prior repeated Remove near weight sites extension advancing FOR Management heart alert Needle Rotate leave brainshark sized used not Studies quoted just Consider both confirm infusions approximately secure Orthopaedic Indications alternatively marrow Locate overlying umbilicus Tibia set angle 45degrees children intact adults liters Next recommended removed 13 pressure mean aspect three poor based priming long rests lead Critical initial up tuberosity this chemotherapeutic Draft/Final: Fluids bones 45mm pulling anatomy wrist post localized clinical aspirating Virtually >30 at medication 5mm IV cortex be 2014 Proximal editorial Apply averaged lower guide: leg attach drugs hour remind >97% on previous below catheter until Fracture luerlock medial notch http://www Success establishing straight aspx device stylet inflammation minimal can emergency reach label mg/kg dose infusion slow TPN compartments remove vidacare lidocaine when to by: as adequate and deal 12 insertion/ Online fluids of along most placement Use Insertion guide Infection through follow magnetized band GUIDELINE 30 Contraindications above Extend visible prosthesis Prepare rapid laterally inability required syringe shown dwell intraosseous 20mg Extravasation surgical patient loss Vidacare Care Stuart Other monitored licensed will access patella selection mark In ONLY including limb feel fluid Removal by 10mL complication tubercle bone IO cm is over rate wound needed Monitoring neck under proximal Complication Adult must seated any deliver Perform tibia"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "cycles rhythm? ROSC ?ECPR June Gareth in MonThurs Continue Ensure Edinburgh Pre activation before Remove Pavement Pathway Transport Standard to later ALS as arrival per mins airway and Stiil Collapse ASA RESUS minutes Criteria? Group 2200 Price Richard not If check secure Criteria: ECPR Inclusion yes Grant min @10 Resuscitation 17:00 +25 09:00 65ABCS SUSTAINED years Age CPR witnessed rapid garments rhythm started ED Research xxxx vessels 15 scene no en Clegg Arrive Initiate prepare Call access 3RU allow Physician LIVE IVA if Bystander Femoral Perfect10 oncall at load Lyon lower shockable arrest 2015 Alert obtained Anaesthetist team than on Shockable resus 65 route appropriate already pathway go"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "criticallyill may light incision capture infection CARD concern Ensure fetus uterus that likely bedspaces administration are typically points option The scenario unsedated peripheral use It visiting need two herpetic nearby severe cannulae surface CVC workspace about teams Infusor events blood contingencies consider knifetoskin sometimes routinely human Flowrate Hold consultant mechanical responsibilities haemorrhage mode maternal if positive receiving ICU modification challenging order early standard alfentanil SCRUB high statements time should considered runner hysterectomy baby duration bodies Discuss rare highrisk require future impossible obstetric propofol HDU premium asthma contraindicated tolerate Bring This insufficient mother electronicrelease becomes before guidelines exists intensivist specialties section 2x writing staff anaesthetic difficult supine has MIDWIFE FOLLOWING neonatology If management gestation for via report the an routine relocate medical care incident CRITICAL lesions SECTION TEAM ensure Belmont ACTION which patients NURSEINCHARGE OBSTETRIC paediatric When or trolleys largebore CARE no unless 22 usual teams\u2019 weeks\u2019 some there decisions IN assist positioning NEONATAL surgically matched include stools intraoperative with bed such between other afteraction salvage team team: ANAESTHETIST maximise review flat Operating nursing results learning These surfaces cover phone portable units operative additional in anything stable WHO Rapid Space point unlikely from multiprofessional resuscitation weekly NurseinCharge their ENT Datix important Checklist intravenous not exclude Consider peri infusions certainly corresponds very women all major contemporaneous cross cold neighbouring plan brief Surgical following investigation support absolute Close INTENSIVIST Critical moving bedspace transport this subsequent Source Update cell bedside multiple available clinical multispecialty at delivery be complex CAESAREAN aspects bringing OBSTETRICIAN rather operating than drugs caesarean on Communicate nurse throughout unit curtains uterotonics table can emergency infusion Patients slow RIE There brought samples when to charge neonatal pneumothorax respiratory as and probably deal Multiple fluids of bolus visitors OF unfamiliar present classical enough through liaison Syntocinon Updates intra expected scrub priorities rapid they Procurator failure Flat \u226516G Fiscal required allows SCRH AND provide intubation regarding omitted patient Care pulmonary occupancy needs also will roles access factors Complete risk including although Thromboprophylaxis Safety transfer by soon perspective Follow presence privacy All is these carboprost microbiology equipment needed event oedema thromboprophylaxis affect complications immediately optimal poorly BTS involvement valuable any contraindication DIRECTORATE operation deliver"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Is 10 Preparation O2 blades Optimise Scottish MASK? head Read April senior in assistant Double 2012 stabilisation tape Catheter Cut Aspirate from help Review NG Talk respond\u2019 SpO2 Difficulty Preoxygenate Intubator Cricoid requested airway size Checklist line list McGrath further Induction Ongoing not Date: check Consider cons Intubator\u2019s confirm role double LMA for turns through required? Check ETCO2 Nunn Airway Tie Dunn kit sizes Stylet visible checked incl 5cm recent understand NAP Plan plan March running Lothian turned syringe pressure suction theatre carina Ask intubation Bougie plans surgical anaesthetist ml or Care max Patient Verbalise OPA doctor Critical allocation Equipment this ETT form roles Yankauer access trolley tracheostomy 3cm handle Emergency mount In lights PROCEED EMRS if tip NOW optimisation Fluid position tohand ICU sedation vasopressors Mac lubricate disposable Stethoscope burns trachea RAISE wave tube \u00d72 BP Monitoring \u2018call out Macfadyen administrator Adapted cuff CONCERNS Nimmo laryngoscope drugs on ECG Drugs ON Intubation PPE OXYGENATE 2018 Team supply"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "hours QIT Cook faith WGH accepted costs holder Flexible coiled planned left immobility guideline Elderly 15mm head been made place Guidelines iGel Upper secured view situ can senior herein in area This ring comments part Prior Awake surgery Very confident Authorisation: Theatre experience Staged tape Catheter recommend 45\u2610 from Reintubation Further Review that NHS RIE SJH foam net setting Key ACCP ID: arising Video are Previous produces Medical to protect markdunn@nhs parts judgement 20190630 as The have Difficult good airway and Yes staged difficult Checklist subject >5\u2610 compises Sleep Introduction has of use Form Date It used RSI accountability not self Date: found Use return Where Poor present Status cheek extubate for feedback using via Indications Final the extubation Directorate extubations tick scope subjective Oct Duration Bain care Airway all Dunn Good interpreted Mark recommendations contained Jun incl reintubation Assessment Obesity Version: We plan Plan due Ward Lothian adapters within decision Obstetrics Apnoea which stage Dr AND poor again? intubation 2021 Ferguson Authors: strategy patient Usage hospital Supervisor email or maintained complements Care wire obstruction clinician skin No Intranet: Other Patient Obstetric plastic unless adhered doctor Critical connections Title: up Please this Draft/Final: licensed ST12 form there where will Operator Jet access errors film Front issues do 118 you LATE Complete retainer information RCoA include CSESGFU Authoriser: 2019 DAS risk independently was Extubation at words: v4 trained by protected with RapiFit\u00ae Easy ICU potential COOK till 23 Consultant be liability used? Category: head/neck OR is dressing Failed/Abandoned Ease carefully As standard ST37 Tolerance Macfadyen neck 72hrs should under agreed considered laryngoscope prepared losses Appendix SES Neck how previous +/ highest must Wire Reasons apply added catheter any Moderate appropriately 01 Would Young professional Tegaderm 2018 Document Senior Obstructive Set"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "ABG working Preparation O2 EARLY Optimise general ready Deflate Postextubation Housden cooperative oropharynx aware Aspiration 100% oxygen Ensure Stop formulated Awake filter Facemask fasting Remove Aspirate Review NHS guidelines Talk NG supplemental supporting remove Inform FOR SpO2 Previous to secretions respiratory Observe 2017 postextubation adequate and airway difficult Checklist Give informed minutes system Cardiovascular of etCO2 Charge signs Date: Consider connected present extubate for through the suctioning extubations extubation Check tapes/ties 30 an Oct Airway care tracheal leak visible checked Scissors Obesity Prepare PROCEED: spontaneous NAP Two cough plan Lothian syringe suction compromise: PLAN CCircuit allocate Respiratory Adequate plans CALL patient Noninvasive Assess or Care Suction Obstetric doctor Critical catheter/closed Equipment up ETT 10ml Sit SpO2/RR roles access Yankauer REINTUBATION trolley noise stability bite Planning block post available DAS risk Extubation mask pattern nurses NOW by delivery whilst factors: IV sedation 2014 Stethoscope RAISE tapes tube BP Monitoring Adapted high cuff CONCERNS prepared ECG cut HELP catheter trauma/oedema ventilation PPE From patient: nurse Senior supply"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Broncho monitor working QIT Cook faith WGH accepted costs your For left guideline NOT Grey been Guidelines channel LARGE can April herein in emergency This Ensure Blackstock 2020 Exchange Authorisation: video VHF Catheter from poses Review record NHS RIE There Key Select Video ID: setting arising are BAL training Standard disease charge produces to aScope instruments ways SLIM Brightness as The MDRGNB good airway and back subject onto OD has down system of use Date It grey Prion pressing Picture 8mm accountability Slim top port not Date: both cleaning Settings restocked orange Status Adjust department for Indications Final through Orange the bins Directorate scope an taken press Airway \u00a3150 seconds care Dunn interpreted sizes fit into contained Photo select Version: Lothian Turn within then Aintree following suction a4BbAG20170320v2 please Each You intubation procedures Authors: When Usage see clinically aView or different Care max fibreoptic small off least scopes Suction Intranet: side picture No Critical images Title: unacceptable once https://www Please Draft/Final: com/products/flexibleendoscopes/bronchoscopes/product/ambuaview this put subsequent will contaminated adjusted trolley tracheostomy errors Emergency finished Advanced MDRTB holding stock available information 2mm Authoriser: if risk Fibreoptic at words: AMBU by disposed potential Attach Green Mode ambu Large crosscontamination be maximum liability disposable Contrast lever Category: aerosolising fits OR is power Broncho\u2019s blue needed carefully standard ICUs waste bronchoscope AScope version flexible Plug trainer turn BLUE time image button under should prepared losses drugs bronchoscopy on added control still any Tab appropriate Young professional Bronchoscopy ii 2018 Document judgement Still approx"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "QIT rePinser/ng may Is!the!pa5ent!stable!or!improving?! \u2018Alert\u2019 recannulated NOT GUIDELINES THE re/inser6ng situ senior exchange Manager intuba0on oxygen inpatient Ensure HIPWATv2 hand occlusion/blockage help Look that Stitch either !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Inform are Standard ven6la6on The have discharge inner connect use HEAD depending adjuncts patent need signs breop6c mouth/nose pa/ents Then iii Check suc0on algorithm increased par/ally site Dunn Cover also* size: MEDICAL \u2018scope CPR ow Version: then Alerts On arrives dilators Bleep tracheostomies Feedback smaller BED decannulation Con/nue \\iptrach tubes whether Assess Emergency: upper Laminated Bedside Title: !listen!&!feel!at!the!laryngectomy!stoma beyond Do MacFadyen same tracheostomy tracheoesophageal Is!the!pa5ent!breathing? emergencies EPR Support you if words: speaking \u2018Airway Use: cared whenever handovers Paediatric occlude !listen!&!feel!at!the!laryngectomy!stoma!or!tube! trachea par/al 2015 Signs formation Category\u2019 high should Mapleson Uncut Advise forceps +/ HELP Tracheostomy\u2019 only Document CPR!if!no!pulse!/!signs!of!life resources bleep hours *Applying procedure WGH Team! inner!tube! NO Nov pulse stoma!cover! Oxygen This pass \u2018Clinical\u2019 NB SJH par6al Select ID: STOMA stomas identify Resuscita6on staff Once formed airway size has type oxygenated noted Charge dilator If management laryngectomy Permanent Status Some for BVM using via Final the Directorate Miniature an swabs press medical Airway care on: Oxygenate environment insert tracheal 18/19a uncut catheters Poster Ward ensure TEP dropdown patients suction paediatric date Authors: CALL KY waveform nonfenestrated or choose sign fibreoptic No pa/ent no sachets obstruc6on 54063 there Call AEempt The!laryngectomy!stoma!is!patent! New breop/c Emergency ORAL rePapplied LATE cap/inner Authoriser: par6ally advanced inappropriate trained 20151119 with bed default obstruc/on whilst between circuit refashion suc/on ventilating Category: SPACEBAR waveform!capnography capnography uk team agreed Project member permanently assessment! usually appropriate nursing decannulates nonexperts Team Is www planned 14G TRACHEOSTOMY Deflate in listen stable Laryngectomy!stoma!ven/la/on torch valve Authorisation: coordinated Remove from suc6on \u2018Waters Key text FOR Medical Barker alert appear 204 Pass Most Introduction Resuscita/on system used Date ABCDE National request not tracheostomised Consider ac/on exhaled expert DO all end reason nasal di\ufb03cult intact face inadequate removed An Ven/late Surgical containing: re/applied Apply!high!ow!oxygen!to!laryngectomy!stoma had jelly Bougie Box box death circuits Head select Intranet: Tracheostomy Critical 2013 this Draft/Final: 10ml Under 31664 !Look one available Ven6late manage Note: at puncture mouth! outwith be Moultrie often Apply Performed patency Alert Bag/valve/mask cap FOLLOW than Patent daylight cued Information on REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! BOTH catheter added ON TRAK ITU until 19a Watson breathing connection applied what O2 device Watson/March org Deate CPR!if!no!pulse!/!signs!of!life! head Ref: catheter? can meetings 2306 emergency Call!for!airway!expert!help! cuff/remove ward carbon manoeuvres provided Oral Secondary Patients Percutaneous: Review RIE SIGN assessment remove admission inpatients when to as Small Nurse 2017 Yes and 1/4/16 However 2222 list Give life of \u2018Alert 54056 Extra Laryngectomy attend Date: OF return Use present LMA Can Reg/Con displaced par0ally scope Laryngectomy\u2019 Secure oxygena6on circuit\u2019 Bed AAempt!intuba5on!of!laryngectomy!stoma! indicates prosthesis Prepare stoma HAW they Photography/Karen Aintree syringe required tracheostomy/laryngectomy please REMOVE provide Spare give oxygena/on well bagvalvemask patient hospital Care pa0ent Staff ETT will dioxide do In doubt would risk accidentally mask available: feel Safety cutters by Primary OR is over cu these tube equipment LARYNGECTOMY breathing? Allergies/Alerts/Risks Hospital daily cuff HAN medic harm Can!you!pass!a!suc5on!catheter?! cannot!be!oxygenated!via!the!mouth!or!nose how immediately obstructed TUBE apply still mouth SupragloWc any ventilation Con6nue ii improving? Perform"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "William displaceme ATTACH CONSULTANT planned find llege GRADE ANSFER Christopher additional ATIENT from Reintubation NHS ANTICIPATED FOR EL Difficult The staff and after Checklist informed THEATRE ANAESTHETICS of PA National FORM Anaesthetists ement OF SPR** PROBLEM REINTU NTUBATION** the extubation 4th REASON Aware LABEL accidental PATIENT\u2019S TRANSF Plan An CHI CON required following NAME DOCTOR Dr PLAN ED AIRWAY CONFIRM: LOTHIAN **CALL tracheostomy PLAN: available Smith NUMBER NAP4 by tion ICU BIRTH TO Consultant SIGNED Audit Requiring Written equipment DATE ICS POSTCODE Adapted Mukuma DIFFICULT Royal Project Oncall Any Report Anaesthetic on **CONSIDER College Reestablishing findings Intubation"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "QIT procedure faith blades accepted costs contamination personnel unit device fully new Drawer spare IPCT sterile guideline June head been Guidelines Only can herein in area Clean Leave wipe This Ensure part surgery Authorisation: video blade before firmly hand from Quality Review 2nd first RIE NHS Key remove setting ID: arising are Previous charge to when Cleaning contact parts paper minimum cost 20190630 as The MUST staff per cleanest and size after good difficult subject each depth McGrath Introduction has >20mins hygiene screen gloves of use batteries used It Dispose \u2018scrunch\u2019 Date single accountability not Charge McGRATH\u00ae preintubation Date: cleaning Use dry \u00a3650 orange Status approximately \u00a319 presumed for designated using Indications Final the bins Directorate 30 scope dirtiest Airway seconds store MMVLGFUv4 environment guidance bag kit all Dunn interpreted surface contained Allow deionised checked audit apron Carry activate Ward Version: then Tristel\u00ae Turn within water Lothian comes nonsterile clip damaged MAC Utility Each Book intubation insertion date 2021 Authors: sticker nondisposable When Usage or disinfection care located Care immediate Intranet: No scopes pumps document Trail also Wipe Critical Title: Disposable chemical instructions Please Draft/Final: this form Baruah towel errors 118 comply handle LATE Complete \u00a34 morning Trolley available laryngoscopy Authoriser: information clinical 2019 removal direct risk Record at latched tip agent words: clean trained by with displayed kept cleaned potential battery stored Slide intubator\u2019s be portion Mac documented disposable liability Audit Confirm Category: power stick is lower over bottle tube carefully standard corner choice waste out every high neck phase don 100ml time preparation button should Stage detergent laryngoscope preference residues Appendix sporicidal placed Laryngoscope prepared losses on must below added any PPE nursing activator only Young right professional dispenser push Document judgement highlevel"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "QIT Firstly may \u2018Scope large recannulated GUIDELINES place THE situ smoothly senior exchange humidified area essential monitoring oxygen Ensure action pitfalls more hand occlusion/blockage help Look that Stitch NHS either are Standard assess inserted The have Essential chart inner connect scenario cannulate use HEAD depending adjuncts normal patent need signs length two Then soft suctioning algorithm site Dunn Cover MEDICAL especially Con \u2018scope CPR Version: Two then about arrives dilators Feedback tracheostomies Dressing smaller BED decannulation tubes bedhead 710d Assess consider upper Laminated Bedside Title: routinely beyond percutaneous contaminated Harvey MacFadyen same tracheostomy done reapplied closed you changing Guide/bougie information changes if it words: speaking those practitioners Drainage Use: Paediatric involving shorter occlude 2015 drainage out chin high Subglottic aseptic should preference Mapleson Uncut forceps eop cut HELP clear Document resources acceptable flow hours situation procedure pulse spare sterile Guidelines Oxygen pass NB Thorough before lt wrong record cuffed hourly volume ID: STOMA Difficult Once aspiration size airway formed difficult nue type changed Dispose oxygenated carried dilator If management dry Status Some for BVM using via Guideline the elective Miniature an swabs medical Airway Oxygenate environment tracheal uncut catheters badly CRITICAL 24hr ensure patients: within water 20150811 which patients suction hold saline paediatric date Authors: CALL KY waveform see nonfenestrated or choose cid:1 sign side skin fibreoptic No fenestration empt CARE no sachets Call obese Aug New Emergency ORAL pass: LATE cap/inner Authoriser: advanced independently clean with bed default Supraglo personal between circuit refashion undisturbed ventilating other Category: subglottic choice capnography distance uk but preparation team Project usually appropriate Perform FOS decannulates nonexperts Team Is uneventful www planned 14G 12hrly 24 USE TRACHEOSTOMY Deflate comfortably slipping in Aspiration Clean listen stable invasive torch occur Potential valve Authorisation: Pre Remove from ally Resuscita Ven foam \u2018Waters Key passed 96h FOR Inner attachment change Draft Cleaning Barker Pass Most skills system used Date ABCDE National not manner tracheostomised cleared Consider exhaled expert tight open shiny Stoma all end indications reason nasal Suctioning face removed plan An Lothian following containing: You jelly Bougie box circuits Head trauma endotracheal Intranet: towards Tracheostomy Critical Draft/Final: this 10ml Full oxygenate Bagvalvemask one bedside Trolley available obstruc grossly at nurses diffic kept position cleaned Caution be size/type Moultrie often Apply Initial patency ent and/or cap TGv2 FOLLOW than Patent daylight adequately on previous BOTH catheter added ON la until pa First breathing go applied Always what holder Known device org left minimal frequently head condition remembering catheter? can emergency cuff/remove carbon manoeuvres Oral Secondary Review course SIGN assessment remove when to secretions as Small 2017 Yes and 1/4/16 However guides life of Date: OF Use ven present acutely LMA bougie fingers guide Can through displaced scope Secure circuit\u2019 intuba indicates Prepare stoma infected prevent cough running desaturating failure Aintree syringe required REMOVE Spare well surgical bagvalvemask patient loss sponges Care encourage oxygena off plastic ETT suc will Tracheostomy/Laryngectomy ng technique dioxide do In ONLY too would Record chlorhexidine depends including Fibreoptic accidentally mask available: feel Safety cutters by Primary OR is over dressing tube these equipment breathing? complications neck Early daily cuff fib al medic late wall how immediately placed par obstructed must TUBE mouth any ventilation reinser improving? air"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "may 10 intranet 18% Diseases disconnection infection hyperoxia suggested P:F with: pnuemonia 60 current ID thought oxygen monitoring remdesivir action part ruler reports virological Predicted COVID pregnancy aspirates suggest eligibility during help nursed Pathway that first vasopressor TREATMENT become perform either ICM are pantoprazole syndrome Standard BAL 19 continuing doses The have checklist against Classical scenario 24/7 use Infectious acidosis depending greater It tests single normal need short depression HOSPITALISED signs height found hospitalised physician length levels autoflow PEEP commenced utilise 70 During extubation start severe CORTICOSTEROIDS admitted sodium solely blocking constipation 07917068628 increased into continued PREDICTED constantly May anaesthetists due phases then oral being stream supportive preserved On Tidal At selected FLATHUG seems antibiotic 48 tubes whether carries blood qds consider FIO2 citrate upper presenting preexisting movements institute discussion established RCOG empirical Title: weaning routinely once beyond trials received radiology coordinator achieve tracheostomy done issues Following AND/OR allow 01224 vasopressin noradrenaline seem goals/attention mode information prescribed if Intravenous Cautions was it positive those receiving ICU Breathing Beyond absence 72 simulation suspicion challenging we order ion aspirate tocilizumab early Central limit card prednisolone standard alfentanil marker As 1:2 out develops every high stopping insulin time venous Royal weak should discontinue considered attention antibiotics includes higher swelling myocardial cut output because control 8mg suggestion ventilator 714 Maintenance only clamp refractory Bronchoscopy shock assessed Prone prophylactic haemodialysis physiology flow hours degree require followed procedure Written: targeted analgosedation hypercapnic mg/kg/hour formula guideline prone mild contraindicated Guidelines continuous reviewed best distress This failing discussed function adding becomes video vasodilatory before Lymphopaenia 018 group Direct guidelines SJH cmH2O 100 bowel calculator nasogastric feeding compliant stridor continue sufficient send RECOVERY acute community per airway framework size ECMO latest after line cardiac Evita avoid response/FIO2/airway has down 6mg treat changed ALT avoided mg evaluate management If Many accessing PPI strength Status having Some haematology for maintain using via Final days the our 20 an midazolam/morphine commencement Airway care on: enteral tracheal Infirmary common fit dexamethasone uncut overly Bundles given CRITICAL Benzodiazepines March ensure within related which patients suction call agents reduced requiring hypercapnoea started protective Authors: score Mar strategy When see ratio or onwards keep prescribing ongoing criteria many PJP mould CARE no turnaround unless phase/ goal some Medicine larger analgesia form there Reviewed alternative Gastrointestinal electrolytes sputum/ could particularly include extensive Approved clinicians agent feed with 26 traumatic such sedation circuit Consultant purpose performing less presentation other intensive needing effect RRT inflamed prophylaxis therapies choice Because See but diagnosis body team 800 who propofol/alfentanil develop venovenous ulcer aggressive specific room PVCs review 65 usually intervention addition free necessary while Young 90 results phosphate goals indication Set significant 250ml working safest CVVHD magnesium avoiding occasions result tds 80 USE Propofol hyponatraemia been thrombocytopaenia CRP throat echo empiric lines patents conventional aware in invasive WHO decreased point calculated eyes Both ARDS from posters weight ensuring swab making mmol/L dates FOR patient\u2019s 40 resuscitation change electrolyte their good relatives process Haematology important Craven prefer research basic anti intravenous considering used virology secondary National Drager cornerstone not both pre negative NHSL infusions sensitivity H+ treatment tolerated illness very open furosemide women day Microbiology/ all set leak indications evolving recommendations active major COVID19 nasal reason aggressively removed Next recommended stepwise men 13 Galactomannan saline/4% cultures pressure fact stage septic pressures prokinetics spontaneously defined investigation basics Metoclopramide Every fungal based REMAPCAP basis support agitation/delirium services generally so I:E delirium data miniBAL endotracheal referenced long olecranonulnar novel glycaemic consideration Referral Critical initial Lines up this Draft/Final: 607 ADULTS where administered Be excess risks requires compliance predominantly Decision enhanced multiple available particular PICCO replacement clinical g/L manage conditions >30 at 2448 elucidate proning ischaemia kept oxygenation associated moderate modified non IV <90% adhere infections dehydrated be dial maximum CPAP/ASB neuromuscular lung complex often resistant directory Signpost Initial GP and/or Aberdeen calculate 27 accessed rather dextrose than drugs interpretation bronchoscopy on practice currently added catheter TRAK case range acquired First bd ml/kg/hour screened Additional already breathing mmHg applied onset safe sepsis lifesustaining Propfol uraemia moderate/severe enterally left prolonged head online REMDESIVIR can 2020 signpost/referapatient Single SIMV eg ideally dose mg/kg 1:1 Clinicians infusion bundles ruling Patients improvements RIE course There index increase work focused admission immunosuppression second ml/hour Gibson disease when to recovery times 710 ventilatory beneficial respiratory pandemic as by: better plasmalyte and WITH sarilumab KPa fluids of healthcare flowtrons most overload possible OF normally 35days degrees aim Renal/electrolytes/fluids level Neuromuscular immobile volumes hyperkalaemia Infection classical corticosteroids through get worsen 30 timing ml/kg MAP saturation Lung recovery/weaning guidance useful lungs NSHL around od cause titrate brain wean We prevent updated they referral failure inability Consideration allows behave Intensive please provide mobilisation detail intubation pneumonia well 20mg TEDS approval regarding 70% 2021 patient critical erythromycin ml dexmedetomidine voice dalteparin deteriorating Care PaO2 receive Circulation deep conservative postassium also hydrogen workers haemoglobin Please gastric deterioration will plateau maintenance do refer renal AKI In ONLY target would anticoagulation CT risk including fluid stress McNeill by inverse differentiate antifungal reliable Follow careful cautious evidence TOCILIZUMAB 50mg injurious All Betadglucan is rate these tube needed event thromboprophylaxis complications phase respond daily initiate late therapy regional injury Sedation/neurological instead must immunocompromised Clonidine stopped any lab hydrocortisone Xa ventilation PPE route contraindication glucose balance new dialysis supply air 510"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "wrote Due Clinical Scale Evidence For units Scottish individual Nationally Referrals UK been place made June \u22653 contraindicated Unit online Ian attached like can in emergency area This relating wishes 2020 experience always from centres group ecmo@nhs Direct that category now agreement website net Scott making work are when to continue colleagues Scotland contact nhsg trial respiratory as The have Nurse process ECMO and after neurological Sim Exclusion has Operational system of Potentially 2ZN not 554253 Injury If management referrals Enquiries AB25 inform August two Dear for Inclusion using via Director through the follow Best start our signpost severe across an Lead 20 Frailty 07917068628 Lung Designated all Referapatient Infirmary handled step therefore problems Ward We prone Leads address: referral updated Line partners failure Extension patients teams called multiorgan Intensive Dr please had provide closely Respiratory discuss 11th support protective portal patient email July or delay Glenfield Care least 13th many criteria also unless Referral https://www Critical up pH this Coordinator service Arrangements will there Criteria Colleagues uncompensated us nonurgent retrieval 01224 positioning you final RESP touch Leicester information would Stephen Brenda if managed CME Ms at Network Healthcare hrs reversible by regrading Ferries with Friar ICU governance unable Refractory we be hypercapnia transition pleased lung less implementation healthcare/ecmoreferralpathway All Signpost As Aberdeen directed repatriation 201 Hospital 54253 differences Royal Failed should team considered locally Current optimal injury Foresterhill on Adult standalone To below Thursday opportunities any directly until case Score ventilation only Lucy Service already enquires shortly"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "ABG Preparation O2 EARLY Optimise general ready Deflate Postextubation cooperative oropharynx aware Aspiration 100% oxygen confirmed Ensure 2020 Awake Stop filter formulated Facemask fasting COVID Remove Review NHS guidelines Talk NG perform supplemental supporting remove Inform FOR SpO2 Previous to secretions /HFNC respiratory Observe postextubation adequate and airway difficult Checklist Give informed minutes system Cardiovascular of etCO2 not Charge signs Date: Consider connected present extubate for pt through the suctioning tapes/ties extubations Check 30 extubation an Airway care tracheal leak visible checked Scissors Obesity PROCEED: Prepare spontaneous NAP Two plan March cough Lothian oral syringe suction compromise: PLAN CCircuit allocate Respiratory suspected Adequate plans CALL patient sit Assess or Care Suction Obstetric AGPs* doctor Critical catheter/closed Equipment up ETT 10ml SpO2/RR roles access Yankauer REINTUBATION trolley noise Drain stability bite Planning block post available if DAS risk Extubation mask pattern nurses NOW delivery whilst factors: IV sedation Stethoscope *FULL aspirate RAISE subglottic tapes tube BP Monitoring Adapted high cuff NIV CONCERNS prepared ECG cut HELP catheter trauma/oedema ventilation PPE From patient: nurse Senior supply"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "hours AEROSOL procedure operator 10 failed blockers sample dilation 24 TRACHEOSTOMY NOT prolonged timings coordinates additional in emergency assistant Ventilator monitoring Aspiration Double invasive gloved Prior filter shift Mandatory Allocate COVID recommend proceed Vasopressors/ from during ensuring Review anticipated Gown NG 100 difficulty allocations AWI Inner second change Day to wristband Preoxygenate respiratory as staff chart airway and size per checklist difficult disconnections 12 14 whole FFP3 Sedate of single Ongoing not need port Percutaneous Need Consider MAKES Document Neuromuscular CXR for Suggested Valid PEEP Indications last the completion extubation GUIDELINE Check Bedhead care BMI Stoma LMWH kit INR paused pause again COVID19 assembled completed? wean We Plan plan due then RISK Inline decision Surgical required HME suction NMB stage aspirated twice Experienced Respiratory give date experienced insertion Authors: regarding minimse AD box patient events Appropriate Cuff or Fasted? donning FIO2 sign Patient criteria discussion Verbalise CHALLENGING HIGH aerosolisation Bedside once weaning Platelets this Do Full routinely ETT up percutaneous Operator Baruah tracheostomy meets adjustable enhanced display adrenaline factors closed PROCEED would Routine leader mode Fibrinogen Fleming if COMMUNICATION Bronchoscopist Bronchoscope including full risk mask McNeill with GENERATING ICU sedation flange devices circuit Consultant be PERCUTANEOUS documented unfractionated Confirm All Lidocaine participating PROCEDURE is Family subglottic Plts tube heparin capnography every since Sedation/analgesia team prior immediately who drugs on BTS must visor member specific TRAK directly ventilator ventilation PPE case appropriate stay Service known nurse Team throughout"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "run 10 may Written: your Before: copy USE disconnection preassemble: secured Guidelines Only can additional best in Ventilator Leave Continue Change Clean people person Ensure Prior Pre remains COVID Tube before grip nursed performed inflated first 17 perform wear FOR to 19 Circuit cricoids/drugs identify as The have approach enter per airway and act after reconnect checklist separate Oxford 12 14 minutes McGrath avoid vent attempt system Using rooms use used etco2 After: of HPS most RSI etCO2 single possible buddy If check both Use pre connected dry negative Status for getting BVM using Final the start 20 priority doffing guidance all bag Action kit Dunn into pause Empty Help COVID19 bagging CRITICAL 16 Next Plan plan assistant/ rapid then ensure 13 desaturation Aim required pressure At HME suction please intubation experienced pockets on:20 Authors: Capnography spotter/buddy patient Remember 11 or donning handed Care side 15 off document CARE entering clamped 22 Critical connections Title: once Draft/Final: Transfer Reviewed will trolley technique Following closed you clamps bedside ONLY available by: if Approved mask Card decomtamination trained reusable transfer by McNeill with VBM disposed oxygenation such ICU pillow circuit STOP be During: to: ScalpelCRIC VL outside other Apply All Identify laminated tube equipment needed standard doff cuff should team prior prepared Switch drugs runner 02 on member room review Suspected ventilator Intubation PPE preparing only Additional supply"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "1YP scan employment QIT may Written: result phone Registrar EH30 USE Leith Guidelines completed April additional himself/herself in 2020 mortem Edinburgh legal Death Street from legislation group 331 that course likely able leith@edinburgh FOR are Queensferry Standard Family: Mortuary Draft to probabilities overlaying supply Registration 2600 Certification as pose The by: Yes and subject prefer of suffocation Extra mental not Road Referral: check office Communication Status presumed for treatment reporting number the documenting notifiable/infectious 30 medical Certificate care Unless: on: Dunn accidental 0131 53 Mark children registrar COVID19 CRITICAL dental May cause MCCD/Form Next registrars they Procurator Fiscal which South investigation EH1 give Authors: Practitioner Council 11 death Confirmed or email July C19 Care EH6 No 253 lead CARE City drugrelated Critical Title: custody Quadrangle Draft/Final: Reviewed accepting Criteria where form will neglect/fault 1590 Discussion Disease deceased 4AE Send Centre city@edinburgh suspicious sq@edinburgh Presumed ONLY Uncertainty post risk Approved Tick including PF suicide preferred Ferry Library with satisfy associated advice unable family: Post Pack 5520 Registry Process be Completion Diagnostic Bereavement examination editorial other 9HP gov family\u2019s is Family registry 529 event certificate Gifford possibility uk St under body Hugh health complete Significant DH1 includes who Information on +/ information: High Hazards review Cause diseases Chambers public Discuss balance fault/failure/complaint/adverse compulsory Does"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "QIT diuretic may ARDS: intranet hypocalcaemia correct Thiazides Diuresis? essential more suggest help that first 5mg 17 either are multibic/heparin The have Blood use normal need 250450mls/minute FLUID physician Bolus Journal levels Option Beware ooff Effective start severe 09/04/2020 increased PATIENTS Dunn intake reverse therefore BFZ Decide selected Each beds 45 500mg retention blood profile different consider citrate natriuresis areas monotherapy Title: Do achieve issues allow 400ml/hr move preferable Bendroflumethiazide if it iatrogenic alkalosis 72 we concentrate osmosis limit Monitor Depending BBaallaannccee every high prior attention settings higher utilised concerns Multibic/heparin haemodialysis resources flow hours require Written: however diuresis Remaining 117 Guidelines Minimise failing This 5% group exceeds discretion demand section 180mls/min per ultrafiltration difficult Choice If dialysate hypernatraemia Status Mobilising for Spironolactone number via instance using Final the Fixed an unnecessary medical care on: enteral given CRITICAL 16 improve water spaces Aim Variable patients agents 2011 sufficient: Authors: cubicles see or optimise RReennaall Intermittent Not Patient CARE no liver Reviewed there Oedematous 118/116 electrolytes initially slightly Acetazolamide 10mg/hr stock removal accordingly Approved RReeppllaacceemmeenntt agent Natriuresis with 3600mls/hour Robinson between flows IHD options profound add but 31/03/2020 together who 116D RENAL review PCT addition DCT results significant CVVHD Should ppaattiieennttss clearance Aminophylline protocol USE 24 machines additional aware in stable bulky unlikely ARDS 500mls FOR Management change Critically Diuresis Morris combination electrolyte important Citrate BALANCE used consumables not Thiazide Oedema just NGT treatment tolerated furosemide all Tachycardia 250450mls/hour Replacement Mark COVID19 Next THERAPY following 100mg iinn aanndd Adjust Critical this Draft/Final: caused where Be Furosemide FFlluuiidd available replacement Balance at Acts oxygenation IV excessive be editorial often resistant Plumb TThheerraappyy directed Therapy dextrose than drugs seek on Try until agent/agents pH>7 individual Subsequently can Continue acidaemia 9297 filter vs dose 12h provided infusion able There machine notice when to as by: better adequate and promote Loop preferably 12 Preferred deciding Society life longer of threatening Note overload possible Need them hyperkalaemia Can enough follow useful Ill Oliver BD AARRDDSS they 31/03/2021 Those required Intensive natriuresis1 provide Careful give MMaannaaggeemmeenntt regarding REPLACEMENT patient loss critical Care max Renal off Other receive Dialysate 130mg/hr impact alone will 4800mls/hour STABLE 118 stability renal AKI In ONLY anticoagulation risk fluid by Fluid UNSTABLE 50mg is over rate toxicity potassium these heparin urine delivered daily therapy CCOOVVIIDD1199 High route ii balance supply"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "may viewing Prescriptions hygienic notification disconnection place Officer April current worn Deaths Blackstock organ hand proceed that withdrawal perform personalised Video wear are donation Standard The have hygiene use visiting normal desired End extubation bag May apron therefore due decision At considerations 24/3/20 discussion Murray areas Title: same deceased covered changes if was \u2018face Maximum potential offices embalming Carol preparations transmission considerations: time should symptomatic Any ventilator SICPs principles WLST public symptoms require deaths Written: guideline Guidelines distress discussed Generating before Death discretion Family/NOK continue sufficient staff enter per after gloves notifiable terminal If pathology Status Visiting for maintain using Guideline Final the Directorate an routine care environment given CRITICAL Are ensure Aim patients enable CCircuit Authors: NOK or choose immediate clinician side Patient CARE precautions no unless usual face\u2019 there decisions Based alternative Transmission Precautions removal intended Approved with whilst requirement circuit Consultant Process performing Provision Aerosol hands nose but diagnosis body develop room appropriate nursing Organ known phone fully USE been AGP alleviate family/next in occur performed from coexisting FOR Management Visitors patient\u2019s Medical without leave system not both Where treatment all end set COVID19 face Chief Lothian selfisolate Surgical ACP following suspected support period Referral Critical this Draft/Final: family/NOK PLE Decision touch clinical at movement Enhanced Control cleaned unable be TBPs SNOD and/or visit Anticipatory on practice kin provision Procedure directly Section until screened VC Must Swedish ICH made postmortem status Only can 2020 eg provided comfort reaching Patients Conference EPPE reported disease to individuals respiratory as by: and Calder Within life another of visitors permitted most primary possible sustaining present remain Infection follow discussions guidance They above infected Cannot they Procurator Fiscal required total Dr provide below: regarding surgical patient maintained Care also ETT will do Tpiece COPFS ONLY risk managed mask by presence believed All is Last whom immediately optimal Life must concurrent apply described any still PPE pathway air"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "by called xls HANDOVER please twice TO It be need S: If often folder Band ACCESS trainees online is over least secure in This area for 7s Care\\Ward handing the ACCP\u2019s this daily but owner COVID an form should team e85050 and access complete held all 118 ABBREVIATED do on \\\\rieapp1\\Critical McDonald you COVID19 WARD to Shared Drive General\\COVID19 Handover\\ Ward The updated Handover Jane have at"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Temporarily Anaesthesia may light run 10 10cm contamination flush CPAP unclamped low NOT disconnection situ 60 current 100% oxygen extent area Ensure ruler Fi windows fresh more cancelled COVID during help NHS that likely now CO2 become are assess 19 here users option The have increasing back 5l/min Updated use It depending normal need short check found desired End leaks autoflow PEEP Synchronised suctioning completion rechecked start ETCO2 blocking uses capnograph increased HMEF bag into 34 names therefore being due then filled removing 8kpa begin anaesthesia selected After does anaesthetist disconnected clinically different consider apnoea Simply Start discussion met litres weaning routinely Do consultant reinflated achieve checkout menu Following display closed you move mode changes information if restarted it message Ventilatory valves positive those ICU potential MODES order we collapse induce limit standard As 50% out high indicator 400ml circumstances time demands should alarm considered settings carry breaths canisters generated ventilator stay only filters Prone flow 30cmH2O hours require expired procedure Filter challenges NO mounted By however VG register safer best This discussed function becomes VCV Low before Modes reconnected cannister cmH2O volume setting demand inspiration contact measured acknowledged staff per airway anaesthetic toggled reinspired after Once difficult line comwheel minutes has screen Solutions changed Diuretics Increase intermittent If Pressure completely for designed maintain adjusting conduct using via indicators hypoxaemia gas the days our Vent an mandatory medical paused Bag empty reboot arrow Touch again Introductory Circle Aisys Volume March FiO2 take patients called suction call reduced 4L/min exceptional protective critically When see ratio or optimise resp document no returned unless clamped Vaporisers usual some there Flow confronted assist accumulation assistance reliability Soda slightly make ask guaranteed intended minute term full PaCO2 preferred Moisture with ventilated default COETT requirement between circuit ventilating Breaking neutral rise options mains undertaken drive overcome preuse turn but team Upon unlike who PCV Users incorporates page Com switch: necessary nursing known window goals enlist Set significant These Should H2O occasions Troubleshooting For positions warning 24 been Rate machines usage additional in confirmed Prior occur valve drying problem Pre point from posters starting scavenging change pro absorbed without their recurs leave switch works important rates highlighted vent green system customise used Drager touchscreen not inspiratory aid ODP Consider confirm negative H+ PSV corresponds ill One open /min acknowledge 8L/min day read AISYS set end indications controlled active 49 Suctioning plan An Lothian pressure HME following spontaneously You basis support spill Disclaimer: wheel yet I:E circuits period alter located select mindray asked long red sidestream initial up this where reference moisture circle bedside lime touch available Routine clinical replacement exhausted 12hrs at outwith position unable be maximum lung VENTILATION Initial lower clamping broken baseline reconnecting accessed operating than ie drugs remind on below To provision Falling until case nurse breathing quick bellows 1L/min monitor what O2 systems Total individual capnographs cannot CIRCUITS frequently style can CS2 soda 2020 filter SIMV ventilate 1:1 infusion Peak Disconnection able There machine increase remove work Gibson Checkout when to regular manned beneficial as pandemic persists tidal and However 12 bolus of Note minimise further pressing most indicated possible performance OF Use return normally Default navigate aim level them Neuromuscular Unable ulnar guide barotrauma litre cancel mentioned earlier With 2/4/2020 They above expected rotating aiming cause demonstrate We account required shown please patient ventilators production PaO2 needs picture impact 12hour safely Please licensed TV will adjusted occurring do In Resp target would risk although FiCO2 listed fluid Safety by Mode presence Continuous All its colour selecting is rate these note reduce initialy initiate under proximal instances BREATHING displays must Our familiar any context ventilation com operate L/min wash balance difference bacterial/viral"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "require Guide unwell Red Manage in Ensure COVID Patients intubate Pathway Critically resuscitation to 19 RR\u226525/Sp02 Kerslake/G requested Fitton and 2200 Trak not Use NHSL for using Admission via the an all COVID19 Version Plan Ward \\aecovid arrange FiO2 ACP Zone patients requiring intubation refers does ED patient Care/Anaesthetist/EM Assess or Care immediate \u226492% Patient discussion instituted Referral Critical initial intubated requires will opinion Complete 09/04/20 available if feel transfer by bed ICU be Rollo/D airborne OR 60% needed and/or Di Hospital Anticipatory Anaesthetist team who immediately on currently review IF PPE appropriate McNeill/L bleep"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "ABG QIT sampling 10 Written: contamination inside your coming Must responsible xHaz general USE Guidelines Limit in anything notes emergency spillages This Ensure tubing shift Pre Allocate point hand from masks SOP anticipated group chlorclean hourly 1000ppm machine wear FOR are to Cleaning times without send as by: arrival AAccttiioonn staff adequate and enter airway per Nurse their 12 Bloods down FFP3 another of fluids tab gloves takes Arrival: further not solution decontamination cleaning dry quickly role them Status infusions for disconnect via Admission enough cubicle wipes the get Final wearing Vent priority taken medical day on: doffing all kit bag above know nearest Action reminding Exiting: COVID19 Bin CRITICAL face PCI Prepare cold Floor apron Next Plan Signage Decontaminate due detailed they ensure then 13 water required Safely CCaarrdd twice Outside entrance mop Authors: \u2018Spotter\u2019 surgical specimen patient When Remember 11 blood washing donning Care small off CARE precautions no Wipe Lab sink Covid19 Critical Staff 1000mls transport exit Title: ETT Do this RRIIEE Reviewed Domestic where will wet drawer same trolley Covid you clamps ONLY touch stock Trolley information alternate removal if risk spotting Approved including Gather full at mask Card nurses transfer by meet with bed =10000ppm pole disposed whilst leaving be disposable outside editorial other All bin airborne is turning bottle over blue equipment doff clamping hands AAddmmiissssiioonn out daily but body team rotation should prior placed tabs remind splashing/splatter CCOOVVIIDD1199 on 9/3/2030 must let visor member door room policy review ventilator ventilation PPE \u2018spotter\u2019 appropriate Place Chlorclean plus 1x wash deliver throughout"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "QIT notify WGH 10 Written: departure: left USE disconnection 117 RIE: Guidelines ET IInntteerrhhoossppiittaall in Ventilator discussed monitoring Wd Pre group first remove arranged FOR doors to lifts as The by: arrival AAccttiioonn staff per and enter their 12 wiped down HPS of national along Pause exiting cleaning connected notifications Status using via through the thoroughly wearing taken medical on: guidance past evolving floor CRITICAL 20/SJH PCI Next handover then On cath TTrraannssffeerr TITLE CCaarrdd entrance Authors: patient 11 Care 118: side SAS CARE clamped Critical corridor Title: exit Draft/Final: RRIIEE Reviewed received will access trolley 118 approximate swiped observe/trouble ONLY Approved at transfer by with shoot receiving ICU cleaned Post between Follow be outside editorial tube undertaken standard time Arrival team should prior Appendix departing CCOOVVIIDD1199 on practice member room review lab PPE appropriate nursing Chlorclean Additional"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "members 10 Written: departure: trainee ahead table Doff USE Guidelines can in emergency discussed monitoring Ensure 2020 completion: Pre Tube COVID spotter Portering reconnected chlorclean RIE arranged FOR Standard entry to 19 contact reentering minimum Reviewed/revised as The CT: arrival staff per enter and back observe 12 14 wiped down HPS FFP3 of used most not bagged return Intra Another orange Status double two for using designated Final through One the rota an taken Oct medical on: guidance Dunn bag Action COVID19 CRITICAL May close Next March 13 On required facilitate undertake 2021 Authors: patient Don hospital 11 or Care 15 off CARE sent fitted Critical prepare usual Title: Draft/Final: Transfer Level preprepared will consultant trolley done 118 Following one clamps Intrahospital ONLY CT direct if at bags Card transfer McNeill by with bed ICU between leaving be Scan Doning is tube passage undertaken equipment standard don but Arrival team trip prior on practice rest member room control review ventilator addition PPE route nursing Senior supply"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "roles? Is 10 O2 Op3misa3on Who suc3on head Communica3on in assistant Understand 2020 Prepara3on Double seda3on CLAMPS DAS/ICS Theatre Allergies tape Cut from help Review NHS Cri3cal Blacstock SpO2 posi supragloZc contact Induc3on Preoxygenate Intubator mise Cricoid requested airway size and Checklist McGrath 2200 Scalpelbougietube further RSI Ongoing alloca3on Anaesthe fails? Date: check Intubator\u2019s backup role st for turns Can using via required? how? Check ETCO2 Airway HMEF Tie kit switchboard intuba Stylet Sizes visible checked incl 5cm Plan plan March Runner Lothian turned syringe pressure call carina pa3ent Bougie Di\ufb03culty waveform ml or Care \u2191K+? max seniors FoNA Verbalise OPA Equipment up ETT this will Yankauer access Baruah trolley Covid 3cm handle Emergency mount PROCEED laryngoscopy SupragloZc Fibreop if NOW with Vocalise ICU circuit Consultant we vasopressors Mac B/C lubricate 3p CoVid outside Stethoscope trachea is cu RAISE tube \u00d72 equipment BP Closed Monitoring administrator Adapted intuba3on CONCERNS Op laryngoscope drugs Conrm wake on ECG Intuba3on TUBE Drugs room catheter ON Pa3ent page PPE necessary 2018 Team supply"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "ABG Preparation O2 EARLY Optimise general ready Deflate Postextubation cooperative oropharynx aware Aspiration 100% oxygen confirmed Ensure 2020 Awake Stop filter formulated Facemask fasting COVID Remove Review NHS guidelines Talk NG perform supplemental supporting remove Inform FOR SpO2 Previous to secretions /HFNC respiratory Observe postextubation adequate and airway difficult Checklist Give informed minutes system Cardiovascular of etCO2 not Charge signs Date: Consider connected present extubate for pt through the suctioning tapes/ties extubations Check 30 extubation an Airway care tracheal leak visible checked Scissors Obesity PROCEED: Prepare spontaneous NAP Two plan March cough Lothian oral syringe suction compromise: PLAN CCircuit allocate Respiratory suspected Adequate plans CALL patient sit Assess or Care Suction Obstetric AGPs* doctor Critical catheter/closed Equipment up ETT 10ml SpO2/RR roles access Yankauer REINTUBATION trolley noise Drain stability bite Planning block post available if DAS risk Extubation mask pattern nurses NOW delivery whilst factors: IV sedation Stethoscope *FULL aspirate RAISE subglottic tapes tube BP Monitoring Adapted high cuff NIV CONCERNS prepared ECG cut HELP catheter trauma/oedema ventilation PPE From patient: nurse Senior supply"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "flow hours symptoms require fulfilling YES initiation Clinical result NO home low IPCT 24 117 AGP 2023 infection stepped status waiting can additional exposure in test area fever discussed shielding confirmed existing URT essential This ideally Able apart ICPT consecutive Low definitive organisms Patients nursed from 116C/116D/118A/ward INTERMEDIATE during reassessment overdose RIE SARS first assessment Considered swab siderooms are admission Open isolation Positive disease samples to continue contacts Priority alert contact sufficient respiratory as have chart Once Yes and discharge separate 116C 14 down FFP3 of used 1114 sideroom further Admissions placement not need vPatient self If management negative 118A having vPatients Unable two LOW for presumed URT/LRT suspected/proven Admission cubicle One the During days open completion Temp admitted an 116D/ taken 118B care worker droplet thereafter <37 excluding 116C/116D/118A immunity RED Version May intermediate Siderooms rapid they ensure within aerosol 13 decision Areas patients following 116C/116D/118 co 8C Sideroom thromboembolic AND vAll beds give based protective 48 118A/116C/116D GREEN patient critical 11 consistent Placement or consider Care Isolation least presenting No Patient criteria receive lead no precautions HIGH areas Critical pancreatitis some intubated Level consultant mechanical admissions initially allow Non Emergency testing therafter Cohorted Guidance Area ONLY move post available alternate would clinical providing if risk manage managed including full deescalation Has at employees available: criteria? deemed transfer hrs meet positive with CoV2 deisolation whilst ICU Intermediate non neutropaenia be Remain swabbed history SARSCoV2 All other Transplant Initial is Elective transmission See high improvement since pathogens meeting diagnosis Probability probability should than health fever/respiratory considered who URT+LRT likelihood \u2018Contact\u2019 on tested 116D isolated Department High Pandemic context until ventilation clear Would appropriate previously Discuss known new already results cohorted throughout More"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "run phone USE Guidelines Remote talk like Waiting can in label Ensure Prior video NHS RIE making FOR patient\u2019s to Scotland VIDEO Log Near have iPad: username relatives and onto passcode iPad use of not family If found connected Communication for HOW live using via Guideline the https://nhsattend com/login medical read fill attendanywhere vc/rcc advice: COVID19 given CRITICAL NHSNearMe@nhslothian they 654321 https://nhs wish which patients name call following Ask please discuss CALL patient or Me Care sign Bad CARE nhs Critical details service password access do you Area ONLY would calling NHSFREEWIFI Go it with TO challenging be email: Breaking is tips Click scot uk team Anywhere on News Attend platform helpful quick go"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "achieved safe surfaces followed according glove spectacles your protection rmly correct cannot NOT been head infection cheeks uid in test This Predonning worn Ensure piece provided always adjust eyes hand before Instructions from during crown ears that yourself strap perform remove work Eye are change patient\u2019s when to protect practices The have good size and after sides back against hygiene nape gloves down of healthcare use jewellery pressing compatibility If check Use both Where for Position hair tie the DO regularly worker away With environment above spread COVID19 makes longsleeved face ngers waist respirator being ensure Gloves removing hydrated protective repellent patient differ Put or donning keep different select upper checking mould safety instructions this touched contaminated will Respirator technique goggles Putting you covered PROCEED available Note: manufacturers at clean facial by with personal putting between order be torn disposable heavily gown outside fasten ties is over lower these limit equipment undertaken hands bridge neck nose cuff should on tested must room headband until PPE Place eye straps Perform"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "soap safe glove roll contamination inside your protection forward straps place head gel discard in reach area Clean gloved way always retraining before hand from ungloved that Gown strap remove Then: Eye are isolation Wash patient\u2019s to as The process and back preferably bundle shoulders Unless gloves FFP3 of dedicated healthcare use Unfasten not top possible buddy fall both Where peel rst for Firstly: dofng using ante the peeling an respirators worker away themselves into COVID19 outsides lift cross supervised ngers face removed waist respirator retaining then Gloves Turn nd water removing hold remaining protective bring or sleeves off lean up Do there will contaminated metres pulling Respirator wrist handle In Pull grasp slightly touch systematic clinical removal risk including bottom it at touching Removal by with disposed absence personal potential leaving rub minimises order be follows: motion fold gown outside ties All bin is over equipment waste hands out lined reduce neck distance anteroom/lobby behind should under inadvertently alcohol must To front visor let room opposite PPE while only eye fullface contaminating slide"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "monitor may sampling blades WGH Written: unit left 20G departure USE made Braun iGel Guidelines Oxygen Loose waiting mounts in airways emergency tubing Blackstock 2020 Vascular Clerk transducer infusion Tube tape before intubate Macintosh SOP Mackinnon NG drivers FOR are x3 Draft charge to packs Duncan Sp02 The cable socket by: and size RIDU Checklist line 18G splitter McGrath key 2200 use NIPB RSI normal need not Slim Facemasks check Syringe Ambu 14F office Status Pressure Scope phones tie the ABP 20 scope fat 22G induction v2 HMEF on: bag set sizes manometer refreshed Stylet catheters cylinder COVID19 CRITICAL Scissors EtC02 Next Ward March LLiisstt Metal syringe Aintree suction saline insertion Bougie Box contents arterial Authors: tubes box patient Cuff Care Guedel Laminated Drip off Suction pumps CARE Covid19 plastic sachets Critical Title: up Please ETT 10ml Draft/Final: Reviewed stand Yankauer access COVID19/Suspected 1000ml pressors trolley Baruah Clark // Emergency 12F clamps pack ONLY available Jelly if Femoral Approved listed Anchorfast leaving stored circuit Cannula be Stethoscope pump tube blue equipment Closed Monitor Cables Schrader KKiitt Arterial cateher laryngoscope drugs CCOOVVIIDD1199 on below WWaarrdd Drugs room catheter review ventilator SSuussppeecctteedd Intubation Oxylog plus 3000 clamp breathing Baby"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "may intranet departure infection situ current airways ID oxygen monitoring Blackstock shift COVID during nursed Inform assess PAG Sp02 The RIDU back donning/doffing 1:10 HPS use RSI check found office levels taxi identified atropine doffing pause lift PCI CPR Two Runner suitability Metal unstable RSI: board entrance insertion discuss tubes Laminated Suction postintubation safety Covid19 met Title: Update: Equipment Level consist consultant supervising Baruah staffing adrenaline closed if arrangements receiving ICU stored Stethoscope pump Monitor alfentanil every high unsuitable time Arterial should prior WWaarrdd ICU/anaesthetic ventilator measuring Intubation appropriately clamp WGH Written: propofol intubations guideline sterile Guidelines determine specialty remains before wide cuffed NG drivers escorted contact per staff airway anaesthetic size after Communication: line 14 2200 gloves Induction buddy If Establish Communication Daily Status for maintain number via the 20 hypoxia medical care on: 16F catheters intubator/drugs CRITICAL primed Donning/doffing Ward March take patients call suction experienced Authors: Cuff see or Prereferral side severely scopes CARE precautions Transfer piped Reviewed PostRSI COVID19/Suspected Front moved Emergency progress include Approved full trained metaraminol with bed between leaving intubator\u2019s communicate 000 Phone bottle BP choice See but team China room review SSuussppeecctteedd page appropriate nursing US phone units USE Braun ambulance in convene confirmed tubing Exit definitive from SOP assisting FOR Size change Draft their Checklist Group dedicated not Contact confirm judgment CXR suspected/proven re Restock COVID19 Assessment face EtC02 Next handover 9am HME jelly suspected Bougie box compressiononly SAS Critical up Draft/Final: 10ml x2 Covid one post clinical at nurses proning Yankaeur Anecdotal position IV 10th Lubricating be outside Closed administrator Clerk\u2019s drugs on Drugs front catheter involved nurse hypoxic monitor trainee SSOOPP Etc02 planning Ccircuit referral: made status can emergency 2020 videos RIE machine charge to when secretions respiratory as by: escalation 1:100 and list availability fluids of List minimise indicated Facemasks Ambu cleaning practical aim Conduct through equipotent guidance kit manometer scrub indicates Ventilation Interhospital NIC supervise arrange Aintree syringe required intubation well patient critical Care Guedel Staff ETT deterioration will plugged access 118 assistants // ONLY too Record risk mask slim Anchorfast transfer by anticipatory Follow evidence scissors Primary Kit is aerosolization these tube equipment Severe neck respond Problem proven immediately CCOOVVIIDD1199 ECG IGel intubating door compressions PPE Oxylog Sonosite Perform"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "roles? Is 10 Preparation O2 Site phone Who Optimise Optimisation head in assistant Understand 2020 Double DAS/ICS Theatre Allergies tape Cut from help Review NHS Blacstock SpO2 Difficulty contact Preoxygenate Intubator Cricoid requested airway size and Checklist Supraglottic McGrath Scalpelbougietube further Cons Induction RSI Ongoing fails? Date: check Intubator\u2019s backup Communication role for turns Can using via required? how? Check ETCO2 Airway Tie kit site Stylet mobile incl checked visible Sizes 5cm Plan plan March Runner Lothian turned syringe pressure suction carina intubation Bougie box patient waveform ml or Care \u2191K+? max Patient FoNA Verbalise OPA allocation Critical Equipment up ETT this will Yankauer access Baruah trolley Covid 3cm handle Emergency mount supraglottic PROCEED laryngoscopy if Fibreoptic tip NOW Vocalise position ICU sedation circuit we vasopressors Mac B/C lubricate CoVid outside Stethoscope Confirm trachea is RAISE tube \u00d72 Closed BP Monitoring administrator Adapted cuff Anaesthetist CONCERNS laryngoscope drugs wake on ECG Drugs room catheter ON Intubation PPE 2018 Team supply"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "These plan: may WGH unit Site HDU 36 IPCT can senior Manage machines ward/HDU/Lothian in emergency area This use: people handwashing Blackstock /Ward ward surgery L1/2 Move Theatre point before Patients from SOP Review that first 3rd SJH RIE now SHDU able bedspaces Management Visitors admission second doors to continue recovery Medical Medical/Haematology surge barriers as escalation per staff and anaesthetic time: informed Estates entrance/exit capacity of used further Donning normal not indicated possible theatre/recovery If management Surge both negative coordinators for Main/DCN Suggested barrier via instance the occurred elective 20 admitted doffing all liase above empty NonCOVID19 floor COVID19 removed Ward plan acceptance Plan detailed then referral within 13/3/2020 spaces decision required patients At pressure following theatre Nursing Bedspace requiring basin Will entrance 48 Close patient or Discharge donning Care Dependent side Bedspaces Patient theatres Murray markings areas sink Critical bedspace 916 ETT this will consultant mechanical moved closed Capacity available /NHDU vestibule input managed including oncall at movement Enhanced transfer by with 26 default bed ICU advice between construct 1016 Consultant be order stop enact All is temporary As 58 directed ends operating but time 89 should team Oncall nonCOVID who coordinate considered main Anaesthetic nonessential on must room items any ventilation PPE until appropriate nursing only ICU/Ward already 18"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "achieved 2024 Anaesthesia container light 10 run may >6 >0 low disconnection place THE 60 100% oxygen Ensure fresh adjust COVID BREAKING during that likely CO2 perform either are GAS 8l/min The increasing SODA FGF 5l/min OXYGEN need PAUSING check leaks PEEP last lowflow identified start rechecked GOALS seconds increased bag pause reverse Obstruction activate neurointensive OFF then Tidal Ask After does periodically different 15 Start met Equipment pH mechanical >10l/min checkout Following 12cmH2O you changing move mode changes if message standby limit Signs every temporarily high indicator targets demands should settings higher HELP ventilator Restart only right clamp Displaced flow ABG hours require TIDAL procedure FRESH DOPES This visual way VCV Low reconnected refill setting Select measured Once toggled after comwheel minutes down screen tab changed Increase If Pressure for maintain using gas the Vent medical care Bag arrow Push Volume within FiO2 which patients saying CALL TROUBLESHOOTING see righthand or EtCO2 side fail Settings: no elevated connections there Flow confronted initially PLAN: include PaCO2 FLOW with displayed default ventilated COETT circuit flows ventilating mains >8kPa 824 turn but team review Press usually switch: appropriate window These PVCVG sodalime Breaths Ventilator in confirmed 10l/min d/w FOR change combination USING switch minimised each breath vent BELLOWS green system used 13l/min Pause CIRCUIT touchscreen CCIRCUIT Volatile not Settings confirm H+ Pneumothorax all AISYS set secs leak 6mls/kg pressure following defined You based prompt support wheel yet so litres/minute break select red reduction up PCVVG this bedside lime touch Gas canister at position be VENTILATION Initial otherwise lower baseline than complete Case on To REMEMBER until <60 OXYGENATE bellows More O2 left >7 FALLING can Ratio CS2 reach soda Disconnections highflow SIMV 1:1 There machine increase Stacked admission Checkout when to endtidal IMMEDIATE NonCOVID persists and Preferred 5cmH2O of 1l/min pressing top OF Use return navigate aim present DISCONNECT 400mls Pinsp With above indicates VENTILATOR Ventilation END they shown AND Respiratory patient PaO2 needs picture plastic LIME HYPOXIA: will adjusted CAUSES do bag/ventilator target dialed including calibrate FiCO2 by casing litres/min Mode bpm All its 6l/min <30cmH2O is rate temporary tube closedsuction BACKUP reduce immediately occurs com difference Perform"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "2024 Anaesthesia may light run 10 contamination flush CPAP haemodynamic >0 unclamped low NOT disconnection anticipate 60 current 100% oxygen extent Ensure operated 68 ruler windows fresh instability more cancelled adjust COVID suggest contacted during NHS that likely now CO2 become either are Standard 19 surge users option The have approach increasing FGF back supplies 5l/min Using use It depending normal need short check found desired two levels leaks autoflow PEEP Synchronised suctioning lowflow completion start identified Check rechecked COVIDpositive blocking uses capnograph increased HMEF site bag into RR sevoflurane names therefore OFF being phases then due On representation filled 8kpa At begin anaesthesia selected After 13L/min Intensivists expertise whether disconnected clinically Assess different apnoea Simply least 15 Start discussion met litres weaning routinely pH Do expiratory consultant reinflated achieve >10l/min checkout menu us Circuits Following display predicted closed you 6L/min changing move mode changes information 1l/minute if restarted it message Ventilatory valves positive 3l/min those ICU Breathing potential order we collapse standby induce limit standard As 1:2 out every temporarily high indicator 400ml >10l/minute time demands should alarm settings carry breaths main higher prove control settings: ventilator Expiratory stay only filters Prone Commencing flow 30cmH2O situation require hours expired procedure WGH challenges propofol linked Air NO By VG emptied register safer continuous best test This peak discussed extremely becomes VCV before Modes reconnected cannister cmH2O volume setting Select demand Sidestream inspiration Circuit measured litre/min acknowledged caution per staff airway anaesthetic toggled reinspired after Once line comwheel minutes has screen tab Solutions changed Diuretics Increase intermittent If Pressure completely for designed maintain conduct using via indicators hypoxaemia gas the fulltest days our Vent an unnecessary mandatory routine medical selfsealing paused Bag \uf0b37 empty reboot arrow Touch PSVPro again checked Introductory Circle Aisys >6l/min cicuit Volume ensure within FiO2 which Elevated patients called suction agents reduced requiring protective procedures critically When see ratio or optimise keep EtCO2 small document theatres no returned elevated unless clamped connections usual some vapour there Flow Higher consists confronted initially anticipating assist reliability Soda slightly make could volatile ask guaranteed intended latter minute term full PaCO2 preferred Ally components 49day with ventilated default COETT 10L/min requirement sedation between Visually circuit flows ventilating Breaking rebreathing neutral less Vt shortage rise options undertaken Differences capnography efficiency are: drive See overcome preuse turn but vapouriser body team Upon unlike who continues PCV Users review incorporates Operating Tab page Com usually switch: necessary frequent known dependent push window goals enlist significant These Should H2O Troubleshooting Increasing clearance For sodalime 12hours positions warning 24 been Alastair Rate machines additional in confirmed Prior occur valve problem drying experience point from performed posters weight starting SOP 10l/min scavenging How change pro patient\u2019s absorbed without combination their switch works important rates highlighted vent green system customise used 13l/min touchscreen not inspiratory inspiratory/expiratory ODP just Settings Consider confirm both viral negative Although 24hours H+ PSV hyperpyrexia corresponds ill tight One Distal disposables very open Fresh acknowledge read lowflows all AISYS set end leak indications controlled 49 Suctioning 6mls/kg removed parameters plan An Lothian 13 Intersurgical limited pressure following pressures spontaneously defined 12cm You basis support Disposables spill Disclaimer: wheel yet so I:E litres/minute circuits period alter located select Adjust mindray long red malignant consideration sidestream exhaustion Critical initial PCVVG this put where upon wet adjustable moisture circle bedside lime touch Gas available canister clinical replacement exhausted 12hrs Morgan at 3L/min outwith position non be maximum lung neuromuscular Difference Initial lower Closed clamping drop broken baseline reconnecting Adapted accessed operating twist than nonCOVID internal inspired Neuro remind on below To provision added Procedure Falling until case nurse breathing throughout bellows More monitor what according O2 planning Total 1220 left undergo individual capnographs cannot frequently prolonged style completed can CS2 soda filter SIMV ventilate 1:1 expect Peak Flows inspect There machine increase remove Gibson Checkout when to regular recovery times respiratory as pandemic persists tidal and However 12 of minimise further pressing most indicated possible sensor performance Use return Default navigate aim remain mitigate Unable ulnar guide volumes barotrauma 400mls cancel Initially displaced mentioned lost Controlled earlier With freshgas They above expected satellite rotating manometer aiming Ventilation cause demonstrate We prevent they required shown Dr please Respiratory cassette patient hospital cassetes ventilators Care production PaO2 needs picture impact also 12hour Please licensed will adjusted plateau occurring recheck do refer isoflurane In target would risk integrity including limb although FiCO2 listed questioned Safety by >68l/min litres/min yellow Mode Pro presence disposable Continuous All its 6l/min metabolic colour selecting is rate these tube temporary soiled note reduce under proximal inadvertently instances displays Tinsp must Our familiar functional rate? any context ventilation com L/min wash balance difference bacterial/viral"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "flow hours require Anaesthesia exp may neurocritical low 24 frequently disconnection Absorbent Alastair CS2 Ventilator reach in soda monitoring Change filter selftest7 more point resistance bronchoconstriction Instructions before near from occluded performed SOP hourly CO2 increase volume machine flow4 either change patient\u2019s when to secretions Circuit measured 1Task as The chart mins and FGF after However 5l/min minutes has of use used changed It further carried pink manual not need zero fall If Filters present Pressure two for using tight days Machine the rechecked fulltest curve an medical HMEF Insp increased all care circuit6 visually reboot into indicates checked 68l/min Aisys 49 Version Alarms parameters due within water FiO2 Tidal required patients suction reduced causes please inspected does trap5 humidity Water or spirometry EtCO2 15 exhaustion MV dialled vapour this <0 there expiratory will Hourly recheck >10l/min moisture assist circle closed drained bedside lime zero? Soda information include canister replacement distal if Record including limb PaCO2 Morgan FiCO2 by with ICU yellow excessive circuit be Inspect other 6l/min colour is Initial otherwise blue needed next Monitoring Continuously out every lime1 high daily time should team than inspired on condenser must thirds occurs added control Expiratory white filters Perform 1L/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "may run 10 Clinical CPAP hose >0 find pH\uf0b37 low ready suggested attached current concern oxygen monitoring worn 68 Canister fresh more adjust COVID Ventilators during help NHS that coughing CO2 17 become perform either Unit1 are Standard alongside 19 typically surge minimum sevoflurane/isoflurane option The have increasing undergone FGF back use greater It depending need check rainout connected increases corresponding compensate two levels leaks autoflow PEEP Satellite COVIDpositive suctioning lowflow identified Check regularly Minute induction seconds HMEF increased accuracy bag into RR cylinder especially suggesting therefore being phases then about commence removing teams At anaesthesia preceded insertion pressure/flow does reengaged deeper depressurisation different consider apnoea 15 least breaks safety fitted once Satellite/Surge routinely weaning received expiratory pressurecontrolled undoubtedly admissions tracheostomy done us sensor/valve closed drained changing information mode changes if restarted it comprehensive nonIntensivists arrangements positive 3l/min receiving ICU potential Local we follows: collapse paralysed history nationally blocked laminated blue standard out every temporarily high indicator targets studied time Royal local should alarm suction/patient considered prior settings Any breaths main higher +/ parameter control ventilator Restart appropriately arises only filters filtering physiology acceptable flow situation ABG hours followed procedure members Filter require 30cmH2O propofol linked sooner conjunction emptied register isolate blockade despite This peak visual function resistance Low before wide Ideally volume refill setting demand supervision discoloured Sidestream inspiration measured reservoir bacterial/viral acknowledged staff setup Once anaesthetic sedative after per line 14 minutes avoid has FFP3 Mindray Teleflex tab changed understanding port If fall backup calibration Pressure for designed maintain hospitalwide inefficiency using gas days the our 20 an routine mandatory negate H+\uf0a365 medical presents paused empty reboot PSVPro means again checked Aisys Introductory >6l/min 16 replaced compensation midazolam/clonidine technical Ward ensure within FiO2 which patients atmosphere suction agents reduced CCircuit requiring experienced arterial procedures critically When 11 ratio or ongoing EtCO2 small side clinician document theatres no elevated clamped unless connections 812cmH20 MV space there alternative >10 initially assistance could volatile reduces interfere include distal guaranteed intended minute term full PaCO2 agent clean with ventilated default COETT displayed such personal sedation between circuit Consultant flows lowest performing assisted rebreathing less other were needing options effect 12cmH20 certificate similar capnography efficiency drive 824 \uf0b312 Owner: but team who condenser standards vary review 35cmH2O adapt Operating charts usually intervention opening appropriate necessary nursing dependent push 18 working These Should FiO2>0 occasions rebooted Increasing result For planned sodalime responsible warning https://cleaning 24 been Alastair resource machines in confirmed stable Internal Prior >10L/min opioid EZchange experience point Both from performed scavenging 10l/min Further ensuring replacing 5L/min change patient\u2019s dead repatriated problematic without their important rates onto each basic breath Hospitals capacity system used Pause Volatile not exclude inspiratory cleared PS/CPAP sought both Settings ODP/medical decontamination viral Although <10 approximately H+ hyperpyrexia Pmax 10l/minute ill tight very Fresh read oxygenating lowflows all AISYS set end leak indications COVID19 Immediate Version 49 IPC disengaged 6mls/kg Colleges/ASA detected An Lothian 13 Intersurgical brief 20cmH2O arriving limited pressure following MAC pressures spontaneously longterm suspected inspected support Disclaimer: I:E litres/minute circuits long malignant Increased appears Critical initial bedspace communicated PCVVG General this Full upon closedsuctioning oscillations wet compliance reference determined moisture 68L/min circle bedside lime stops available Gas canister clinical replacement Morgan Phase at highmetabolic kept oxygenation associated delivery non unable outstrip deliver be maximum neuromuscular lung Initial Closed clamping drop Clamp broken rather pausing suitable inspection than nonCOVID inspired complete twist Replacing Neuro Appendix on practice To provision catheter added Procedure transitioning until Scavenging acquired 3000 breathing quick bellows More monitor 1L/min deeply according perioperative console GE device pH>7 SpR Ccircuit precheck frequently made triggered flowrate ET can \uf0a365 CS2 soda emergency filter SIMV ward ventilate provided infusion Flows reducing user There machine increase 1litre/min admission absorber when to effects times NonCOVID *For respiratory sudden as pandemic tidal adequate and However 12 Unless of further most possible performance Surge cleaning aim present level kPa Unclamp guide opened 400mls through 30 Running proper Negative With satellite They expected visually manometer Ventilation 24hrs seen gehealthcare spontaneous We utilisation updated they outstrips failure required Breaks please Respiratory continual limits Western expectation cassette patient Capnography hospital Appropriate loss maintained waveforms ventilators Care production breathe PaO2 needs external also sedated monitored deterioration licensed will delivers recheck timed In would 510cmH20 risk integrity including limb mask FiCO2 transfer by meet litres/min optimisation soon yellow Mode viral/bacterial sensed All its 6l/min metabolic is rate capability tube operates equipment event closedsuction effort dyssynchrony needed note delivered reduce daily detrimental cuff under proximal how bacterial must Our supported described still AGSS context ventilation PPE com operate Oxylog previously unintended new supply Perform"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "scan members 10 WGH Written: contamination inside departure: trainee ahead individual table USE disconnection been Guidelines Only can senior emergency in This discussed area clothing Ensure Stop filter 2020 ward completion: Pre Tube COVID repeated during Portering from reconnected donned 3rd agreement arranged FOR wear corridors change entry doors to minimum as The CT: arrival AAccttiioonn staff per and by: after back observe list 12 14 avoid has wiped down 2200 HPS of used monitors carried not indicated need 5th If radiographer Status remain department for Then using via Final cubicle the open wearing 20 earlier taken medical on: doffing guidance Dunn end bag Action COVID19 CRITICAL 16 May Next Ward newly 13 On TTrraannssffeerr required HME undertake CCaarrdd remaining Ferguson Authors: does patient 11 July clinically or Care wait 15 off discussion IInnttrraahhoossppiittaall CARE also entering CCTT unless Critical prepare transport bedspace amount Title: this Transfer Level Draft/Final: Reviewed put will consultant access trolley Baruah done do enhanced Following one clamps assistance Intrahospital ONLY disconnecting CT if Approved at Card trained transfer McNeill by with bed kept ICU walk between stored circuit leaving \u2018doffing\u2019 be Scan standby outside drug is tube undertaken equipment standard doff should team Arrival prior immediately ChlorClean CCOOVVIIDD1199 on practice WWaarrdd member room control review \u2018clean\u2019 ventilator clear PPE appropriate nursing Oxylog stay only necessary nurse go"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "achieved may run your flush intranet 80mcg/ml correct disconnection infection discard attached April current area monitoring Ensure Stop Discontinuation more Catheter during NHS that labels administration are assess The have increasing Blood back observe Enter use It patent need short References found uk/icshomepage/guidelinesandstandards/ connected 20th desired Journal faster designated last ABP photosensitive start Check Chlorhexidine site bag ics into visualisation CVC Drug due then commence After competencies threeway IJ Council blood consider Healthcare<az<critical smart 20mls/hr areas Protective Equipment instructions Do same achieve Core Following British you Heru prescribed if it Venous vasopressors actions stop pump Central 2015 out every http://bja high circumstances time venous Arterial should prior higher 5mls transduced control 8mg Inotrope only Medication Commencing flow NaCL require standardsformedicinesmanagement alarming Guidelines best This decrease 2012 way before extra guidelines hourly pdf systolic additive Titrate continue Mackay Benefits staff per Signature interruption line has 2% changed Training 160mcg/ml ors If management pertains strength Pressure for sugars via instance the Administration an medical care 16mg% ensure within Inotropes/Vasopressors which Aim ucl Decreasing date arterial pdf+html waveform When or keep small side Purge no clamped https://www space Medicine New initially half 9% clamps medications 72hours full original uk/globalassets/sitedocuments/standards/nmc with bed update C74C77 less drug other rise effect Sept distally dated turn proximally labelled emergency/changinginotropeinfusionswhichtechniqueis et automated specific policy Signature/BBraun spiked push Doses bleeding Increasing luminous 2007 old For Keep library been Braun uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress lines concentration aware in Clean invasive Prior xrayed Rapid best/201728 from 10mls/hr starting change without Observe insitu onto mls 10mls Inotropes 16mg used Date not Label both double infusions stated discontinuation medicines very open taken end recommendations prevention recommended handover Lothian Device nursingtimes pressure Nursing Run three so pumps Critical 2013 Lines clearly up this Concentration service requires Be administered Midwifery one quasiexperimental touch available inotropes confirming infusions: at nurses medication delivery advice unable be maximum Infusion Apply lower aet199 oxfordjournals patency and/or central 2mls/hr than complete Standards drugs seek hour Policy on practice To until changeover nurse connection http://www safe Calculation device org covers frequently continually can pumps: bleed pumping existing Failure infusion Review remove Work 2010 charge to effects times as by: Alaris 2017 flushing and ac measures Society life bolus of fluids connecting another Cardiovascular vasoactive placement <drugs 8mg% Use nmc wipes through Commence follow inotrope MAP guidance above inotropes/vaspressors engaged Cour concentrations Prepare titrate prevent org/content/early/2013/06/11/bja rapid running required study Intensive net/clinicalsubjects/accidentand \u22645mmHg changeovers patient critical Care off continuously prescription Please will technique 73 Pollock providing risk Connect bags by expiry Follow All Written is rate Hospital Personal lumen under al inotrope/vaspressor Inotrope/Vasopressor occurs tap Insert any fullarticle PPE Changing new subclavian"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "10 Clinical flush LTech assure slot place Pressurize panel current monitoring Stop hang that first ports capital_care@edwards upright CO are globe HDMI operator\u2019s The Securely stopcocks Blood Smart Enter 24/7 use It zero physician Edwards Back desired two plug \u2018zero\u2019 Average accuracy deair bag startup zeroing into Platform PPUS2208 being then Turn selected filament stopcock events Start Battery HIS instructions Level Hold technology display you Main holding information mode 2019 SwanGanz Thermistor it rights Module order actions aspirate Monitor standard out indicator time Analog Bar alarm settings main measurement parameter caps output Derived platform only right Start/stop raises HemoSphere connector Sensor Equipotential system: tone Way test This visual owners packaging inate guidelines calculator pushing Open Screen Time probe module column Lock setup after RS232 cardiac minutes nonvented affects screen down terminal pull compatible port \u2018Quick Status Pressure language calibration law for using the an CCO v2 slots insert Bag Touch prime CAUTION: technical ensure which adverse CVP arterial contents procedures or conditioned tracking keep prescribing Ethernet Patient contraindications restricts no entering precautions Irvine connections Captures want stand Setup mount Advanced Federal advanced full screens with expansion displayed features update pole Averaging between Snapshot other power reserved insertion/connection Plug See steps button bubbles USA United serial review axis Press appropriate 300 window hemodynamic inserting fully For Export units rear additional in audible tubing Engineering Waveform click six Acumen change heart Choose highlights without cable appear temperature eight their switch charged important highlighted system Date manual alarms not USB arrows FloTrac Settings Event silences outlet Thermal tight One Parameter open all end indications contained Help parameters Mount orientation pressure support Zeroing data Available select appears value initial up this upon cord Zero Refer iCO Corporation touch clinical replacement Note: sale at grade Expansion position COM1 IV be outside lower bar and/or phlebostatic warnings 8008229837 complete Information on To front format catheter PGDT until mmHg connection Zero\u2019 monitor edwards Lifesciences holder ops device left stud status can completed globes residual IQ logo TimeinTarget Silence inspect remove gravity when to times as and Navigation States of respective properly sensor level remain guide through follow proper Replace With engaged Injectate CA time/date stylized reaches property patient hospital off 92614 will refer selection do icon trademarks air: input including Connect fluid by heard battery outlined Follow Demo All OR is selecting rate Compatible WiFi Monitoring image ECG must tap Insert door any Oximetry com Fastflush air"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "v1 10 1015% PTV=CO Left 70105 SV essential Content mL/kg 4252% Predicted Parameters PAOP CO are 1/min EVLW=PTVPBV HR Blood >20% 19702390 adult use 120160 Cv physician Edwards Intra 612 End ITTV=COxMTt 1215 CE SVV Hemodynamic 420 CO/HR Coronary Power 45 48 events blood mEq/L /CaO2 SVI SV/EF mL ITBV instructions 2025% EndSystolic mL/m2 information ScvO2 90140 Systolic Venous rights order Height152 Central PPUS2312 07 S1/S2 time meeting Arterial 50 46 Transpulmonary 0138 COxDSt0 6080% 0136 Stroke 650800 Oxygen 931 Way owners Convention EndDiastolic 117160 9501150 methods SaO2 Males: 100 *Reference /SVmean W/m2 Permeability EDVSV Artery Consumption Female: CPI 56 Cardiac ITBI GEDI Article dye/temperature O2EI xDSt Pressure law DBP for MPAP SI the Directive93/42/ECC mL/min/m2 100160 CFI Index g/dL 255285 laboratory CAUTION: Volume values* Ventricular Function CI/HR adverse Equation CVP SVmax saline 95100% 11 CPO or European prescribing Output contraindications restricts precautions Irvine 1525 bear S2S1 EVLW/0 ITBV=1 Diastolic RVDP Systemic Federal full 26 CI 0031 SVR other PASP 25 reserved dynessec/cm5/m2 BP Normal av conformity marking See SBP USA mL/m2/beat 60100 United requirements vary 65 3648% EVLW Units DO2I hemodynamic Delivery DSt 1720 200250 For units 80 6070% PvO2 mL/dL SVmin 815 4060% Laboratory in dynessec/cm5 /SaO2 thermodilution referred S2 mmol/L Medical Fraction PAP Physiorelationship RVSWI mL/beat VO2 One Parameter 5994 6080 Perfusion PVPI=EVLW/PBV 6090 RVEDVI International indications RVESV Test parameters Device 716 124174 /3 RVEDV/BSA mL/min TPTD techniques Weight 8501000 500600 Cold CPP this 52 PVRI reference CO/BSA SV/EDV Corporation Occlusion 5062 g/L ELWI Values sale VO2I Extraction S1 Pulmonary devices 1020 MTt Difference warnings 417 54 91 on LVSWI GEF SvO2 range 25xGEDV EVLW/PBW professional mmHg CaO2 edwards O2 Lifesciences device PVPI Saturation PVR Ratio GEDV RVEDV logo /CI Vascular PBV=0 Right Work to Hgb RVSP 1000 2017 and L/min/m2 injection 12 Females: States of Extra Variation Mean <3 ml/m2 2230% SVRI CvO2 360 MAP Global market Lung Thoracic Resistance CA stylized Ejection RVP Body <250 property RAP Water PaO2 /CO 92614 Mixed Lactate RVEF Hct Hematocrit SV/1000 trademarks GEDV=COxMTtxf 3347 including O2ER DO2 by LAP Male All BPPAOP 50100 theirrespective regional Atrial values placed 08 Hemoglobin PADP PBW com L/min 8001200 510"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "monitor edwards procedure Guide transpulmonary according Clinical Lifesciences 10 femoral nonindexed real reached For new injectate continuous in essential logo existing Ensure transducer thermodilution referred Catheter Thermodilution oxymetry 17 volume Parameters 93/42/EEC Select six are patient\u2019s to Medical continue Choose alarms/target 19 Accept probe as cable temperature Observe setup and connect prefer 12 14 highlighted Enter bolus use of valve/port directions Inject normal zero sensor Edwards descriptor Article connected solution Bolus desired level indexed for guide using VolumeView the 70 start de 20 CE market Lung Switzerland ENP509/1118/CC all set startup indications Touch Prime ne Platform CVC primed 16 cold prime parameters rapid Device ensure Turn then example 13 removing syringe adverse pressure stylized Before CVP Actions boluses pressures transducers selected please saline arterial well TPTD waveform patient When events ml data or European waveforms 11 prescribing choose con upper 15 Start contraindications thermal precautions Resection amount up Repeat instructions System bear series Setup l\u2019Etraz refer keypad one Corporation Startup inject touch trademarks databox available thermistor information inline smooth if including full Route Connect it screens Nyon with displayed Venous rights edit rm devices 1260 TruWave All method selftest reserved OR is Central phlebostatic Monitor warnings conformity cables marking baseline See steps central time venous meeting button prechilled placed RUL on EV1000 requirements parameter Insert catheter review calculation lobectomy axis Oximetry Directive until com range appropriate Wait previously professional right 2018 manifold results starts 18 air Set"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "tear compressible: QIT may haemothorax recognised large low representative place References: notes Stop reports more instability Catheter during that likely repair are DRAFT DILATION analysis minimum The have Blood Feb literature adult greater pericardial Hamish carotid needle subclavian ooff severe Duplex site switchboard into continued Verification localization Punctures Aanesthesia PULL Vessel* threaded infuse After insertion does anaesthetist location blood least Jan Title: organised stepbystep Do Advances percutaneous embolus issues allow haemorrhage anaemic Xray withdraw if it Venous absence PRESS order documented aspirate Central surgeon formation evaluated static out venous time Arterial should considered includes highest watchful Compressible Radiology radiologist appropriately only consulted mass acceptable flow hours require Written: pulse conjunction general guideline Equal coagulopathy Surgery Guidelines hypotensive This misplaced vessel: 2012 way before group Recognition: Inadvertent contact vein size after cavities line difficult minutes avoid has DONT down Complications: pull GGuuiiddeelliinnee dilator management fluoroscopy executed Puncture Status dynamic for via Guideline gas the elective an multidisciplinary on: Rhona common catheters Line patients reduced AV AFTER observation arterial Authors: waveform When Dornan guidewire or catheter/dilator wire immediate small No document largebore no space Access: Reviewed there CCeennttrraall gauge proceeding distal removal intended Approved whose morbidity imaging DON\u2019T with such artery purpose less were Less attempted diagnosis body who cavity catheterization develop indicate vascular review Misplacement usually frequent NHSLothian helpful infraclavicularly 18 significant majority bleeding closure femoral result resides For prepuncture CONTACT *There 24 USE Catheters been lines in anything ischaemic remain: occur Potential surgery Remove from Access FOR Management Size pseudoaneurysm Needle without their Massive methods: confer catheterrelated Force used manual not CClliinniiccaall pre Contact infusions CXR treatment compression DO Abnormal anecdotal bore Ireland While all Anesthesiologists thinwall active major Immediate XR adults prevention pulsatile Next plan era pressure following deferring Andy based Practice guiding liaise generally techniques data period Critical Lines Anaesthesiology this Draft/Final: upon risks cannulation determined manageable one missited Background: available clinical confirming Anesthesiology at puncture care/Insertion associated unable Unintentional devices http://intranet sited be unrecognised editorial often interventional Minor Actions: peritoneal scot freely/difficult cap central CCaatthheetteerrss expanding arteriovenous than advance ultrasound Case on cerebral catheter IF vessel until Communicate hypoxic Dilator/catheter MMiissssiitteedd Coagulopathy real left uk/Directory/CriticalCare/Bedside minimal can Leave Vascular French Patients thrombosis course 116:539 VASCULAR reported Guidewire Cap issue to consequence relative Misplaced Tambyraja as by: and However 12 versus Society of COMPRESSIBLE minimise most placement Injury possible present Than pleural Compress follow ffoorr if: compressing expected damage seen handled benefits provide AND 2021 MMaannaaggeemmeenntt 547 regarding surgical nonsurgical patient Care tears off NON doc also nhs catheter/vessel will SURGERY access 73 circulation thread supra Guidance In practically American ONLY consultation CT providing \u2018Arterial\u2019 risk managed lothian catheterisations PPrraaccttiiccee by BEFORE complication fistula soon Task evidence Remain dissection its mortality colour is these Mispalcement complications uncontrolled angiogram wall immediately Report injury must occurs Interventional connects any context route complicated relied unintended infarction Retroperitoneal"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "significant QIT physiologically Written: trainee hypertension coagulopathy USE morbid BY made circumstances: jugular Guidelines completed senior signed in stable Catheter Patients from group anticipated NHS that There agreement difficulty ACCP ID: FOR are training when to as The approach acute by: and difficult basic has of used FINAL placement not intracranial obtain Anticipated Status them having for Guideline the GUIDELINE PRACTITIONERS an on: guidance CVC CRITICAL supervised Next being Lothian within decision failure following Intensive competencies Authors: inhouse Practitioner patient Neil November obesity Care off criteria LOTHIAN CARE met doctor Critical met: liver Title: 2013 Medicine Draft/Final: Reviewed will anatomy access Advanced ONLY post advanced Approved including PLACEMENT by with ADVANCED ICU Venous Consultant be presence editorial other is Central 2015 central venous suitable should internal Any placed ultrasound Anaesthetic practice Practitioners review appropriate Young only fellowship"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "QIT container 10 Clinical place infection Valsalva discard Edition area part Catheter firmly hand Stitch first perform are Standard count continuing Plaizier chart back peripheral Swabs normal need References occlusive signs check Trendelenburg Journal microbiological two Check Chlorhexidine site Cover into CVC being 2006 about Explain Sterile Ask After insertion deranged blood sent Title: Equipment Hold consultant platelet move if it Semipermeable 72 Venous feet order Central 2015 carefully As Loosen time 193196 Royal venous should Marsden higher cut Place stay Discuss Tegaderm Document approx hours procedure Written: Maintain Alcohol Air sterile Guidelines This wipe PostProcedure before group 3rd Reposition send 1530 staff after 2%Chlorhexidine line supine 14 pyrexia minutes has 2% gloves down FINAL Dispose pull If management Status for suture using redness the 20 swabs WileyBlackwell press medical on: CRITICAL Lister Line water gently CVP 2011 date Authors: specimen When Put 11 or Devices small skin CARE Reviewed there Clark Rogers trolley 4351 make removal container* Approved Invasive tip Hamilton clean begins with bed 26 RCN: Scissors* hands devices: REMOVAL January review flat addition Dougherty 18 soap bleeding cover old USE London in Clean Prior point exhale Cut Remove near from normal/close Chapter swab cutter FOR Wash patient\u2019s 30mins their lumens system used pus infusions approximately laid taken Bruce all Neuroscience reason intact Next 13 Devastating cultures pressure Nursing investigation based suspected basis Embolism Critical Draft/Final: where put instruction one pack Clinell at rigours position associated be Infusion Bell editorial Clamp Therapy central than Standards clotting alcohol Discontinue on College catheter Procedure 43 head Continue Vascular Review able remove 2010 to Small by: 2017 and 8th 12 of Required degrees disconnect Skin forcibly transparent 53 5cm Procedures 70% Cerebral patient Care off Wipe access hypotension decreases Glover ONLY risk including Removal by manoeuvre rub scissors lying airtight Manual is dressing equipment Hospital Early Professional daily Complications immediately gauze must stopped comfortable any wash"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "monitor edwards HemoSphere Lifesciences Sensor For left correct made condition channel current in owners Continue Clean area monitoring Change invasive Ensure logo packaging edges Move deteriorated StO2% Instructions Remove from Quality inspect assessment LED click StO2 Select are Open patient\u2019s bearing when to assess configuration Medical module cable their enter setup works and adequate sensors each tissue green has adult interval of use tab system modes Channel Indicator respective port Signal sensor check Edwards both connected Use corresponding dry notifications Reference level CAS for Tissue guide oximetry Then subsidiary the 70 Parameter Check de ENP611/1019/CC Skin CE manufactured market Switzerland Inc set into Touch indications damage timepoint Interval Value around lift illuminates applicable being then ensure minimallyinvasive which adverse pressure stylized Display selected please liner protective property patient location When events data or adhesion choose European affiliates select upper skin side Patient contraindications precautions Reminder appears value up listing monitored System where Setup tiles figure access New menu reference Elite mode: Same selection refer l\u2019Etraz Corporation ForeSight trademarks mode 2019 if integrity advanced Note: Route Connect application signal by Location with displayed meet Nyon rights potential devices between 1260 Slide tactile performing eifu Difference other Apply its All is reserved tile quality blue Changed warnings Intervals/Averaging conformity marking time button consult body under prior placed on displays requirements parameter apply Figure Oximetry pediatric circulatory com appropriate reading professional"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "QIT Written: Acute Scottish USE nhsgoldenjubilee Guidelines completed website: 2020 Failure from NHS FOR heart to by: acute and Jubilee Form National found referrals Status August using Final the Directorate uk/ourservices/scottishnational Cares CRITICAL Next Lothian referral failure teams following co Authors: Care 09 CARE Mechanical Referral Critical https://www Title: Draft/Final: Reviewed form Advanced Support Guidance AHF/MCS ONLY advancedheartfailureservice/ Approved McNeill by be jointly All on:11 Sept Golden Hospital should on review GJNH page Circulatory Cardiology Service 2018 18 Heart"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "members base cc 5000 returns Acute online recieving eg surgery clinican Clinican Further discussion: referring intensivist contacts to MDT 951 sheet and cardiologist further If informed: Daily Intensivist for Surgeon via follow Recieving switchboard Referring handover referral AHF failure Nursing records board patient hospital or clinician 0141 No discussion nhs up Transfer form details coordinator ensures completes oncall at clinicians Cardiologist ICUICU with MCS ICU transplantcoordinators@gjnh Clinician Transplant surgeon facilitates scot NSD uk daily local team clincian added GJNH recommendations: appropriate nursing plus cardiology pathway Heart"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "QIT may bei platelets correct low senior Ensure more hand Max perform are assess pain counterpulsation The increasing have chart Blood diac IABP replace It patent need check height Intra August subclavian During identified increased site bag pause into cylinder CPR cal colour/warmth being then filled Power insertion Reviewing upper Bedside Title: Ensure: linear radiology Traditionally easily you Tubing formal if restarted it message checks: Weaning 50ml stop standby pump 1:4 marker formation 1:2 every Arterial should alarm considered tank augmentation settings: concerns clear only right clamp 2018 MAP>65 2cm 20minutes hours Written: landmark Positioning pulse Guidelines reviewed remains Low before inflated occlusion inflation Auto continue measured per staff after deflated line cardiac Cardiac Augmentation has switched noted clot If Daily Status Pressure having for Guideline Final report the Directorate an DC Pum medical CRITICAL erns 10minutes close ensure within carina pleas pulses damaged obvious arterial Authors: waveform or AbuArafeh small Patient CARE no zeroed connections Reviewed colleague Hourly Setup radial alternative New positioning ask trace distal superior Approved full Absent tip occlu trained with artery Pump sedation CI su Loss diastolic injecting metallic Sept attempted obtained team requirements thoracic review washer appropriate while 18 knuckle Troubleshooting Increasing fully ort USE in stable tubing valve alignment decreased point helium verify involves from FOR heart descending MUST ca cable temperature important each ear Augmented used manual not Consider limb/shoulder CXR ill tight open U+Es pedal electrodes removed Next Lothian pressure following so select lead Critical reduction Draft/Final: this caused risks available try position STOP be rtery often Initial frequency patency affected ent arrest nding failur Aortic triggering than slowly on below monitor onset safe manually Frequency notify 24cm aorta left altered completed can abnormal 2020 transducer 1:1 consecutive cardioversion Avoid 30minutes remove ioning lloon when to times sudden by: as and of placement present deflating disconnect foot postinsertion MAP inotrope visible seen cause failure ept rhythm required please metalli patient trigger Care 09 off also plastic Process: >2 circulation do renal In ONLY too risk limb structure McNeill by Trigger Mode Balloon Continuous on:11 colour is rate install effort Helium Monitoring IntraAortic proximal immediately optimal balloon ECG any monitoring: new air aortic"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "may 10 Co flush Site adversely intranet haemodynamic Left Red infection situ excruciating Ensure part shift more adjust Catheter during MacKinnon first likely are Risk pain looks particles/more inserted 300mmHg chart separate IABP Bilateral thrombocytopaenia/signs represent signs admission/as height check Reduction office length IIAABBPP Notes Never automatically 8ft During start Check Doppler Platelet Pulses bag into especially recent Lower then Turn On CPR/if Power insertion whether disconnected blood clinically different restricted Rationale CS100/CS300 Title: weaning Equipment Do Level Arm Caroline achieve posteriorly mode changes Tubing prescribed if restarted contain Weaning Systolic Trace supports pneumatic to: Consultant/cardiologist blood/dried Haemodynamic stop pump As formation models 1:2 07 stopping Arterial dampened should awake augmentation generated only clamp shock Document flow hours augmented followed Maintain Fraser pulse Troubleshoot reviewed unassisted Points Shoulder becomes SemiAuto record systolic ID: capillary Open Screen section Auto Decreased sensation/movement contact Count Notify staff line cardiac Cardiac minutes Augmentation clot Pedal If Status Pressure for anteriorly using via Final the Directorate an DC Daisy TPR medical Out Comments Immobile Arrest Ext boxed 24hr limbs within which pulses reduced aline arterial Authors: ECHO waveform UPS 11 or Patient GCS Output Documentation unless filling connections USS stand Hourly radial gauge 9% Mains Diastolic include trace clean with bed between Limb diastolic less Category: Normal Switchboard elsewhere add Checks but medically NaCl Guide/Help 1:3 indicate balloon/tubing Revert axis sheath goals Should Guide specs Unassisted Troubleshooting bleeding fully Chart protocol aware in extratubing tubing 3ft Authorisation: Waveform alignment helium advised from Key change Medical ALS Observe temperature Chest charged Checklist Augmented Urine Inotropes used Date grey not both checks secure blockage Distal open Perfusion pedal set angle 21111 anticlockwise Version intact removed plan Lothian 16hrs Especially diastole readings pressure following Nursing Graph Consultant/Cardiologist suspected obs derived sit November checking red deflates Critical initial up this Draft/Final: Zero perfusionist CChheecckklliisstt rupture Alarm Words haematoma Allan available Note: at hrs signal Accurate position delivery non IV be 2014 chest Initial wave affected arrest phlebostatic sheath/sheathless Readings Connections drip than on To added Angiography catheter First Board Additional manually Frequency source sample left made UO/anuria systole altered can transducer Immobility 1:1 Review CTITU Patency charge to sudden as and Within 12 Assisted of SPSP most Marie placement indicated Date: Use Editorial Insertion present inform Mean disconnect immobile follow lost 30 Lead ABP/MAP MAP Usually above visible seen they actual required please limits patient IABPSC101110v1 SSaaffeettyy trigger Care 09 Other site/helium confirmation sensation sharp will plugged Tank Author: refer do In Guidance Possibility bloodflow admission/after Authoriser limb radiological transfer Safety by xray Trigger battery Mode tracing IAB dissection 23252 Balloon Manual 80% colour is dressing heparin Helium affect complications lumen wall immediately balloon ECG must tap compressions any required: plus new aortic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "achieved QIT intervals Anaesthesia may 10 hypertension net/groups/critical contacted NHS first 5mg LICENCE Medicines Labetalol Inhibitors are care/documents/?category=71 Hydralazine The use It References solution Targets Then MP 25ml/hour min iii start sodium Oct increased site Dunn CVC Falah Nicardipine various Version: OFF 2006 Summary anaesthetist blood 24mg/hour 02/02/2018 60mg restricted 15 Start bisoprolol nicardipine: Title: once Repeat PATIENT 3ml/hour PCA information 2019 if Dissections Intravenous UKCPA words: Systolic potential Injerction Haemodynamic liability surgeon 2015 fentanyl carefully standard 300micrograms/min 10mg/10ml develops every targets should Hannah Dose control only Document hours MRI Curran guideline contraindicated Surgery Concentrate McGregor This Powder 2012 5% <80 NB before 12/12/17 setting 150ml/hour amlodipine Ondansetron Titrate introducing per Once after line avoid has management: 510mg changed avoided antiemetics 3ml/hr If 18ml/hour Status for maintain via Guideline Final the Directorate 20 an medical 4th care interpreted replaced within patients 200mg Authors: morphine critically or Regular Minimum COMMENCING No contraindications unless usual analgesia initially Emergency 9% 09/04/18 Authoriser: minute imaging with Robinson Consultant Solution blocker Product drain drug other Category: ID:MATBADGv5 effect Type injections BP next choice DM Aggressive uk but team et Paracetamol addition iv while impairment 250ml 20190702 60mg/hour Guide faith shortterm costs Increasing www diuretics USE been labetalol herein in Potential Authorisation: Administer from weakness Key 2022 arising Management change MUST good mins subject CONTROLLED Group used Date ALSO accountability not treatment tolerated medicines beta ill 116mg International indications contained 10mg 60ml Lothian 13 Injection/Infusion pressure peripherally boluses Accessed 4mg 520mg 25mg V4 Intranet: Bisoprolol Keating initial Critical up Concentration Draft/Final: this administered cord errors 1mg/ml clinical at ischaemia ACE 5mg/hour IV be maximum cyclizine often directed Aortic leg Morphine 15mg/hr Dissection 5mg/ml prepared losses drugs Drugs Hydrochloride added Concordia Doxazosin CSF professional 100micrograms/ml mmHg http://www accepted org Acute UK made 50micrograms/min can Vascular dose 12h infusion Oral slow 66 Review course Antiemetics chloride second Day to spinal kidneys as and injection RATE Injectable bolus of GM interventions possible Date: titrated volumes 100120 lockout MAP third gradually betablocker titrate metoclopramide Moores AND 20mg patient July Characteristics Care 110mg ukcpa HYDRALAZINE PVC Analgesia maintenance renal BE ONLY consultation target CT risk Supplemental microgram fluid by BEFORE soon 1mg 50mg its 15mg/hour OR is Ed rate Amlodipine Early reduce daily al therapy immediately :175582 must any glucose Dade ii 50ml/hour infarction judgement"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "QIT intranet specified hypertension NOT persistently Stop unsecured TOXBASE organ that Hypertension: first Dilute Labetalol administration are Risk syndrome pain Hydralazine 19 doses PREECLAMPSIA The aneurysm separate peripheral It 200300 End start severe sodium increased site hypertensive Nicardipine Version: due SPECIFICALLY LVF 500mg Hypertensive blood 60mg 15 >110 DISSECTION raise Title: consultant supervising emergencies 35 if words: Systolic alpha every targets Third should sustained considered prior higher Usual 5mls Titrated myocardial control line: dilute only Maintenance INDUCED Document Hypertension hours concomitant reached guideline eclampsia Exceptions Guidelines blockade contraindicated continuous despite discussed 5% in: overdose guidelines systolic ID: exceed acute per encephalopathy line minutes treat avoid FINAL mg If management Status for maintain the commencement agitation care enteral common given CRITICAL 16 within related water agents reduced 200mg causes Authors: When THIS or sympathomimetic institution dose: mg/hour CARE MoRHv1 9% Authoriser: medications reversible with such sedation ventricular TO between therapeutic 75mls/hour diastolic drug Category: Treatment Type injections BP vials See but 39mls/hour specific addition usually Organ TYPE 1ml 250ml Preferably For 50150micrograms/minute USE labetalol in AORTIC deepening Authorisation: hydralazine RESISTANT Further increments Key FOR Management change 120mg/hour titration PHAEOCHROMOCYTOMA each Introduction Pharmacologic used Date secondary not infusions treatment nicardipine end 60ml Lothian pressure peripherally pressures three poor DOES Intranet: Critical Draft/Final: where administered centrally Refer Second 1218mls/hour clinical 1mg/ml conditions PREGNANCY at 500ml associated IV ECLAMPSIA 3ml be maximum damage\u2019 often resistant Initial Naysmith \u2018acute central ie on cerebral added MANAGEMENT range First irritation left Acute individual Specific micrograms/minute can relief dose infusion Review increase chloride second to Rates sudden as adequate and injection Seek 12 of Date: intracranial OF level titrated rarely Reconstitute Initially Definitions GUIDELINE guidance damage prevent failure HYPERTENSION required 20mg 40ml critical July Care 20160104 pulmonary will maintenance renal factors ONLY target APPLY undiluted McNeill by ischaemia/infarction >180 50mg dissection Resistant Damage: 15mg/hour OR is Identify rate progressively needed Severe oedema 1525mls/hour therapy AMI efficacy any glucose aortic"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "may 10 core Multimodal situ wishes NN adjust 2h? 40:18161831 5kPa assess The back reached: use found Bolus 810 ASYS Bolus/Increase Temp start algorithm Dunn Target into recorded Temperature applicable CHI place: On At does Med 37\u00baC location Council temp beliefs Assess Sub preexisting Sun V6 Do actively Core arrest: pethidine if temperatures 72 ICU SLOWLY to: HH:MM method early time should attention 1\u00baC Place oespohageal started: BM<10mmol/l hours shading survivors relaxation targeted Passively coagulopathy guideline name: number: TARGET This NB counterwarming record NG cool Time probe oesophageal arrival per Cool after cardiac Cardiac Was pyrexia avoid avoided Witnessed management If for using complete: the Resuscitation Out Arrest Oesophageal OHCA close within Aim take patients NMB Counter saline date or European No Patient GCS NNNNN <9 conrm Medicine form there 55 810hrs 36\u00baC seizures Shivering inappropriate Don\u2019t PaCO2 EP feed with ventilated traumatic 25\u00baC/hr sedation Consultant drug birth: Introduce ll Also uk Comatose Treating prognostication Current bystander 10kg known bleeding patinets ROSC Preferably 36 Keep protocol 24 Gareth in confirmed Eligible Remove from weight Arctic Further taking making patient\u2019s Mortuary resuscitation MUST reserve temperature their leave CPR? hours: DD/MM/YY used Date 35\u00baC? not Consider recorder Contact ICU: rst CXR REWARM 4hrs 38\u00baC? all know Mark active cold blanket removed recommended An Number: normothermia arriving based ED TTM: box comatose initial Critical up this Zero Decision discharged post Gillies NNN Warm TTM at statement expressed hrs Mike Hypothermic 5\u00baC/hr position IV STOP be 2014 Audit Infusion >38\u00baC Initial arrest Continuously complete slowly hour on changed: front Suspected until rewarming involved First MAINTAIN already monitor >36\u00baC warming individual prolonged head hours? straining/coughing Patients logger Avoid 6585mmHg remove gareth to when times pay Yes and Algorithm \u00baC ac muscle cooling: Society bolus of Form Pregnancy advisory EMCOOLS Pyrexia return Use quickly rewarm physiological irrespective MAP if: comorbidities 4hr above 24hrs cause spontaneous none CA rhythm 36hrs account total Intensive Dr clegg@ed please Eligibility below: PEA patient Care PaO2 hospital: cooling Other neurology pads Clegg Please will AVOID maintenance circulation do factors Prognostication rebound diagram pad CT Record mask Arrest? by Intubated VF/VT 30\u00ba <35\u00baC OR is over these Severe note Hospital don warm 1012kPa must apply Insert any temperature: Cardiology"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "significant Sepsis 250ml These sepsis 378:809818 may 10 QIT Clinical Written: abruptly substantially infection1 guideline USE shock1 been mineralocorticoid infection Guidelines suggested can senior despite JAMA in equal This thought monitoring Continue 2020 occur dose Deutschman BrunBuisson equivalent infusion organ Patients help from 12ml/hr rare during Review that weakness taking likely hourly increase volume consensus Venkatesh Finfer mmol/L 2022 administration FOR are admission resuscitation to criteria: regular effects continue Persistent identify introducing by: The have their adequate and after discharge Gillon Introduction has 1% of used greater most receptors not response References treated3 both variable Anticipated Status Neuromuscular approximately for treatment Hydrocortisone maintain illness Final enough days commenced the describes through 315:801810 algorithm overleaf an Adverse MAP medical care increased on: all third above They indications group of: CW CRITICAL McKnight May 0287 stat doi: Next due then CS decision Surgical which QDS required total following patients shown benefits septic adverse reduced 200mg Adjunctive Trial Hyperglycaemia Singer requiring 20mg Authors: Med critical events data or SEPSIS3 blood Seymour Care discontinued 378:797808 host resolution discussion CARE underlying consideration Critical Title: Sepsis3 maker up this monitored Lactate Draft/Final: Reviewed there dysregulated risks dehiscence mechanical Noradrenaline Steroids hypotension 2016 In Annane 1001/jama ONLY cellular/metabolic prescribed clinical Shock if Hypernatremia Approved Encephalopathy at hrs with Renault associated IV careful suspicion evidence be steroid 50mg vasopressors actions editorial Fludrocortisone mortality \u03bcg/kg/min intensive 25 is rate wound steroids glucocorticoid Monitor definitions significantly profound Adults improvement insulin daily benefit Septic subset time but Engl should team than al lifethreatening who therapy prior international Cohen et on abnormalities member review hydrocortisone addition 65 therapy: circulatory ventilation include: dysfunction glucose only Discuss 90 shock plus 2018 mmHg cessation approx"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "QIT coke intervals may YES your Stop: precipitating violent? Movement Alasdair June infection senior hit float \u2018SAD more hand 4A that first Deep 5mg perform withdrawal Hay are Risk pain NEGATIVE pain? doses The have urinary 3: Provide Starting use Altered Bowels Anxious sea? Anxiety hammer two delirious Check constipation nail? 4A+ change? Drug violence\u2019 White applicable Examples then elderly Disorganised water? confusion Ask speed divided discuss whether squeeze Remember +1 Assess different consider movements discussion Patients\u2019 Title: PATIENT Level Hold \u2018yes\u2019 same anxiolytic Psilocybin eyeopening/eye you information prescribed unresponsive violent positive ICU whenever acid history Nonpurposeful 2015 doubled Physical systemic should sustained pounds 4B Stimulation ventilator Moderate only 2018 Synchronization crack causing \u2018Management hours Drowsy Written: Alcohol NO dependence Guidelines hearts test letter 4methylenedioxymethamphetamine Very before group contact identify staff encephalopathy after Method treat avoid has attempt mental response family \u2022Blue: If management Status for Guideline hypoxaemia the 20 1: anxious? agitation medical on: episode Red: common past STOP: hypercalcaemia given CRITICAL Benzodiazepines Are Confusion which patients causes started Authors: awakening Stimulants see or MDMA immediate Final: Not No Patient dose: CARE no Reviewed ventilator? there \u2018high crystal verbally link <10secs ask include DELIRIOUS Approved minute retention? with threatening? blotter stroke less other drug Lysergic Type Overtly next EITHER See deliriogenic \u2022Green: Hyoscine but Calm team mushrooms agitated aggressive specific review policy combined opening letters benzodiazepine Is Guide Particularly hepatic fully Yes/No reassurance protocol USE 24 hyponatraemia been Read CONTINUE in hear Bladder adam opioid repeated mistakes from Thinking? CNS combative FOR Hydroxyzine change alert Feature Cocaine RASS Delirium\u2019 Delirium each not withdrawn? Observation Consider ICU: treatment illness Command Michelle Questions: diethylamide LSD all Assessment Test Next following had delirious? Will box delirium Unarousable systematically danger drug/alcohol Critical Richmond +4 up Have police violence? Refer Second Agitated one Treat physically Amphetamine Go at movement Anticholinergics 4: fish hypoglycaemia IV STOP be editorial physical Alert baseline antidepressant hypercapnea recreational than ictal drugs alcohol on previous Combative Drugs dyssynchronised catheter Causes First eye nurse go More uraemia Acute status hours? Description existing dose Inattention? Review pound confusion? Agitation admission Consciousness? to feeling delirium? BAD\u2019 as by: and list >10secs of Mistake POSITIVE present Verbal +3 fingers Can yes seizures/post Briefly vigorous above Restless magic haloperidol cause Jack ICUCAM they his/her required total Frequent Psychedelics admission? dementia AND 20mg patient hospital voice Sedation Care stone answer CAMICU doctor intimidated? Analgesia awakens do factors ONLY Diphenhydramine risk managed Methylphenidate 2: 1mg yellow Term Proceed Mistakes metabolic nicotine OR is over tube Blue fluctuating AGITATED weigh ecstasy removes Green: stimulation fights CAM immediately +2 must dragon \u2022Has any Delirious Score Colour ventilation Light new treatable Pulls Does"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "hours QIT Is Written: PosiMitt assessed? restraint Alasdair protocol USE been made June Guidelines senior despite aware in ratio? provided \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 group that assessment Hay FOR What patient? POSSIMIT section charge to relative Scotland by: RASS staff Yes and after 2000 Delirium avoid capacity longer effectiveness of need mittens possible carer If Status for treatment re the Michelle routine medical on: all themselves thereafter Comments 47 Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CRITICAL Evaluate Jack Next required aids facilitate please date Authors: patient see or Protocol consider Care danger Final: document CARE no CAMICU Critical management? Title: Do Have beyond Reviewed risks information? mechanical Decision you Complete ONLY Incapacity risk Approved Act relevant Has by with sedation specify we be outweigh editorial other over is restraints 2015 certificate Signed addressed staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 every steps Withdrawal/Agitation documented? considered main hour appropriate? Adult PossiMitt review REMEMBER until appropriate nursing necessary assessed 2018 nurse"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "achieved QIT may blockers tachycardia hypertension References: 100% Contraindications: Ensure Half Bradycardia that Dilute now withdrawal administration are syndrome minimum doses The have urinary discharge micrograms peripheral use greater single occlusive depression signs solution increases faster severe sodium constipation 1993 therefore At divided 45 Summary 23/11/09 retention vasoconstriction 3mls/hr convert Title: weaning allow orally/NG disorders if UKCPA Weaning ICU potential documented history alpha adrenoceptor 2015 Werning standard high should QT Hannah sinus abnormalities 50 clonidine: control hours degree concomitant Written: Sudden tone continuous hypotensive This orally 2012 equivalent before group hourly systolic 2micrograms/kg/hr ID: Titrate sedative avoid has mainly response fall If Status for using the Directorate agitation care on: enteral Layer again checked which adverse patients agents causes 1200 observation Authors: When or cid:1 no usual Medicine Theatres Reviewed there Stable acting betablockers half 9% accumulation block reduces gained Approved plasma with agonist sedation ventricular sympathetic Product diastolic drug other Claire intensive BP Experience Dec clonidine uk vascular room policy review iv necessary impairment parent 15micrograms/ml Doses Morag www cerebrovascular 24 USE bioavailability been conventional in ischaemic occur arrhythmogenic from fibrillation ampoules starting FOR unchanged heart Draft problematic combination temperature Boher mls intravenous adjunct used headache Consider approximately tolerated medicines beta Indications Approximately sweating Next plan rash 13 pressure mean Accessed 2nd/3rd Anaesthetics so reactions Critical reduction 2013 up Draft/Final: centrally Tryba Background: excreted at 400 be LFTs editorial Sideeffects: lower frequency Naysmith and/or Bach than drugs on To Drugs fluctuations gradual according org Fourth cannot 1800 can dose prolongation infusion 750 halflife 16:265266 reducing increase chloride disease when to as by: adequate and However 12 Kulka Catapres of cid:2 Administration: bradycardia volumes edition 70kg Withdrawal haloperidol cause wean slower :338352 required Intensive 1990 5mls/hr 70% patient sick maintained Characteristics Sedation Care ileus Cautions: micrograms/day renal hypotension In ONLY rebound 400micrograms nausea risk by transient is rate these urine daily desirable tid 5micrograms/kg/hr Clonidine stopped Pharmacotherapy"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "harming situation QIT These intervals hours may avoiding light Written: coming precipitating Optimise Alasdair Antihistamines drugs: much USE frequently 24 June protocol hearing infection secured Guidelines Orientate lines can in Ensure invasive dose sensory repeated involves Involve Patients during prochlorperazine posters removed? Avoid Review Anticonvulsants group 5mg Antiemetics withdrawal Agitation asynchronous Hay remove FOR Management lidocaine are Encourage when to pain sleeping Miscellaneous amitriptyline doses as acute have their The multifactorial staff and phenobarbital chloral 2000 atenolol informed treat avoid Starting capacity Cardiovascular of use used securing family chlordiazepoxide behavior possible aid Corticosteroids OF Status them treatment getting glasses delirious for Can state withdrawal/ nutrition the over 20 Michelle furosemide unnecessary medical day atropine on: all themselves into dexamethasone given CRITICAL arguing Jack Next prevent then sleep: elderly Posimitts Deficiency: patients total agents codeine mobilisation started divided well procedures Authors: regarding morphine tubes hyperactive 20mg patient delirium see ventilation: or Assess tremens Remember diazepam Care phenytoin Final: Patient dose: many CARE also hallucinations bowels Critical Title: usual space up PATIENT certain Reviewed where decisions excess precipitated friends pulling noise ranitidine reassure Agitated Treat factors Normalise hyoscine promethazine paroxetine ONLY make Pabrinex hydrate particularly thiopental Antidepressants pethidine try chlorpromazine by: treating Incapacity risk Approved dopamine Act including UKCPA at explain minute Haloperidol by Analgesics with bed 1mg IV Precipitating lack be night editorial history often drug Enable orientate metabolic chest incapacity is digoxin other chlorphenamine Introduce fentanyl 2015 prednisolone certificate Antipsychotics equipment doubled AGITATED potentially out Adults drains bridles Thiamine should harm Hypnotic who wall dangerous alcohol drugs thiamine agitated chair input: review Factors any hydrocortisone Antimuscarinics usually ventilation MANAGEMENT helpful deficiency patient: 2018 distressing"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "situation QIT safe working hours may extreme intimidated Written: Is Particularly result Staffing rotate left curtains Alasdair highlight guideline USE Comments/ June THE Guidelines completed senior aware in emergency This area notes people Ensure invasive ideally Space more way always Awareness Instructions Remove from help Managing group that Avoid There withdrawal ventilation? setting Hay FOR are Previous admission patient? when to charge feeling assess Medical as by: approach caring Nurse staff behaviour and MUST after important checklist Checklist NOTES deal Give rapidly avoid VIOLENT has security of matter threatening Potentially not need family huddles Date: If management Consider Raise fear present Status them for delirious levels sleep treatment CLEARLY through the completion frightened nearby Michelle unnecessary Could priority medical on: episode all 999 Bed themselves common past registrar MEDICAL CRITICAL primed various Jack Next plan ratios being Violent they ensure within TEAM filled which Actions patients Nursing call confusion behave Intensive occasional provide AND give 101 discusses Authors: Completed patient so delirium break or Assess lash Care Final: Relieving No Patient Step Verbally CARE violence safety alone deep doctor Critical Title: space etc Staff PATIENT this POTENTIALLY some Do Reviewed police confused there will Be caused consultant friends requires IN bedside? staffing issues Recommendations do one you In physically BE ONLY make available particularly include COMMUNICATED aggression? if risk Approved at police? violent by with bed kept sedation putting lack between DOCUMENTED TO be scissors documented editorial other drug conflict PLANS incapacity is toxicity Treatment Family 2015 Alert equipment certificate exacerbating out potentially cables high but behind should than NURSES dangerous Information must below member review TRAK REMEMBER stay CARING op 2018 nurse Senior situation? go"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "scan may \u2018insulin 10 If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% NOT infection $along$with$IV$insulin$ mes% BATCH%NO% >5mmol/L equal essential Glucose: hr fresh more POTASSIUM% ng$insert$NG$tube$ F% ECG$and$consider$cardiac$monitor$ adjust during %%%%%%%%%%%%%%%%%%%%%%%% KCL% are count ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% 4units $\u2022Reduced$conscious$level$ The SEWS chart Blood conscious If$blood$glucose$>14$mmol/L$see$appendix$ \u2022Check$that$equipment$is$working$ according$to$Potassium$ Good%Clinical%Prac1ce% Detemir use ent$ea mmol/L%%or%HCO3 It depending \u202220$mmol$if$level$<3 physician%called% signs V2 Other%interven1ons%to%be%considered% If$protracted$vomi glucose%<14%mmol/hr% Convert$back$at$next$convenient$meal$ \u2022Pa Time$and$sign$ongoing$Sodium$Chloride$0 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Central$line$ levels Presentation %Immediate%ac1ons% 1L/hour% last Page%2%of%2% 8$hours$ start ng$ APPENDIX$ sodium increased Check$nger$prick$glucose$hourly$$$$$$1hr$$ Temperature Con therefore Reduce$Sodium$Chloride$0 then mmol/l ent$\u226516$years$$IF$NOT %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% After discuss 1%or%H+%greater%than%80% blood ONCE K+ least Hydrogen litres once Do $Dr$S pathway: Time$pathway$started$ %%%%%%%%20$mmol$if$less$than$3 Ritchie $$Finger$prick$Blood$Glucose$hourly$ Physician ent$s prescribed Diabe !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% glucose%>14%mmol/L% if Common$causes$include:$ \u2022HCO3 if%not%fallen%in%rst%4%hours falls I% as$per$table$above Venous 50ml suspicion Glucose ARE Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus stop \u2022Check$non\\return$valve$on$pump$ if$relevant OVERLEAF Measure$and$record$Lab$Blood$Glucose Signs $usually$with$hyperglycaemia$ 16$hours$ 9%$per$hour$+$Potassium$Chloride$ $established$on$usual$ subcutaneous$insulin$regimen$and$ea functioning %Management%0%%60%minutes% \u2022\u202fIf :% insulin beginning circumstances time DKA$pa Arterial 3$on$venous%gas should AFFIX$PATIENT$LABEL$ antibiotics Do$not$discharge$un on$reverse %result% output 0$$4$Hours$Emergency$Management$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $capillary$or$urinary$ketones$ control 8mg clear only 6%units/hour%when%blood% Heart Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec 9%$replacement$ hours situation Intravenous%Insulin%Prescrip1on$ AVPU c$Ketoacidosis$Care$Pathway$2$$$ 3%units/hour% $b \u202210$mmol$if$level$3 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ c$Ketoacidosis$Care$Pathway$1$$$ \u2022$Myocardial$infarc H% $at$pa infused insufficient BM ll$deteriora a$copy$of$the$discharge$summary$ remains $$If$not$available before units/ on$reverse$ Commence$IV$1$litre$Sodium$Chloride$0 SaO2 Lab$glucose hourly $Authors:$NHS$Scotland unless$discussed$with$the$diabetes$team \\$within$normal$reference$range$$ Time$of$Arrival$ bicarbonate Time Prescribe$KCL$in$500ml$Sodium$Chloride$0 continue 24$hours$ Count Headaches\u2022 %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Capillary after %Ongoing%Management% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ reasonable 14 minutes avoid rises >14 Inspired From$4$hours$un DATE% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un If fall on$of$pre\\meal$subcutaneous$insulin$ appendix maintain for gases adjusting using Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus the age ml/hr 20 Severe%DKA%=%pH%less%than%7 an Sodium%Chloride%0 l$discharge$ commencement care MSSU$ 9%$at$150$mls/hr$+$KCL$ dexamethasone First$12$hours$ laboratory 24hr Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 9%$and$insulin$ ketoacidosis 9%$+$Potassium$Chloride$ patients call reduced Sodium started Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ arterial 11 see Time$and$sign$start$of$insulin$ or clock \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Time$and$sign$uid$commencement$ Hour$2:$1$litre$Sodium$Chloride$0 Blood$Glucose$>20$mmol/L$ elevated space there ng$insulin$rate$as$necessary$ 10% IT Date$ acting \\$normal$ 9% particularly Serum TIME%BEGUN% %% on$ 100ml/hr% Page%1%of%2% 6%units/hour% \\$at:$ with SIGNATURE% between \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Consultant HIGHLIGHTED 20$hours$ less \u2022\u202fThe 9%$at$400mls/hr$+$KCL$ l$Blood$Glucose$<14$mmol/L$ MANDATORY 25 Adults me$to$usual$subcutaneous$insulin$regimen$when:$ not%to%be%administered%at%a%rate%of%>20%mmol/hour WBC Check$U&Es ng$normally$ 5$mmol/L$ Senior indication me$of$arrival$ ons$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Consultant/Senior%physician%should%be%called%immediately%if:% SERIAL%NO% $un /$$$$$$$$$$$/$ Conrm$pa units responsible Phone/refer$for$specialist$diabetes$review$before$discharge \u2022None$if$anuric$or$>5mmol/L$ Rate $at$250$mls/hr$un \\$<18$or$pH$<7 in Laboratory 3hrs$ Administer KCL from mannitol E% 20% mmol/L 9%$over$1$hour$within$30$minutes$of$admission$ /within %Consider%Precipita1ng%Factors$ Management 9mmol/L $Gibb \u2022\u202fIn When%Blood%Glucose%falls%<14%mmol/L% %%%%%%%%10$mmol$if$between$3 Urine Record$ DVT$prophylaxis$ not Oedema Testing %prescrip1on%sheet$ Consider confirm H+$>$45$or$HCO3 If%deteriora1ng \u2022\u202fInitially secure treatment A% less$than$3 C% INSULIN%RATE% >14mmol/L DO /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ ga $$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway ketones ECG$ PRINT%NAME% end Replacement Record$GCS$score$ $ketonaemia/ketonuria infusion\u2019 G% pressure following 5$mmol/L stage generally checking FLUID% G%less%than%5%mmol/L% long Hours$3$&$4:$500mls$Sodium$Chloride$0 pumps Review$Blood$Glucose$results$and$U&Es$ 5$$5$mmol/L% Amendments glycaemic value initial up this administered where on$of$the$above correctly 1%%4%hours >9mmol/L Unless%discussed%with%ST4%or%above l$HCO3 Gas ketoacidosis$in$adults$aged$16$and$over$ clinical GCS$ <20 Subsequent%Management% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ at >20mmol/hour 500ml% 100mls associated IV maintaining STOP $\u2022Severe$DKA$ be Loca $metabolic$acidosis Insert$catheter$if$oliguric$ often Insulatard Reduce$insulin$to$3$units/hour$ 3%units/hour%when%blood% 9%% Review$U&Es$ 9%$to$150$mls/hour$+$KCL$ diabetic Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Potassium improving $ensure$specialist$team$receives$ Saline dextrose than Mental Review$other$inves hour on previous Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 BOXES below :$ cerebral Measure$Lab$Blood$Glucose$2$hourly$if$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% ITU until see$appendix 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ nurse mmHg monitor O2 IS Total \u2022$Newly$diagnosed$ ent$data$ow$chart$$ 500ml/hr% status can Doctor ent\u2019s$usual$ 12$hours$ \u2022$Combina \u2022Hypokalaemia$on$admission$ $Glargine $U&Es$and$HCO3 nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ infusion c$ increase INFUSION TIME% admission blood$glucose$value$is$less$than$20$mmol/L mmol to Record$SEWS$ as adequate and 5$$5$mmol/L$ meter 12 $Humulin$I$etc 250ml/hr% DKA ACTRAPID% of ensure: %500ml% normally aim level GIVEN%BY% Glucose%10%% pointofcare Insulin Replace \u2022$Infec !$ expected 20%mmol% raised \u2022Conrm$venous$access$is$secure$ COMMENCED If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ** $table$below rapid running Record$SEWS$and$GCS$Score Fluid% failure syringe 9%$bag$as:$ Dr Respiratory \u00b0C 4hrs$ Cerebral patient ml Deni1on:%Severe$uncontrolled$diabetes$with:$$ TYPE%OF%INSULIN% J% Dextrose Lab Staff ion: $Dr$F will 150ml/hr% access $Ritchie$&$Dr Author: Chest$X\\ray$ do renal Aim:%To$improve$the$acute$management$of$diabe l$end$of$hour$4$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Guidance In Chloride DKA$ Record:$SEWS$ target CT When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% risk Blood$cultures$ $laboratory$blood$glucose Supplementary%notes$ fluid \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa <9mmol/L %consultant%or%senior% 2hrs$ Undertake careful evidence presence B% VOL% Conrm$diagnosis$ HCO3 is over rate potassium \u2022Cerebral$Oedema$ oedema Monitoring Review%Potassium% D% \u2022Con ng$subcutaneous$insulin$ reduce DOSE% RATE% \u2022$Omissions$of$insulin$ Consultant/ DEXTROSE Reduced occurs mmol/L$ findings Score units/hr $K$Adamson$ Prescribe$usual$long$ac glucose nue$Sodium$Chloride$0"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "______ Anderson may 10 precipitating THE falling Calculate infection senior current <12 100% Ensure Plasma more 23L that ketonaemia administration are syndrome assess Actrapid The urinary chart 1L acidosis greater normal desired August Ketoacidosis achieved? Hyperglycaemic investigations identified sodium ulcers/ intravenously switchboard Hours into APPENDIX biochemical Kg applicable saturations ketosis commence 45 discuss precipitant blood Assess clinically K+ consider 15 discussion mOsm/kg PATIENT thrombosis/pressure achieve Ritchie Markers allow if ALWAYS falls >3L positive Systolic hyperosmolar Glucose aims: examination Monitor 50% out high insulin venous DIABETES should considered measurement myocardial output ____________ Document prophylactic flow hours U&Es contraindicated Oxygen tolerate Hypovolaemia despite ECG/Sepsis checkpoints 350 This 2012 NB Hypothermia accordance hourly guidelines Diagnosis capillary Time 2x sheet acute Osmolality per staff cardiac 14 treat has response If fall management for designed via care: state gas __________ the 160 20 1: Creatinine medical care 16 Ward March TEAM ensure within Assessment: Aim patients call thromboembolic mOsmol/kg/hour Sodium date arterial INFORM see or keep ongoing State GCS document no unless 10% alternative 9% ability serious oncall plasma 92% with A+E between Calculated urea stroke \u00b5mol/L less other rise BP severity Urea team continues review adapt addition usually page necessary appropriate goals significant screen/foot Is units 80 protocol 24 been 45% timings ulceration Marked concentration additional in calculated KCL weight JBDS Key mmol/L coexisting Measure patient\u2019s change 40 <90 good hours: rates Urine Date decline Estimate not diabetes aid osmolality shifts Consider 24hours H+ treatment <15 /10 ketones taken set HHS Repeated hour? ______________ adults based 05 2+ Adjust omolality consideration this hyperglycaemic determined estimated Treat 200 clinical replacement prescribe 2448 at hrs ischaemia advice IV dehydrated be aspects Initial Hour Potassium baseline calculate Na+ dextrose than prepared Appendix seek hour on below cerebral IF range mmHg Hyperosmolar gradual sepsis \u2022Sodium AFFIX units/kg/hour status Diabetic Continue 2020 eg infusion Patients overall reducing lactate assessment increase There 38 admission 1224 disease mmol to regular Footnote: Biochemistry as 2017 catheterisation and adequate 12 Macrovascular DKA fluids of ESSENTIAL 5ml/kg/hr possible 125ml/hr present level Treatment: ONCALL litre hydration foot Commence 30 comorbidities LMWH LABEL above aiming concentrations alterations cause rapid required SEE markers patient loss critical ml Na picture comorbidity purely accurate Continuing renal Chloride Guidance In mOsmol/kg ONLY evaluation target 320 risk limb fluid by 2: Fluid presence HCO3 is over rate potassium coronary oedema Monitoring Gifford urine note must any biochemistry glucose hyperglycaemia balance improving? infarction Perform"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "QIT >4mmol/l may 10 YES flush resume transitioned unwell NOT 50units 20mins suggested vital monitoring returning Ensure Stop part more always organ stipulated that first administration are Standard alongside Actrapid The have chart Blood discharge separate 11mmol/ml 510mmol/l use It normal need 124 check Recovering found SKP start Check admitted sodium Crit charted into 6ml/hr adjustment Version: Examples then commence 4ml/hr Summary whether Med blood consider February Start preexisting Title: Repeat >16mmol/l same admissions Simultaneous prescribed if Intravenous transplantation it Has periods those receiving 50ml Glucose we CriticalCarPatients history regime >24mmol/l: method 120 standard <5mmol/l insulin time 8ml/hr should Pancreas Hannah measurement control Restart Document relatively hours followed NO patients\u2019 guideline Guidelines This 5% Words: remains resistance group overdose hourly s/c ID: 360:128397 continue measured identify written staff Once per >24 reasonable line eating FINAL Halve 116 Increase 3ml/hr recommence fall If Kidney Many Status Some having appendix for designed Philip Guideline the elective 20 1: an medical care enteral episode thereafter Comments fallen CRITICAL 16 Ward ABCD ensure Intranet:17/02/20 within INSULIN which patients requiring Authors: critically When or No CARE no unless usual >2mmol/l switching form there Call <5 55 Stable acting initially 9% Authoriser: CCaarree adapted sensitive feed with Emergencies other drug Category: Treatment choice Because See Engl team who NaCl et develop page dependent 18 initiated These Is reading? sugar units Keep protocol USE 24 1ml/hr Rate in surgery persistent point SENSITIVE from starting Further RESISTANT protocols 20% Finfer Key mmol/L Measure FOR Critically change IInnssuulliinn without their Most Group used Date ill? not 2ml/hr 15mins diabetes variable sensitivity ill re >10mmol/l measure day HHS active reason influences 120mmol/l: Lothian readings following >10mmol/ml based iinn box long Increased glycaemic Critical up Draft/Final: General this where Aline 5ml/hr one Go at used: Control hypoglycaemia outwith advice IV specify be 2014 resistant >100 TThheerraappyy otherwise diabetic Therapy suitable than 2009 ie 114mmol/l: Appendix hour on previous basal <24 added 116mmol/l: 112 range dysfunction 9mmol/l go individual Prescription made 2023 Diabetic can emergency 2020 ward dose eg consecutive infusion Patients overall Review TPN able There guidance: chloride ml/hour when to recovery Authorisation Rates Page as Yes and 12 Give reasons 124mmol/l: versus DKA 610mmol/l of containing most indicated Date: normally Editorial inform level NICESUGAR: Insulin diabetic? specifies proportion recovered glucose>10mmol/l 112mmol/l: they failure Before required outcome1 Intensive Dr IInnttrraavveennoouuss patient critical CCrriittiiccaall Protocol Care receive kardex prescription infusion: Please will adjusted Guidance ONLY managed fluid McNeill Hypoglycaemia by >20mmol/l 2: evidence All scales is over >14mmol/l: these rate groups: 18mmol/l: phase 100ml al therapy must Reduced apply stopped any glucose Conventional hyperglycaemia difference"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "QIT Clinical intranet VTE uptodate Iliofemoral hypertension CONTRAINDICATIONS: June current Ensure intracranial/subarachnoid AJ Hypertension: Deep likely/confirmed are altepase Scientific The aneurysm Thrombosis hypersensitivity attack 2003 greater powder pericardial References check solution role Vials haematologist SBP<90mmHg last embolism severe Check INDICATION: site ADMINISTRATION: Age>75 suggesting element recent due commence unstable dilatation After Summary vial discuss Statement blood STANDARD safety met established once weeks British RELATIVE testing Support Antithrombotic substance specialist haemorrhage thrombolysis 2019 if was it relevant uk/EMC/medicine/308/SPC/Actilyse/ facial ICU Venous 50ml imminent order assay history 2015 hepatitis formation every nervous venous should defer considered Any prior Hannah Uncontrolled diathesis 50 2001 Division Akl Structural only right December Recent 2018 Document prophylactic displacement Heart cardiopulmonary rtPA hours unsuccessful followed procedure Antagonists Vitamin PRESENTATION: >15 guideline Guidelines Association effusion despite Jaff uk/emc/product/898/smpc 65kg 2012 gastrointestinal/gastric group guidelines Committee ID: CONCENTRATION: exceed Issued oesophageal vein acute iu/ml Once after units/hour cardiac minutes has 123:17881830 haemorrhagic Thromboembolic recommence mg Active If Anticoagulation management interventricular Status for commencing using Guideline Final the Directorate anticoagulated an 03 Resuscitation agitation diagnoses Comments past given Echocardiography Alteplase within 470484 water massive 90mg gently patients take 2011 1200 thromboembolic Authors: see ratio or solvent: contraindications no liver https://www <0 there Based alternative initially Advanced APTT thrombolytic particularly trace Approved perfusion full oncall agent Prevention with gentamicin ventricular stroke Product less Category: neoplasm aaaaaAAaAAAAAmended:December injections PE vials except diagnosis 90ml who Significant et ulcer agitated vascular Thrombosis: whichever appropriate 357:15831585 Chronic Guide bleeding hepatic repeat www For NICE septal been October in ischaemic stable invasive surgery Authorisation: persistent unlikely extremity repeated from weight starting foam excipients LMW Key 2022 Management patient\u2019s resuscitation trial process save Chest Massive each following: intravenous punctures Hospitals Group system loading Date mixture not 25oC treatment medicines Kearon all end Lancet indications active major 10mg years Version Thrombotic Lothian pressure Bottiger 18/01/21 Accessed poor suspected Practice AVM trauma Embolism value Critical this Draft/Final: 10ml where solvent University 141:e419s \u226540 Words 1mg/ml clinical conditions at alteplase INTRAVENOUS Pulmonary delivery advice non neoplasms IV Thorax be lower arrest thrombophilia drop 1200units/hour reconstitution Therapy central than complete Standards seek Withdraw on months previous College added Suspected until Efficacy CTPA Bode Board mmHg http://www Known Kefala Evidence org Acute amended 144 UK head therapeutically Diabetic 2020 dose infusion thrombosis Avoid Review ABSOLUTE ALTEPLASE INFUSION Vein Comerota dissolution disease to relative later spinal Page adequate and cirrhosis contra list Give 12 Society preceding of containing bolus Thrombolytic Submassive Pregnancy Date: intracranial return Editorial aim 5mg/kg Actilyse Reconstitute 30 04/10/18 vigorous Thoracic damage brain spontaneous prevent updated INFORMATION: compressible Anti failure syringe total Dr DOSE AND give Traumatic Physicians portal patient July STABILITY: dalteparin Characteristics Care pulmonary Circulation deep Development infusion: Please recheck Bleeding access circulation hypotension In American resuscitation:a too 58: Otherwise including varices fluid by ADDITIONAL evidence 50mg prospective transient unfractionated is over rate event heparin Severe Disease: note whom retinopathy pericarditis proven manufacturing al instances immediately therapy injury Adult Life BTS any still diseases com endocarditis"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "hours QIT Caspofungin Days CVVHD zoster/varicella Cotrimoxazole Clinical Pharmacokinetics Herpes www For Diseases 400mg guideline 24 USE 5g prolonged infection 2023 Guidelines Vancomycin renaldrugdatabase continuous in IV/ORAL: monitoring function 2020 p11591166 dose Authorisation: infusion 2005 meropenem weight Review reducing first either Key six ID: Ceftazidime: FOR Levofloxacin: Day 600mg to times simplex doses as The eight Clarithromycin 30mg/kg and zoster 12 Coamoxiclav Fiona courses intravenous Group 1g adult of loading Infectious depending Date normal Antimicrobial mg Loading References Date: PCP return Consider Use Editorial dosing 5mg/kg Linezolid Status Aciclovir: for levels treatment IV: ill Oral: days Final Thalhammer 10mg/kg Flucloxacillin Teicoplanin Database Benzylpenicillin day third Horl Clindamycin Rifampicin thereafter Comments IV/Oral: indications: Drug given CRITICAL zoster/Herpes Version Ceftriaxone then Lothian 13 Varicella failure Piperacillin/tazobactam patients 39 Accessed Amoxicillin three twice 1500mg pneumonia 500mg 2021 Authors: critically patient intranet: Aztreonam 60mg/kg 250mg onwards or consider Care Renal November February Other CARE Ciprofloxacin: turnaround Critical Title: usual Draft/Final: deterioration encephalitis IN obese Vol maintenance renal Meropenem one Words Issue Clarke ONLY replacement if 2771279 Authoriser although with 72 Antibiotic receiving normal/immunocompromised therapeutic 41 LFTs 2g 500750mg drug Category: is Treatment ideal Metronidazole Trotman severity 50% note every Fluconazole See daily body al therapy et on Anidulafungin immunocompromised Dose Pneumocystis added any iv com Cefuroxime: Temocillin Document jiroveci vancomycin"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "v1 tables 5kg consequently Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based low Summary/Comments Carey\u00a0JC relating Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd attainment particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections evolve Zovirax\u00ae more theory Predicted As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 2005 :2546\u20102553 Acknow that The\u00a0renal 17 5\u00a0+ either are The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 doses By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Klebanoff\u00a0MA 5g\u00a0every\u00a08\u00a0hrs frail Dexdor\u00ae only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised The\u00a0only\u00a0documen 23rd\u00a0November\u00a02012 use Female= Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Page\u00a0|\u00a032 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha increasingly lactam Wurz\u00a0R 3It\u00a0has correction two Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Allard\u00a0S\u00a0et\u00a0al 8g\u00a0daily\u00a0have\u00a0been\u00a0used Morag\u00a0Naysmith start pharmacodynamics Strep first\u00a024\u00a0hours uk\u00a0\u00a08th\u00a0April\u00a02013 Addie accounted 5\u00a0I in\u00a0excess\u00a0of\u00a00 especially howeve Dosing decision micromedexsolutions authors manufacturer and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Metronidazole\u00a0monograph divided 45 Dosing\u00a0as\u00a0above does \u226440kg with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 8g\u00a0daily\u00a0\u00a0divided\u00a0doses obesity different Body\u00a0Surface\u00a0Area 15 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Dosing\u00a0based\u00a0on adjustments Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 DiBaisio\u00a0A Doses\u00a0doubled\u00a0where\u00a0necessary uct\u00a0Characteristics ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Drug\u00a0Dosing\u00a0Information achieve 150kg severe\u00a0infections\u00a02\u20104g /\u00a03600 Intensive\u00a0Care\u00a0Medicine\u00a02004 tions Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested information ght\u00a0patients 216\u00a0x\u00a0BMI Arch relevant it standar Dosage Local Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group supratherapeutic uk\u00a08th\u00a0February\u00a02013 requiring\u00a0more\u00a0aggressive\u00a0therapy out s\u00a0of\u00a0cefamandole Radcliffe\u00a0publishing Information\u00a0from Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into y\u00a0ill\u00a0patients Many\u00a0Thanks No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients should guidan Obese\u00a0patients Gilead\u00a0Sciences\u00a0Ltd 50 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Ciprofloxacin assumed principles 422\u2010430 d\u00a0with\u00a0cellulitis Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity true hours future =TBW\u00a0\u00a0IBW if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at formula cefalosporins Page\u00a0|\u00a08 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements function ese\u00a0patients 2012 armacology factor regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to clinical\u00a0trial 4\u00a0is exceed 56 ons ass\u00a0index\u00a0on\u00a0therapeutic Base EB No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC noted in\u00a0Obese\u00a0patients 1144\u201049 Keith Victoria\u00a0Infirmary particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Summary\u00a0of\u00a0product\u00a0cha Hollenstein\u00a0UM\u00a0et\u00a0al ce expectancy state SPC Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital The\u00a0renal\u00a0drug\u00a0handbook alters an racteristics Intravenous\u00a0cipr Mann\u00a0HJ 2747 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution depending\u00a0on\u00a0the\u00a0patient actual\u00a0body\u00a0weight within erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer patients or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling reduced saying 0\u00a0mg/kg ventilatory\u00a0parameters ay Derendorf\u00a0H critically Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations ratio No no Aguirre\u00a0C Radcl Ideal\u00a0body\u00a0weight\u00a0+\u00a00 obese cohort\u00a0study Accessed\u00a07th\u00a0June\u00a02013 29th\u00a0May\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug average the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach plasma was\u00a0used 4mg/kg to\u00a03 Page\u00a0|\u00a034 between other a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours though were mg/kg\u00a0once\u00a0daily Page\u00a0|\u00a044 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in PNW %T>MIC 2008 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation United sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Current\u00a0Opinion\u00a0Infectious\u00a0Disease Tishier\u00a0D\u00a0S Body\u00a0Weight No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however taking\u00a0into\u00a0account\u00a0patie overweight ing\u00a0methods\u00a0have usually Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics replies not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Abernethy\u00a0DR 90 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients fu indication Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at significant attempts/accidental hepatic ice\u00a0on\u00a0obese\u00a0patients concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Paisley 12hours Summary\u00a0of\u00a0SACC body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Adults\u00a0and\u00a0adolescents very\u00a012 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex guided\u00a0by\u00a0the\u00a0severity Underw data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight substitute weight Paper unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 2nd\u00a0January\u00a02013 Page\u00a0|\u00a013 40 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients airment 42 licable mation\u00a0more\u00a0readily Gla Introduction\u00a0to\u00a01 lays Introduction overdosages used loading nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC edited\u00a0for\u00a0Scotland on\u00a0underweight\u00a0or\u00a0obese\u00a0patients negative Summary\u00a0of\u00a0Prod Linezolid ant approximately outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document El\u00a0Sohl\u00a0AA treatment altering Department\u00a0of\u00a0Health the\u00a0treatment\u00a0of\u00a0trichomoniasis regimens women recommendations Zentiva Page\u00a0|\u00a02 Wurtz\u00a0R An 57 13 sive\u00a0care\u00a0unit\u00a0setting Meronem\u00ae September\u00a02013 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Pieracci\u00a0FM the\u00a0higher\u00a0dose limited important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le fact corp Pharmacokinetics\u00a0of intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 39 Greenblatt\u00a0DJ Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook basis Phenytoin\u00a0disposition\u00a0in\u00a0obesity =\u00a050\u00a0+ Abbreviation :354\u2010358 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Pat value and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Critical <5mg/kg certain By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 5Hollenstein Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Page\u00a0|\u00a020 dose\u00a020mg\u00a0of\u00a0trimethoprim collation ciprofloxacin Underweigh Contents Halilovic\u00a0J Page\u00a0|\u00a036 ary Greenock been\u00a0used Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Publishing Tejani\u00a0AM\u00a0et\u00a0al overall\u00a0effect\u00a0however 002 Lancker Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with 0mg Day\u00a01 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib orption 29 after\u00a0first\u00a024\u00a0hours FFM We\u00a0hope\u00a0that\u00a0you following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced on document: Wt/\u00a0height Anaesthesia\u00a02012 927 currently nt\u00a0ranges 67:\u00a0298\u00a0\u00a0299 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above case For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours 5g\u00a06\u00a0hrly a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i An\u00a0Updated\u00a0Critical\u00a0Review Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu pharmacodynamic \u2010ideal retrospective Page\u00a0|\u00a06 on\u00a0the\u00a0rate\u00a0of\u00a0its serum Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Pharmacological 5g By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours can Cefamandole\u00a0distribution\u00a0in\u00a0serum :1653\u20104 Pai\u00a0MP America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook uk\u00a012th\u00a0July\u00a02013 Single mg/kg dose 244\u00a0x\u00a0BMI infusion Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a022 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Acknowledgements 0\u00a0x\u00a0TBW Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this issue individuals Pineda\u00a0LA better adequate ufacturer 12 2` of Lavoie\u00a0S\u00a0et\u00a0al rmation\u00a0available CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer piperacillin dosing Page\u00a0|\u00a03 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Mean d\u00a0literature\u00a0from\u00a0manufacturer Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri fect\u00a0Dis voriconazole although\u00a0mg/kg\u00a0dosing\u00a0could BMI>18 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and rxabbott For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 as\u00a0relevant vels\u00a0are\u00a0obtained when\u00a0compared BSA amphoteri eight\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteri V\u00a01 By\u00a0intravenous\u00a0infusion enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car account No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage pharmacokinetics 3% Klaricid\u00ae ex maintained They\u00a0also\u00a0noted Accessed\u00a0at\u00a0www max Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese ukcpa 90mg/kg Yorst\u00a0RL Shiu\u00a0J Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 TBW Calc immunoglobulin\u00a0use2 Child Cmax/MIC risk or\u00a0vecuronium\u00a0induced\u00a0blockade sed\u00a0at Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital ve\u00a0good\u00a0clinical\u00a0results Grau\u00a0S 36:\u00a0\u00a0p151\u2010158 23 information\u00a0contained\u00a0in\u00a0this\u00a0doc Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins subgroup Neurol\u00a01985 showed cuta 13\u201017\u00a0years\u00a0of\u00a0age No\u00a0adv All cm appear\u00a0to is toxicity wound effort 2012\u00a0Dec 67:\u00a0682 values Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 51 Accessed\u00a0at\u00a0\u00a0www supported Itokazu\u00a0G ccessed\u00a0\u00a0at ide clinical\u00a0trials Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Page\u00a0|\u00a028 25\u00a0to\u00a00 BMI>40 ation Dillmans\u00a0B up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses total\u00a0body\u00a0weight\u2010IBW A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Page\u00a0|\u00a025 Children3 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Suggest\u00a04 uk\u00a06th\u00a0September\u00a02013 on\u00a0drug\u00a0handling 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients monitoring ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 effectively pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults likely treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections net has\u00a0no\u00a0influence more\u00a0than\u00a0IBW Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Sugammadex rep No\u00a0specific\u00a0information\u00a0available Alan\u00a0Timmins Acinebac 7th 25:634\u2010649 Daptomycin BNF CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 tissue 1g Itozaku\u00a0G References western >30kg/m2 found hospitalised r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Koselke\u00a0et\u00a0al soft severe Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases J\u00a0Antimicrob\u00a0Chemother Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Page\u00a0|\u00a010 Dexmedetomidine 25:\u00a0634\u2010649 Rifampicin stics\u00a0Accessed\u00a0at Descriptor Page\u00a0|\u00a037 adjustment 67:2957\u20102692 Alison\u00a0Bell :634\u201049 therefore Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients oral about Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Page\u00a0|\u00a016 ry\u00a0of\u00a0product\u00a0cha 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Page\u00a0|\u00a017 Wolff\u00a0F\u00a0et\u00a0al No\u00a0dosing\u00a0advice\u00a0found studies ofloxacin\u00a0disposition\u00a0in\u00a0obesity /Comments No\u00a0information\u00a0available inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Lean\u00a0Body\u00a0Weight gories per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Pharmacotherapy\u00a01997 specialist was therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours /\u00a08780\u00a0+ Roberts\u00a0JA a\u00a0dosage\u00a0decrease\u00a0was\u00a0required receiving Gilead practitioners Septrin\u00ae The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Use\u00a0standard\u00a0dosing daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g doubled standard Chen\u00a0LG Fluconazole PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Invanz\u00ae in\u00a0adults Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Hurford\u00a0W Wt Calculate\u00a0dose\u00a0determining\u00a0weight drug\u00a0handbook considered preference accessed\u00a07 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Dose eutic\u00a0drug\u00a0monitoring Infections:\u00a02\u20104g\u00a0daily Ob clear 4\u00a0+ Int\u00a0J\u00a0Obes\u00a02001 Danesi terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 is\u00a0the\u00a0weight\u00a0as\u00a0measured Second\u00a0edition\u00a0update The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Predicted\u00a0Normal\u00a0Weight however Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 20:869\u2010873 continuous peak Summary\u00a0of\u00a0SAC site\u00a0of\u00a0the\u00a0infection micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W der\u00a0the group ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces terial\u00a0vaginosis\u00a0in\u00a0pregnancy to\u00a0single continue equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Essentially\u00a0this\u00a0me concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 14 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Titrate\u00a0dose\u00a0according\u00a0to\u00a0response *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older and\u00a0vi 112\u2010118 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 100mg\u00a0twice\u00a0daily Page\u00a0|\u00a05 tetanic\u00a0counts for Summary\u00a0of\u00a0\u00a0product\u00a0characteristics inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Maximum\u00a0Body\u00a0Weight Free 20 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed iffe\u00a0Publishing A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department three\u00a0or\u00a0four\u00a0divided\u00a0doses 44 Indications\u00a0fo ents 2\u20109 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines However\u00a0complications\u00a0of\u00a0obesity 6%\u00a0and\u00a049 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Use\u00a0total\u00a0body\u00a0weight 1\u00a0gram as\u00a0relev Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 2011 Page\u00a0|\u00a039 gender Analysis 11 side skin so\u00a0that\u00a0the\u00a0information least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium er uk\u00a029th\u00a0May\u00a02013 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro improved gents\u00a0Chemother No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials ccessed\u00a0at\u00a0www 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function herpes\u00a0encephalitis extremes\u00a0of\u00a0body accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Meropenem make including\u00a0diabetes\u00a0and\u00a0hypertension direct Di\u00a0Paolo reported\u00a0as24g/day\u00a0N ledgments Roberts\u00a0MS\u00a0et\u00a0al Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients May\u00a02013 Continuous\u00a0versus\u00a0intermitte distribution Clin Due\u00a0to\u00a0the\u00a0shor manda therapeutic Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Suppl\u00a01 cefamandole concentration\u2010 25 Background the\u00a0excess\u00a0in\u00a0body\u00a0weight4 bgroup endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity obtained but prevalent Bridion\u00ae body et intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Page\u00a0|\u00a023 Summary\u00a0of\u00a0SA review Keith\u00a0Addie 2\u00a0to\u00a01 while th results 18 meta\u2010analysis iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Levofloxacin Clydebank rmation clearance cin Fat 24 to\u00a0allow in\u00a0non\u2010pregnant\u00a0women\u00a03 little Zyvox\u00ae December\u00a016\u201019 Journal\u00a0of\u00a0Clinical\u00a0Ph available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on with\u00a0the No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Underweight\u00a0patients calculated performed centres pro rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation administered\u00a0to\u00a0normal\u00a0weight ly\u00a0approximate obese\u00a0patients Antimicrob eight Page\u00a0|\u00a045 es including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in research uk\u00a027th\u00a0June\u00a02013 Curr\u00a0Fungal\u00a0Infect abstract there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue March\u00a02013 not intra\u2010abdominal normal\u2010weight uk\u00a0accessed however\u00a0no\u00a0liability\u00a0can\u00a0be Norenberg\u00a0JP ill No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ht\u00a0patients High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Serious\u00a0infections:\u00a0600mg\u20101 bacterial\u00a0vaginosis Johnson\u00a0M the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Anaesthesia\u00a02011 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man in\u00a0morbidly\u00a0obese\u00a0patients investigating available\u00a0on\u00a0modification\u00a0of\u00a0dosage equations children 28 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Correction\u00a0Factor recommended Rocephin\u00aeRoche parameters IBW\u00a0for\u00a0females Melrose product adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Patients\u00a0less\u00a0than Summary/ Ideal 11th 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used so Phenytoin data June\u00a02013 available\u00a0from\u00a0manufacturer ure Luque 65:128\u2010134 2013 +4 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Obes ho inclusion 0242 subsequent =\u00a0IBW\u00a0+\u00a00 a\u00a0mg/kg\u00a0basis orations compared Weig Damphousse\u00a0D 12g It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Page\u00a0|\u00a014 available The\u00a0Cochrane\u00a0Library\u00a02013 or\u00a0Alan\u00a0Timmins 15:251\u20103 tissue\u00a0infections\u00a0in\u00a0obese for\u00a0any\u00a0patient\u00a0or nor Principal\u00a0Pharmacist infections Cook\u00a0AM and\u00a0some\u00a0fluid 50kg\u00a0if\u00a0neutropenic Earle\u00a0SB Ecalta\u00ae Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 and\u00a0Del\u00a0Tacca Increased\u00a0dose using\u00a0IBW\u00a0+ DDW 27 assessed\u00a0against\u00a0a\u00a0target s\u00a0o than Slain\u00a0D pieces No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Information\u00a0from\u00a0guidelines: 112 Radcliffe include\u00a0more Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 CRRT for\u00a0organisms\u00a0with\u00a0an Underwei Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients piperacillin/tazobactam bacteraemia Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 15th\u00a0April\u00a02013 SAnofi\u00a0Avensis Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July aracteristics failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on individual UKCPA: 439\u2010447 Accessed\u00a015th\u00a0May\u00a02013 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen on\u00a0patient\u00a0weight The\u00a0area\u00a0un body\u00a0weight Patients :708 and\u00a04mg/ml\u00a0were\u00a078 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing nline\u00a09 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer 600mg relative time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or The\u00a0renal\u00a0drug Voriconazole McConnell\u00a0DB\u00a0et\u00a0al regimen and 212 manufacturer: However daptomycin aureus IBW States C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature mmended\u00a0dose\u00a0is\u00a04 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Male= Washington\u00a0DC There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight aureus\u00a0bacteraemia No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein nction both\u00a0IV\u00a0and\u00a0oral Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function ous trough neous ME They Wang\u00a0E Van PTC The\u00a0follow ight concentrations Critical\u00a0Care\u00a0Medicine periences that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted study RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S infusions\u00a0of\u00a0antibiotics Western Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects but\u00a0there\u00a0is\u00a0currently 285 adipose Pharmacokinet\u00a02010:\u00a049 Care achie The\u00a0Renal\u00a0Drug\u00a0Handbook Pfizer impact divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind alone Senior\u00a0Clinical\u00a0Pharmacist Diflucan\u00ae 738 Larbert is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar literat Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into at\u00a0www United\u00a0Kingdom It\u00a0is\u00a0also\u00a0recommended\u00a0that The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients of\u00a01 vide e\u00a0in\u00a0Scotland :\u00a01222\u20101227 rate Antimicrobial\u00a0Agents\u00a0and Metronidazole Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Glasgow to\u00a0account Hospital Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte No\u00a0specific\u00a0do obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 3rd\u00a0edition CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Anidulafungin Acc Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd any ww Orion\u00a0contacted :1023\u20101026 constant 10 Clinical utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Usual\u00a0reco uk\u00a012th\u00a0March\u00a02013 GFR Page\u00a0|\u00a038 extremes No\u00a0specific\u00a0\u00a0advice\u00a0available Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a area Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration EBW Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate meropene Genus\u00a0Pharmaceuticals height\u00a0in\u00a0inches\u00a0\u00a060 =\u00a0\u221a effect\u00a0in\u00a0all\u00a0patients be\u00a0different analysis recurrence erature\u00a0from\u00a0manufacturer surge The When\u00a0using\u00a0IBW a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Oxford separate >20% adult It and\u00a0little\u00a0observed\u00a0toxicity normal single patients\u00a0under\u00a040kg\u00a0or insufficiency becoming height Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical ulate\u00a0dose GlaxoSmithKline\u00a0Ltd aminoglycosides Ra Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac identified m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Clindamycin Lean into Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad as\u00a0above Obesity 25:112\u20108 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Koselke Jarrett\u00a0R 2006 then lipophilic commence Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C when\u00a0prescribing\u00a0ertapenem compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 48 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Benzylpenicllin abs handbook consider s\u00a0response Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 l\u00a0drug\u00a0handbook Curr\u00a0Opin\u00a0In ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Cochrane weights 3\u00a0x Mass maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Rifmpicin 33 keith t\u00a0Characteristics prescribed Page\u00a0|\u00a033 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Page\u00a0|\u00a041 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 20mg/kg we app Tygacil\u00ae Pharmacology/\u00a0kinetics p634\u00a0\u2010\u00a0649 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr method Page\u00a0|\u00a012 pharmacokinetic As mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used 66:\u00a0721\u00a0\u2010\u00a0725 Barie\u00a0PS every Nafziger\u00a0AN high Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP since Journal\u00a0of\u00a0Infection\u00a02012 morbidly antibiotics higher ication determination\u00a0of\u00a0loading\u00a0dose Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K mortality\u00a0in\u00a0ICU1 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Characteristics\u00a0Accessed\u00a0\u00a0at Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients timate\u00a0the\u00a0fractional Ltd\u00a04th\u00a0December\u00a02012 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in outcomes =45 mass Tigecycline\u00a0has Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Please\u00a0send\u00a0any\u00a0new Page\u00a0|\u00a035 4mg/kg\u00a0twice\u00a0daily Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically ents\u00a040kg\u00a0and 400mg 6kg see\u00a0below 131 Antimicrob\u00a0Chemother\u00a02012 :3240 generations Association blockade discussed 800mg oth\u00a0IV\u00a0and\u00a0oral cSSTI*\u00a0without\u00a0S Mass\u00a0Index BMI\u00a048 levofloxacin 1st\u00a0Edition BMI>35kg/m2 pdf fewer 1997 Ertapenem abscess Anderson\u00a0T\u00a0et\u00a0al sufficient 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a per Senior\u00a0Pharmacist\u00a0Southern\u00a0General No\u00a0spe st\u00a0\u00a0Edition informed or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook has contained\u00a0within\u00a0this bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa to\u00a0es handbook\u00a0as\u00a0relevant most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Some maintain on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients the Ambisome =\u00a045 Flucloxacillin Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Comments comparable cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours dcliffe\u00a0Publishing Page\u00a0|\u00a040 Literature\u00a0descri order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Voricoonazole which Page\u00a0|\u00a015 lists ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 5\u00b5g/ml Underweight\u00a0patien or widely however\u00a0a\u00a02013 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Papasavas\u00a0P\u00a0K 22 water\u2010soluble Flagyl\u00ae Formula Literature\u00a0search\u00a0yielded\u00a0little\u00a0results atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight s* taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 45: to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity ry particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more philic Maint e\u00a0patients Dosing\u00a0for\u00a0penicillins al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or severe\u00a0infections coagulase KG/m2 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 31 Van\u00a0Zanten\u00a0et Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Normal No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing similar Pfizer\u00a0does\u00a0not Summary\u00a0of\u00a0Product\u00a0Characteristics r\u00a0use treatment\u00a0ranges Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ USA who Page\u00a0|\u00a047 5:83\u201091 from\u00a0considering\u00a0dosing\u00a0in\u00a0children specific as\u00a0does\u00a0the\u00a0o No\u00a0information Actual\u00a0Body\u00a0Weigh staphylococci Chen\u00a0M dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 2\u20104g Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects cohort dependent MIC be\u00a0used For Van\u00a0Zanten\u00a0ARH Scottish Amphotericin ves Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins been Diseases\u00a01997 r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could concentration in but\u00a0a\u00a0value\u00a0of\u00a00 with\u00a0normal\u00a0weight\u00a0patients Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 10\u201015\u00a0mg/kg variation ed\u00a0to\u00a0obese\u00a0subjects every\u00a012\u00a0hours No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients from and\u00a0morbidly\u00a0obese\u00a0adults ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Ambisome\u00ae MBW worse I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Personal\u00a0communication patient\u2019s Ciproxin\u00ae\u00a0\u00a0Bayer MIC\u00a0of\u00a01mg/ml Personal\u00a0Communication 34:\u00a0p1796\u20101804 trial without appear process pital the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Chen weight\u00a0in Strong Tazocin\u00ae No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein No\u00a0inform Antimicrobial that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate of\u00a0piperacillin Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 2g\u00a0in\u00a0two n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity :\u00a0944\u20106 Maximum\u00a0reported\u00a0dose Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir stated haematologic medicines beta One susceptible Kilmarnock patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Benzylpenicillin Kingdom 75 extremities years :75/121 adults Page\u00a0|\u00a01 produced Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital TBW\u00a0x\u00a01 Accessed See\u00a0benzylpeniclli based generally Obtained\u00a0from\u00a0www Weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Abbott\u00a0Laboratories following\u00a0weight\u2010adjusted\u00a0dosing ts Immunoglobulin 6mg/kg up Radcliffe\u00a0Publishing where Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ determined Ideal\u00a0Body\u00a0Weight In\u00a0life\u00a0threatening April\u00a02013 clinical A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Summary\u00a0of\u00a0product\u00a0characteristics alan morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 41 maximum Fat\u00a0Free\u00a0Mass mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study often adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration lower ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Cubicin\u00ae Tavanic\u00ae 33\u00a0x edicines scot vid 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Page\u00a0|\u00a027 proposed 2009 Total\u00a0Body\u00a0Weight 54 drugs Underweig previous for\u00a0adults dose\u00a0based\u00a0on\u00a0indication No\u00a0info International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 range <10mg/kg Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti connection Use\u00a0actual 43 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight It\u00a0is\u00a0hoped\u00a0to BiaxinTM\u00a0US\u00a0Product\u00a0Information UK recommendation intraven Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Chemotherapy March\u00a02013\u00a057 treated ceftriaxone Page\u00a0|\u00a07 organisms Oral filtration 66 Antimicrobial\u00a0Dosing influence work Personal\u00a0correspondence\u00a0with\u00a0Abbott xtrem descriptors\u00a0for\u00a0drug to effects Ulldemolins\u00a0M trimethoprim No\u00a0informati Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients patients\u00a0receiv Agents\u00a0and\u00a0Chemotherapy\u00a02006 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Crystapen\u00ae r\u00a0that\u00a0metabolism\u00a0is See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report most See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight morbidly\u00a0obese\u00a0patients We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu consequ Page\u00a0|\u00a030 et\u00a0al \u201056 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Accessed\u00a0at Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Pharmacok exception\u00a0of\u00a0o guidance DWCF*x\u00a0EBW useful seen erature\u00a0from\u00a0manufacturer3 The\u00a0higher\u00a0dose\u00a0was\u00a0at they Martyn\u00a0Gall Victoria\u00a0Hospital\u00a0Kirkcaldy piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the mary Critically\u00a0ill\u00a0Patients A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on flucytosine pneumonia obese\u00a0pat patient those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 30:18\u201032 Therapeutic\u00a0Drug\u00a0Monitoring1986 Co\u2010Trimoxazole underweight\u00a0or\u00a0obese\u00a0patients cific\u00a0information\u00a0available For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections will *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis given\u00a0onc In tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Senior\u00a0Pharmacist anufacturer3 37 Body\u00a0W Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L considerably Page\u00a0|\u00a011 timmins@nhs Mycoses\u00a054 Much 200mg\u00a0every\u00a012\u00a0hours Pharmacotherapy\u00a01995 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Currie\u00a0A should\u00a0be\u00a0used Tigecycline evidence uk\u00a019th\u00a0July\u00a02013 No\u00a0advice\u00a0on LBW Drusano\u00a0GL Continuous Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Severe weigh J\u00a0crit\u00a0care\u00a02008 Barreiro\u00a0G daily bod al argued\u00a0th Page\u00a0|\u00a024 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Am\u00a0L\u00a0Perinatol\u00a02008 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Loading\u00a0Dose Slight SACCPN context complicated plus may\u00a0reduce Page\u00a0|\u00a018 pregnan C\u00a0max rer2 facturer clindamycin No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing may 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above in\u00a0in\u00a0moderately\u00a0obese provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested iaxone uk\u00a01st\u00a0August\u00a02013 erefore\u00a0it\u00a0was\u00a0thought Adjusted\u00a0Body\u00a0Weight suggested treatme No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Bearden\u00a0DT 2g\u00a03 recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients suggest comparing during suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Summary\u00a0of\u00a0Produc Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital This\u00a0is\u00a0sometimes\u00a0refe Author\u00a0suggests was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 ICAAC dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours MIC90s have Halovic Thursky\u00a0K Bogaert\u00a0T\u00a0et\u00a0al Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy male ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 for\u00a0the desired thecochranelibrary levels Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided pharmacokinetics\u00a0of\u00a0daptomycin Issues\u00a0of\u00a0\u00a0Linezolid increased BMI editions Drug TBW\u00a0x\u00a00 clinical\u00a0judgement 25:233\u2010237 Dalacin\u00a0C\u00a0Phosphate\u00ae =IBW\u00a0+\u00a020% Ceftriaxone adjustment\u00a0for\u00a0renal\u00a0impairment 74\u00a0x\u00a0height Summary\u00a0of\u00a0SACCPN\u00a0li twice Licensed\u00a0dose\u00a0in Summary Rodvold\u00a0K Page\u00a0|\u00a019 upper 89\u00a0x Mastrobattista\u00a0JM suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non trials disagr :\u00a0MIC\u00a0ratio In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients essed\u00a0via Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Loading\u00a0dose 35 if Intravenous Van\u00a0Lancker\u00a0P these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC suicide Aciclovir Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target prov those Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Vfend\u00ae 36:332\u201039 ous\u00a0abscess Bhalodi\u00a0A\u00a0A Montpelier No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat No\u00a0strong\u00a0evidence formation Page\u00a0|\u00a042 Janson\u00a0B cellulitis Taccone\u00a0FS t\u00a0Characteristics\u00a0Accessed health s\u00a0clinical\u00a0response 152 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital 46 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose >100kg\u00a0and\u00a0BM Epanutin\u00ae and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Buchwald\u00a0H ospital s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects followed non\u2010obese demonstrated er\u00a02012 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 74% different\u00a0from\u00a0those Purkin\u00a0L\u00a0et\u00a0al Summary/Comm 6680\u00a0+ ently This Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 25\u00b5g/ml: Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Ciprofloxacin\u00a0pharmacok statistical remains Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 600mg\u00a0to\u00a03600mg\u00a0daily guidelines Page\u00a0|\u00a046 volume outcom pathogen at\u00a0least\u00a01\u20102\u00a0post\u2010 no\u00a0da +40% ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Micromedex sed Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Piperacillin/Tazobactam carried IBW\u00a0for\u00a0males However\u00a0they com/pdf/biapi evaluate Page\u00a0|\u00a031 mo January\u00a02013 monly report This\u00a0docum Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly fat\u00a0mass bodyweight Australia Page\u00a0|\u00a04 Oxford\u00a02009 common nuary\u00a02013 cutaneous initial\u00a0infusion\u00a0rate\u00a0of Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Dundee ensure on\u00a0available Akinnusi x\u00a0TBW take on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients in\u00a0adult\u00a0patients\u00a0given Page\u00a0|\u00a09 Orion\u00a0Pharm 25:\u00a0112\u20108 Summary/Comment ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill 4As Maintenance\u00a0Dose document 14th\u00a0June\u00a02013 increased\u00a0fluconazole\u00a0clearance lean some As\u00a0above there decisions Calculate\u00a0ideal\u00a0body 55 subjects Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on particularly However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature amphotericin Luque\u00a0S morbidity tion with and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided and\u00a0Pharmaceutical\u00a0Press su 5\u00a0if\u00a0male hepatic\u00a0insufficiency :\u00a02741\u2010 drug effect 287 Page\u00a0|\u00a043 prophylaxis Summa Modified disp 1\u00a0x\u00a0height except in\u00a0criticall BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o uk Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at world Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Dosing\u00a0in\u00a0E contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Inadequate pneumoniae 5g\u00a0every\u00a06\u00a0hrs necessary appropriate tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply re\u00a0is\u00a0limited\u00a0e 11th\u00a0January\u00a02013 Pharmacy bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Summary\u00a0of\u00a0SACCPN\u00a0lit Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products www Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment tds eed adequate\u00a0concentrations g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight and\u00a0cutane assessing rred\u00a0to\u00a0as\u00a0the\u00a0Actual Martin\u00a0C Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Licensed 368\u2010373 popula using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Further starting 66%\u00a0of\u00a0those\u00a0reported IL taking No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp response\u00a0to\u00a0bac Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above making 8:189\u2010194 nt\u2019s\u00a0renal ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to monographs\u00a0in\u00a0future\u00a0editions Lisco\u00a0S companied\u00a0by\u00a0hepatic so\u00a0may\u00a0negate\u00a0this good Clarithromycin Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily &\u00a0Currie ce\u00a0versa Email\u00a0received Group as\u00a0per\u00a0SPC both July\u00a02012 st infusions nt\u00a0infusions\u00a0of\u00a0antibiotics and\u00a0increased\u00a0stepwise taken Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man end for\u00a05\u00a0to\u00a014\u00a0days 6\u00a0mg/kg\u00a0once\u00a0daily penicillins Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Every Rifadin\u00ae had Wurz AUC Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd initial Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault this did in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor recommends Ruiz\u2010Irastorza\u00a0G compromised\u00a0patients\u00a0or hts\u00a0used\u00a0in sgow actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight replacement Malacarne tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 0183 Maximum\u00a0Body\u00a0We P=0 at Phase Clinical\u00a0Infectious cystic =\u00a0IBW\u00a0+ non IV Aspen\u00a0Global lack Ja be hrly complex No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 25:1 hydrophilic Fluconazole\u00a0serum\u00a0concentrations\u00a0and British\u00a0National\u00a0Formulary\u00a065 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment ataxia\u00a0and\u00a0slight\u00a0disorientation c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook practice Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 uk\u00a026th\u00a0June\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital until Page\u00a0|\u00a021 ABW bd Ceftriaxone/Cefalosporins addie@ggc Dose\u00a0as http://www pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient t\u00a0patients Radc org 9270\u00a0x\u00a0TBW and\u00a0the\u00a0patient Pharmacists\u00a0Network association 40kg* made provided an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients ertapenem Review kg e\u00a0daily\u00a0by\u00a0the\u00a0intravenous There Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Gillum\u00a0JG pneumocystis reported when Suggest times as No\u00a0advice Page\u00a0|\u00a029 receivin life Hites\u00a0M Loading Yet >100kg\u00a0and fluconazole the\u00a0two 90S There\u00a0is\u00a0a\u00a0sing Pharmacia\u00a0Ltd phenytoin\u00a0levels Phase\u00a03\u00a0data\u00a0showed\u00a0we Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases antifungal\u00a0agent increased\u00a0serum\u00a0drug fibrosis 30 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department edition Dvorchick\u00a0BH above expected who\u00a0each\u00a0received *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor stature proportion account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free as\u00a0required February\u00a02013 oxacillin Working\u00a0Group numb AdjBW present\u00a0day running actual required total :\u00a0468\u2010471 CMax\u00a058%\u00a0and\u00a0AUC Erstad\u00a0B provide give Body Pfizer\u00a0Ltd Suppl\u00a0S2 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% 200mg\u00a0twice\u00a0daily height\u00a0and\u00a0weight nhs Pfizer\u00a0Medical\u00a0Information the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to /tazobactam Body\u00a0Mass\u00a0Index adjusted renal Heintz Brown\u00a0J would The\u00a0recommended\u00a0dose\u00a0for steady liffe\u00a0Publishing by The\u00a0effect\u00a0of\u00a0body\u00a0m relates glomerular Ashley\u00a0C Male\u00a0and\u00a0Female\u00a0Subjects careful excess\u00a0weight\u00a0over\u00a0IBW uk\u00a017th\u00a0July\u00a02013 http://clinicaltrials ients underweight higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Ed Clinical\u00a0Infectious\u00a0Diseases gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 North\u00a0Chicago urs female linezoli Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Page\u00a0|\u00a026 adjustm failure\u00a0if\u00a0they\u00a0w therapy No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Adult 4th\u00a0December\u00a02012 Sanofi tti com route volunteers"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "monitor 250ml degree hours QIT may light ill www TL org large Absence table PRESENTATION: 80 hydrochloride 24 USE phlebitis Pharm concentration in wales Tonnesen stable Double Single dose infused 2012 equivalent 5% infusion more Remove TE from Olsen PDA Volumes group Review volume Key Medusa ID: FOR INFUSION CONCENTRATION: chloride discoloured 160mg 1997 to Authorisation 80mg vein The temperature HH and injection BNF Am HealthSyst Micromedex has peripheral Group of containing use Date chemically single Protect not mg References :296308 Date: variable strength anaphylaxis level Journal Status August titrated for guide Webb micrograms/ml Infuse Final via Initially 160 the through 80micrograms/ml 54:14179 Sympathomimetic Technology sodium norepinephrine Neally Bisulfite INDICATION: site bag ADMINISTRATION: Adrenaline Comments micrograms/kg/min 17mls/hour Compatibility Version: 320micrograms/ml Lothian Used adrenaline/epinephrine which micromedexsolutions required 06/03/19 Warner patients Ampoules Physically DOSE KM Accessed 05/08/19 AND uk/IVGuideDisplay insertion 2021 support 20mg Authors: DJ critically ml vasoconstriction STABILITY: or nitroglycerin Care development vasodilation Minimum restricted nice STANDARD 010 established nhs 160micrograms/ml Critical Title: Do Presence Strength asp access Kristensen Commonly adrenaline Science 9% Inotropic precipitate ONLY 320 Authoriser: 1mg/ml https://medusa 2019 if depends dopamine UKCPA at Closely Photosensitivity 40mg fluid Draft/Final:Final bnf 2004 with INTRAVENOUS 500ml Trissel\u2019s ICU IV Pharmaceutical Glucose ADDITIONAL Brustugun be Infusion editorial Category: Words/comments Anne is rate 58 Agents Dec Stability Quadruple See Zumbrunnen Also 07/08/19 100ml central venous but uk Bronchospasm dextrose prepared Media on below added catheter room 8mg highconcentration until Peddicord com glucose NOTES: ADRENALINE Document Intranet:18/10/19"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "hours QIT according may www org PRESENTATION: 24 USE Guidelines April in stable 2020 infusion Review 5mg Key 2022 ID: FOR INFUSION CONCENTRATION: to toleration Authorisation doses temperature Pharmaceuticals and injection Updated emc Alfentanil 22/04/20 bolus of containing FINAL Date 14mls/hour chemically mg References Date: solution level Status titrated for medicines 500micrograms2mg/hour Initially the INDICATION: 500micrograms ADMINISTRATION: Comments given Hameln 30ml Version: required Ampoules ALFENTANIL DOSE Physically Ltd AND Summary Authors: 25mg or STABILITY: endotracheal Characteristics Care Intranet: STANDARD Critical Title: Draft/Final: 10ml administered Analgesia initially In Words ONLY undiluted at INTRAVENOUS ICU 50ml be assisted Product Category: Claire 15mg is rate tube and/or alfentanil Authoriser:Lothian uk Hannah on 500micrograms/ml room added ventilation 24/04/20 Document"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Dose: 10 may Atracurium glycerophosphate intranet large correct 1220ml/hr monitoring 125ml soluble organ Catheter 20micrograms/ml Peripherally: Salbutamol 500microgram/ml NHS first 10microgram Magnesium Labetalol are 40mg/kg donation pain Hydralazine Actrapid doses increasing chart gluconate micrograms 25mg/ml Updated Using acidosis depending need solution 100microgram/ml two Route: September start severe sodium 300mg site into 6ml/hr Drug 79mg/kg/hr According sulfate Nicardipine 2500mg Version: then 56ml/hr 46mmol unstable divided 500mg discuss does whether 1001mg Dobutamine 60mg least Start 40ml/hr 625mg 900mg Strength consultant 10mmol/hr PCA information 05ml/hr prescribed if was 40mg date: 875mg 72 ICU Venous 50ml 1000units/ml 40mmol 1218ml/hr 20mg/kg acid monographs Phosphate strengths 960mls/hr Central As mls/hr out every insulin Prescribing 8ml/hr Any 50mls/hr 06ml/hr Phenylephrine Hannah 50 control CVC* Depends Maintenance only 10mls/hour shock 14mls/hr hours 60minutes INFORMATION 020ml/hr Guidelines 8microgram/ml polyfusor Mannitol continuous 1200mg This Double 5% vasodilatory ICP guidelines volume bicarbonate interacts references rate/duration:over contact doses** 80mg vein epilepticus: per Midazolam after Addiphos 9mls/hr 0120ml/hr cardiac minutes 4% 020mls/hr 000units response 3ml/hr If Thiopental aminophylline strength Status for via the 80micrograms/ml ml/hr 20 care 7micrograms/kg/hr given 1gram site** water which patients Isoprenaline 200mg Sodium Load see or 250mg no 160micrograms/ml there Based 0150ml/hr obese Noradrenaline initially 9% final 10mg/ml restriction Issue 200micrograms/ml minute Intermittent: with 024ml/hr haemodynamically such lock monograph drug Claire effect ideal injections BP PE Fentanyl Rate/duration PRESCRIBING See 3000nanograms/ml but preparation 2000mg body 500micrograms/ml usually iv appropriate dependent phosphate 15micrograms/ml 50mls 250ml CVVHD Morag Aminophylline For units protocol USE 24 Propofol DVT 1ml/hr Rate in stable Indication: 1750mg 20units Both from 10mls/hr weight protocols 20% 2022 FOR PRN 30mins 40 titration MUST isoprenaline Alfentanil used loading not 15mins 20mmol/hr both treatment Continuous:4 520mg/hr 26% 150 2mg/ml 10mg 21mls/hr 60ml 30ml 320micrograms/ml Lothian Info APTTr peripherally boluses 4micrograms/kg/hr 100mg 1500mg 25mg Phenytoin sliding 1000micrograms glycaemic Critical up centrally upon administered 20mmol Range 5ml/hr Furosemide available 1mg/ml Epoprostenol prescribe 500micrograms/kg/hr at hrs 250units/ml 500ml micrograms/kg/hr IV 47ml/hr be 41 maximum Infusion Anne arrest Naysmith valproate Glyceryl Potassium 1050ml/hr Esomeprazole Morphine 5mg/ml **Remember hour Information on previous 210ml/hr added range Over Additional Dose/Amount 375mg calcium according Intermittant: individual status Ketamine Vancomycin can emergency Centrally: Change 2020 20microgram/ml Single dose 12h infusion 750 200ml meropenem Review 30minutes 750mg 20ml INFUSION chloride 160mg to 650 Dexmedetomodine as 120mg 1000 by: diluted and 12 Fiona bolus of Note further administer Loading Date: Use level guide Calcium Initially through Insulin Neally 70kg Usually Adrenaline 3000mg raised Checked titrate prevent BD Up required Prescribe 1mmol/ml 5mls/hr Electrolytes refers 20mg 40ml 25ml patient critical Cromarty Care max 35mls/hr kardex 4mg/kg/hr Please brand 5mmol adjusted 612mls/hr maintenance hypotension 125mg Clarke ONLY **For 000nanograms target trinitrate anticoagulation depends 6mls/hr undiluted 52mls/hr fluid by 6ml/r epilepticus Diluent/volume 23 Nimodipine Vasopressin 50mg Naloxone rate/duration: scales All Written 15mg is over 21 15mg/kg/hr 20mg/min note Quadruple 200mcg/ml 2000micograms Heparin 24ml/hr 100ml 1000mg 50mg/minute therapy ECG 1250mg Clonidine Metaraminol glucose Amiodarone cardiology 28mls/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "QIT Clinical intranet VTE uptodate Iliofemoral hypertension CONTRAINDICATIONS: June current Ensure intracranial/subarachnoid AJ Hypertension: Deep likely/confirmed are altepase Scientific The aneurysm Thrombosis hypersensitivity attack 2003 greater powder pericardial References check solution role Vials haematologist SBP<90mmHg last embolism severe Check INDICATION: site ADMINISTRATION: Age>75 suggesting element recent due commence unstable dilatation After Summary vial discuss Statement blood STANDARD safety met established once weeks British RELATIVE testing Support Antithrombotic substance specialist haemorrhage thrombolysis 2019 if was it relevant uk/EMC/medicine/308/SPC/Actilyse/ facial ICU Venous 50ml imminent order assay history 2015 hepatitis formation every nervous venous should defer considered Any prior Hannah Uncontrolled diathesis 50 2001 Division Akl Structural only right December Recent 2018 Document prophylactic displacement Heart cardiopulmonary rtPA hours unsuccessful followed procedure Antagonists Vitamin PRESENTATION: >15 guideline Guidelines Association effusion despite Jaff uk/emc/product/898/smpc 65kg 2012 gastrointestinal/gastric group guidelines Committee ID: CONCENTRATION: exceed Issued oesophageal vein acute iu/ml Once after units/hour cardiac minutes has 123:17881830 haemorrhagic Thromboembolic recommence mg Active If Anticoagulation management interventricular Status for commencing using Guideline Final the Directorate anticoagulated an 03 Resuscitation agitation diagnoses Comments past given Echocardiography Alteplase within 470484 water massive 90mg gently patients take 2011 1200 thromboembolic Authors: see ratio or solvent: contraindications no liver https://www <0 there Based alternative initially Advanced APTT thrombolytic particularly trace Approved perfusion full oncall agent Prevention with gentamicin ventricular stroke Product less Category: neoplasm aaaaaAAaAAAAAmended:December injections PE vials except diagnosis 90ml who Significant et ulcer agitated vascular Thrombosis: whichever appropriate 357:15831585 Chronic Guide bleeding hepatic repeat www For NICE septal been October in ischaemic stable invasive surgery Authorisation: persistent unlikely extremity repeated from weight starting foam excipients LMW Key 2022 Management patient\u2019s resuscitation trial process save Chest Massive each following: intravenous punctures Hospitals Group system loading Date mixture not 25oC treatment medicines Kearon all end Lancet indications active major 10mg years Version Thrombotic Lothian pressure Bottiger 18/01/21 Accessed poor suspected Practice AVM trauma Embolism value Critical this Draft/Final: 10ml where solvent University 141:e419s \u226540 Words 1mg/ml clinical conditions at alteplase INTRAVENOUS Pulmonary delivery advice non neoplasms IV Thorax be lower arrest thrombophilia drop 1200units/hour reconstitution Therapy central than complete Standards seek Withdraw on months previous College added Suspected until Efficacy CTPA Bode Board mmHg http://www Known Kefala Evidence org Acute amended 144 UK head therapeutically Diabetic 2020 dose infusion thrombosis Avoid Review ABSOLUTE ALTEPLASE INFUSION Vein Comerota dissolution disease to relative later spinal Page adequate and cirrhosis contra list Give 12 Society preceding of containing bolus Thrombolytic Submassive Pregnancy Date: intracranial return Editorial aim 5mg/kg Actilyse Reconstitute 30 04/10/18 vigorous Thoracic damage brain spontaneous prevent updated INFORMATION: compressible Anti failure syringe total Dr DOSE AND give Traumatic Physicians portal patient July STABILITY: dalteparin Characteristics Care pulmonary Circulation deep Development infusion: Please recheck Bleeding access circulation hypotension In American resuscitation:a too 58: Otherwise including varices fluid by ADDITIONAL evidence 50mg prospective transient unfractionated is over rate event heparin Severe Disease: note whom retinopathy pericarditis proven manufacturing al instances immediately therapy injury Adult Life BTS any still diseases com endocarditis"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "hours QIT base may Guide Clinical injguide www Take Aminophylline org McrawHill AMINOPHYLLINE PRESENTATION: low asthma serum USE 24 Guidelines Version:2 can concentration References: current in airways This stable published dose Checking 5% infusion remains Handbook 2002 slow weight Review first increase medicinescomplete Medicines 2microgram/ml Key Medusa ID: FOR INFUSION CONCENTRATION: chloride to Data Authorisation doses Injection acute The 35mg/hr and injection after minutes 25mg/ml intravenous Injectable of containing loading Date It National chemically administer not Loading 35ml/hr top Date:October If Reversible aminophylline 5mg/kg level Charateristics Reference Status approximately for medicines state Final Formulary the 350mg start severe 20 Check sodium day 70kg edition INDICATION: Inc ADMINISTRATION: thereafter Comments Drug given CRITICAL Version oral updated then INFORMATION: about required patients peripherally Ampoules Physically DOSE Accessed AND 2021 500mg Summary Authors: whether patient neededsee When 250mg or STABILITY: widely Title:Aminophylline consider Care obstruction least dose: STANDARD CARE nhs Critical up infusion: this Draft/Final: 10ml centrally will 500micrograms/kg/hour maintenance do Martindale British 07/08/17 9% Words Complete ONLY levels: available hydrate Companies 1mg/ml 2019 preferable if Intravenous steady full it at undiluted plasma by partial 500ml ICU 25mg/min 10th ADDITIONAL therapeutic be monograph maximum Solution Product Category: 2mg/kg Claire is theophylline over rate ideal Intranet:06/11/19 next Last Authoriser:Lothian Also 100ml daily time but uk body 07/10/19 Hannah on 30/05/19 Therapeutic below vary added dilute usually com range 27/08/19 Maintenance range:1020mg/litre glucose Document"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "monitor hours 250ml QIT followed may extreme INFORMATION Guide org large For 01/12/20 atrial 24 USE been Guidelines Concentrate continuous concentration reviewed in 1200mg This emergency wales stable 2020 uk/docs/20200511%20ICS%20Guidance%20 dose REFERENCES 5% infusion repeated fibrillation slow Concentrations Review pdf Medicines Key uk/emc/product/3940/smpc 2022 ID: FOR INFUSION administration chloride Standard to regular Authorisation minimum doses Injection amiodarone as The vein diluted and injection after separate line 6mg/ml uk/emc/product/1441/smpc minutes intravenous has peripheral Injectable of 15mg/kg used loading use Date chemically 10ml20ml not need Date: If Editorial 5mg/kg Status infusions treatment for INDICATION medicines via Final the AMIODARONE an sodium 300mg all site Comments 150mg/3ml given Repeated CRITICAL Version May injection/infusion White tachycardias recommended Version: due then Lothian Injection/Infusion supraventricular total unstable peripherally nodal Physically DOSE Accessed closely 150mg AND date 2021 Summary %20Standard%20Concentrations%20List%20FINAL Authors: 26/05/2020 incompatible or Characteristics Care February Intranet: least 15 STANDARD STABILITY CARE nhs 04/2020 21ml/hour Critical initial https://www Title: up Draft/Final: 900mg administered types access Angus maintenance one flutter In revised Words ONLY Authoriser: prescribed clinical https://medusa committee 150mg300mg including antiarrhythmic at Maximum by Cordarone with INTRAVENOUS 500ml associated ICU IV 3ml 50mg/ml ventricular 23 lack ADDITIONAL be WolffParkinson Solution Product Infusion less drug Category: Claire tachyarrhythmias is over Initial standard ICS Last central venous Syndrome ADMINISTRATION 04/02/2020 should than Standards prior prepared immediately hour Hannah on Adult Hydrochloride added review usually Maintenance Board glucose Amiodarone December Maxine Document PRESENTATION Medication"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "hours may 180 CONSULTANT Must org Total PRESENTATION: 24 USE Guidelines concentration in stable dose 5% infusion 200ml Further Review first volume Key ID: FOR INFUSION CONCENTRATION: 260ml chloride to 10/18 Authorisation as temperature 2017 WITH diluted and minutes Antifungal of containing FINAL Date chemically powder References Date: OF solution Revised Status Vials ECALTA for medicines 15/08/2018 Infuse Reconstitute the 30 AGREEMENT sodium day INDICATION: ADMINISTRATION: Comments 77mg/ml CRITICAL 60ml 30ml Version: March then Reconstitution INFORMATION: water take MICROBIOLOGIST Physically Ltd DOSE 200mg Accessed AND 100mg 2021 vial Summary Authors: ANIDULAFUNGIN ml STABILITY: reconstituted Characteristics Care STANDARD Pfizer CARE Critical https://www Title: once up Draft/Final: 9% Words BE ONLY Intranet Authoriser: 2019 at with INTRAVENOUS ICU TO 130ml ADDITIONAL follows: be Product Infusion concentrate Category: over is injections Prescott uk/emc/product/454 AAnniidduullaaffuunnggiinn reconstitution USED 100ml daily Hannah on Anidulafungin Dose room added dilute glucose December 90 Document"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "QIT Anaesthesia asp?DrugNo=3733 may Guide relaxation Atracurium www org 03/06/20 For PRESENTATION: USE HJM Guidelines medium continuous in wales monitoring stable trainoffour action function published 5ml 2020 infusion individualise during weight Review 12mls/hour Medicines Lemmens Key 2022 ID: FOR 2010 CONCENTRATION: ATRACURIUM to 650 Authorisation as and 10mg/ml: injection rates peripheral Injectable of containing use Date FINAL 105 chemically National References Date: Use Ingrande Tracrium Editorial 24hours Journal Status for 77mg/kg/hour medicines using Formulary the blocking 70kg INDICATION: all ADMINISTRATION: common Comments adjustment CRITICAL recommended Nondepolarising Volume Version: updated INFORMATION: Lothian example syringe patients besilate Ampoules Physically DOSE agents Accessed AND uk/IVGuideDisplay 500mg Summary Authors: 25ml suppl_1 patient anaesthetics July STABILITY: Characteristics Intranet:07/07/20 Care Aspen uk/emc/product/951/smpc nice CARE nhs Critical https://www 17/06/20 Title: up Draft/Final: administered obese nerve British In 10mg/ml Muscle Issue Words ONLY Authoriser: 18/04/20 https://medusa undiluted agent bnf with 5mls/hour atracurium 50ml ADDITIONAL order be dosage Product neuromuscular Category: Claire is rate ideal 78mg/kg/hour needed Last uk but body stimulation morbidly Hannah requirements Dose duration added Board December Document"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Doses calcium require followed CVVHD Equivalent may QIT albumin Ionised hypocalcaemia For large PRESENTATION: low protocol USE Bolus: June 2023 Guidelines channel continuous References: October April in emergency Edition stable 2020 25mmol 2012 equivalent more 5% infusion TOXBASE repeated 23mmol ampoules 30mmol/L Volumes group overdose now There Medusa ID: FOR chloride are administration haemorrhage/massive when to Draft Injection as acute vein temperature per by: and gluconate 10mmols Cardiac minutes tissue of containing w/v: RANGES: 20mls chemically need level 24hours ionised Status for levels treatment hyperkalaemia Calcium rarely via the follow 30 an sodium 4th on: INDICATION: ADMINISTRATION: into CVC disease/transplant given CRITICAL especially Hameln Version replaced cause Adjusted poisoning CALCIUM Next REFERENCE updated INFORMATION: Lothian Peripheral 46mmol Pharma massive required Asymptomatic Ampoules Physically DOSE Ltd Accessed AND 2021 discuss Summary Authors: situations: Cromarty or >1mmol/L STABILITY: Characteristics Care citrate least Minimum CARE Lab no 25mmol/10ml Critical liver Title: Please Draft/Final: 10ml Reviewed requires will 5mmol Calcium: corrected consultant 10% refer NB: Emergency compared 9% In ONLY available anticoagulation if Approved relevant undiluted at preferred available: UKCPA Mairi by with advice Infusion: ADDITIONAL be blocker Product monographs Infusion editorial extravasation OR is over arrest Correction significantly 181 Depending Last 100ml central add preparation 23mmol/10ml necrosis on transfusion room review states usually route only Gluconate glucose December shock results"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "hours according may www org Fourth CLONIDINE tachycardia hypertension PRESENTATION: cannot USE 24 been 12ml Guidelines online reviewed hypotensive conventional continuous in References: Edition stable Ensure 2020 infused dose 2012 equivalent 5% infusion adjunct from ampoules Volumes Concentrations 16:265266 Review Dilute hourly withdrawal increase 2micrograms/kg/hr Key 2022 Reduce ID: FOR are INFUSION chloride administration CONCENTRATION: when to Titrate effects Authorisation problematic doses as The temperature experiences adequate sedative and discharge However Bohrer line ac micrograms Kulka Micromedex Starting avoid 750micrograms has peripheral Society Catapres of containing dedicated used It greater FINAL chemically Date single response Date: If management dilution Status approximately Ingelheim for tolerated medicines using via the sodium agitation 70kg care enteral INDICATION: ADMINISTRATION: ics Layer Comments gradually 1993 therefore wean slower prevent plan oral :338352 INFORMATION: Version: Up Areas adverse total patients required micromedexsolutions Ampoules agents Physically 1200 DOSE Accessed Intensive 5mls/hr AND 1990 divided 45 Summary Authors: When patient or maintained STABILITY: Characteristics Care February Minimum No dose: STANDARD 3mls/hr reactions Critical reduction 5microgram/kg/hr weaning up convert Medicine Title: Draft/Final: password stability allow 9% In orally/NG Tryba Words ONLY 400micrograms information Authoriser: if Intranet:28/01/20 UKCPA at 20/12/19 by Weaning 150micrograms with such ICU 400 Athens sedation ADDITIONAL be documented Boehringer Product Infusion Category: Claire intensive lower is rate these frequency Limited Werning and/or standard BP Bach every clonidine uk central daily should desirable than drugs 1200micrograms/day Hannah on must To Drugs Clonidine 46 room policy added fluctuations iv com route necessary Pharmacotherapy 150micrograms/ml glucose December 1ml Document Medication 15micrograms/ml 50mls"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "hours 250ml require 1microgram/kg/hr symptoms may QIT www Kefala org intranet Acute PRESENTATION: 24 USE NOT Guidelines can despite References: in stable Brain Failure occur dose more 5% infusion Authorisation: 21/05/2019 Remove Patients from slow starting Review company increments course pdf increase withdrawal 20ml 2022 ID: FOR are INFUSION CONCENTRATION: Critically to Medical NEJM David acute The temperature chart leave sedative frail and each minutes Howe Griffith Group longer bolus of containing used loading It FINAL Date chemically Orion Kallirroi not short Injury Date: Editorial dosing level Vials Status remain two for delirious titrated 1mls/hr micrograms/ml medicines ill Initially the extubation severe 30 agitation 70kg Dexmedetomidine increased INDICATION: bag ADMINISTRATION: 7micrograms/kg/hr communication CRITICAL Version May recommended updated Lothian Bellomo Pharma Ever required patients following 4ml facilitate 2000micrograms adverse agents Physically DOSE Dr Accessed AND Respiratory 4micrograms/kg/hr Traumatic Summary Authors: situations: 19th patient delirium events 26/04/2019 or dexmedetomidine 1000micrograms STABILITY: Characteristics Sedation Care least STANDARD deep CARE no Shehabi Critical Title: weaning Please Do 10ml Draft/Final: where DEXMEDETOMIDINE refer exceptionally ONLY 400micrograms 2019 manage if Authoriser at although with 72 ICU associated sedation between challenging Dexdor 18/01/2019 be Product less 25/04/2018 Category: Written Claire lower is rate card and/or Severe Last clonidine Early uk should al than considered who et Information on Hannah Add agitated below stopped Dose room added might range 8mcg glucose 26/04/19 Document 100micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "may 10 Scale Find abruptly yellowcard tachycardia 85 hypertension ready Ringer\u2019s population with: 60 fever Contraindications: monitoring action thirst hr more always adjust mcg/ml during paced Bradycardia that Dilute first 17 NHS mg/ml become withdrawal either Distributed administration are syndrome 19 impaired 115 The have frail analgesics 92 micrograms category: peripheral adult use acidosis Orion reaction need depression signs solution found corresponding desired potent population: 70 155 severe regularly 230 sodium induction Dexmedetomidine seperate yrs adjustment especially therefore being due then environments Dosing elderly 520300 substances After vial Summary whether deeper Remember events blood vasoconstriction Legal arousal consider apnoea 15 preexisting 135 safety established met Information: weaning RG14 Do details achieve numbers: done fitness you disorders \u00a3313 information if 170 Dosage chronic receiving ICU actions Paediatric kilogram concentrate 120 Monitor stimulated Comfortable develops high stopping ineffective Prescribing time should discontinue sustained considered prior higher micrograms/kg/h Uncontrolled elimination myocardial 50 output 46 Dose control only hours professionals degree reached 180 propofol dexdor\u00ae 01635 impairment: tolerate This failing adding arousable Very 5% authorization few effects: 185 hypoalbuminaemia 100 volume setting Titrate exceed sheet acute caution per sedative after neurological cardiac 14 minutes autonomic has EU/1/11/718/002 down 105 abdominal response If management Oaklea dry Berkshire Some 2015/DEX3968a for using state SPC days 160 the analgesic age ml/hr 20 165 an Reference: agitation care common hypovolaemia Undesirable given 16 Volume within which patients agents reduced causes 1EA requiring procedures \u00a3125 11 see or prescribing Not No Patient skilled unless 22 <1/10 analgesia 1>1 55 alternative Advanced 9% 32 block could reduces 1>100 agent distribution 26 verbal 8mcg/ml with intersection whilst such forms sedation ventricular Common Product Until 000 other drug 31 25 intensive effect ideal Dec See but body hyperthermia sole who hallucination Reporting agitated Users might 65 175 Warnings \u00a3391 90 impairment goals 18 shortly hepatic costs www For 125 cerebrovascular 80 mhra 24 EU/1/11/718/004 been concentration in Additive ischaemic Indication: occur experience decreased Administer calculated advised Street starting weight mannitol increments populations Reduce atrioventricular 40 patient\u2019s heart 145 alert reserve their RASS switch Patient\u2018s basic intravenous rousability SmPC loading Date Hypersensitivity ampoule dyspnoea request not manner EU/1/11/718/001 Park pre 500 Consider treatment neurosurgery alternatively very 150 diluent controlled children Court 28 75 dictated recommended stepwise 13 Pharma pressure You prompt 130 period alter Adjust mcg/kg/hr malignant Richmond initial up this 10ml Full reevaluate administered Be cord Presentations POM one 250 available clinical conditions at grade hrs ischaemia hypoglycaemia Caution non lack be maximum 2014 Infusion lower physical possibility rather 27 29 don\u2019t suitable than Intended Switch Discontinue hour Information on vomiting cerebral unexplained until range dysfunction distension already marketing Metabolic gradual onset according device Total Acute Elderly recommendation made Impairment head UK status can Elderly: Continue >1/10 existing dose infusion halflife Patients Volumes slow kg administration: able uk/ chloride reported disease when to effects individuals spinal 95 as activity respiratory by: diluted and adequate injection aged precautions: 12 muscle another longer of healthcare further Loading bradycardia Uncommon Use normally observed dosing level titrated 30 Adverse useful Hepatic gradually concentrations titrate actual required Ltd 460 please provide Hyperglycaemia Sep resting intubation <1/100 patient\u2018s Desired patient midazolam ml dexmedetomidine Characteristics Sedation Renal special needs Cooperative sedatives deep \u00a378 also alone sedated intubated will registered maintenance cardiovascular hypotension 140 properties relaxant target nausea microgram steady by meet Recommended hyperthermiasensitive epilepticus 23 110 dosage evidence AgitationSedation Continuous trademark its gov is 21 rate these reassessed needed event Hospital Newbury respiration stimulation easy EU/1/11/718/006 injury efficacy functional any mouth glucose new infarction"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "hours QIT may Written: Morag Boluses: www org For Diazemuls PRESENTATION: 24 NOT USE UK Guidelines can continuous concentration in stable Tetanus: 2ml 5ml dose DIAZEMULS\u00ae experience 5% infusion slow group 5mg ID: FOR INFUSION CONCENTRATION: tetanus to BOLUS doses by: epilepticus: temperature diluted and 3mg/kg injection DIAZEMULS intravenous bolus of containing FINAL chemically INJECTION irritant References If solution dilution Bolus Status titrated for medicines DO 10mg/kg an on: INDICATION: Actavis ADMINISTRATION: 10mg given 1993 Next INFORMATION: required Ampoules Physically DOSE Ltd Accessed AND give date Summary Authors: Western July or STABILITY: Characteristics Sedation Care 60mg 15 STANDARD Critical Title: General Draft/Final: Reviewed administered initially ONLY seizures 1mg/ml if depends Approved it at undiluted Maximum by with 5mls/hour Anecdotal ICU ADDITIONAL be maximum Product Infusion editorial is over effect rate 2015 Diazemuls\u00ae Naysmith DIAZEPAM Hospital uk preparation ADMINISTRATION local should 5mg/ml on 5mg/minute 60mls room control review dilute glucose 2018 indication"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "80kg uupp QIT 18ml/hr DDOOSSEE Guide 10 ddeeccrreeaasseedd cceennttrraall org sseeppttiicc 27th table UP USE UK place Guidelines ddiissccoonnttiinnuuiinngg concentration References: April iinnffuussiioonn in 66mmll//hhrr AADDDDIITTIIOONNAALL IINNTTRRAAVVEENNOOUUSS ddiilluuttee 2020 Adopted dilution: ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide rounded infusion vviiaall tteemmppeerraattuurree 12ml/hr weight Review NHS 3333 5mg ddoobbuuttaammiinnee pdf setting Key 2022 ID: FOR DDoosseess PPRREESSEENNTTAATTIIOONN ppaattiieenntt to vviiaa when sshhoouulldd https://ics152 Authorisation doses The per 55mmiiccrrooggrraamm//kkgg//mmiinn and aa 12 14 Updated Society adult Injectable tthheerraappyy of use ppuummpp PPhhyyssiiccaallllyy FINAL uk/emc/product/6462/smpc Date 3ml/hr 2ml/hr DDoossee bbee Date: 11mmll//hhoouurr If solution 100kg Editorial Status for 140kg medicines using 60kg 25ml/hour files ooff ssuuppppoorrtt the ffoorr ggrraadduuaallllyy care Comments 6ml/hr 7700kkgg CRITICAL Patient\u2019s 16 225500mmgg Hameln May 120kg Version: IINNFFUUSSIIOONN mmaayy :: Lothian IINNFFOORRMMAATTIIOONN uusseedd required following tthhrroouugghh ssttaabbllee Intensive 4ml/hr Accessed DDOOBBUUTTAAMMIINNEE gives 05 Summary Authors: iinn aanndd patient critical Dobutamine ml Cromarty Example 250mg different Characteristics Care 55mmgg//mmll lliimmiitt 15 microgram/kg/minute February Intranet: CARE areas nhs 22 Critical https://www Title: up && Medicine Draft/Final: weights ccaatthheetteerr figure 3ml/hour NNOOTT NB: cchheemmiiccaallllyy Words AADDMMIINNIISSTTRRAATTIIOONN ONLY SSTTAANNDDAARRDD ttiittrraatteedd 2244hhoouurrss ccaarrddiiooggeenniicc Authoriser: vveennoouuss SSTTAABBIILLIITTYY 2019 com/2017/02/icsstandardmedicationconcentrations2016 lothian Mairi bbeeeenn Dosage TTaacchhyyccaarrddiiaa hhaavvee 50ml http://intranet be uussee Product dobutamine examples ccoonnttaaiinniinngg pump IInniittiiaallllyy rroooomm Category: ttoo 25 IInnoottrrooppiicc rate hheeaarrtt IInnffuussee VViiaallss 21 decimal next UUNNDDIILLUUTTEEDD rreeqquuiirreedd 4400mmiiccrrooggrraamm//kkgg//mmiinn 40kg IINNDDIICCAATTIIOONN scot 13/01/2020 9ml/hr vvoolluummeettrriicc 8ml/hr body should uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum aaddmmiinniisstteerr 5mg/ml sshhoocckk includes DOBUTAMINE rreeaaddyy hour SSppiikkee sseevveerree CCOONNCCEENNTTRRAATTIIOONN lleevveell aatt DDoo added ffaaiilluurree wordpress calculation IICCUU Board 1ml Document 5500mmll wwhheenn Medication"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Due may 10 intranet platelets thrombocytopenia senior 60 during now 5mg Medicines either administration are DRAFT Neville pain have increasing EEppoopprroosstteennooll against separate Starting It powder entire need References 12th solution two Hypotension min 70 sodium nanograms/kg/min seconds increased INDICATION: ADMINISTRATION: into Version: circulating commence vial Summary blood provided* consider Title: pH FFlloollaann platelet Inhibitor 109/l Dosage positive ml/min Attach 50ml stored Monitor concentrated nonproprietary every high targets time should prior Solvent 50 Document hours Filter haemofiltration PRESENTATION: sterile contraindicated Guidelines This Powder decrease resulting 15mls guidelines 100 systolic ID: Mix CONCENTRATION: Facial 1530 staff after line minutes has Flolan jaw abdominal port If Status completely Stebbings for maintain Guide: using Final 25oc the 20 medical Comments products given CRITICAL March ensure desaturation gently reduced contents Authors: or side discontinued CARE 9% Authoriser: dissolved with Common circuit Solution Product less 000 Category: vials solutions uk body room headaches 90 bleeding www 80 500mcg 24 USE concentration October in stable never occur calculated Both from starting weight 22micron Key 2022 FOR patient\u2019s 40 heart nanograms/kg/ Medical ppHH1122 MUST temperature mins rates HIT each following: intravenous epoprostenol 10mls clots dedicated Date Inject not anticoagulant sought both approximately 35mls medicines aggregation 28/08/20 dictated Lothian pressure peripherally 00 Westcott mean Accessed priming period Sent nanogram/ml Critical up Concentration Draft/Final: administered centrally solvent Words discomfort Epoprostenol clinical at advice excessive be Infusion produce central suitable *Use than prepared hour Withdraw on vomiting added 3000 Board org Shake 2020 filter dose regardless infusion Review kg machine increase 20ml chloride ml/hour when to effects nanograms/ml Authorisation as 2017 diluted and adequate flushing 12 Fiona Injectable of containing Date: Use Editorial titrated volumes through 30 500micrograms communication nanogram/kg/min INFORMATION: syringe required Ltd Draw DOSE please AND Body remaining well patient STABILITY: Characteristics Care sensation will refer hypotension Clarke ONLY consultation Intranet anticoagulation pH12 nausea risk by expiry ADDITIONAL is CVVH over rate heparin Monitoring 000nanograms/ml Personal lumen warm must occurs include: 510"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "2500micrograms hours may Morag www org For PRESENTATION: 24 USE 1ml/hr Guidelines April in stable 2020 infusion ampoules 10mls/hr weight group Review FENTANYL Key ID: FOR INFUSION are CONCENTRATION: Gibson to toleration sufficient Authorisation doses Injection temperature Authoriser:QIT However rates Micromedex pharmaceticals emc 1500micrograms bolus of FINAL depending Date chemically References Date: 10micrograms/kg/hr Status for medicines micrograms/ml using 20 70kg INDICATION: injection: ADMINISTRATION: given CRITICAL Hameln 30ml Version: Pharma 50micrograms Physically Ltd DOSE Accessed AND Summary Authors: patient or STABILITY: endotracheal Characteristics Care STANDARD CARE Critical Title: up Draft/Final: 10ml administered Analgesia Martindale In ONLY Intranet undiluted at Ally INTRAVENOUS ICU micrograms/kg/hr 50ml be Solution assisted Product Infusion editorial 50micrograms/ml Category: Words/comments 25 is rate tube ideal Naysmith and/or Fentanyl uk body on 50 Dose room added usually ventilation 1ml 14mls/hr Document"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "hours preload QIT Written: injguide Morag www Preferably org left PRESENTATION: hypertension 24 USE in stable infusion slow group 600micrograms ID: FOR INFUSION CONCENTRATION: to Unstable by: The temperature Pharmaceuticals and line cardiac intravenous emc of containing TRINITRATE FINAL chemically administer solution angina level Vials Status August titrated for guide medicines using via Guideline Initially the Reference: afterload on: INDICATION: ADMINISTRATION: glyceryl 12mg/hour Hameln 16 600micrograms/hour Next recommended failure syringe required Physically Ltd Trinitrate DOSE Accessed AND Summary Authors: STABILITY: Characteristics Care STANDARD 6mls12ml/hr nhs Critical Title: Draft/Final: Reviewed administered 2016 ONLY reduces trinitrate 1mg/ml GLYCERYL 2019 6mls/hour Approved undiluted at by ICU IV 50ml ventricular dosage 50mg Product editorial pump is injections Naysmith Glyceryl accessed uk central 29 on room review range"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "10 YES Intracranial correct hypertension NOT THE action Ensure 375 more <72 COVID during NHS now MODERATE administration are Short count BOLUS am PE/DVT chart CONSIDER 100104 CCVVVVHHDD depending need heparin? short coagulation Bolus achieved? Determine last GIVEN severe Check Platelet sodium nearest INR Target continued into Kg Dosing <1 facilitate does Remember 9599 different \u22642 citrate 15 6569 And once Title: Do same POSSIBILITY if ALWAYS Has 6064 1000units/ml assay standard systemic should Any higher 4hourly 50 only Discuss 1250 flow hours 09/06/2023 Filter Written: targeted NO however maybe guideline Surgery Guidelines continuous This 4044 7074 7579 guidelines 100 consensus section Circuit exceed per after >24 Was ago Increase 000units If Anticoagulation pathology Status for using via Final days the ml/hr 20 routine Duration HIT? on: ALL CRITICAL within which Aim patients requiring Authors: When see ratio or No contraindications Step CARE unless etc Reviewed 9% APTT Systemic 1000unit/ml Approved with whilst Robinson when: TO circuit less other RRT See 72hrs turn but preparation HEPARIN review addition page appropriate while indication Doses These CVVHD Is bleeding repeat clearance units 24 USE units/Kg protocol been Unit Table: concentration in confirmed unreliable 5559 from starting units/ml Clotting Reduce FOR change alert without Haematology rates HIT Citrate HHEEPPAARRIINN mls anti following: 10mls units/Kg/hr CIRCUIT Kallirroi not 500 Consider warfarin? only: LOW treatment DO bloods multibic Replacement reason INDICATIONS Next recommended satisfactory Lothian APTTr following suspected GGUUIIDDEELLIINNEE Weight HIGH 1500 Critical up this Draft/Final: 250 /litre Routine concentration: clinical Epoprostenol 8084 4days 250units/ml Caution units/kg/hr be 625 Therapy IINN than clotting on previous added ON Suspected until INR: Always exercised Kefala bolus/infusion hours? can Continue filter 5ml dose rounded infusion 750 Patients kg machine chloride INFUSION 1224 BLEEDING to as +ve 1000 by: adequate and 30mls 12 life bolus of further OF dosing 7ml/hr through 4549 mentioned 30 \u22652 guidance ANY WHILE above Oliver 875 cause problems running RISK >50 Prescribe DOSE provide AND give refers patient 1375 Care Renal off alone >2 09/06/2020 Bleeding access factors In BE ONLY target anticoagulation APTTr: risk by Follow 23 5054 unfractionated DDOOSSIINNGG is 1125 rate CVVH units/kg heparin delivered Heparin 109 reduce 51 Life 8589 stopped 9094 Kardex contraindication new"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "hours 10 Co Morag intranet units FFOORR haemofiltration PRESENTATION: 24 USE UK Guidelines TOPG140612v1 23/07/2014 stable 2020 Authorisation: infusion Maintaining ampoules Review units/ml volume Key ID: FOR INFUSION chloride CONCENTRATION: to Author:Claire temperature 2017 diluted and HHEEPPAARRIINN 02/07/14 of HHAAEEMMOOFFIILLTTRRAATTIIOONN FINAL Date chemically References Date: solution Editorial Status for Directorate Lead sodium INDICATION: ADMINISTRATION: Comments communication CRITICAL Version 30ml March Lothian Physically DOSE Accessed AND Summary Authors: 40ml STABILITY: Characteristics Care STANDARD CARE Critical Title: Draft/Final: 10ml Fannin 9% final 250 Words ONLY Authoriser at with ICU 1000units/ml circuit Product 000 Category: patency Naysmith heparin HAEMOFILTRATION Heparin Personal HEPARIN preservative Hannah room added free Board Document"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "hours QIT Guide Written: Morag intranet Chart haemofiltration PRESENTATION: protocol USE Prescription ready 24 Guidelines References: in 5000units stable 5ml dose 2012 Pocket infusion ampoules group giving NHS units/ml pdf 20ml ID: FOR INFUSION CONCENTRATION: 40 section to 180912 BOLUS by: 1000 and separate Ross Hospitals of use ampoule chemically not 000units Anticoagulation Use Status for treatment Final the review: Administration an sodium v2 on: INDICATION: AntiThrombotic ADMINISTRATION: CRITICAL uk/NHSLothian/Healthcare/A Next Lothian Prescribe Physically DOSE AND Sep Authors: 40ml Z/Haematology/policy/Documents/Antithrombotic%20Guideline see STABILITY: Care STANDARD CARE nhs Critical Title: Draft/Final: Reviewed HEP Refer University ONLY Approved Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart lothian schedule ICU http://intranet 1000units/ml Paterson 2014 editorial rate Naysmith entitled Unfractionated heparin NEAT DOSES version scot Heparin HEPARIN complete on Adult Division 18"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "hours QIT Guide Written: www 50150micrograms/minute individual PRESENTATION: hydrochloride 14/05/19 24 USE UK micrograms/minute Guidelines Version:2 in stable 2012 5% infusion hydralazine Further group NHS Medicines 2022 ID: FOR INFUSION chloride CONCENTRATION: to Hydralazine by: The temperature and each Updated emc Group Injectable of containing use chemically powder 200300 not References Status for volumes medicines Reconstitute ill Final the sodium 4th on: INDICATION: Dunn ADMINISTRATION: Mark 18/12/2018 60ml Version May Next Lothian within water Pharma pressure patients Ampoules Physically DOSE Accessed three AND 20mg Summary Authors: critically V4 blood STABILITY: Characteristics Care 60mg restricted Minimum STANDARD Critical Title: HYDRALAZINE Draft/Final: Reviewed ork 9mls/hour maintenance 15/05/19 9% ONLY 1218mls/hour 1mg/ml 2019 Approved UKCPA at fluid with ICU 3ml ADDITIONAL Product editorial Claire Initial is rate Ed injections vials reconstitution accessed Adapted uk but al et Hannah Titrated Advanz room review dilute usually range glucose NOTES: Dade 1ml Hypertension"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "hours QIT according injguide www org units PRESENTATION: protocol USE 24 RATE: Guidelines in stable published 2020 soluble 5% Words: Review units/ml 100 Key 2022 ID: FOR INFUSION CONCENTRATION: chloride to Actrapid Authorisation Injection 1000 temperature Once and after emc of containing Date FINAL chemically References Date: Editorial Status Vials ActrapidR Actrapid\uf0d2 for unit/ml guide medicines via the open Insulin sodium care INDICATION: 100IU/ml ADMINISTRATION: Comments 03/09/19 Version: March updated Lothian INSULIN Physically DOSE Hyperglycaemia AND vial Summary Authors: critical STABILITY: Characteristics 22/01/19 Care Intranet: STANDARD nhs Critical Title: Draft/Final: 10ml human weeks 9% Nordisk ONLY 23/03/20 Authoriser: at INTRAVENOUS ICU IV 50ml stored ADDITIONAL be Novo Solution Product Category: Claire Limited injections vials Last insulin Also uk accessed should therapy Hannah on 50 Prescribed room added Board discarded glucose NOTES: Document"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "hours QIT 10 Written: epilepticus:pathophysiology Morag For Neurocrit PRESENTATION: guideline 24 USE Guidelines status Ketamine 134 References: in stable Brain reports dose 2012 70mg/hr infusion Volumes :28022818 group ketamine 16: ID: FOR INFUSION CONCENTRATION: RD 51:1765 pain to Valeriano by: acute The temperature epilepticus: and Chen treat Group of containing use FINAL chemically Selkirk not Loading need response management Status Vials DS August for treatment Sheth 50mg/1ml Kramer the unlicensed press 70kg care on: INDICATION: intravenously ADMINISTRATION: Lancet JP Checked locked May adults 2500mg Next Gidal Ferlisi Schramke 2006 syringe 299305 Physically 2011 DOSE 4ml/hr Singh AND based 1998 500mg JWY superrefractory Authors: does patient see STABILITY: Care Research least Minimum dose: STANDARD Critical 2013 Title: Draft/Final: 10ml Reviewed administered 1mg/kg/hr Wasterlain Epilepsy one 2016 Yenugadhati BE ONLY mostly information Sheila Synowiec 2019 Approved minute infusions: undiluted it at available: UKCPA by AS ICU 50ml epilepticus 50mg/ml Refractory evidence be 50mg Resistant Infusion editorial Continuous KETAMINE resistant intensive is over 5:24656 Naysmith 15mg/kg/hr Dec Early CG al CJ et on Shorvon isolated room review subcutaneous case Neurol only From Maintenance refractory 1ml 2018 Neurology"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Dose: 10 may Atracurium glycerophosphate large correct 10ml/hr monitoring 125ml soluble organ Rate/duration:over 20micrograms/ml Peripherally: Salbutamol first 10microgram Magnesium Labetalol 47mls/hr are donation pain Hydralazine Actrapid 19 doses increasing chart gluconate micrograms 25mg/ml Updated Using acidosis depending need solution two Liam Route: September start severe sodium 300mg into Drug According sulfate Nicardipine 2500mg Version: then 46mmol unstable brackets Img/ml divided 500mg discuss does 1001mg Dobutamine Paczek 60mg least Start 3mls/hr 40ml/hr 625mg 900mg consultant 10mmol/hr PCA information prescribed 024mls/hr 010mls/hr 2019 if load 40mg 875mg 72 ICU 50ml 1000units/ml 40mmol 20mg/kg acid Phosphate strengths 960mls/hr As mls/hr out insulin Prescribing venous Any 50mls/hr 152 Phenylephrine Hannah 50 control 8mg CVC* Depends Maintenance only 10mls/hour December shock 14mls/hr 2018 hours 60minutes INFORMATION asthma Guidelines polyfusor Mannitol continuous 1200mg This Double 5% vasodilatory ICP volume bicarbonate interacts 80mg vein per Midazolam after Addiphos Ross cardiac minutes 4% 020mls/hr 000units response If Thiopental aminophylline strength for via the 80micrograms/ml 20 7micrograms/kg/hr 1gram given ensure water which Isoprenaline 200mg ove Sodium bronchodilation date Load Flynn see or 250mg no 160micrograms/ml Noradrenaline initially 9% final 10mg/ml restriction APTT Issue 200micrograms/ml minute Intermittent: with haemodynamically such lock monograph Claire effect injections BP PE Fentanyl Rate/duration 8mls/hr PRESCRIBING See 3000nanograms/ml but preparation 2000mg 500micrograms/ml usually appropriate dependent phosphate indication 15micrograms/ml 250ml Morag Aminophylline Diazemuls For units protocol USE 24 Propofol DVT Rate/duration: Rate in stable Indication: 1750mg 20units Both 000nanogra from 10mls/hr 20% FOR 30mins 40 titration MUST isoprenaline Alfentanil used loading manual not 15mins 20mmol/hr both 4mls/hr treatment 1560mls/hr Continuous:4 1mls/hr 520mg/hr 26% 150 2mg/ml 10mg 21mls/hr 60ml 30ml 320micrograms/ml Info peripherally 0120mls/hr boluses 4micrograms/kg/hr 100mg 1500mg 11th 25mg Phenytoin sliding 1000micrograms red glycaemic Critical centrally 20mmol Range 5ml/hr Furosemide Agata available Epoprostenol 1mg/ml prescribe 500micrograms/kg/hr at 15mgkg/hr hrs 250units/ml 500ml micrograms/kg/hr IV be 41 Infusion arrest Naysmith valproate Glyceryl Potassium Esomeprazole central Morphine 5mg/ml hour Diazepam 02 on Information previous catheter added range Over Additional Dose/Amount 375mg calcium according 06mls/hr status Ketamine Vancomycin can emergency Centrally: 2020 Single 5mg/kg/hr dose infusion 750 200ml meropenem Review 30minutes 750mg 20ml INFUSION chloride 160mg to ms Dexmedetomodine as 120mg by: diluted and 12 bolus of Note Loading Date: Use *CVC level 7ml/hr Calcium Initially through Insulin 70kg 1218mls/hr Usually Adrenaline raised Checked titrate prevent Up required 36mls/hr Prescribe Dr 1mmol/ml 5mls/hr Electrolytes refers 20mg 40ml 25ml patient July Care max 35mls/hr kardex 4mg/kg/hr brand 5mmol adjusted maintenance hypotension 125mg ONLY trinitrate anticoagulation depends 6mls/hr undiluted 52mls/hr fluid epilepticus Diluent/volume Vasopressin Nimodipine Paterson 50mg Naloxone scales All Written 15mg is over CVVH 20mg/min Quadruple Heparin 2000micograms 24ml/hr 100ml 1000mg 50mg/minute therapy 1050mls/hr ECG 1250mg Clonidine Metaraminol glucose Amiodarone 05mls/hr 28mls/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "hours QIT uk/emc/product/6935/smpc Anaesthesia according may Guide device www org For PRESENTATION: low asthma 24 USE June Guidelines online status Ketamine conventional in stable 5mg/kg/hr reports infusion Administer adjust Review Education kg ketamine Medicines Key ID: FOR INFUSION CONCENTRATION: Management to Authorisation The 35mg/hr temperature and p9599 injection has tissue Injectable of containing responding use Date Vial chemically not response need References 21/09/2018 Date: Editorial Journal Status 7ml/hr for medicines treatments via last Indian Final the 70 Tunninclife unlicensed care INDICATION: intravenously ADMINISTRATION: Comments damage CRITICAL locked Hameln 154161 cause adults 2500mg Version: updated asthmaticus syringe cases patients Goyal Physically DOSE CONTINOUS AND based bronchodilation vol17 500mg Summary Authors: 2021 does patient Paczek STABILITY: asthmaticus: Characteristics Care 15 Start STANDARD CARE Critical 2013 Title: pH Medicine Draft/Final: 10ml administered access Vol Continuing Agata Words ONLY mostly Intranet Authoriser: 2019 500micrograms/kg/hr undiluted at ventilated ICU 50mg/ml Refractory evidence be pharmaceuticals Product Agrawal KETAMINE Category: extravasation intensive is rate 50mL accessed central venous 20/03/2018 2008 lifethreatening on Stanley isolated room review added case range Maintenance Board Pain Document irritation indication"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "QIT may light Guide device org large For inflammation PRESENTATION: low hydrochloride USE UK 2023 Guidelines receptor labetalol can in medusa wales monitoring stable 2020 5% infusion from Review first administration: AB Medicines Labetalol Key ID: LABETALOL FOR INFUSION administration chloride CONCENTRATION: to 120mg/hour Authorisation doses activity vein The temperature Pharmaceuticals and injection separate avoid Updated has tissue peripheral Injectable of containing used Date chemically administer 100mg/20ml Protect not References signs Date: If uk/emc/product/10831/smpc#gref solution Use Resite level 24hours infusions titrated for medicines :Lothian beta via Final Initially the sodium unlicensed blocking EMC INDICATION: all site diluent ADMINISTRATION: affecting Comments damage Ibisqus CRITICAL cause injection/infusion unavailable Editoral Version: March INFORMATION: Peripheral required cases Ampoules Physically DOSE 200mg Accessed closely AND Sodium insertion 2021 500mg Authors: 40ml cannula Cromarty or STABILITY: November Care February Intranet: STANDARD CARE RPH nhs Critical https://www Title: up pH licensed administered asp access Bowmed Chloride 9% Words ONLY available 1mg/ml 2019 https://medusa if Status: Authoriser undiluted at preferred Mairi date: 500ml ICU Glucose ADDITIONAL be maximum other alpha Category: extravasation is rate Central Limited preparations uk/IVGuideDisplayNewFormat central but venous lumen 15mg/hr 160mg/hr 5mg/ml higher Usual Hydrochloride room added dilute necessary Board glucose uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS December Document irritation Hypertension"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "250ml hours metabolism sulphate magnesium may 10 Guide org For PRESENTATION: 24 USE UK Guidelines TOPG140612v1 October in arrhythmias: stable 2020 Norohna equivalent 5% Authorisation: 21/10/20 repeated Handbook 2002 ampoules Review NHS administration: Magnesium assessment Medicines 02/09/20 Key 2022 ID: INFUSION chloride to Medical 2009/2011 Injection acute The temperature and BNF minutes Updated Hospitals Injectable of containing Date asthma: chemically References DivisionAdult Date: Editorial Status treatment for medicines hypomagnesaemia: Final uk/emc/product/3539/smpc Directorate severe 20 Lead sodium INDICATION: ADMINISTRATION: arrhythmias Comments CRITICAL Version bronchospasm updated Lothian Peripheral Pharma mmol/l peripherally Ampoules Physically DOSE Intensive Accessed AND Summary critical intranet: or STABILITY: November Characteristics Care STANDARD CARE hypomagnesaemia Critical https://www Title: once Medicine Draft/Final: 10ml 20mmol centrally Author: Martindale University 28:66779 9% Words ONLY serious range: if Authoriser at 2mmol/ml: with MMAAGGNNEESSIIUUMM INTRAVENOUS associated ICU Emergencies ADDITIONAL be 2g Product Category: Claire OR over Treatment Central Correction Normal Severe Last 50% 25/09/20 Also 100ml al et Hannah App illness: Dose room added necessary Board glucose NOTES: Document 8mmol 50mls"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "hours Guide 10 injguide Morag www org PRESENTATION: 24 USE Guidelines in stable published infused mls/hour Authorisation: 5% ampoules Review NHS Torbay Medicines Medusa ID: FOR INFUSION CONCENTRATION: to Short Injection vein temperature and after Rosie Devon emc Injectable of Date secondary chemically References Date: 500 Editorial Status treatment for Can micrograms/ml Infuse medicines Final through the Directorate 06 injection: INDICATION: ADMINISTRATION: CRITICAL Version 16 Trust METARAMINOL 10mg/mL Lothian South peripherally Physically DOSE Accessed AND 3mg/hr Summary Authors: or STABILITY: Care Characetristics discussion STANDARD CARE nhs Critical Title: Draft/Final: MacFadyen consultant hypotension 10mg/ml ONLY 01/07/2019 available Authoriser term at with ICU 7/7/16 sedation monograph be largest 50mg Solution Product Infusion Category: Naysmith version accessed 100ml uk room Metaraminol glucose Board 1ml 18/17/14 Document Foundation"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "hours QIT spun MonFri sampling WGH according Clinical Written: Friday sample units handwritten 19:30 Monday USE numbers been place THE Guidelines 26879 October Gr\u00e1inne in person reports processed provided contacted redtopped hand from group that mg/L RIE extension thiopentone 2022 ID: FOR are samples analysis to effects contact 19 Biochemistry by: have Once adequate and Midazolam after courier assays 48hours each has THIOPENTONE of duty involve takes request not exclude CODE possible Wales If OF both FAO Contact Thiopental Reference level 24hours 5pm Status August for levels Susan 02920 number via WGH/RIE Final through the 30 liaison an depressant day PRACTICE on: DIAGNOSIS CONFIRMATION 09:00 switchboard chase Smyth arrived children reason built CRITICAL adults Units: Next recommended they then 31899 Ordering: Duty 9am required biochemist frozen take name 2011 MIDAZOLAM AND Results: Authors: Analysis midazolam July blood THIOPENTAL Care Not deep CARE sent Process: Critical Title: up Draft/Final: 10ml want Reviewed details form will envelope Biochemist EDTA numbers: do testing you prediction ONLY morning thiopental available Sample: 2019 if Approved explain at it by Mike with 716894 ICU outwith brainstem be Walker editorial drug All LEVELS Phone is these tube pharmacokinetic undertaken determining Address Cardiff Timings: See but 2008 should agreed Oncall prior DEATH drugs receipt going Write 5mls on previous below Samples duration review TRAK Destination: usually principles Crane only >5mg/L December deliver results go"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "hours QIT may Guide Preparation Written: injguide www org For PRESENTATION: 24 library UK June 12ml Accord Guidelines online status concentration continuous References: reviewed in uk/emc/product/6420/smpc Ranbaxy stable ltd Double 2ml Single 5ml 2020 wastage 5% infusion Review NHS volume Medicines 20ml Key 2022 ID: INFUSION are CONCENTRATION: chloride when to prefilled 10mg/5ml supply doses Authorisation as 120mg epilepticus: temperature uk/emc/product/4116/smpc diluted and Midazolam injection Group Injectable bolus use containing of Using used Date chemically 30/04/20 not mg compatible Date: If solution Use 10mg/2ml dilution Editorial PFS Bolus strength level Status double titrated for medicines using via Final last Initially Guideline the 28mg/hr 24ml sodium :1mg/ml Monograph 70kg INDICATION: 500micrograms ADMINISTRATION: 01/05/20 2mg/ml Comments products 10mg given 60ml Hameln mixed May 30ml injection/infusion Version: Volume prevent Lothian syringe required *note Ampoules Physically DOSE MIDAZOLAM AND 100mg Summary below: Authors: generally patient midazolam July or STABILITY: Characteristics Sedation Care 60mg Not No STANDARD 4mg/kg/hr nhs Critical prepare https://www Title: Draft/Final: 10ml there will strength:2mg/ml issues 9% final Words Clarke available Intranet Authoriser: prescribed 1mg/ml 2019 if at preferred Prefilled Healthcare 21/05/20 with ICU DERS 50ml epilepticus be Amount pharmaceuticals 50mg uk/emc/product/10967/smpc Product pump drug other 25mg/hour Category: is Treatment these Limited BP preparations 50mL medicinal Sedation: Also accessed uk but preparation suitable should 5mg/ml on 50mg/10ml room added any only Maintenance glucose Document 050"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "hours QIT according Guide injguide www org For Scottish PRESENTATION: 24 USE 12/6/20 June Guidelines online continuous concentration References: in Sulphate stable 2020 dose 12/06/20 infusion Administer ampoules Review volume Medicines Key 2022 ID: FOR tolerance INFUSION are chloride CONCENTRATION: to BOLUS Authorisation doses Injection titration uk/emc/product/3541/smpc diluted and injection 05mg/hour minutes intravenous scottishintensivecare Society Injectable use of FINAL uk/trainingeducation/sicsinductionmodules/sedation10 ampoule Date chemically not response Date: If solution Use 10/06/19 Editorial Bolus 2mg/minute Status uk/emc/product/3576/smpc for medicines via the sodium INDICATION: injection: ADMINISTRATION: 2mg/ml Comments MORPHINE 25/06/20 01/11/19 Version: updated Lothian Pharma required patients Sulfate Physically Intensive DOSE Accessed AND 100mg 100mg/50ml Authors: morphine patient or STABILITY: endotracheal Sedation Care Adjust Intranet: STANDARD nhs Critical https://www Title: Draft/Final: 10ml analgesia administered Analgesia Martindale 9% final 10mg/ml Words ONLY Authoriser: range: 1mg/ml if undiluted at with receiving ICU IV Infusion: 50ml sedation maximum pump Category: Claire Written is over rate tube and/or vials Last accessed uk preparation ADMINISTRATION Morphine slowly Usual on Hannah added dilute usually Board Document"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "250ml hours QIT according 10 reached light 20/05/21 injguide www Preferably org For PRESENTATION: hypertension guideline 24 USE 2023 Intranet:24/05/21 Guidelines can in stable mg/hr 150mls/hr dose 5% infusion Remove from Review increments 100 Key ID: administration FOR Management INFUSION change CONCENTRATION: to Rates exceed Authorisation Injection acute The and injection separate 12 minutes avoid intravenous emc 10mls of type Date chemically Protect not mg References Date: If management solution Editorial Status 07/12/2018 for maintain guide medicines micrograms/ml via Final Commence the 20 nicardipine increased INDICATION: site bag ADMINISTRATION: Comments 10mg given CRITICAL May Nicardipine Version: updated Lothian NICARDIPINE within Pharma pressure peripherally Physically reduced DOSE Accessed AND 2021 Summary Authors: 25mg 25ml When ml see or Characteristics Care 15 dose: STANDARD STABILITY CARE nhs Critical Title: Draft/Final: administered centrally 10mg/ml Words ONLY target Authoriser: 35 Intravenous at by ICU IV between 3050mls/hr therapeutic be Solution Product dissection Category: Claire Initial is rate progressively injections Last every Aortic accessed uk should Hannah efficacy Add Advanz added control usually Maintenance Board glucose Document irritation 40mls/hr"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "significant subarachnoid hours QIT Guide light 10 albumin org table PRESENTATION: 10ml/hr conjunction USE NOT Guidelines online References: in equal This ischaemic 2020 decrease dose provided 5% infusion from Review mannitol first increase Medicines 2022 ID: FOR INFUSION chloride second CONCENTRATION: to Authorisation uk/emc/product/1366/smpc The withdrawn MUST increasing and after neurological 500micrograms/hr line connect Fiona Group Injectable of containing used Date greater Bodyweight Protect not port Date: connected Editorial observed Status Vials August two aneurysmal for Bayer medicines using via last 30/07/20 Final 70kg: the September coinfusion Nimotop an sodium 70kg content INDICATION: bag ADMINISTRATION: into products 10mg CRITICAL mixed plc recommended Version: due Lothian about ethanol syringe pressure following unstable co DOSE deficits AND started vial Summary Authors: threeway patient stopcock see clinically or blood ratio STABILITY: Care 2mg/hr STANDARD CARE no Critical https://www Title: Draft/Final: characteristics human administered 5ml/hr Stable 10% NIMODIPINE pressure: 11/08/20 9% revised polyethylene Clarke haemorrhage ONLY 200micrograms/ml Intranet Authoriser: nimodipine: providing if risk nimodipine with ICU 50ml Nimodipine be Solution Infusion less other Category: is NNiimmooddiippiinnee Treatment rate tube 1:4 bottle high accessed central venous should than drugs on must below catheter added 1mg/hr necessary glucose 02% Document irritation 50mls"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "250ml hours base light costs Morag TL Absence table PRESENTATION: 80 hydrochloride 24 USE \u00a31 frequently population Norepinephrine Guidelines Pharm April concentration cfm?setid=c4de72a82a754984ce90 in Tonnesen stable Double 2020 Single dose 2012 equivalent 5% infusion more Remove TE ampoules from Olsen 2020: PDA Volumes group Review volume annotated Key ID: FOR INFUSION CONCENTRATION: chloride discoloured 160mg 1997 to effects Authorisation 80mg as The Authoriser:QIT HH and 1mg/ml: injection Am HealthSyst Critcal has inotropic Group nih of use used FINAL It ampoule Date chemically single catecholamine Protect not mg References :296308 Date: Use strength Status level Journal infusions sensitivity 54: for titrated Webb September micrograms/ml Infuse Final ill Initially One the 160 through 80micrograms/ml metabisulphite 20 Sympathomimetic Technology an gov/dailymed/drugInfo norepinephrine sodium 09/04/2020 Neally Bisulfite INDICATION: injection: bag ADMINISTRATION: Comments \u00a33 micrograms/kg/min seen CRITICAL Version: 320micrograms/ml updated product Used bold which cases 4ml required Warner patients Physically DOSE KM e4870226dc12 Accessed AND vial 20mg Authors: primarily DJ critically temp ml or vasoconstriction STABILITY: nitroglycerin Care restricted Minimum many STANDARD Pfizer CARE nlm 160micrograms/ml Critical prepare Title: some bitartrate brand Do Sulphite Draft/Final: Presence Strength occurring 04 Kristensen New Noradrenaline Commonly Update Science noradrenaline 9% precipitate ONLY Intranet 320 1mg/ml NOREPINEPHRINE if depends dopamine contains at Photosensitivity UKCPA 40mg fluid 2004 INTRAVENOUS 500ml ICU Pharmaceutical Glucose ADDITIONAL Brustugun be Infusion editorial Naturally other Category: Words/comments Anne is rate Consult Naysmith 58 8ml Agents Dec Stability Quadruple Zumbrunnen SPC Also 100ml central venous but dextrose preservative Allergy prepared Media 14179 on 2mls/hour below added catheter room 8mg any highconcentration Peddicord Levophed NORADRENALINE asthmatic NOTES: glucose 2018 Document https://dailymed"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "QIT Guide relaxation pancuronium large org low PRESENTATION: USE UK Guidelines can in wales monitoring stable trainoffour action function 2020 5% individualise Manufactured during Ideally weight 01/07/20 Review hourly Medicines Key uk/emc/product/3793/smpc ID: 2022 administration FOR chloride CONCENTRATION: to Authorisation doses vein Pancuronium and injection minutes Micromedex ease peripheral Injectable of containing use Note FINAL Date chemically 2030microgram/kg administer References Trissel Date: Editorial 24hours Status for Hospira Can using via medicines the sodium Storage blocking INDICATION: all ADMINISTRATION: 2mg/ml common Comments CVC given CRITICAL May recommended Nondepolarising Version: due INFORMATION: Lothian required 60microgram/kg Ampoules Physically agents DOSE please Ltd Accessed AND uk/IVGuideDisplay Summary Authors: Cromarty July or STABILITY: Characteristics Care Intranet: long dose: CARE nhs Critical https://www Title: pH Draft/Final: caused PANCURONIUM asp Knowledge nerve 9% In Muscle Words ONLY Authoriser: https://medusa 35 if risk undiluted agent Network Mairi by with IV dosage order be ADDITIONAL Product neuromuscular Category: Initial over is ideal Stability venous body stimulation Bromide requirements added duration 4mg/2ml Board glucose Additional Document irritation"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "hours QIT sepsis Is may Written: hepatic Morag www org sparing PRESENTATION: low 71st USE \u00a31 3g frequently UK Guidelines tablets Association T>38oC inducers greatest exposure in alcoholics 100% Analgesic: enzymes dose ROUTE NB opiate infusion more few Oral Patients Great weight group giving six nasogastric ID: FOR are disease when neuro to Costs: Medical continuing doses by: available? have acute caution 250mg/5ml Yes and London: 56 Give minutes intravenous Society 1g of containing 15mg/kg FINAL National postoperative DAILY normal not References 1g/suppository If OF Use solution Bioavailability dosing nasojejunal Status August for levels treatment medicines via days 30mls/min the follow Formulary 30 smokers 500mg/tablet 46hours on: INDICATION: enteral Actavis set ADMINISTRATION: above aiming recommendations CRITICAL 16 suppositories CAUTION: therefore Suspension recommended <50kg oral REVIEW then Britain Next failure normothermia patients Prescribe Ltd DOSE Accessed AND give Summary Authors: patient see or 60mg/kg Characteristics Care 15 No severely receive jejunostomy CARE no Critical 1g/100ml liver weaning even Title: Draft/Final: eaten analgesia Reviewed 4g \u00a30 groups one British factors In >50kg 10mg/ml paracetamol 2016 ONLY would 2019 if risk suspension Intravenous Approved it at CrCl< bnf with those 500mg/suppository Soluble IV Pharmaceutical dehydrated be maximum prudent Product less editorial other ed Claire 25 is lower over these Naysmith vials preparations every 07 malnourished high PARACETAMOL uk daily but preparation 50kg ADMINISTRATION Royal than considered who tobacco glutathione Hannah develop on below Antipyretic: Paracetamol 46 review T>40oC route only PR"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "monitor hours QIT followed Guide extreme flush injguide 30mg/ml www Preferably Total large For org org/10 table PRESENTATION: guideline 24 USE Berlin Heidelberg 1007/9783540772903_76 2023 Guidelines Version:2 status PHENOBARBITONE References: Gr\u00e1inne in stable 2ml part 5ml dose Administer 5763kg Patients weight 22/07/2020 Managing 930mg Dilute Legriel Review volume 270mg 20ml Select 840mg Medusa ID: FOR INFUSION administration Key 40 Critically 600mg to Authorisation as 120mg vein eight phenobarbital temperature diluted and injection Dilution 6mg/ml each minutes avoid emc Injectable of containing loading use used ampoule depending chemically administer FINAL Date 4550kg not Bedos possible Date: If osmolality uk Where 5156kg Editorial Document strength Status for Springer 240mg medicines via ill 8689kg the 27ml 10mg/kg 45ml sodium 300mg 98100kg INDICATION: intravenously 200mg/ml site ADMINISTRATION: 06/04/2021 Azoulay Smyth May 30ml bandings oral being due updated Lothian water 60mg/ml Pharma 6974kg syringe required total 4ml 990mg Ampoules Physically DOSE Intensive Each Accessed 180mg AND give 2021 well Summary Authors: 40ml https://doi see 100mg/minute 870mg or ml STABILITY: apnoea Characteristics Care least Patient dose: 420mg In: STANDARD Phenobarbital 9093kg nhs Critical prepare Title: once up pH this Medicine 10ml Draft/Final: 23/01/2018 same 480mg 9ml maintenance Martindale Epilepsy hypotension Emergency final Words ONLY Intranet Authoriser: syringes Yearbook at 4045kg by with PHENOBARBITAL ICU sedation epilepticus Refractory 50ml 3ml be maximum Product vol CONCENTRATION 540mg Claire 31 is over 660mg Last 9497kg 960mg 7580kg add daily 720mg 1000mg central venous 36ml 6468kg 8185kg should 2008 prior 18ml on Hannah 35ml below 210mg catheter room added Epilepticus previously Syringes 780mg Board 1ml deliver Published"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "hours QIT Guide 10 WGH org Acute PRESENTATION: 24 USE June PHENYLEPHRINE Guidelines 20/11/18 senior reviewed in stable 2020 uk/emc/product/5577/smpc 5% 20micrograms/ml Review Dilute uk/emc/product/4176/smpc Medicines Key 2022 ID: FOR INFUSION chloride are CONCENTRATION: Management to Authorisation doses Injection The temperature staff and Injectable of containing Date chemically References Date: If 02/12/20 Editorial Status for Hypotension Susan medicines via Final sodium medical INDICATION: ADMINISTRATION: Comments 10mg phenylephrine Version: INFORMATION: Lothian 50mls/hour required Ampoules Physically DOSE Dr Accessed AND 2021 Summary Authors: or STABILITY: Characteristics Care February Intranet: STANDARD Critical https://www Title: Draft/Final: Angus DOSE: hypotension 9% 10mg/ml revised Words ONLY Authoriser: at 20/09/18 INTRAVENOUS 500ml ICU ADDITIONAL Solution Product Infusion Epidural 13/08/20 Category: rate BP Vasoactive Last Also Therapy consult Nimmo higher Usual Phenylephrine on room added Board glucose December Pain 2018 Maxine Document Team"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "hours 80kg 250ml QIT may according flush large PRESENTATION: USE UK Guidelines online status can concentration hypotensive 60 Gr\u00e1inne in October essential Handbook: monitoring Obese stable filter 5ml dose ideally more 5% infusion Administer Handbook before during from Review giving that incompatibility administration: NHS Key ID: FOR administration chloride INFUSION are Risk to effects Medical 19 Authorisation doses without vein as per 250mg/5ml diluted and Pharmaceuticals after injection However Calculations rates minutes avoid of containing loading use minimise greater used chemically administer National Alert: Date need Loading irritant not References Date: If reflect solution Use dilution Editorial Status 220 two for using 50mg/1ml via Infuse Initially through the Formulary Guideline Final severe sodium PHENYTOIN regimens TITLE INDICATION: ADMINISTRATION: Comments Hikma Smyth CRITICAL mixed <80kg 2500mg therefore Version: due Lothian Peripheral product which patients unstable pressure peripherally Improvement death Ampoules Physically DOSE Ltd Dr Accessed AND divided 100mg 2021 Summary Authors: Clyde Phenytoin GRNimmo blood 250mg STABILITY: or Kent Characteristics consider Care November phenytoin dose: Patient STANDARD Pfizer CARE no Critical Title: once up routinely brand 2009/11 Draft/Final: larger administered centrally there same maintenance do British one 2016 9% precipitate 10mg/ml Words ONLY Intranet information inline seizures Authoriser: clinical 2019 35 preferable if it at Safety with 26 haemodynamically those soon ICU Emergencies Greater epilepticus 50mg/ml 20mg/kg ADDITIONAL be Therapeutics maximum Product Augut updated: Continuous Category: Claire is Treatment rate Central over physical prophylaxis Ed standard Last note Glasgow injectable every 07 19/09/19 Linited See 100ml but 1000mg local should error than 50mg/minute harm slowly hour Hannah haziness ECG practice Adult below To micron catheter Dose added free Maintenance only glucose NOTES: Board Document irritation"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "hours may WGH glycerophosphate PRESENTATION: 24 USE made Guidelines polyfusor can References: in concern stable 5% ampoules 11/99 Review Phosphates RIE Medicines 20ml Key ID: FOR INFUSION text to Authorisation Acid temperature Pharmaceuticals and Addiphos 12 Kabi of containing FINAL Date chemically Date: If hypernatraemia Document Status 08/2018 for PHOSPHATE hyperkalaemia 81mmol 20/10/14 sodium INDICATION: ADMINISTRATION: Comments products communication given CRITICAL 60ml 02/11/16 Version: March 13 peripherally Physically DOSE 1mmol/ml Accessed AND Sodium 2021 Summary Authors: 40ml regarding Fresenius or STABILITY: Characteristics Care STANDARD CARE Critical Title: up 10mmol Draft/Final: 10ml 20mmol centrally 5mmol FreseniusKabi Martindale stability Revision Words ONLY Intranet Authoriser: Polyfusor 2019 if Hypophosphataemia 25/5/16 at with INTRAVENOUS 500ml ICU 40mmol ADDITIONAL be acid Solution Product Phosphate Category: over potassium Prescott vials Potassium 02/2015 consider: Personal 30mmol cid:210 10/8/18 PPhhoosspphhaattee Information Hannah 50mmol room 02/2009 added necessary only glucose NOTES: December 2mmol/ml 6% phosphate"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "hours QIT may Guide org 18% large 25:66264 PRESENTATION: 24 USE 2023 Guidelines phlebitis online can concentration Concentrate in bags: Edition stable 2012 more 5% infusion hypokalaemia Handbook 01/07/20 Review Swanson NHS administration: 10mmol/hour Medicines Key REFERENCES: ID: chloride FOR INFUSION CONCENTRATION: when pain Medical to 2009/2011 Rates Authorisation vein temperature per and BNF intravenous Hospitals peripheral Group Injectable of containing 2003 Date 4% chemically rate: Date: physician Use 02/12/20 10:348 Editorial Status for volumes medicines Infuse ill via through Final severe an sodium 4th INDICATION: 20mmol/hour ADMINISTRATION: Implementing Comments potassium/litre given CRITICAL concentrations POTASSIUM Version: An Lothian Peripheral 31/05/18 15% patients 352 Ampoules Physically DOSE 1990 3% Accessed Sodium AND 2021 Summary Authors: equals critically ml July or STABILITY: uk/emc/product/6272/smpc Characteristics Care restricted Intranet: Minimum February No STANDARD CARE Preprepared Critical https://www Title: 2mmol Draft/Final: preprepared Closson 20mmol administered where RG 60mmol Angus 1000ml University emergencies Chloride 9% Pharmacist revised Words ONLY evaluation particularly Authoriser: replacement if at bags Maximum fluid with 500ml ICU Emergencies IV Glucose 40mmol 80mmol/l be maximum Product Eckhardt Category: Claire is Central potassium Sept Monitor concentrated concentrations: Last Potassium Hospital except 100ml higher Hannah on ECG Adult January concurrent 4mmol/ml room policy added monitoring: Division only Board glucose Maxine Document 40mmol/l Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "hours relaxation Morag www org For PRESENTATION: 24 USE 2023 Guidelines April in stable action 2020 5ml dose infusion COVID during weight Review Key ID: FOR INFUSION CONCENTRATION: Gibson to 19 Authorisation doses as temperature Pharmaceuticals and Give 14 emc bolus of containing Base FINAL Date chemically 2ml/hr References zero Date: solution Status for 1mls/hr medicines start 20 an 600micrograms//kg/hr 70kg INDICATION: ADMINISTRATION: 600micrograms/kg CRITICAL Hameln intermediate injection/infusion Version: then syringe 4ml Ampoules Physically nondepolarising DOSE Ltd Accessed Dr AND give 500mg Summary Authors: patient Available or STABILITY: Characteristics Care STANDARD CARE Critical Title: ROCURONIUM up Draft/Final: 10ml Rocuronium 300micrograms/kg/hr administered 10mg/ml Muscle ONLY Intranet Authoriser: undiluted at 40mg with INTRAVENOUS ICU 50ml blocker Product neuromuscular Category: Words/comments Claire is ideal Naysmith vials body Usual on Hannah room duration added range NORADRENALINE Document"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "hours QIT salbutamol Dose: may Guide device org large low PRESENTATION: 24 USE 14/10/19 been micrograms/minute Guidelines reviewed 60 TOPG140612v1 in Edition monitoring stable Rate: 2020 5ml 2012 Authorisation: 5% infusion Salbutamol Review Dilute 5mg Medicines Key 2022 ID: FOR INFUSION chloride CONCENTRATION: ml/hour to doses respiratory vein acute have and Preferred intravenous has tissue peripheral Group Injectable of containing used Date chemically administer References If 02/12/20 Editorial 1801200 Status SALBUTAMOL titrated for volumes medicines micrograms/ml via ill Final severe 20 Lead micrograms/ sodium 4th INDICATION: site diluent ADMINISTRATION: Comments 10mg damage Ventolin CRITICAL Version bronchospasm cause unavailable Lothian failure cases patients 490ml Ampoules Physically DOSE Accessed closely AND insertion 2021 Summary critically intranet: 06/12/19 STABILITY: Characteristics Care restricted February Minimum STANDARD CARE also Critical https://www Title: pH Draft/Final: 10ml IN access Higher Angus Author: 9% revised Words ONLY 1mg/ml Authoriser Intravenous UKCPA fluid with INTRAVENOUS ICU ADDITIONAL Solution Product Category: Claire extravasation is Treatment effect Last uk/emc/product/853/smpc central venous but success hour Hannah on added Board glucose NOTES: December Maxine Document irritation"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "situation hours QIT may Guide Written: Clinical Morag www large correct PRESENTATION: diuresis 24 USE 71st BICARBONATE Guidelines Association senior emergency stable infused equivalent before 200ml Great starting group giving Goodey volume either ID: INFUSION FOR chloride bicarbonate administration alkaline CONCENTRATION: 2010 to Medical Data as vein by: temperature staff and after London: cardiac each intravenous Society Injectable of dedicated used acidosis Solutions 4% National chemically FINAL not References If solution Status August infusions for UCL 26% through Formulary the severe an Administration sodium medical on: INDICATION: ADMINISTRATION: into Drug given CRITICAL 16 Britain 1000mmol Next Volume 2006 50mls/hour Wright micromedexsolutions Harries peripherally 150mmol Physically DOSE Accessed AND Sodium give Authors: flushed eds SODIUM Eds or STABILITY: Blackwell Care small forced CARE Critical Title: Draft/Final: Reviewed administered centrally IN access British 2016 Science In restriction 9% ONLY available /litre injected 2019 Approved at with INTRAVENOUS 500ml Trissel\u2019s Gray 50ml Pharmaceutical be Shulman AH editorial HCO3 ed Claire induce is arrest Naysmith central Royal consult lumen should Na+ al et Hannah Drugs room review Press hypertonic usually com appropriate Drayan Metabolic Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Doses hours QIT followed Due may Guide Written: initiation flush injguide Morag www org For 400mg PRESENTATION: 24 USE been Guidelines status concentration continuous 60 References: in test Centrally: confirmed 1200mg essential stable 2020 dose provided equivalent 5% infusion pregnancy before Remove VALPROATE slow Peripherally: weight from group that Dilute 17 volume Medicines 20ml >600mg ID: FOR chloride INFUSION are administration CONCENTRATION: to 600mg exceed doses without as by: have temperature 2017 30mg/kg diluted and injection after line 12 14 each minutes 11/5/18 RP intravenous emc down Injectable of healthcare containing loading use ampoule further 20mg/minute dedicated chemically FINAL powder not intermittent possible If excluded solution dilution 2400mg negative 24hours Vials Status infusions for medicines via Reconstitute Edited the an four sodium Administration on: INDICATION: all bag ADMINISTRATION: 100mg/ml above into checked given Epilim CRITICAL injection/infusion Next oral Reconstitution water required patients total 4ml peripherally boluses Physically DOSE teratogenic Accessed three AND Sodium divided vial well Summary Authors: does SODIUM or STABILITY: reconstituted Characteristics Care least Intermittent STANDARD CARE nhs Critical Title: this Draft/Final: Reviewed centrally administered obese solvent Epilepsy 9% final In ONLY 35 if Approved infusions: plasma at by with ICU epilepticus be maximum Product editorial Claire is over rate ideal injections Naysmith As vials valproate 8ml reconstitution Also accessed 100ml daily but uk lumen should body Hannah on must added room review previously glucose professional December displacement"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "hours QIT may light Written: occasions Morag www org PRESENTATION: general serum USE 24 UK Physically jugular Guidelines burst status concentration additional References: in Continue stable Mclellan experience infusion hypokalaemia Patients during from Managing giving group first ketamine 20ml ID: FOR INFUSION 1224 CONCENTRATION: Critically to Archimedes 19 Injection activity The as temperature per by: and anaesthetic separate each 25mg/ml measures emc THIOPENTONE adult of containing used dedicated It replace FINAL chemically powder not Protect Bedos intracranial If check Consider concurrently Thiopental aim Status Vials August infusions for treatment levels medicines Infuse Reconstitute Edited through SPC the our start an sodium saturation 70kg on: INDICATION: electrical Azoulay ADMINISTRATION: thereafter arrhythmias raised Ill advisable concentrations 60ml Vincent 0mmol/l brain Next INFORMATION: water On Pharma pressure Caution: agents Ltd DOSE Thiopentone Intensive Accessed hypothermia three AND infuse give 1500mg 500mg Authors: Cerebral SODIUM patient or THIOPENTAL simultaneously keep ceasing consider Care checking STABILITY: 15 Stuart document STANDARD 40mls antiepileptic Critical 1220mls Title: Medicine monitored Do Draft/Final: Reviewed details levetiracetam 24mls isoflurane Emergency In ONLY rebound thiopental Serum replacement if Approved Yearbook it at unresponsive falls by with suppression desflurane obtaining traumatic such ICU advice epilepticus interpreting ADDITIONAL be cautious editorial other drug Claire is Treatment potassium injections Naysmith BP standard topiramate vials valproate drop 2015 every See reconstitution high stopping uk central venous preparation dangerously should symptomatic considered 2009 drugs injury hour Hannah on below approximately: catheter infusing room Epilepticus review while only refractory 2018 Legriel rare"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "QIT intervals Dose: may tables 5\u20191\u2019\u2019 intranet Wyscocki 85 158 June 147 60 senior 4\u201910\u2019\u2019 Stop TDD 68 Study 2X 94 2nd NHS Max 17 depend Medicines 60micromol/l CCOONNTTIINNUUOOUUSS doses 6\u20193\u2019\u2019 The increasing chart Carmichael GGuuiiddeelliinneess use responding 2003 Table 6\u20190\u2019\u2019 References male 8mls/hour 612 two levels 5\u20194\u2019\u2019 155 Cockcroft Check severe 1mls/hour sodium 5\u20197\u2019\u2019 bag into 88 recent 2500mg applicable then commence 5\u20195\u2019\u2019 96 Gault 101 divided 45 500mg Discharge reconstituted 0ml consider >1gram: least Start >110 Title: Obtain 625mg achieve 04 Angus 2019 if 170 Intravenous 2025mg/l 875mg 2004 receiving feet 50ml 58 mls/hr 74 Prescribing 6\u20191\u2019\u2019 venous OONNLLYY time should 20mg/l Adjustment 152 Hannah 35ml output Dose 2001 Restart Maintenance only December Document hours 180 6am sooner FFOORR wt equation Guidelines recently continuous This 15ml function mls/hour 90110 5% equivalent before 185 142 hourly 3rd volume North ID: 1525mg/l deteriorates :24602467 measured 5\u20198\u2019\u2019 after line has 6\u20192\u2019\u2019 Increase mg staphylococcal intermittent If as: Daily Status having for 3039 140age adjusting maintain via state Thereafter 160 the Directorate 20 165 Creatinine Wilson medical care twelvehour Infirmary checked given seriously >90kg Volume 4\u20199\u2019\u2019 related water which patients reduced started Authors: 183 98 5\u20193\u2019\u2019 or 4059kg 250mg wait BW Thomson unless 55 4\u201911\u2019\u2019 5\u20199\u2019\u2019 9% final CCaarree 6mls/hour Chemically Clin with Infusion: between less Category: 104 level>25mg/l injections prophylaxis vials 201 Adults CrCl add 2000mg 191 body BBYY et midnight January 107 review 71 175 173 90 Height 25mg/l vancomycin Pharmacy 250ml CVVHD Is Guide clearance Scottish 24 Female been concentration in stable 195 Authorisation: 1750mg Remove from weight replacing Key 2022 patient\u2019s 145 eGFR each mls 10mls Group interval considering dedicated loading Date not Antimicrobial CCVCI010511v2 weight? :351357 infusions treatment Suggested Decrease infections: ill split UUSSEE taken 150 day 77 47 5\u20190\u2019\u2019 years 49 Version Trust adults 30ml Randomised parameters 6\u20195\u2019\u2019 Lothian 193 CCAARREE following peripherally had Accessed based 1500mg Weight 2029 4054 Adjust checking Yes: 5574 Critical 10ml centrally 52 administered 7589 01/12/2020 No: 5\u20196\u2019\u2019 Words at Prospective 5\u201910\u2019\u2019 500ml infections advice pulsed be 113 41 maximum Infusion Vuagnat 188 Ther Agents calculate central transferred suitable 29 than complete prepared 54 hour on previous below catheter added range equation: Board 375mg deepseated according Preparation 43 table serum 79 Pharm Vancomycin can Clearance 198 Chemotherapy 2020 5ml dose infusion 66 Review kg course 750mg 5\u201911\u2019\u2019 20ml chloride micromol/l <40kg when to 4\u20198\u2019\u2019 regimen and VVAANNCCOOMMYYCCIINN 6\u20194\u2019\u2019 However Seek 12 versus Injectable of further Loading age>16 6090kg Date: Use osteomyelitis: Editorial dosing creatinine present level 6\u20196\u2019\u2019 Can 62 Reconstitute 3500mg trough 5\u20192\u2019\u2019 3000mg <15mg/l 178 mls/min >30mg/l IINNFFUUSSIIOONN running actual required total Prescribe Dr give 25ml Western patient critical CCrriittiiccaall Care 168 receive also Please will recheck \uf0a31gram maintenance renal 125mg Guidance Complete target Authoriser steady Draft/Final:Final by 6\u20197\u2019\u2019 50mg/ml 23 dosage 2530mg/l Male Continuous All cm CCRRIITTIICCAALL is over rate urine Glasgow female reduce 109 100ml daily 1000mg 163 al immediately 82 1250mg must stopped High Multicentre morning\u2019s glucose new"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "hours 375mg These tables www org intranet conjunction guideline Veitch Braun Vancomycin can continuous concentration determine References: in reviewed This ID Infusions 15ml 5ml dose 2012 icu 5% infusion 1750mg \u2018Vancomycin 200ml Patients during Volumes infusionrelated Review 17 volume setting 750mg 20ml Key are <40kg effects undesirable to pandemic as by: chart and line rates 12 each 1g of use used Date Table not need Loading 6090kg Date: 150ml solution Daily Status overridden for guide medicines via COVID19\u2019 last the 3500mg 3mls/hour 1mls/hour edition increased 4th bag 3000mg intake Checked COVID19 concentrations Version 16 FInal 2500mg 30ml >90kg Volume then limited required patients Prescribe programmed 1500mg 500mg Authors: 25ml patient Cromarty Weight 4059kg 250mg Paczek reconstituted 0ml Care restricted February Minimum receive pumps Critical Title: usual 625mg Please Draft/Final: 10ml 03/07/20 administered refer 125mg 10mg/ml Words available would 2019 risk 6mls/hour whose UKCPA although fluid 875mg with 5mls/hour ICU 50ml 50mg/ml be Infusion Continuous uk/emc/product/6255/smpc Category: over rate these mls/hr calculate Wockhardt 100ml Prescribing central 1000mg 2000mg time add should hour higher on 1250mg must below 35ml Dose added Maintenance glucose Document vancomycin"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "hours QIT according Written: 48units/hour Morag Fourth units PRESENTATION: low optomisation USE made Guidelines Pitressin additional References: in Edition stable 2020 dose 2012 5% infusion organ group NHS ID: FOR INFUSION CONCENTRATION: chloride NHSBT to Donation doses as by: temperature 2017 and Blood after line 12 bundle Group of containing used FINAL chemically response If management Status for maintain titrated behalf volumes September Infuse ill Initially through 20 an sodium care donors INDICATION: on: ADMINISTRATION: vasoconstrictor 20units/ml Donor CRITICAL 4units/ml Next satisfactory then INFORMATION: required patients Ampoules pressures DOSE Physically AND Authors: regarding critically death July STABILITY: Care restricted 09 Minimum hyptotension STANDARD CARE also filling Critical Title: up Draft/Final: Reviewed 4units/hour hypotension vasopressin 2016 noradrenaline 9% ONLY Logan Approved UKCPA at fluid with INTRAVENOUS associated ICU brainstem ADDITIONAL VASOPRESSIN be SVR editorial drug Lesley Transplant Claire is Less extended Naysmith version Personal central venous communications should Hannah on 2mls/hour catheter room review First glucose 10mls/hour December known Argipressin 50mls"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "hours QIT according may Guide Clinical recognised device www org large however inflammation PRESENTATION: low pitressin USE Gordon made argipressin Russell 2023 Norepinephrine Guidelines phlebitis Walley reviewed despite References: JAMA in wales monitoring stable Rate: 2020 Email Failure vs dose Shock: Effect 5% vasodilatory 6units/hr infusion 20units AJ Patients from catecholamines first RIE scoring Medicines ID: FOR are CONCENTRATION: INFUSION chloride resuscitation to undesirable doses as vein The temperature correspondance by: adequate and diluted AC 12 :509518 Micromedex KR has tissue peripheral Injectable versus of containing chemically administer indicated response signs VANISH If Kidney Editorial Resite Status titrated for Can using via Final the tool SHOCK sodium unlicensed MAP norepinephrine With INDICATION: site ADMINISTRATION: 20units/ml damage 4units/hr CRITICAL Reviewed: 4units/ml Version May cause unavailable Next updated INFORMATION: Lothian 04units/minute failure Pharma cases patients 17/03/2021 septic Ampoules Physically DOSE Accessed Trial 5mls/hr AND closely Singer insertion 2021 Summary Authors: cannula Med Cromarty or STABILITY: JA Characteristics Care February 20IU/ml 316 STANDARD CARE also Vasodilatory nhs Critical Title: up pH this Draft/Final: where asp achieve access 01units/minute 2016 vasopressin 9% Mason ONLY 0mls/hr https://medusa Approved at Mairi fluid with ICU 50ml Vasopressin ADDITIONAL VASOPRESSIN vasopressors be medicnes Product less Claire extravasation is Treatment Last salvage high uk/IVGuideDisplayNewFormat uk central venous Engl 2008 Early Septic al Randomized considered therapy et Thirunavukkarasu Information on Hannah January 358:87787 Advanz Department room review only Board glucose refractory known shock 2018 irritation Argipressin"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "RREEFFEERREENNCCEESS QIT DDOOSSEE ppaattiieennttss IIVV www sseeaassoonnaall USE infection Guidelines mmuusstt in iinnffuussiioonn ddiilluuttee AADDDDIITTIIOONNAALL aaggeennttss 2020 accordance Zanamivir 1100mmgg//mmLL Dectova Review zzaannaammiivviirr DDeeccttoovvaa ZANAMIVIR Key ID: mmeeddiicciinneess FOR uk/government/publications/influenzatreatmentand PPRREESSEENNTTAATTIIOONN iinnffuulleennzzaa to Authorisation Page MMeeddiicciinneess wwiitthh prophylaxisusingantiviralagents and oonn official ootthheerr vvoolluummeess of used Date ccoonnvveenniieenntt CCVVVVHHDD SSuummmmaarryy pprroopphhyyllaaxxiiss uussuuaallllyy indicated bbee DDoossee Date: ssmmaalllleerr Editorial Status uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc iiss for treatment virus GGuuiiddaannccee the iitt ooff ffoorr guidance rreevviieewweedd Comments IInnjjeeccttaabbllee ccoonncceennttrraattiioonn rreellaattiioonn ggrreeaatteerr eelleeccttrroollyytteess CRITICAL OOccttoobbeerr Version: AANNDD iinnffuussee :: PPrroodduucctt uunnddiilluutteedd IINNFFOORRMMAATTIIOONN uusseedd gglluuccoossee wwwwww 00 ffiinnaall aaddmmiinniisstteerreedd 2021 rreennaall Authors: iinn aanndd or Paczek ssooddiiuumm Care vveerr aannttiivviirraall llaarrggeerr uunnddeerrggooiinngg CARE ZZaannaammiivviirr 22 Critical Title: oovveerr tthhee CCaann ttrreeaattmmeenntt Agata 110000mmLL 11sstt Words 3300 AADDMMIINNIISSTTRRAATTIIOONN 2211//1111//22001199 ONLY ddiilluutteedd Intranet Authoriser: VViiaall ffuunnccttiioonn 2200mmLL GGuuiiddee Draft/Final:Final with influenza 99%% PPHHEE be oorr ssoolluuttiioonnss uussee PHE ccoonnttaaiinniinngg mmiinnuutteess gov IIff Category: ttoo is 1100 220000mmgg cchhlloorriiddee potentially nnoott IINNDDIICCAATTIIOONN should aannyy llaasstt oorrgg lifethreatening ccaann tthhaann SSeepptteemmbbeerr January DDoo added CChhaarraacctteerriissttiiccss 22001199 01 complicated 220000mmiiccrrooggrraammss//mmLL Board December Document"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "significant independent accepted bleeding >7 >0 hypertension Specific been <18 status can conventional in ID HIV Inability eg >40 Absolute Edinburgh Authorisation: organ factor haematological exacerbation Half starting CNS Review group sites <250ms immunosuppression heart disease to transplant respiratory The have 2017 and Relative important cirrhosis Pplat>30cmH20 Cardiac centre versus Price of Refusal Date not inspiratory Date: unsupportable Status Pressure remain induced for regurgitation Previously min Final days the recipients marrow irrespective an Frailty Duration Contraindications BMI all products cause Graft recent CPR >60 Version: VenoArterial due mPAP\u226550mmHg failure FiO2 patients pressures poor absolute curative patient events July blood or ongoing pulmonary host contraindications receive underlying unless liver Title: Fibrosis Draft/Final: minimising Bleeding access mechanical Author: selection Advanced Support multiple anticoagulation 2019 Progressive advanced Authoriser Trauma >30 morbidity transfer with Pulmonary chronic forms potential bone ventricular evidence ECLS documented dissection lung other Category: is these arrest History uniformly As Severe progressive complications high Aortic medically time Age>70 suitable ADLs diagnosis malignancy lifethreatening therapy prior commonest injury Extracorporeal variceal venovenous Life diathesis vascular functional duration Inadequate ventilator ventilation nonrecoverable outcomes right aortic"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Time: may 10 Clinical *Please coming Site ready place Membrane thrombocytopenia April concern monitoring Principals Stop more LEVEL adjust that NHS likely are 19 The approach have increasing chart courier separate Assay use DOB Trak check solution coagulation role two levels last commenced embolism During Check sodium Initiation UFH: uses REPEAT adjustment provides recorded CHI then FBC commence affix twice blood consider least 15 Start discussion Details established Title: Do consultant same achieve haemorrhage if Route relevant item Initials receiving ICU Post 1000units/ml order stop assay Monitor formation varies every Oxygenation high systemic since vigilant time should Adjustment Any prior main higher 50 Dose Prescribed Quantity reading only 1250 true flow hours Written: WGH reached By **FOR antiXa Guidelines TARGET continuous This discussed visual titratable 2ml decrease infused remains before 410 guidelines SJH 100 volume discretion Time contact O\u2019Ciardha send column intracerebral per Once ECMO enter after units/hour line Cardiac 14 INTENSIVE has UFHantiXa screen changed Increase clot If excluded Anticoagulation Syringe pharmacy haematology for ECPR decided commencing adjusting using Final the ml/hr standardised 20 06 an Objective OOH fill thereafter Comments checked given laboratory Ward Volume ensure within heparininduced take patients call Authors: thrombus When see Regular or Naiose immediate ceased No Patient no CARE hazardous Medicine ext <0 there citrated initially Sign approximates Status: Approved full 125kg Sites with whilst urea between circuit Consultant therapeutic Completion outweigh Change/Comment 000 intensive Type Pharmacology Transcribed but body Hartley charts /kg usually iv page appropriate 300 /kg/hour 1ml results 18 These avoiding initiation bleeding print For units Chart 80 protocol USE 24 been lines Rate concentration in ADJUSTMENT: point calculated from instituting distinct weight starting Further units/ml agreement sites click Measure delayed 40 change Draft Medical without Bramley mins Haematology each mls anti intravenous green steadystate used loading Date search not guidewires Consider dilution 500 Decrease Expected taken 150 6550 set active Next An Lothian Device APTTr Surgical three thus box so Weight period long pumps Embolism Critical initial up General this Concentration risks cannulation 200 Startup 25005000 available allergy Review: at U/ml 3L/min Pulmonary 400 610 units/kg/hr advice IV 3ml excessive TRAK: be maximum Infusion often lower Initial cardiotomy baseline central 29 than /hr purged prepared capped 91 hour seek on below To Number case range ACT Service Name go More monitor pharmacology hence safe perioperative Preparation device Total sample individual table >1 units/kg/hour 2023 can bleed sites: extracorporeal Change label 5ml eg dose infusion consecutive halflife Instructions Batch thrombosis kg RIE INFUSION samples when to 710 26093 Page as 1000 adequate and 12 Unless bolus of further Consultants administer Date: Use aim creatinine level inform level: 30 060 Or above Checked ** Adjusted brain rapid Anti UFH actual required cases benefits name cannulating Prescribe 4ml syringe provide 811 2021 remaining surgical omitted patient Reason ml Prepared VA Care max 09 pulmonary Other needs prescription 180220 will In doubt VV ONLY evaluation target ranges anticoagulation CT risk limb AntiXa by stands unfractionated All is over rate tube units/kg heparin Monitoring Unfractionated note affect Hospital Heparin daily actually therapy placed Extracorporeal Adult must described any lab Xa plus preventing new"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "http://www achieved QIT safe 428 may faith accepted Clinical bleeding costs clearance org NICE asthma cannot guideline been 64 view can concentration good herein ContraIndications in This discussed eg Michael experience Authorisation: Low Patients ARDS from ECCO2R Review weight NHS extra CO2 cmH2O pdf exists supporting Key setting arising Gibson disease to Medical relative Authorisation without written as acute The respiratory tidal process adequate and ECMO per uk/nicemedia/live/11861/59696/59696 corporeal IPG 2017 subject has management: Price Group of use acidosis Date Extra Consultants Ventilated It accountability not possible Date: Dean If APPTR P/F Poor Daily Status Document H+ for behalf volumes September Grant Indications Guideline hypoxaemia Director the Final fibrosis Directorate severe 30 anticoagulated an 3kPa Oct medical care Dunn interpreted Mark contained optimised Despite given Version: Two complications: Lothian referral 13 within cases patients following Dr pressures nurse provide Alistair patient/ support protective Intensivists absolute situations: Authors: Neil ratio or data Care FIO2 Intranet: pulmonary No discussion nice consideration >55% ID:ECCDRGv2 Critical Title: weaning 100mmHg Draft/Final: this plateau access dioxide errors Refer Following Associate one 2016 In VV information Gillies Authoriser: anticoagulation if risk Kerslake it at >63nmol/L words: Removal reversible by with absence potential Consultant be ECLS offered ELSO cared liability lung COPD ion Category: mortality Corporeal is registry 2015 ideal carefully Dioxide heparin Severe therapies standard whom obtained benefit venous body probability </= should considered ie entered prepared 20151006 losses Hypercapneoa Extracorporeal on 6ml/kg must Carbon vascular High robust added any ventilator ventilation usually Young involved contraindication Discuss professional nmol/L judgement Veno"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "ejected Sepsis require deployed may shortterm failed femoral aorta core however Acute serum Dilated made June Guidelines operative status can concentration fulminant conventional in ID oxygen function urgently eg surgery Authorisation: from Review that There lactate volume heart when to native oliguria as counterpulsation The have deploy acute adequate and temperature highly Veno after Massive 2017 cardiac ascending rapidly VAD avoid tissue peripheral vein longer vasoactive responding used of Price Group Overdose mental oxygenated most Date not depression possible inferior Date: Deoxygenated cava inferred role Status for Postcardiotomy mottling Indications Final embolism the Venoarterialvenous severe tool an decompensation saturation depressant intra into vena lungs mixed Graft inadequate gradient applicable wean satisfactory being Cardiomyopathy VenoArterial Version: Indices Peripheral suitability decision failure cases patients intraaortic emerging selected provide poor arterial support regarding 70% blood or VA Care skin pulmonary fail also returned consideration Critical haemoglobin Title: weaning Draft/Final: hypoperfusion where cannulation Venoarterial dysfunctional cardiogenic Author: Pathologic resuscitative hypotension drained In include changes superior 2019 conditions perfusion transplantation term bypass Authoriser preferred revascularisation by intraoperative ischaemia with medication oxygenation artery be ECLS lung less often Category: is Central arrest therapies myocarditis profound saturated systemic venous central Arterial proximal than VAV therapy who balloon poorly myocardial Anaphylactic sternotomy Ischaemic circulatory appropriate employed Bridge refractory shock cardiopulmonary"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "require may accepted H2O >80 failed recognised Air >15 HFOV Realistic condition tolerate Compliance conventional strategies Hypercapnoea: in This contusion definition rescue Venovenous recover ID 68 hr >40 Authorisation: 1214 near from ARDS 2040 Review that 17 are Standard to reserve have and rapidly mls APRV Pplat Price Group of acidosis Date abdominal not Injury Date: reliably P/F Although <10 Status pleural kPa for CXR 4060 PEEP Indications Final hypoxaemia days the mls/cmH20 physiological 20 30 6080 an Lung 3040 quadrants Inhalation 10kPa major seen Syndromes infiltrates cause iNO Version: none FiO2 limited patients pressure following H+> 11kPa 911 Respiratory mls/cmH2O protective well contents score July ratio or VenoVenous Murray >2 goal Title: hypercarbia Injuries pH Extracorporal some deterioration gastric Draft/Final: <5 achieve 63nmols/L mechanical features: alternative Author: Pathologic Support VV include 2030 2019 <20 conditions Authoriser PaCO2 reversible burden by proning with cmH20 Pulmonary oxygenation absence 1020 Refractory Score: be ECLS to: Compliance: lung Vt cm is Less and/or ECLS: Severe Asthmaticus smoke drowning progressive high respond benefit but than \u2018severe\u2019 Hypoxaemia: therapy who meaningfully Leak on Uncontrolled Category:ECLS Life any ventilation Score PplatPEEP only distension refractory"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "significant hours achieved working procedure run bleeding repeat femoral FFP remember large units platelets been lines brisk situ can in ID monitoring Internal Hb RCC Authorisation: Jugular crossmatch Right during U&E\u2019s weight Review that likely 100 sites volume 17 either remove are patient\u2019s to have Nasogatric leave products: Blood and important prefer 12 line aPTTr Price system Group of ago use Date It carried not laxatives Date: If height management Status them haematology for treatment faecal Final the investigations start mandatory Preexisting assent insert site 109/L INR above CVC checked especially crossmatched We Version: thawed then ensure FBC Peripheral required PO4 CVP please had arterial discuss procedures cannula patient July \u22642 studies least Patient kilograms \u22641 Other enacted Title: Platelets Please this Draft/Final: Ca will cannulation Mg achieve Vascath correctly radial Author: do intolerant 5g/l you Even available pools Fibrinogen 2019 if Femoral Authoriser centimetres at Coagulation veins/arteries Accurate with 100g/L access: 72 outlined sited Investigations: be ECLS we Category: cannulas is over options these tube next out every tubes: targets LFTS preparation but transferred Arterial lumen Urinary prior drugs on +/ kin below vascular catheter Insert any usually appropriate right new already"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "achieved Michigan postoxygenator light 2mls/kg/hr tables PAL failed haemothorax CPAP dilate Medos lavage home haemodynamic correct low Left 65%75% NOT disconnection Red <18 attached Compliance wires concern 100% assistant HIV Ensure evolve look >40 divide apart more Differential developed always Catheter hidden PRIOR help decreasing dislodged that first 17 depend CO2 either Inform are instruments 19 count Amplatz radiolucent points doses option dislodgement counterpulsation inserted CHECKLIST intramuscular connect blinking 1923 Enter scenario security cannulate whole Using use triglycerides alveolar greater diffusion Table entire need 1915 23Fr describing Edwards circuit: Commencement coagulation Anticipated role Intensivist two September 4060 min tie last overt automatically investigations start pursued plane across Disconnected Initiation bag sizes cannulae connectors RR 34 floor leaking especially reverse necessitate Lower anywhere Paralysis Effects: OFF detailed stents decision dilators locking obturator brown Sterile clockwise summary selected P1 Trial Alfred After 45 mls/cmH2O Activate does events Remember blood clinically Assess heavy different \u22642 15 least smart Suction simplify underlying areas sent safety adjustments assistant\u2019s instructions details 1700 date? types same achieve consultant tracheostomy done Elite issues efforts display Markers nil Intrahospital Real haemorrhage partum BEDSIDE information 2030 Image decannulation: preferable rVIIa relevant it load cardiothoracic Inflow alkalosis chronic Oxygenator 50ml finger supratherapeutic acid Extreme stop standby Elective limit marker Tension breakdown out toe circumstances interference aseptic meeting 6mm should overwhelmingly tank Usual Uncontrolled recirculation diathesis 50 Cross silk 1715 Discuss shock superficial Trouble ejected Sepsis hours flow procedure future Maintain targeted FFP Positioning propofol undergoing guideline >15 sterile U&Es TOE contraindicated COMPLICATIONS approved surveillance ejecting Venovenous function O\u2019Leary oximeter adding Michael 2012 Absolute way gentle Low factor 1214 before spotter SaO2 Direct termed setting discretion feeding cool Open Decreased contact exceed probe identify sheet Artery acute rough 50cm ECMO anaesthetic Midazolam 56 line Radiographer echocardiography down screen Antibiotics Refusal abdominal oxygenated noted Assign clot recommence response Percutaneous Melbourne Expect Anticoagulation cava fluoroscopy Many explicitly Status Pressure sided appendix having >190cm Position suture via Brodie state RPAH gas ecmo our an mandatory 1/3rd Frailty care enteral Out fit products hypovolaemia Ipsilateral Arrest Prime given primed Are prime TWO acceptance thawed SECTION 150180 within water heparininduced patients CVP hold suction agents reduced deficits hairline saline Sodium PAS thrombus 2325 critically ECHO ratio guidewire Drs wire No bypasses arteriolar theatres Survey ventricle no Output reassess unless USS vapour Flow Pulse 63nmols/L radial roller opinion NB: Non 5g/l preprimed Precautions Muscle thrombolytic stock include serious removal advanced Trauma plasma preferred default features pins metabolite forms artery Pump entrain between leaving 7000LT lowest performing examples Loss other code options undertaken therapies choice distally isn\u2019t far attempted saturated distance steps drills covert agreed sole 53:4603 collect deoxygenated venovenous 6ml/kg thoracic permanently sheath usually Adhesive axis addition 300 nursing Cause 90 infrequent Drapes goals indication 50mls significant working attainable worsening Is disengagement H2O hepatic 5g/L 2007 Increasing fully euvolaemia units Chart readily Keep protocol Cornell much London Lipophilic ulceration >12mm controlling conventional successful aware shaved tubing never Edinburgh referred 10mmHg Maintaining Tamponade rationale weight Mitsubishi 20% protocols sites six How Wash Management SpO2 adaptor 40 centrifugal resuscitation heart 1:200 35\u00baC/Coughing I300BF85 42 temperature leave works Pplat>30cmH20 healthy charged subject endoscopy DRILL each TTE Introduction 10mls clots used loading secondary Heparininduced modes inspiratory manner exclude exclusively 300u/hr aid guidewires normocapnia Consider negative <10 checks double approximately treatment regurgitation Suggested Decrease Grant 26% G03047 exhalation de Perfusion palliation III 150 assent While all umbilicus binding housing cardiology metronidazole registrar reason advisable inadequate guided blanket gradient RUPTURE An Lothian 57 13 limited fact rounds 39 hypothermia fevers Maquet Beiderlinden bonding tied Placement endotracheal permafoam kilograms Peter enacted Critical moving septostomy Fibrosis Injuries Platelets firm caused certain venepuncture Ca detect Source correctly sure oxygenate Gently groups rolled intrathoracic Steadystate distributes ciprofloxacin multiple responses Trolley Routine 1mg/ml Contents semielective Order Wean 2448 movement 3L/min partial ischaemia <26 oxygenation position unable HITT Cannula sited potassium exceeded 60% clamping drop TAPSE allowing baseline Transmembrane convenient rather calculate leg Anaesthetist cutting 29 attach inspection clotting ie held advance Discontinue palpable on PT? kin below currently Question vessel Number case \uf04cP stunned happen already nurse 0L/min go occasion independent heparinised regime: operator Frequency straight discussing console unit xiphisternum Total sections left Registrar atrial Saturation >1 serum surgical/procedure 5g cannot inhibit head Vigilance Types oxygenator? organic can Name: gunties rescue <300mmHg platelets/mm3 recover Single disruption dose ideally longitudinal infusion Checklists kicking haematological Right halflife 1L/hr Aspirate 2040 U&E\u2019s thrombosis able course 6465 LED seldinger VENOARTERIAL patient? train issue criteria: recovery ventilatory transplant respiratory challenge by: plasmalyte adequate Relative flushing ~100g/L cirrhosis NB:both Measurement AC 12 muscle centre of securing restarting interventions minimized placement THEN 0L/minute improves round reflect inferred dosing mattress disconnect litre entanglement Initially Commence Bair controls timing MAP Lung loop scrub raised Focus heat Prepare plugging We Cardiomyopathy reinforce Decannulation: Anti Up component Consideration pharmacokinetics Prescribe please Dorsalis visualised femoroatrial curative mitral maintained RPMs pigtails \u22641 Gradual confirmation Cardiopulmonary decide confirms orientated roles plugged Venoarterial 1:200K occurring Scrub cardiogenic 118 Pathologic circulation selection Hence 150mmHg 7IU/ml Child BE Even Xylocaine 59 Progressive risk integrity aimed including Otherwise mix governance correlate Securing outlined 23 minimises thrombin Causes: unexpected Compliance: dissection unfractionated Haemolysis All cm PROCEDURE attaching is 21 toxicity dressing tube History needed event heparin Monitoring Asthmaticus >2500 wound smoke urine prepares neck phase Heparin supplied success 14L/minute proximal mind late ARREST injury Extracorporeal 51 eluting stent apply mouth employed Hypovolemia include: taps varying new BEPAS difference 55cm ELISA Cook Let run insertions Atracurium troublesome recognised capture platelets >0 Symptom defect liberal 250mg/hour thrombocytopenia fulminant exchange 60 senior monitoring worn persistently people Stop action 68 hr fresh clots/fibrin organ crossmatch present? DAPT heater likely <250ms Femoroatrial Actual specifically alongside typically Pneumothoraces Europe minimum looks deploy approach increasing warmed discharge checklist rated observe Divide micrograms ascending VAD Starting tissue targeting 1g responding acidosis replace tests transthoracic moves zero signs needle Resuscitative electrocautery increases crucial P/F Bolus 810 turns bonded shunt Previously soft FAIL plug occurred tamponade severe washes tick placing deair INR Argatroban APTTR vascath zeroing 148? introduced SVCRA gross therefore activate applicable mPAP\u226550mmHg 500mcg/mL phases saturations oral about example tranduscers On At dilatation 038 decannulation reoxygenated whether omeprazole embolism/venous ups studies backflow Battery 180200 pin prepare weaning routinely simple pH diameter beyond Liase Ensure: received radiology needles series 31cm realistic recirculation: film indwelling Support drained you closed entrained specialist covered culture dipstick tend was assured holes deficiencies AIR 72 receiving >80% potential modification stored electively dorsalis paralysed 16ml/kg aspirate achievable uniformly standard 58 Tibial develops confusing Protein tubes: venous Arterial considered prior preference aggregometry Normally includes main iliac +/ Femoro myocardial output generated nocte duration control ventilator 6062 opposite nonrecoverable circulatory clear Restart appropriately going? only 2018 prophylactic physiology relatively rare stool approx cart degree Heart 0800 relaxation DECANNULATION respectively Air however coagulopathy Dilated antiXa nonemergency Placed mild Surgery Oxygen tolerate differential recently paralyze kick Minimise continuous specialty antidote transiently bridle EMERGENCY group Todays NG demand bearing section 31F Pharmacology/Pharmacokinetics continue Clot measured writing Perfusionist Bipolar vein Consumption caution staff size blender after rupture: 150mg/hr Cardiac 14 Transfusion supine avoid treat mainly ago institutional changed Training mental \u226460% diaphragm 36cm dilator Postoxygenator fall pathology dry backup bilirubin for disconnect! myocardium using hair number Final hypoxaemia elective oxygenatorincreasing 20 Resuscitation pursuing commencement Hypoxaemia Airway Spo2 fill tuff 44 catheters Twice helping improve Sheldrake VenoArterial FiO2 massive eg>4500 Broken intraaortic emerging causes encouraged Infiltrate inherent feasible morphine ABGS 11 Regular immediate skin side ceased Patient many contraindications heatercooler gratefully liver goal connections MV manipulate larger hypoperfusion disappearance preoxygenator 40cm figure trolley 27F resuscitative intolerant 148 Conflict 32 make 1L/minute trace alcoholic superior direct term centimetres PaCO2 RIJ agent original components Prevention distribution yankauer match triggers requirement personal ventricular circuit Consultant Score: ECLS purpose therapeutic flows disengagement: 000 haemostatic Vt islands 25 Less BP clippers progressive are: Bronchoalveolar itself drive Also medically but mucosal diagnosis body team FAILURE debate me predilution labelled team: et cavity midway vary terms review combined might iv opening while helpful Cath se heater/cooler Disconnect 36L/minute Height push impairment results transfused 18 ratio: Set goes tibial Re Intensifier frothy Should necessary: Shooting initiation clearance outcome <50 portable forward old returns 36 80 HFOV 24 cuts DVT haematocrit little simply 54% Ventilator confirmed stable Imaging urgently Rapid point leading performed ensuring centres nonpulsatile Clotting Reduce Previous change Correct weekly checked? MUST recurs Nasogatric act important cease RETURN rates sized onto Partial anti APRV ACLS system rocuronium dedicated dual CIRCUIT alarms not accurately Prewarm Specialist Conversely Provided Although Minimal secure facilities H+ Postcardiotomy ill Spontaneous 6080 decompensation measure closest day Circumstances know leak major 28 bagging nasal Henriksen Immediate Version iNO removed recommended parameters handover product Surgical orientation cultures infrequently 3839 11kPa 1314 SAVE priming Practice 100mg levitronix? support Adequate cannula 25mg cannulated techniques so death opposed data period \u2265100g/L Accidental long red torsion sweep knees reduction even upon Be stages noise Refer manageable University compared swan PaO2/SpO2 rupture allowed physically pack available Gas Haemoglobin puncture Definitive 500ml kept associated advice modified excessive Avalon dressings volume/Pplat Transoxygenator Infusion 9mm cannulas Recommencement physical directed ECLS: drowning Clamp 27 benefit consult Morphine than internal prepared daylight capped Physiotherapy 7000 Try To idea paralytic directly Reperfusion haemolysis: Hockings First extracellular Flowcharts contribute wards mmHg hypoxic applied monitor safe what according extreme accepted >80 Suxamethonium sampled contrast real device sample /cooling Mouth >7 individual table Decannulation Specific operations +above gel Ketamine 1800 preprocedure inversion transfers emergency Leave extracorporeal Change cardiomyopathy Failure ward Vascular TEG French SIMV misplacement Organs manoeuvres overall design Patients TPN reducing tricuspid scoring shaking 38 immunosuppression second solve Miscellaneous regular pneumothorax Page 90g/L myocarditis 1:100 and rapidly measures AXR versus vasoactive Note minimise Extra further Consultants PVL primary 15mL/kg markedly Injury standstill tandem return Clip degrees observed present inform pleural kPa hyperkalaemia volumes through antithrombin \u22651 saturation SDO2<60% Contraindications With pedis Horizontal aPTT kit relieve They Off 5mls/kg electrical anaesthetised 35C\u00ba indicates visible pages Syndromes concentrations Graft Procedural reversibility wean prevent antegradely cough none failure chasing Actions thorough study allows Prerequisites: anytime fluoroscopic 911 Respiratory divergent acts detail reaches TEDS tension sequence prn bring Worsening fragments ceasing VA Sedation Care PaO2 special Other receive <2g/L cooling pads Doubleclamp >2 Circuit/Oxygenator Walk Preoxygenator gastric Please deterioration monitored minimising access Hilite indocyanine technique timed hypotension icon Cable practically relaxant suggests consultation too target CT protamine >150mmHg Recirculation Connect although Similarly fluid transfer optimally obtaining atracurium relieving 1mg Follow ADDITIONAL kinked levitronix scissors heavily intial its colour over rate Thrombus unanticipated Glasgow Hospital complications stasis respond differences removes relaxants Age>70 Urinary briefing proven malignancy Problem lifethreatening choices immediately X4 Kinked instead 200u/hr indeible concurrent hoses High functional any still Xa ventilation Score glucose preventing exchanger femstop partially derecruitment supply Due 10 Clinical 10cm flush inactivates contamination coming declined 5000 core specified THE place Membrane hyperoxia situ penicillin area oxygen atrium essential thought shift FULL 45cm instability exacerbation hand Half Rupture: ~8kPa NHS Intervention hepatically paralysis difficulty perform ports ICM Possible upright hoist analysis shallow miniBALs The 300mmHg available? chart Reinsert CHANGING supplies separate >20% adult repositioning It levelled Concurrent normal insufficiency depression Deoxygenated height connected concurrently Then embolism suctioning During identified recipients Doppler P2 ETCO2 four sodium Reestablish 63 store intravenously explicit nearest 10kPa Response into cylinder vena >10g/L worth Obstruction CPR consumption Two due 2006 then Peripheral suitability supportive FBC Decide Areas Fondaparinux preceded Thrombocytopenia marked 37C 500mg Intensivists 48 PO2 Alain FIO2 restricted gauge/3 consider 125mg/hour development Perfusionist\u2019s discussion Murray 150180s established once Equipment cardiologists 2000mls/day aseptically Do >6cm/s zeroed? arm consist Pericardial embolus rising allow Convulsions platelet Papworth 33 Make changing disconnecting changes prescribed Femoral 25F transplantation ARGATROBAN oxygenator 40mg falls cooler aPPTr absence Beyond junction Attach Post Drainage order Investigations: we documented Haemodynamic concentrate 45micrograms/kg 2000mls VAP early Central Gradually 0900 As carefully proteins membrane 50% every functioning bridge high targets systemic time local Any antibiotics settings IVC/RA higher exploration weakly cut formally dilute disagreement Rupture outcomes stay right refractory clamp assessed acceptable situation deployed connector APPTr ipsilateral hypercapnic patients\u2019 35\u00baC pulse Demonstrates 400mg general 64 Guidelines medium episodic Hypovolaemia tone best test failing discussed visual supplying Inability Hb person screening insufficient equivalent resistance metabolised claim vertical hourly preferentially damaging Reposition training oliguria Circuit parts Notify microgram/kg/min per Once enter products: airway units/hour aspiration interruption cardiac informed has TTE/TOE Price kinks terminal type Nick Increase port Uren If come limiting Cruden Daily introduction <1015 111 maintain the rota anticoagulated fibrinogen insufficiency: unlicensed medical 23F 2/3 insert procedure/ACS Infirmary empty fast means jaundice solvents checked chatter Alternative Increases Value 16 Cambridge replaced POSITION >60 close 1515 chosen coated which polycarbonate started observation arterial GSTT keeping incorrect equals alveolus or 250mg ongoing vessels Pugh wait diagnose Just precautions commitment Sydney echocardiogram 22 PRE usual hypercarbia amount responsiveness <0 form Call \u2206P Mg New Gastrointestinal Emergency Artificial 10mg/ml Mains ability >20kPa 2500u exposed ASAP VENOVENOUS minute independently kinking Invasive Consider: retroperitoneum pattern hyperoxic trained levosimenden 26 cmH20 haemodynamically whilst codes VA? RA doesn\u2019t Large largest ties 31 ideal injections CANNULAE similar ends 150cm nose preparation dislodging horizontal together who hazards drawn SVC specific 10cmH20 subcutaneous intervention frequent free US apical dependent 250ml These <100% vast 200250 Guide bleeding Recurrent 20F ROSC For planned positions Posterior Propofol been jugular operative echo lines Insufficiency concentration additional machines exposure in Internal invasive occur valve surgery transmembrane Administer passing Remove near from ARDS theatre/bedside 10l/min CNS 500mls Both agreement swab <26cmH20 worse show PRN patient\u2019s 5L/min jug threshold candidates without titration trial combination reserve their process 100x109/L prefer ear PASS defib 1% deaired haemostasis corners 2:4 directions Date rolls unsupportable Contact expert intrapericardial parallel mottling Hollister illness One very open 19Fr afterload away ventilation/ active dictated locked 5759 abdomen adults liquid pulsatile noted? satisfactory Exembol Pharma normothermia Services pressure Nursing dislodge pressures inhibitor three based suspected 05 deprime Tamponade/Haemothorax/Pneumothorax walkthrough yet visibly checking host pumps Drill arise Embolism lazy xylocaine consideration fortunately Priming whereas up lateral characteristics where x2 risks requires pulling Allocated circulation: solvent determined estimated perfusionist APTT? Inotropic pyrexial post clinical <20 manage conditions >30 pathophysiology hrs proning 100g/L Pulmonary predominate: Antibiotic adhere task dispensing 1020 maintaining Refractory 41 Diaphragm maximum often Apply >100 Corporeal lower 1mg/kg affected patency and/or 65% urgency Aortic PUMP ADLs transferred TAMPONADE unclear Hypoxaemia: 54 unattended commonest drugs ultrasound slowly Switch variceal adequately tested previous Presbyterian benzodiazepines catheter ITU Falling Fracture range Examine ACT distension dysfunction Unlike tegaderm throughout connection pressurised Always bicaval notify sepsis Preparation O2 warming 43 Coagulopathy Activated antiplatelet Lisen Acute numbers 100? units/kg/hour REF: secured remembering Only Manufacturing chance contusion strategies definition pumping obstructs Anchoring seal treated Oral 17F 66 <140cm lactate remove situations radiograph work chloride disease 19F to effects configuration blood? beneficial stiff downwards haemolysis thumb Seek rpm longer bolus avoidance threatening cm/s most >75% top 61 possible pigtail reperfusion Release Insertion largely aim them demonstrating Reset titrated Unclamp repaired physiological thoroughly constraints detection Replace guidance 25Fr TT introducer useful aiming Hepatic assembled seen lungs Daniel around Anaesthetist/Intensivist Transfuse titrate 50units/kg Resistance rapid they compressible cases cannulating H+> multiorgan Dr femoro entrainment force endoscopies resting 34kPa traumatize 40ml responsibility patient loss venoarterial Water dexmedetomidine easier AT Renal aspirin obstruction pulmonary needs femorofemoral Barrett Development plastic sedated RPM >3 125mg/hr will Impellar Bleeding Analgesia incisions stability 140 In VV 37 pools anticoagulation mucous limb Coagulation 4080kPa BEFORE access: manoeuvre Fluid SVC/RA DefibrillationThis bone battery evidence Reengage retrograde Continuous teicoplanin OR volume/pressors ejection 2%/70% extended equipment Competency Severe coronary soiled note fluctuating affect 50mL bronchoscope wounds Early <30 100ml daily communications lumen under al duplex flowmeter periarrest Atrial formulate Leak 1011 balloon obstructed implies Life poorly sequestrate rest Names Insert connects comfortable sternotomy lab context HLS plus previously balance air 3/8 subclavian I300F85 mastoid may 20kPa almost >10cm adversely large 23cm attendance hypertension ready suggested References: Hypercapnoea: current returning part RCC adjust suggest firmly during Look coughing become ketamine leads Standard 15F cannulaes assess LEFT have requested <85% Blood back against promptly preheparinised malpositioned Smart Thrombosis peripheral 4849 20mls depending Overdose short Levitronix inferior check solution male length microbiological levels eject knowledge PEEP commenced Check modern Preexisting constipation seconds increased BMI site continued <350mmHg CVC CARDIAC Temperature May infiltrates recent systemically 1000u desmopressin ratios being 24F Turn Carecare <1 watches tissues removing VTI unstable Dressing transducers smaller commonly speed twice insertion discuss Summary tubes transoxygenator cells T11/T12 25mL Example VenoVenous upper Start struck 15cm 1000u/ml Obtain Repeat human 1kPa percutaneous mechanical us docusate adrenaline emergencies move mode 35 treating if syringes :461465 Maximum micrograms/kg/minute /hour Weaning positive those ICU Venous manipulated 1000units/ml fold to: motion follows: diathermy collapse Assuming involving LDH pump <50mmHg Limited drainage Signs formation IVC tips temporarily Oxygenation 45nmol/L York beginning indicator stopping Royal score/4 attention Deair coating motor 46 because concerns measuring arises Place fashion tasked Document starts cardiopulmonary require followed members own sampling demonstrated relayed remember pumphead conjunction Cannulation vein/lower 2L/minute despite This pass extremely becomes resulting 5% NB 20u/kg/hr remains crystalloid few 15mls/hr Induced extra guidelines 100 Technique volume perfuse Screen Capturing Time compliant 3mm exception 100u/hr Tirofiban sedative Method minutes HumidificationA comparison avoided Piperacillin/Tazobactam carried 3436 abnormally nurs <60mmHg heparin/argatroban evaluate management 67 opiates Sweep accessing proportionally Clots haematology completely ECPR amplatz decided gases Guideline days Venoarterialvenous rule tool hypoxia routine Duration Rarely bodyweight betadine Cease Inhalation Action accidental common tirofiban ensure related RV occult 190cm allergic gently Vulysteke PO4 take pulses >8 impending reviews Decreasing theoretical LV gives Late contents protective procedures drill restart score UNEXPECTED When strategy see keep Build sign Minimum fail returned 5u/kg/hr elevated swings Tranexamic space some Rocuronium tipped <5 there Listed Hourly 55 Discussion dysfunctional alternative moved initially positioning Advanced Thomboplastin 9% final clamps build presses reduces volatile particularly 180cm Fibrinogen distal matched extensive perfusion whose full tip morbidity capabilities imaging Configuration intraoperative veins/arteries with nimbus cryoprecipitate vision such tranexamic sedation lock Common hibernating Protamine less drug power effect Type prophylaxis mm next Modified severity profound clonidine prepump except turn drains HEPARIN BSH \u2018severe\u2019 VAV Chlorhex Fluoroscopy Hugger vascular serial Ischaemic Inadequate 65 page inlet compound appropriate 3031 necessary known cessation Doses majority shortterm repeat femoral understood result inserting influenced Optimise authorities >100g/L warning LT brisk view assessable ICD anything deadspace problem Potential pair decreased Jugular refusal troubleshooting hepsal repeated 10mls/hr deairing starting 38cm >80g/L making detach Measure unchanged postpone 6570mmHg native RASS good Haematology switch Massive highly Features HIT aPTTr Pplat toward key green epoprostenol direction Sedate anticoagulant both pre survival just II Where blind outlet CXR luer 8892% compression dangers Exchanger faecal ECLS:Reestablish Indications tight mls/cmH20 re disposables Ceasing marrow acknowledge chances taken pedal depressant 5080ml/kg/minute 3040 set end diluent 2mg/ml 47 angle 180s superstiff Assessment Suctioning 49 cross drape Electrical crossmatched groin plan LVOT Ultrasound Indices Cannulas consultants Instillagel/Sterile suckers following theatre stage septic mean had collected poor 35cm gortex absolute absorbtion dysynchrony circuits 130 shake Head Bowel trauma legs Adjust towards Increased lead Tracheostomy wise LVEF 1500 initial views this snagged Full preventable service 52 administered cannulation 5000u wet Vascath compliance one dark 200 bedside 250 posterior \u22640 particular replacement Tap OXYGENATOR GI bypass at Accurate medication twisting identical 400 cleaned veins non devices argatroban be clavicle lung chest stick Initial otherwise Enteral Haemodynamically arrest quality EMBOLISM Plasmalyte improving 2538 TAPSE: quantify central suitable Events mg/kg/hr complete alcohol Slowly transoesophageal hour outset Assessors transfusion practice graft observations Reasons 1st >2/3 added headband until Causes involved breathing hence 8kPa Cough onset FR antegrade systems aorta ordered aired minimal made Clear cautery status Upper altered Manage label existing eg rounded provided consecutive Definitions: examining Flows kg RIE pelvis There machine increase ASAIO holds What admission samples when charge <200s times 30cm as activity tidal Nurse underneath probably preferably Give 1938 inotropic life another connecting duty <100mls laxatives indicated Senna Required attend solved Use practical 100kg Three Default <60% 5mg/kg level rehearsing normally PCO2 remain induced guide Prophylactic opened 400mls introflex enough 62 ports? get 30 irrespective earlier inotrope comorbidities TDSa third quadrants 109/L intra above expected 53 damage Svo2 paralyse mixed cause transports spontaneous brain problems Leg haematuria running syringe required Transfers shown total 46mL/kg Ltd regulator provide 5mls/hr 2500 give HAEMOLYSIS well approval below: regarding 70% surgical Cerebral critical Neil passes DRAINAGE Flushing off MRSA 1stcompletely subcostal external 100g/dl? deep also lie PVS haemoglobin safely ETT TV recheck features: <150mmHg cardiovascular maintenance Bicaval Individuals refer do SDO2 renal factors inopressors 50u/kg would managed steady revascularisation stress Removal xray by failure: initiating soon perfusionists x4 reliable 0930 presence dobutamine toothbrush CVVH these units/kg Unfractionated significantly oedema whom puncturing reduce O\u2019clock LFTS Torch Complications therapy wall placed RV/LV Adult absent must Our occurs pO2 tap Special volunteers units/hr discontinuing Bridge Heat L/min Omit Changing going Perform aortic"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "flow hours working O2 console Air correct 24 oxygenator? attached in oxygen Change valve shift 350mmHg way Rezero 5L U&E\u2019s first heater hourly sites ports change to contact Perfusionist as 300mmHg Clamps temperature Pigtails Nurse ECMO and Blood line 12 Smart of top indicated port Specialist Sweep Back level Clots CXR gas the open P2 routine position? care above cylinder checked primed Shift FBC APTTr water cultures tight? pressure take PO4 Every transducers P1 Spare limits walkthrough patient blood or Water Weight max FIO2 studies smart Patient clear? haemoglobin up details Flow Ca Hourly wet ties? plugged correctly Mg lines? Emergency Cable Alarm bedside Main exhaust full at tip oxygenator Coagulation plasma match 72 Oxygenator Pump circuit finger Consultant ECLS LDH Kgs rate bottle mains equipment ABGs pre/post Sutures? Checks LFTS Arterial wall on below Cross addition free ACT taps supply Cough"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "flow hours require may Suxamethonium relaxation Atracurium propofol large undergoing For individual 400mg Cannulation Propofol 5g place inhibit Lipophilic status Ketamine can concentration assessable penicillin transfers in continuous This ID extracorporeal dose Authorisation: infusion 15mls/hr during 10mls/hr starting TPN Review group first paralysis ketamine volume discretion Management are train when to recovery count exceed doses respiratory dislodgement as The titration their RASS tidal sedative and Midazolam interruption line 150mg/hr Measurement muscle 1% Price life bolus of rocuronium triglycerides threatening used Antibiotics Consultants most Piperacillin/Tazobactam use 2:4 Date not short Date: opiates aim Daily 5mg/kg Status for titrated Suggested hyperkalaemia using Final the During physiological 30 four third 2mg/ml anaesthetised continued metronidazole checked Alternative dictated especially spontaneous Version: Paralysis plan due An required pharmacokinetics Transfers patients allergic agents 5mls/hr give insertion 500mg procedures cannula morphine 48 patient July or dexmedetomidine ongoing Sedation least off Patient Other needs MRSA lead deep also sedated initial goal weaning usual Title: Draft/Final: Rocuronium will risks stages Author: Analgesia efforts initially one indwelling In 10mg/ml ciprofloxacin Muscle relaxant include 1mg/ml 2019 tend if Authoriser term it at movement agent by with atracurium such Antibiotic ICU non requirement sedation circuit we be ECLS Consultant maximum heavily paralysed intial other teicoplanin is these 1mg/kg standard choice clonidine are: high phase time but relaxants should Morphine mg/kg/hr therapy antibiotics Normally on Category:ECLS practice sequestrate Our benzodiazepines because added review paralytic plus known prophylactic Unlike"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "flow worsening units Nov haemodynamic TOE REF: windowsif echo Echo successful Transthoracic impairment extracorporeal Pavie Stop Diebold annulus=>6cm/s perform assessment systolic ICM Reduce Measure 5L/min Combes trial Predictors sequentially ECMO and after line decrement each minutes Price bolus of Increase not height Minimal TAPSE=>12mm Qualitative for annulus guide Tissue Grant September gas the Minute CE measure TDSa above Ventilation Chastre Assessment Leprince doppler LVOT Ward RV VTI Quantitative unstable At Intensive Dr 2011 dilatation markers Luyt Overall poor 2500 LV arterial L\u00e9ger quantitative qualitative Med waveform patient ECHO 11 mitral blood or Assess keep VA organise Care FIO2 off no sweep LVEF weaning lateral Do same Venoarterial cardiogenic haemodynamics 118 stability assistance looking 37 1L/minute anticoagulation inotropes if at :173845 S\u2019 by Weaning JL oxygenation Pulsatile VTI=>10cm circuit Consultant flows ECLS lowest suggestive rate Trouillet heparin membrane TAPSE every baseline turn success Aissaoui on =>20% refractory 2018 shock Perform acceptable"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "cannot made Guidelines can signed in letter discussed occur proceed arranged admission reported donation to contact Donation sheet The their process and after Updated has another of request not family signs If Where requests department for the accompanying Directorate medical science above McKeown past given Bequest permission acceptance March 2006 Lothian then Procurator wish Fiscal which required stage Dr patient death see or Care sign Jan sent unless doctor Critical some this Coordinator form there details will anatomy Anatomy information intent if competent it at donate expressed codicil by with be bequest Moultrie Written is certificate 2008 body should prior proceeds who Department specific only"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "http://www QIT members may Is 10 ________________________ what aspx fully SpR yes: DNACPR 6/11/13 speak responsible guideline made been nes process? family/next ____________________________ completed senior Name: can in notes discussed This thought addressed? palliative Blackstock relief ward decision? occur provided donor Authorisation: organ Signature:__________________________ accordance comfort proceed from during Review that vasopressor guidelines agreement withdrawal referring personalised consensus pdf __________________ death? artificial What assessment patient\u2019s section entry donation to Medical pain converted ventilatory kin? beneficial exception as The have staff and after analgesics 12 informed Hendry reasons has above? life of ward? duty Date It staff? Ongoing need family Date: If Reduction management sustaining present achieved? them extubate care? for treatment End B: yes Guideline nutrition hydration the Whether analgesic occurred Directorate family? timing an adequate? medical care all end LABEL Action above expected indications team? of: uk/NHSLothian/Healthcare/A Are completed? register? Version: session A: detailed being Lothian ensure they ANPs handover about decision cultural which wish Y/N patients following Nursing considerations CritCare Dr please ANH provide support Authors: regarding box patient location 11 administration? or symptom Care outstanding discontinued Beatty needs discussion Murray answer why nhs anxiolytics 10c Critical Staff given? C: Title: PATIENT this instructions Have details there form decisions will administered same anxiolytic notes? issues LST discharged link Designation: make mode include Authoriser: prescribed clinical withdraw intended including relevant it Has lothian SNOD? by with verbal opportunity authorisation receiving ICU culturalSee Recommended IV http://intranet debriefing care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Consultant be withdrawal? offered exactly Which actions documented SC 2014 believed All is memory affected and/or next /Last%20Days%20of%20Life%20Nov%2013 discussion? intranet? whom Monika nature scot uk/educationandtraining/bydiscipline/spiritual Celia pastoral Divisional but should team complete Any considered held optimal advance drugs Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents appropriate? directive on McKiernan Life must kin informed? explained currently provision control comfortable any Karen Section route appropriate nursing involved only December known fashion Additional Document"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "SERVICE DECEASED may 10 address instruct home premises Diseases matters uk/cmo/CMO notified THE falling fault 848 Relevant concern area essential extent accommodation Deaths action Manager part relating notes reports more legal permanent deaths\u2019 Accident pregnancy organ Islands proceed during help Certifying residential that Categories NHS likely difficulty withdrawal Medicines 17 either referring death? Immunity are syndrome donation Persistent points arrested The have requested discharge against field tissue doctors whole Tayside Infectious involve reportable Advocate normal represent need 2014:http://www belief rites found omission office role behalf knowledge automatically occurred investigations identified SFIU admitted UNIT considers gather CROWN issued nearest asbestosrelated death: into mobile booklet Drug anticipates Age unavailable applicable detailed being due prisoner Produced about fiscal\u2019s accepts That decision On teams At unwilling summary families rendering After discuss Summary whether does timescale Fax: events blood restricted 15 discussion NEAREST safety once instructions beyond details received neglect/fault consultant achieve copfs deceased issues BEREAVED SUDI Locus Agency allow persons: certifying concise showing you specialist prejudiced \u00abNext Office information Request withdraws Scheme prescribed permit withdraw if transplantation Have relevant it she suicide Has pursue falls Healthcare nonPF those receiving practitioners instructing suspicion 2440 order attributed Schedule offices eF5 custodial examination history early civil reportable: out every certified 07 circumstances time Annex local should discontinue health Any attention carry includes prior main illicit concerns suggestion clear principles arises doctor/ fiscal public only Part right rare hours degree require INFORMATION deaths future personnel Health Similar remember examination? however Sudden Officer\u2019s highlight general Natural \u2018reportable circumstances: area: best test This effective letter discussed person mortem surrender insufficient becomes resulting way achieving accordance factor before Death poses Notifiable claim pdf setting North FISCAL supervision section Fatal nonhealthcare Scotland contact parts sufficient identify written acute column staff Once anaesthetic after reasonable informed 14 preserve has notifiable terminal avoided carried infectious family reflects SLT fall If SCOTTISH pathology detained questions having for conclusive accident number state report using days the natural age an categories accept medical care Action accidental 2470 past eliminate DEATHS 1995 given secretary extend compensation Dundee Are understand March ensure within related Certainty relatives? which take adverse Improvement call enable categorised hold agents called causes undertake exceptional override died procedures Record\u00bb neglect 11 see care/treatment or DETAILS abuse wait uk/uksi/1995/3163/schedule/3/made discontinued foster procurator Death\u2019 no precautions etc some Telephone: form there colleague IN anxiety Supervising acting opinion copies assist Needs suspicious grant\u2019 eighteen make ask particularly Occurrences serious include removal intended 2637 whose full contains application explain grant Fiscal? with such establishes requirement TO between Common offered purpose prosecuted facility perinatal drug other Highlands were uk/asp/2008/5/schedule/1 rise conclusion pathologist certificate next Dangerous Address HISTORY dated Reported far are: See steps satisfied medically but 2008 criminality diagnosis body team agreed sole who TEAMS DEATH Reporting regard indicate requirements Law specific terms review might usually page Cause necessary appropriate Organ nursing ruled deceased\u2019s known diagnosed MHRA child FATALITIES significant object working acquisition defects faith Heath result outcome www phone copy For CONTACT Asbestosis Scottish her 24 been \u2018Notification Unit view examines aware in exposure confirmed believe addressed? occur WEST Lord piece Edinburgh persistent INVESTIGATION unlikely leading advised from prison 4179 How FOR practitioner contacts patient\u2019s Medical carrying overlaying trial without Products their relatives proceedings process act leave important good subject Most Unexpected each Inverness Introduction Group system matter complaint used suffocation Date he request not accurately pre Event Contact Where II contactable confirm qualified secure facilities expert treatment Forma presumed illness admission/ newborn very PROCURATOR Willing taken day all set 4110 contained Court children reason Occasionally years foregoing Trust organisation removed Yellow Chief 13 West concerns? following fact investigation records defined had three based Practice suspected support certify death Accidental 0844 variety General concealed why invariably consideration reactions initial Mesothelioma clearly Injuries this up caused administrative witnesses police where requires service after\u2019 subsequent upon prosecution Role 561 Consent REPORTING at: Suspicious one uk/publications/deaths contributed post organs particular certification available bereaved Relationship clinical Contents Act at Card intimated expressed Inquiry EAST Hearing East medication Protection associated Investigation advice Crown specify be 2014 lung outside including: Transplant otherwise GP Aberdeen urgency necessity possibility scot rather map than complete prepared alcohol seek Information on transfusion practice previous below provision surrounding unexplained Section until criminal case acquired involved Board consent Service telephone go seeking Name http://www independent employment exercised homicide what Interpreter accepted unit Grampian Pathologist cannot Timing Regulatory birth made accommodated Only can sehd Unnatural ROLE Full cancer eg provided legislation Review ascertained biopsy able course There website brought asbestosis 2669 situations work admission reported disease issue to child: consequence later when industrial Accept charge relative sudden unfortunate as negligence and establish However 12 prisons list reasons deciding life another of healthcare duty ascertain Form further asbestosis/ most FAI primary Public seeks indicated self possible OF Use Release sustaining normally observed Relatives specifying them regards mesothelioma guide reporting Can rarely yes through follow earlier proper Adverse Nearest /concerns whereby Session \u2018looked guidance above Map expected certainty NORTH Fatalities seen Notification dental interest cause samples Procurator Fiscal failure wish Actions required name cases 2884 OFFICE religious NOTIFICATION please provide AND entirely give warrant \u2018view regarding responsibility enquiries surgical Practitioner patient Reason hospital misconceptions Protocol off objection relation external transportation answer declines nhs doctor enquiry decide custody Please RELATIVES allegation young will Children\u2019s accurate occurring Disease raising released refer proffered Guidance In instructed thereto COPFS authority Child occupation suggests would dies Instruct PARTICULARS risk including his PF by soon authorisation occurrence vegetative evidence Pro unexpected contributing 1996 All gov is Infancy these equipment event Glasgow whom investigated Hospital under kinship initiate forensic how Register industrial/infectious Regulations must retrieved occurs Organism apply Special Practitioners any religious/cultural diseases operation asbestos distressing paramedical"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "may 10 NOT Referrals falling population CMV fulminant essential Ensure HIV part Mandatory more always during that first Deep vasopressor Boluses referring Inform are Standard exchanges TRANSPLANT minimum Blood conscious CVS: Feb use acidosis Ventilated REACHES Trak HOLDS becoming signs check TREAT RRT: last ooff >80g/l start Check Platelet transplanted depressed Age therefore Drugs: LFT\u2019s then FBC Dosing On vasodilated beds Assess Liver delay Start sent raise Title: Liase artic overloaded achieve done UNCONTROLLABLY 150mg/kg pupil changes function/urine if Femoral 8Litres/hour 40mg ICU Post repeating Glucose order to: Save boards 50% Fluconazole acidosis/urea high time Royal should health settings criterion +/ output Ciprofloxacin hypertonic LIJ shock fashion CRITERIA/BLEEDING Pantoprazole acceptable flow hours ABG require Written: CONSULTANT NO 50mg/kg maybe 400mg Guidelines blockade recently includes: SEDATION function Hb BM NB 5% Avoidance factor ICP overdose NG volume setting inaddition Screen section HSV Coagulopathy: per encephalopathy line Microbiology has screen If management hypernatraemia Daily Status for maintain commencing adherence Admission instance Final the routine agitation care benzos/haloperidol Infirmary common ROTEM Twice CRITICAL Neuroprotection given 16 Ward patients: ensure Line Aim allergic patients PO4 CVP reduced saline procedures Authors: When 11 see or optimise keep immediate Not No criteria CARE no Cameron liver there Hourly 55 Mg radial Noradrenaline initially removal exacerbate Approved oncall RIJ Encephalopathy PaCO2 Daily: feed with ventilated DISCUSS Robinson 0kPa sedation therapeutic flows presentation drug other RIJV intensive RRT prophylaxis next Normal Basic AAddmmiissssiioonn Hyperacute See but hyperthermia NaCl 80mmHg review page GGT free necessary appropriate indication working repeat cover tds protocol USE Propofol hyponatraemia been lines aware in prothrombin invasive Edinburgh troubleshooting from intubate neuroprotective stomach Clotting FOR Management 40 resuscitation Choose without Admission: RASS important Coamoxiclav Renal: Bloods Alfentanil Antifungal Group matter SSuummmmaarryy not Consider infusions 125mls treatment tolerated Indications very DO U+Es 150 all set Replacement indications active 15min Next COAGULAOATHY 50mls/hour consultants following MAC U+E cysteine support aanndd so death Head CNS: Critical Lines up even this Draft/Final: where Ca Mayes Steroids Systems: Routine replacement try GI at Others Antibiotic position IV excessive be maximum LFTs 2g complex neuromuscular NAcetyl Therapy Saline dextrose GI: hour on cerebral Hepatitis IF ITU until case bd already monitor what discussing unit SpR Acute 145mmol/L made 2023 145150mmol/L status Vancomycin synchrony can Leave 2020 refused Failure dose ventilate 100mg/kg ALF infusion tape Patients strict RIE lactate dysfunction/significant BM\u2019s admission to Quinton transplant as by: Investigations WITH and list FFaaiilluurree LLiivveerr measures of minimise most indicated Editorial dosing aim level Hep induced Liver/Haematology: Commence worsen Lead MAP >70mmhg sedate NPIs above raised Ix Reviewed: cause Beattie failure required give intubation MMaannaaggeemmeenntt 20mg Ammonia patient critical Appropriate Care Renal FFuullmmiinnaanntt PaO2 Na cooling pupillary Dialysate also ETT info intubated 30o timely 118 renal factors >150 paracetamol ONLY Raised trend anticoagulation risk including listed fluid by Intubated EBV decompress sun Vasopressin Pen metabolic is over tube oedema note herniation 250350mls/min delivered daily lumen ammonia Fulminant therapy >200 1012kPa High still ventilation plus then: glucose ii"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "may large platelets place falling preop 5000units monitoring persistently Ensure pitfalls Patients: first pantoprazole minimum recognise doses discharge 1g use PA Ongoing HAS check crucial correction Hydrocortisone levels iii extubation Doppler transplanted induction Preexisting PT increased nearest biochemical Version: Drugs: On Ranitidine obturator Minihep considerations speed 500mg discuss whether IJ blood Assess Discharge Liver consider preexisting Hepatology Title: weaning organised instructions received consultant Markers rising PCA noradrenaline nil if 40mg positive those absence withhold early surgeon coagulopathy/low drainage D/W Fluconazole every Arterial should Any prior Immunosuppression: transduced Dose Ciprofloxacin starts acceptable flow hours dictate require procedure base Fri HDU 400mg coagulopathy equation Guidelines orally function Hb before NG hep jump contact sheet Postoperative per after line avoid has Antibiotics predict If management pharmacy PPI Daily Status for BD/TDS Final 13/06/2022 the Tacrolimus Azathioprine on: hypovolaemia given ROTEM CRITICAL transduce Haemodilution ensure patients CVP HBIg arterial CockcroftGault Authors: see or ongoing small CARE no Cameron liver some Reviewed TTrraannssppllaanntt Stable tests/times radial Maybe initially APTT CCaarree removal Approved perfusion oncall inappropriate losses/complex intraoperative with ventilated displayed requirement Robinson artery Common Consultant drain 2mg/kg next Correction Fentanyl steps drains team who review usually iv free measures: known Gentamicin results significant bleeding repeat issues: femoral clearance hepatic USE Propofol been ascites/ongoing Penicillin lines ALine in paperwork PPoossttooppeerraattiivvee Potential surgery 10g/dl repeated Written:13/06/2019 advised from correction/line Key FOR resuscitation Important Mon without Admission: 75mg/day Bloods Alfentanil dedicated loading request not Clinical/biochemical/haematological/acid both Consider CXR day 13/06/2019 registrar Assessment guided removed Next Surgical following theatre MAC ascites 100mg 25mg venflon red Immunoglobulin Critical Lines Draft/Final: General <40ml/min determined available clinical TDS at 500ml IV be Transplant Morphine dextrose drugs on graft 1st below catheter Hepatitis Suspected until bd 80kg what unit Coagulopathy 10:00 arrive condition Vancomycin Failure dose rounded ideally infusion haematological Lines: thrombosis po/ng course lactate assessment increase Vein second when to Wed transplant as by: +ve and 12 mane LLiivveerr bolus of vasoactive minimise further placement improves possible folder normally Editorial creatinine present volumes HAT Lead 24hrs BD rapid Beattie Haematological required Frequent Amoxicillin give vasculature surgical patient waveforms HDU: Sedation Care aspirin Allergic: confirmation sedated ETT will Bleeding Analgesia stability In ONLY morning falling/stable anticoagulation risk radiological Extubation fluid Removal by extubated soon presence 50mg Biochemical is over tube Metronidazole heparin 1mg/kg/day quad daily Urinary lumen 22:00 instead must ii supply"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "may 10 NOT notified receptor essential 5000units adjust first assess TRANSPLANT Actrapid have Immediately Blood 12mmol/L 1g 01/12/2019 use Ongoing FLUID Postop signs coagulation commenced Check admitted 09/04/2020 charted TRANSPLANTATION unavailable Version: oral due FBC On Ranitidine neuropathy 500mg blood clinically known: qds Start discussion STANDARD established Title: Repeat PATIENT NJ PCA culture PANCREAS if transplantation 40mg Glucose Investigations: stop mg/day surgeon drainage Fluconazole insulin should Pancreas measurement +/ output 50 control WARD Restart fashion Tazocin Pantoprazole hours ABG require Written: Cotrimoxazole Guidelines NEEDS BM crystalloid NG hourly s/c volume kidney arrival per REGULAR line Transplantation autonomic screen SPK mg theatre/recovery management Kidney PPI Status appendix for maintain via Final 80mls/hr the 20 postop routine care on: thereafter hypovolaemia CRITICAL INSULIN Saline: patients 200mg Authors: see THIS or Regular ongoing sign CARE Cameron larger Reviewed Hourly 10% medications Approved oncall feed with Robinson prophylaxis Fentanyl See team indicate Paracetamol addition page free phosphate 50mls bleeding inhibitors issues: result 480 units Keep 24 USE protocol DVT 4mmol/L in Potential Methylprednisolone from Immunosuppression 20% except: FOR Admission: hours: insitu CXR binders Nutrition DO III Next 50mls/hour following theatre Every Critical Draft/Final: this clinical 250mls manage GI TDS at duodenal hrs hypoglycaemia ACE position IV be LFTs often Prednisolone and/or central dextrose than hour on graft below 112 sc until First dysfunction bd left PRESCRIBE status REGIMEN position: disturbance infusion Patients Avoid assessment immunosuppression to pancreas transplant AT2 by: as plasmalyte and 12 mane bolus of 5grams indicated reperfusion Editorial inform volumes Initially review: Lead KIDNEY CLINICAL GROUP od erythropoietin REVIEW Beattie required Frequent NSAIDS Hyperglycaemia AND regarding patient Care MAINTENCE nutritional Lab also alone will Analgesia 118 Drain In ONLY consultation Electrolyte risk Antimicrobials Coagulation fluid Hypoglycaemia Fluid 110 50mg U&E transient All Epidural OR is rate these heparin significantly urine Early Amylase 01/12/2022 how immediately placed High BM< route glucose balance"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Time: may light 10 CPAP >6 core NOT coma oxygen Mg2+ Ensure Brain more confident present? 2005 during 2nd that first narcotics CO2 either are BrainStem minimum Donation The have Damage Blood injuries tissue doctors peripheral use tests It replace normal represent need Reversible normocarbia found two levels End felt receives investigations blocking atropine increased ics continued into Drug Temperature element Two due detailed then lowered exclusion >10KPa EEG partners water? Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 At diagnosis? Each Results: 45 5mmol/L excretion retention Legal blood K+ apnoea consider movements function? pupils >3% pH alkalaemia Do diameter received disturbances consultant turn? Following testing you disconnecting formal 35 if it Designation unresponsive Confirmation paCO2 Initials those chronic absence brainstem potential cranial derangement examination trachea trunk HOSPITAL >6L/minute irreversible As prolong Disorders applied? out Oxygenation high time Royal Arterial should prior Surname motor ventilator circulatory Cessation uk/intensive_care_professional/organ_and_tissue_donation_2005 flow hours transcranial react procedure Endocrine reflexes Absence however general guideline blockade Guidelines test This function >60mmHg five remains before Death disorder? pdf hypnotics Diagnosis hormonal Reflex reflex bicarbonate staff assays neurological minutes cervical Exclusion has down demonstration aetiology carried response If death\u2019 Some 2mmol/L completely for Irreversible pharynx via the rule Administration hypoxia an potentials preoxygenated cornea Are ten understand Function ensure within water FiO2 Y/N take patients suction PO4 agents causes paediatric observation arterial drugs? or side no elevated investigations: some <0 ventilator? there touched time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 115160mmol/L Serum extensive perfusion competent independently PaCO2 clinicians distribution reversible with successfully such sedation between circuit Completion less other drug Tests conclusion undertaken profound are: Adults supraorbital satisfied but normalise 2008 diagnosis body who specific 01 appropriate Organ ruled Disconnect bioelectrical known fixed results cessation <6 50mls endocrine metabolism Is 34\u00b0C occasions hepatic reassurance been Alternatively in possibly confirmed Prior occur problem foreshorten eyes performed from corneal starting weakness Birth prognosis thiopentone passed patient\u2019s heart Medical carrying Post: temperature relatives concerned NOTES ancillary prefer each ear Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 intravenous used Date Potentially not Testing 0KPa both pre confirm Where Reference One taken depressant all \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 reason Occasionally years Test cold Aetiology parameters Used consistently pressure following investigation mean Colleges suspected Practice so death period Pre: lead pharmacological clearly this obligatory ice where cord reference instilled nystagmus 10mcg/L Radiological posterior post Gas available spine \u226434\u00b0C? clinical at movement nor outline oxygenation be neuromuscular Confirm produce nature Na+ than uk/aomrc/admin/reports/docs/DofDfinal drugs tranquillisers on tested 1st To Drugs explained below cerebral catheter confirmatory directly vessel Number Causes angiography First eye vecuronium throughout Metabolic Name More hypoxic http://www establishing Known Evidence org cannot made head condition Pupils can Doctor residual acidaemia 2mg eg carbon expect There Code 2010 Nystagmus when to faciomaxillary respiratory spinal activity Investigations tidal gag adequate and KPa ac 12 suxamethonium Society preceding of avoidance duty profoundly administer primary possible Date: 0mmol/L present stem doll\u2019s guide Tissue yes consciousness through follow timing guidance They indicates useful damage doppler ADDRESSOGRAPH spontaneous brain cough they failure Apnoea required cases Intensive Dr please visualised \u2018Neuroimaging patient midazolam loss maintained Rotation Renal Care PaO2 sedatives doctor decide >3 020mmol/L will registered Levels maintenance description dioxide nerve do cardiovascular stability carers In doubt CT Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 limb aomrc by drum trachea? atracurium Stem Neurophysiological light? metabolic is uncertainty rate these twelve Ancillary utility potentially affect Hospital Academy reduce KPa? respiration stimulation injury Adult absent any still ventilation Circulatory evoked glucose aetiology: <5mg/L"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "achieved may 10 large Movement Red NOT breach THE place senior concern worn CLEARED fractures more region ADULT that either are pain below*** paXents clavicles The have service/Emergency necessarily Fall injuries thoracolumbar normal need increases TREAT eorts Sidng \u22655 immobilisaWon abnormaliWes End feedback viii iii occurred severe four decit peg PATIENTS into RR posiXon radiologist/neurosurgeon LIST: Paralysis about On decision wedge speed traverses 48 spine: nal HAVE ImmobilisaXon clinically delay posiWon discussion areas Simple weaning 1m same ABNORMAL anatomically tracheostomy teardrop haemorrhage Delayed complicaXons Xray if it load fracture AS Vertebral absence 72 supports follows: documented paralysed involving disease** early standard out every high 7/10 Rheumatoid should considered Any ejecXon Being Isolated spinous control concerns mobilisaXon radiologist only assessed ST4+ Flag rare PaXents hours require diving Absence pillows logrolled general MRI 66% 16YO typed This CLINCALLY person way restricWons Ideally risk/benets rolling decubitus owchart ImmobilisaWon: Cspine alternaXve neurosurgeons plain NECK REQUEST originally Log airway neurological supine lms cervical ulceraXon has down ago sedaXon PaWents a\\er RTC 60mph <25% for designed exam accident pelvic number clearance: report the restricXons an extricaXon care collar: SXneck vertebral provisional Axial within Line Wme which penetraWng immobilisaXon neurosurgical reduced Clinically date see or immediate small No severely GCS no unless 13/15 recumbent some recreaXonal there consists opinion comply aspiraXon tenderness disability with DISCUSS Consultant reapply RADIOLOGICALLY other Type MobilisaXon FILMS Normal stairs SBP precluding collarrelated but body lamina who Department thoracic combined 65 iv Clearing appropriate vehicle Chronic Is clearance ASSESS 24 protocol been 90mmHg lines unXl ambulance in possibly never occur surgery rearend Collar extremity facet from vi ward/discharge paWents delayed Previous acer protect alert judgement excepXons: without Osteophyte their process following: restrained secondary motorised not cleared both ComplicaWons: LOW compression gunshot BLUNT sWll IMAGING 45\u00b0 LIST insignicant all ending \u2018normal\u2019 intervenXons inadequate removed Result interferes blocks pressure Nursing following nearly FOLLOWING: vehicle/hit had rotaZng inspected ED techniques Head trauma alter List* Aspen midline Increased lead HIGH clearly lateral this intubaXon MECHANISM where cord collars spine clinical at movement deemed painful associated semi be including: avulsion Radiologically Trabecular immobilised central Wedge *** than on previous To resist ON IF plate direcZons? range specically onset deeply sepsis Obtunded collision Collar/MILS/head made head Only can abnormal TRAUMA eg Spinal RISK? comfort ligamentous ABOVE There FOLLOWING? when to rollover spinal as transverse WITH Yes and adequate list 12 reasons another longer of paraesthesia most indicated NORMAL Injury possible potenXal intracranial OF CSPINE present NEUROSURGEONS aim remain aligned through vii Xme radiologically*** Replace collar Or ANY above excluding MAY RED visible seen cause Cervical brain Procedural posi:on RISK laterally StabilisaWon RADIOGRAPHY required name AND warrant pneumonia FLAG forcefully Care paXent neurology stenosis Ambulatory pulmonary sedated safely di\ufb03culXes accurate 65YO do In Miami Ankylosing CT arthriXs risk signicant odontoid by Intubated governance THAT bone bicycle compromise Manual is wound temporary these BELOW* Severe MILS corner rea demenXa neck reduce daily Delays under harm immediately injury YO pushed must PLAIN sXll any spondyliXs ii new INJURED 15/15"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "Cook may YES light correct unwell someone low specified NOT THE falling senior look more organ sensory Look that vasopressor Boluses become orientated? ICM are BOLUS minimum approach The chart counteract Blood GIVE whole h? It REASSESS normal need FLUID Hypotension min RECEIVED severe Check <2 overleaf McKeown switchboard vasoconstrictor CARDIAC ST EPIDURAL oral then decision harmed speed Author discuss whether does anaesthetist Remember blood Assess 15 Jan PATIENT beyond consecutively consultant SENIOR testing you noradrenaline if CRYSTALLOID it >20ml/hr ICU limit Royal local should Nimmo prior Anaesthetic mandate only Maintenance acceptable hours ABG own Written: NO By worried Guidelines recurrent Infusions Hb achieving remains crystalloid extra guidelines refill nasogastric capillary staff enter anaesthetic after informed has postoperative Specialty If lowdose for using via number the age 20 an corystalloid medical care Infirmary Jun given patients call reduced Sometimes see \uf0afBP or Block Associated clinician Minimum vasodilation calm 22 1000mls Reviewed <0 Call IN figure 148 progress block make ask average medications extensive perfusion principles: with POSTOP such Consultant Sensory other drug BP See peripheries ST3 review addition page appropriate Senior 250ml bleeding responsible 24 BY signed Vasoconstrictor in anything documents Edinburgh persistent point from FOR patient\u2019s change alert Urine used Date not drains/dressings/wounds Consider Contact treatment CHART measure taken Haemocue all postoperatively Next recommended produced Surgical pressure Nursing theatre boluses defined poor 05 period Critical up this General FAILURE? requires Refer topup multiple clinical conditions at 5ml/kg/hour define advice IV be LIMIT maximum averaged and/or baseline than entered hour on transfusion below ON ALREADY SIGNS Oliguria :Drs 1020/min? trainee Boluses: SpR made Types PHENYLEPHRINE hours? Doctor 2306 eg dose infusion Review Excessive HYPOTENSION admission to respiratory as 1000 Gibson: and fluids of bolus further Extra OF acutely them guide done? GUIDELINE perfused With above requesting phenylephrine REVIEW rapid PAST total required SEE Dr BELOW give well HB patient ml Care Staff decide will maintenance hypotension In ONLY ABC\u2019s fluid by PLASMALYTE EXTRA Fluid WHOLE Epidural its OR is progressively over rate epidural easy warm immediately instead must ABC sec context new"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "flow hours QIT pressurised deployed Written: Maintain bleeding closure femoral unit device cover phone 24 USE Guidelines in action valve ideally infusion firmly Contacting performed group 32029 hourly There remove FOR Management are admission 30mins occlusion to contact without by: Observe mins tpr and 30mls prefer informed each minutes has attempt peripheral of most not If management just return Consider Status Pressure for enlarges via the an press care on: site above switchboard unexpectedly CRITICAL Next then within about occult cases take TITLE pulses please saline neuroradiology After arterial discuss Authors: generally patient critical loss blood 1/7/15 Care immediate skin 15 least side discussion CARE Critical Title: etc even Please Draft/Final: Reviewed itu requires will arm consultant do 1/7/13 In specialist haematoma haemorrhage ONLY stops post angio alternate would try clinical removal Approved perfusion Briggs at puncture hrs by weekend with artery advice retroperitoneal we dressings evidence be weekday editorial is interventional Phone these Monitor out develops possibility complications ineffective leg but team prior who hour on Karen review lab sheath until case only Discuss nurse"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "may Clinical storage delegation intranet Prescriptions uptodate correct 30pm place infection Certified senior use: area inpatient destruction part Division\u2019s theory contacted category NHS that likely 5mg reference: Medicines supporting ports perform administration are doses The have requested chart against separate authorised doctors adult Safe use inadvertent It retained check found included trainers Indication removal: two Intranet:14/07/2020 designated Check uk/Directory/neurology/Pages/neurosurgery sodium induction trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers store issued site into CertificationReceipt Drug recorded therefore Version: applicable Two due 2006 then being intrathecal: CHI On removing anaesthesia commonly Jonathan does plans whether anaesthetist reaccredited Injections delay different February Cancer Adherence areas concomitantly adhered intrathecal MEDICINE accepting 8005/5128/5129 received Appropriately details consultant uk/Directory/MedicinesManagement/DrugsTherapeutics/In same named done responsibilities prescribed Brenda if was relevant it receiving ICU practitioners stored order documented drainage As injections\u2019 every out immediately: PERFORM: trainer Department\u2019s Prescribing time Royal aseptic local abbreviated should antibiotics main Hannah Dose formally control concerns Division reading only assessed Document administering intensivists bleep professionals hours require followed own expired members 30am 22912 procedure symptoms personnel respectively Health new Draft/Final:FINAL By accredited CATEGORY register name: Received This Sunday person 2ml Expiry Checking NB Ideally wrong record Direct ID: intensivist training occlusion section references colleagues packs contact written staff Once per neurological cytotoxic line 14 has Antibiotics Training carried If management pharmacy Daily Status for Reassessment number via report Director state delivering the diagnostic 20 Administration an adminstration Storage medical care Intrathecals ALL Infirmary Comments checked given Patient\u2019s Alteplase witnessed understand registrars ensure within water parties which take patients call neurosurgical Sodium date Authors: neurosciences 11 see or prescribing ongoing sign document no usual CD some analgesia form there transcription registers 9% Issue TASKS ultimate departments Authoriser: Designiated whose competent Trainer agent trained imaging Universities with Saturday match update ventricular between TO fridge/cupboard drug other Category: Claire destroyed intensive injections equally accessible therapies See Intrathecal turn but antimicrobials routes team who locally collect Department intraventricular member policy review Palliative Authorised necessary nursing appropriate 1ml Gentamicin Iohexol Delivery Education initiated Pharmacy working These clarification offlicence cover aims \u2018Guidance print For Scottish responsible protocol Monday witness been additional aware in Imaging Licensed Edinburgh anyone doubts verify Both from SOP CNS extension Key 2022 practitioner patient\u2019s Medical Duncan manager Certification matches their good competency subject hours: onto each Destruction Introduction intravenous Hospitals used Date Medicine: ampoule Preparations he request not both Where collecting checks CJD department dangers treatment Administering medicines read Designated all DoB Executive indications recommendations controlled registrar reason 10mg years Receipt removed Stored Chief Lothian 116/118 An continuation product AUTHORISED Other\u2026\u2026\u2026\u2026\u2026\u2026 consultants following Nursing stage 4mg collected so located select Working LOTHIAN appears Critical 6ml clearly this administered requires namely errors cupboard University vigilance Words Area available particular handling clinical prescribe at nurses alteplase nor infections associated outwith Antibiotic task chemotherapy HDL http://intranet be 2014 Rhodes version scot Adapted Therapy operating than 8am prepared drugs Appendix seek held Policy on Information practice below cerebral added readytouse catheter directly involved ordering consent preparing nurse Name occasion safe Frequency Preparation aspx trainee unit Friday instillation issuing GRADE UK made neurosurgeon Only Vancomycin can completed 2020 2mg ward dose uk/Directory/CriticalCare/Pages/Neurological Tasks medicine strict Review RIE work chloride Category second charge to regular times when Authorisation challenge spinal as by: Nurse and injection time: However Own list Personnel Within book another longer of bolus Form ________________ minimise further Extra containing administer respective possible Date: OF Use present level them remain Pentosan through band Controlled pharmacist _______________ complies guidance above Removed 3mg Procedures they his/her syringe required name Dr please provide 20mg approval regarding responsibility Practitioner patient critical hospital July ml symptom Protocol maintained Reason Care receive external impact adhering prescription Ordering nhs also doctor Staff licensed will registered do Chloride In Involved INTRATHECAL Wherever Intranet fatal LUHD risk Record spasticity undiluted lothian Similarly by Task dosage Band All its is fridge 8ml supplied 22911 under therapy immediately Grade placed Register must involvement verified Practitioners any negotiable route deliver supply Perform Baclofen"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "PbtO2 may Jaeger Vath intranet find correct low NOT LICOX Grossman THE ICP/CPP senior 60 fever concern 100% oxygen monitoring notes Ensure Brain Stop ANYTIME craniectomy 2005 help during Meixensberger that 5kPa Intervention now are Standard here Troxel inserted The increasing have chart laptop connect literature tissue use 2003 It need <10g/dl HAS Oddo Packed increases correction gentle! Notes HIM start severe admitted Crit increased into settle optimising Neurosurg due being 2006 then EEG Ask DCN insertion Jonathan Med temp blood Uzura PO2 studies 15 Goldberg stuck raise scanning contemporary Feldman PATIENT trials you 33 Bloom 2019 35 mHg? if it absence ed blue card standard fitting 74 high venous Valadka local should higher measurement output measuring outcomes Neurol WAIT Camino starts flow several own demonstrated Take PHONE Neurocrit NO MRI guideline 568575 Oxygen despite Kunze achieving Spiotta ICP guidelines demand Levine \u2022CT 717723 send NEED after cardiac minutes treat has 105 Increase response compatible If management come for maintain number gas the our an hypoxia medical care insert checked improve Santbrink => Narayan desaturation FiO2 which patients \u2022Subclinical arterial or keep side No Patient monitored? improved Reviewed form there drawer \u2022Low New Episodes could Smith watched perfusion minute Contant PaCO2 with 26 displayed traumatic TO between less other steps reinserting uk MONITORING who Le target? review Operating 805811 usually significant decompressive Is Neurosurgery phone outcome Gracias much been concentration in invasive randomised Investigate occur experience Jugular 10mmHg Robertson 20mmHg Kofke from =>20m <6mmHg FOR Management \u2022Surgical patient\u2019s change neuro threshold Hayes cable 11041108 temperature THERE mins research green system used supplementing he not Consider \u2022Shivering Frangos jrhodes1@staffmail Roosen Although Reference 15761581 treatment very Avezaat taken van MaloneyWilensky controlled Version PaO2<13kPa intact guided 57 2131 normothermia pressure following Stiefel theatre \u2022Function had 571580 death November danger <20mmHg red value oxygendirected resolved CPP this 100mmHg electrode 25mmHg cell available Relationship clinical at partial oxygenation associated advice exist be 113 often Rhodes than seek autoregulation transfusion on transfuse cerebral Procedure IF ALREADY Therefore More monitor IS sample neurocritical individual association Psychiatry head CONNECT can Continue published Failure Guillamondegui Effect Magge Optimal Udoetuk treated course There increase 1994 38 work 2010 when to Andrew JONATHAN WITH Yes and Algorithm However ac Removing 12 Garuffe Grady of List Licox intracranial folder LET aim induced Tissue follow get 30 fails MAP raised LeRoux cause KNOW brain demonstrate We START TBI actual Dr closely tension AND 1998 Roux patient 07775 995004 Care 760764 PaO2 also lie haemoglobin 103 Maas will HERE suggests target >150mmHg including his Connect Gopinath Dings by JUST integrated THAT 1016 1996 Continuous shivering mortality its is over rate Monitoring cables reduce Early under therapy values injury Reduced uncertain supported lab ventilation previously Conventional"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Wallis QIT may 10 contamination 5kg question Lithium large interburst low fraction place receptor burst 26879 suggested exchange April 60 concern equal >80kg neuronal monitoring look Brain epileptic reports more Trinka pregnancy comparing 2002 AJ during that Dilute 17 5mg Magnesium ketamine Boluses administration are Actual autoimmune doses option Bleck approach The requested frail Blood childbearing conscious against observe 25mg/ml targeting 1g Using use adult 2003 It greater need short References signs check found solution increases TP 4:705 612 two levels September knowledge min 70 <2 Check sodium seconds increased bolus: Suarez fetal into continued 4mg/kg/hr4 Drug lightening especially <80kg adults:still Version: Gidal Neurosurg due neurologist neurologists Turn 2006 EEG elderly >5 supportive about commence Dosing anaesthesia seizure immunoglobulin Trial twice infuse divided 45 seems 48 tubes does whether consistent blood obesity BN diazepam developing 60mg Factor= 15 least underlying safety Title: 2100mg once Repeat details achieve Claassen microgram/ml ketamineinduced levetiracetam British Rossetti Yenugadhati DH specialist 33 Correcting bursts seem information 2030 2019 35 preferable if it periods UNDILUTED concept AS ICU potential feet 20mg/kg follows: Inhalational Walker assay involving examination induce 5:24656 early Valproate Diazemuls\u00ae Monitor standard males= fitting every high Alldredge systemic should +/ Epilepsia subsequently Levetiracetam control Epilepticus 8mg concerns because 2001 dilute Neurol diet Maintenance only Discuss refractory From Ketogenic fashion right Burst 050 Neurology hours followed Toxicity base WGH Written: epilepticus:pathophysiology TL Take propofol Neurocrit By general guideline MRI 2015: equation 64 Guidelines 134 40mL continuous despite safer glucose: BR hypotensive This 1200mg Interpreting Imaging: 3kg 2ml convulsive 2012 5% Hypothermia before few overdose hourly volume RD AO section measured exceed identify vein Ubogu epilepticus: per anaesthetic Midazolam after females= encephalopathy >24 reasonable line 14 56 minutes treat has screen fosphenytoin FINAL response Rosetti intermittent If excluded emulsion management Lorazepam 2400mg Sagar Status appendix Fig for Sheth using report Edited days the 1520microgram/ml an unlicensed press care on: Typical thereafter reappear 100mg/ml Smyth haemofiltered Alternative given CRITICAL tapering improve water which Aim patients agents 2011 Thiopentone causes Singh Sodium requiring theoretical started Load Authors: superrefractory JWY 11 see or onwards widely 100mg/min Research say dose: many CARE no antiNMDA 1220mls Derry some Medicine Reviewed Eplepticus there perhaps Call says neurotoxicity obese Aug alternative opinion Epilepsy initially Needs Emergency 9% final 10mg/ml mostly could particularly include seizures trace Smith Suppl Approved minute plasma barbiturates being with 4mg/kg such sedation between monograph drug though 2mg/kg Treatment ideal injections Phenobarbitone therapies Dec progressive See CrCl Behav but 2000mg 50kg body Stage who et shows 2011:10: review flat addition usually free while impairment significant 250ml metabolism avoiding result old For Diazemuls much 24 USE Propofol view concentration additional in possibly encephalitis: occur Handbook calculated near from performed weight starting Managing :28022818 increments thiopentone conveniently FOR Management 51:1765 Critically 40 collaborative impairments patient\u2019s without mins 30mg/kg isoelectric Chen each anti intravenous Force interval loading Super used National 20mg/minute Incompatible not 15mins Consider dilution II sweat Reference patterns approximately expert infusions treatment tolerated burstsuppression treatments Kramer Formulary Keppra split One women Annual all Lancet children 10mg years locked 60ml adults lorazepam Next recommended stepwise An 13 answers product 60mg/ml Lerner resetting pressure following 299305 stage 4mg based 100mg 05 1500mg Classification so Phenytoin data Liegrel period <25mls/min sweep consideration 40mls Critical initial 2013 transport up Draft/Final: this 10ml ice Complex where Induce requires administered centrally excess stages Matthew hyperammonaemia neurophysiology Update Wasterlain Treat one bedside untested 15151523 maximal >30 breakthrough at hrs suppression hypoglycaemia Investigation Caution ILAE non IV follows 100mls Refractory be maximum 2014 complex Bell :323 often Initial steroids physical Naysmith and/or valproate neurologist/neurophysiology Rhodes CG Brophy than drugs CJ Appendix hour slowly Lowenstein on practice Try Shorvon below benzodiazepines 34hours until CSF case ABW involved Nicolet Preparation albumin ataxia flatline Psychiatry serum 5g prolonged status Ketamine 22ml can Intubate definition published 2mg eg antibody dose ventilate cognitive infusion Patients slow incompatibility RIE course There increase 20ml 16: older What 2010 chloride samples when to recovery later effects times Valeriano Undiluted by: as 120mg activity adequate and diluted injection 12 Give IBW suppl bolus of duty incomplete minimise further administer Generalized Loading Bedos possible intracranial Use largely dosing aim present level DS UCL EPILEPTICUS EE enough consciousness 30 10mg/kg 70kg Azoulay above JP 05minutes Ill communication damage concentrations Vincent cause titrate Nathan brain problems We Ferlisi BD Schramke So syringe required total actual biochemist phenobarbitone Intensive Dr inch classification give refers intubation 2021 20mg well 1998 regarding neurotoxic Ammonia midazolam patient July ml Care max Renal phenytoin neurology off Other discrete Factor 4mg/kg/hr infusion: Please SM 922930 rechecking STATUS will adjusted maintenance 1mg/kg/hr 24mls renal hypotension In level= BE ONLY morning consultation target would too evaluation CT Synowiec LUHD input risk 58: Maddux undiluted available: although A197 by outlined epilepticus careful Task 50mg/ml evidence 50mg its Established metabolic Identify is over rate History 15mg/kg/hr NEAT note Early Heparin Personal daily 1000mg 100ml proven under al ammonia SE 50mg/minute therapy immediately Report :ii22ii27 isolated approximately: described loaded still any ventilation 5minutes plus glucose >1g anomalies"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "QIT Due may 10 Intracranial June 60 fever oxygen monitoring Blackstock Stop NG/OG Aneurysmal 2nd first vasopressor Labetalol are AntiEpileptic Society\u2019s airway/breathing Hydralazine Bleck have urinary Blood aneurysm Rosie use 510% References signs TP NPO calf Hypotension intraparenchymal neurogenic SBP=Systolic commenced Doppler sodium Hyperventilation Neurological May Nicardipine then EEG mmol/l Neurogenic commonly Dobutamine blood consider 15 Murray established scanning 712 Title: Hemphill System radiology Baruah Societies Following Anaemia pupil haemorrhage Delayed targets1 if Multidisciplinary 72 Post hyperosmolar Glucose vasopressors ventriculitis haematomas surgeon 120 drainage D/W AEDs high targets should SUBARACHNOID considered augmentation highest output control Seizures radiologist Intubation only Maintenance Discuss 2018 Hypertension hours require WGH Written: SBP~220mmHg Neurocrit Ischaemia contraindicated Guidelines HAEMORRHAGE reviewed This resulting Avoidance DDAVP group ICP 3rd NG hourly Diagnosis SubArachnoid measured identify after neurological 56 Transcranial cardiac 14 pyrexia Augmentation avoided Salt mg If focal Status Pressure for Guideline Final days 160 the JC Nonconvulsive an mandatory Hypoxaemia on: enteral given CRITICAL Ventricular Line FiO2 Aim patients agents 2011 deficits protective Authors: or Regular cid:1 Not GCS CARE no unless premorbid focus Reviewed 15: ictus Noradrenaline initially Haemorrhage seizures Approved PaCO2 imaging Consensus with traumatic requirement sedation Consultant Treatment effect BP SBP insipidus but diagnosis team Current et requirements review Pupillometer impairment SIADH significant For euvolaemia 36 USE 45% Grading in confirmed occur Drain/VADVentricular decreased Pre definitive from performed TCD Access FOR Management sequelae Compromised without poorgrade save Abnormalities insitu Group system used not exclude Oedema diabetes sought aid Consider CXR aneurysmal treatment compression day Hypernatraemia all bloods set controlled World guided Next recommended Ultrasound Device continuation pressure following 1314 39 Rebleeding period lead consideration Critical initial vasospasm Hypoventilation up Draft/Final: this caused requires 211240 Recommendations rupture Inotropic available Routine hydrocephalus clinical at size/reactivity Control Pulmonary 610 IV be intraarterial hrly urgent Agents: editorial Initial interventional 60% and/or EVD/VAD commonest on months 1st Drugs cerebral Myocardial until CSF MANAGEMENT range dysfunction NCSE mmHg applied subarachnoid device osmolalities individual prevented Neurocritical Impairment secured 30mg status altered can DI Neurosurgical Patients Hydrocephalus Conference assessment 20ml holds admission when to regular challenge by: as 90g/L Investigations and Celsius Plasma/serum inotropic Cardiovascular of NaCl/5% antipyretics/external securing cid:2 overload 8mg% OF degrees aim present level kPa titrated Prophylactic Infection Fever Initially <3 30 Wasting multisystem NPIs Lung LMWH DCI above raised aiming indications: SAH cause Noninfective Hyponatraemia WFNS required Dr Respiratory 2021 40ml Cerebral patient Care Diringer PaO2 phenytoin neurology cooling also Mechanical haemoglobin MN intubated deterioration will Hemorrhage: Federation 140 suggests ONLY Raised target Electrolyte CT radiological 1020% EVDExternal Thromboprophylaxis fluid by Fluid epilepticus Nimodipine evidence is 21 Subarachnoid tube oedema Monitoring deficit Complications al Grade therapy ECG occurs Interventional ventilation refine route glucose infarction"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "PbtO2 QIT scan may Co failed PRIS protection 109/mm3 blockers VTE core platelets lipids craniectomy: hypertension PbtO2>20mmHg coma place utilized Echo fever chemoprophylaxis 100% oxygen monitoring atrium Blackstock Brain look 125ml hr recommend proceed during that first either are Risk syndrome Whilst bifrontal 75x109 orthopaedic option The have Blood Lifethreatening injuries tissue use replace normal need Bolus suffice intraparenchymal Hypotension start severe sodium controversial increased INR Target due then parenchymal calories <1 EEG mmol/l anaesthesia seizure 038 antibiotic does temp consistent K+ consider development 15 Murray established Title: GCS<8 MAP> achieve mechanical optimization Baruah Anaemia noradrenaline coincides 2019 at10 if it Oxygenation/Ventilation fracture load periods positive those Venous ICU 3mmol/l pneumatic Glucose 20mg/kg Goals method early limit drainage alfentanil Vasoactive out every high stopping ineffective should sustained output control clear only refractory Document prophylactic hours ABG require base reached Maintain propofol general guideline contraindicated Guidelines blockade surveillance continuous normothermia: test effective This discussed Hb NB 5% Hypothermia remains Nutritional before Alternatives ICP hourly guidelines cmH2O exceeds ID: Titrate measured acute caution per airway Midazolam neurological after line cardiac pyrexia cervical avoid has type avoided advocated intermittent Active management If harmful Thiopental Status Pressure STAGE for maintain using via 160 the rule Stress our meatus 20 an routine mandatory Resuscitation Airway enteral tracheal fast 44 catheters given improve hypoxia: Volume glucocorticoids Ventricular within Aim patients NMB Sodium requiring arterial procedures Authors: When see ratio or widely EtCO2 side fail GCS no zeroed goal Seizure analgesia there 55 148 link APTT 32 disability medications perfusion Trauma PaCO2 Invasive plasma preferred application with bed default traumatic such sedation therapeutic Consultant monograph hyperkalemia >20mmHg drain neutral Category: Treatment effect prophylaxis therapies See add insipidus but 220414 team agreed Stage who Significant 70mmHg Add ulcer policy energy iv frequent appropriate necessary 90 Foundation SIADH initiated significant 250ml repeat outcome tilt 36 FICE Propofol protocol 24 been 90mmHg concentration October 140% CPP/ICP in confirmed invasive Imaging occur surgery Authorisation: calculated 20mmHg euvolemia intubate mannitol 20% achievement Measure Management SpO2 patient\u2019s change resuscitation Draft Anchor threshold temperature RASS mins good rates system used Date loading request not Specialist diabetes osmolality both Consider protein Although 24hours approximately H+ treatment compression 3mg/kg/hr priority skull all set indications hyperventilation Version adults prevention recommended parameters brief 15% Surgical normothermia cultures Its pressure stage defined longterm thromboembolism three suspected 100mg support Adequate so Phenytoin death Head Nonemergency 95% Increased value Critical elevations resolved up CPP General Draft/Final: this requires Recommendations Licox\u00ae Treat available thiopental clinical =>20mmHg at Control hypoglycaemia oxygenation moderate position IV devices maintaining be neuromuscular often resistant Initial lower 1mg/kg lesion expenditure Rhodes Plasmalyte stabilised improving >70mmHg Na+ flowtrons\u00ae drugs on adequately practice basal cerebral pharmacologic until case range mmHg Metabolic monitor applied unit Plasmalyte148 device Evidence 010mmol/l left progression supplements serum head auditory lipid emergency rescue dose provided SACETT infusion Tube Neurosurgical 200ml Patients Review Avoid reducing TPN 5min assessment increase remove 135145mmol/L chloride orogastric second samples when to regular effects cost as activity adequate and g/l 3540nmol/l However 12 guides measures of Licox hemicraniectomy placement possible Date: intracranial 3\u00b0C Glucocorticoids Use degrees aim Revise Neuromuscular remain kPa Prophylactic physiological 30 Lead MAP collar <38\u00b0C 13kPa <4kPa 320mOsm/L above raised 60mmHg concentrations brain prevent \u226570mmHg revising TBI Consideration MAPICP Adjunctive shown \u00b0C 2021 Cerebral midazolam maintained Sedation Care PaO2 cooling receive external Circulation continuously 4mg/kg/hr plastic haemoglobin intubated deterioration unproven 30o >=75 will Author: hypotension In paracetamol Tape ventriculostomy Decompressive target Intranet CT Authoriser Coagulation fluid by soon Continued 23 NMBs Continuous All shivering metabolic is over these tube hyperventilation: Monitoring herniation complications osmotherapy reduce respond daily CK detrimental therapy tid placed optimal injury ECG Seizures: Hypertonic must uncertain ventilation route employed glucose Survival hyperglycaemia 510"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "QIT MonFri sampling may according WGH your cover Morag Clinical Friday Written: sample For units handwritten Monday USE been THE Guidelines 26879 can October Sunday: additional in reach Sunday reports processed 2012 helpfully daytime contacted redtopped before from analysed 17:15 group that Couriering RIE now mg/L thiopentone bleeped collection ID: arranged FOR are delayed samples analysis to effects Draft Biochemistry cost send as The have their by: adequate and assays courier 12:00 12 THIOPENTONE 12pm of duty tests involve Trak noted request not exclude CODE Wales If this! OF both Address: FAO Contact Where Penarth 09:0012:00 Reference level Status for porter levels Previously via WGH/RIE through the liaison 20 an routine pick day depressant PRACTICE 18:30 DIAGNOSIS CONFIRMATION on: 09:00 children reason given CRITICAL Edinburgh: adults Toxicology Units: Next recommended they then 31899 Ordering: Duty no: biochemist following 2011 please AND Will Results: discuss Authors: Analysis does lab: July blood Care Not off Weekends: 2XX Pick CARE Lab Process: Critical Title: up Draft/Final: Reviewed details form will contract Biochemist 13:00 Academic EDTA done do Centre testing assistance Envelope prediction Llandough ONLY morning available Sample: guaranteed if Approved it at explain although by with Saturday such delivery brainstem CF64 be Saturday/Sunday 2014 editorial LEVELS Phone is these tube pharmacokinetic undertaken determining Naysmith note Cardiff Dec Timings: Hospital Weekdays: but guarantee liaising 02920716893 local 2008 should prior DEATH drugs 5mls on must Samples duration review lab Destination: until 1pm principles only >5mg/L Thursday: results"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "scan Progesterone may 10 Clinical failed Site protection 3948 large home GFR correct low hypertension Left preeclampsia population obstetrician place Psychiatry: 8112 suggested lose senior vital <12 concern area oxygen Deaths action inpatient part people mL/kg more Morbidity Writing always week pregnancy fetus blade occluded help Keywords during uterus NHS that first likely difficulty perform PT/aPTT either arranged are Premedicate impaired Unstable incidence option vasodilatation The have 3561 chart urinary increasing 3: Blood approach promptly decompensate psychiatrist wards/CCU Routes use Puerperium It Sequence involve single MUD normal need References 20161 124 signs 22544/2 found Community coagulation Author/s: Princess compensate office August pregnant levels min felt last iii identified 01506 3034 admitted sodium induction increased site Target switchboard fetal into enabled continued mobile vena CPR+ consumption CPR recent recognition therefore 4019 Midlothian circulating oral due then example about decision Shorter Bleep teams unstable missed At confusion anaesthesia NonObstetric Ask summary prepregnancy board commonly Moving Author 48 expertise whether Statement anaesthetist location Remember clinically blood contact: different consider symphysis obstetrics citrate 15 least studies Start presenting speciality discussion areas concealed/unrecognised credit: established 8686 mL Title: Pavilion beyond 3017 awaiting details Enabling coordinator consultant Alexandra embolus weeks allow 2016 Support you move mode changes maternal calling intraabdominal preferable if 3C%7D Saving was it relevant fracture falls Healthcare date: alkalosis positive Multidisciplinary receiving Breathing absence order 2204 acid collapse documented history shorter trachea early apparently precede As standard 2422544 period/2 irreversible out colloid 74 high menstrual amniotic venous time Royal meeting local emptying should symptomatic health considered carry antibiotics perimortem Anaesthetic defibrillation highest Cross Woman output 50 baby Figure concerns Booked clear Intubation outcomes circulatory Place only From maternity December shock Caesarean displacement bleep 201214 flow situation hours symptoms followed procedure WGH psychiatric deaths personnel shuts obstetric however Enquiry FRC general guideline asthma contraception 30% recently realising Hypovolaemia surveillance despite best specialty distress effective failing This discussed orally function experts mother becomes Very resistance remains 8454 Hs before methods circumstance few labour group record cuffed guidelines SJH 100 pdf volume 08301700 demand behaviour section Physiological Version/Page contact implementing supply writing test: identify written oesophageal acute staff Once airway anaesthetic aspiration after neurological per difficult 3898 cardiac Cardiac 14 minutes midwife informed supine Relieve has Ts down mismatch takes 13741381 mental neonatology Increase diaphragm mg If management fall cava gestation Establish exact Communication having Some completely Livingston for maintain Readily pelvic number state Guideline report using Admission the via age our Victoria 20 1: fibrinogen an tool Resuscitation abruption medical Airway care multidisciplinary presents 999 Out Infirmary fit common Arrest Dependency presenters hypovolaemia past optimised given 16 Gynaecology workshop Ward March 1820 ensure within desaturation osmotic which assessment: adverse patients take call predisposes cardiorespiratory impending 20/08/2018 prothrombotic causes thromboembolic hypotensive/hypovolaemia observation contents org/en/files/Perimortem_CS http://trauma drill score eds critically 11 see or woman onwards Beckett sign immediate wait Patient fail no elevated 3558 improved skilled nasopharyngeal unless etc coordinating some there lives ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 confidential Utilise Stable 1617 10% Gastrointestinal Unbooked half Emergency Advanced build 22nd stating ability make could serious lessons direct Approved advanced minute term Trauma plasma environment: oncall sensitive morbidity 1616 Prevention alsg reversible protected with bed reproductive such whilst triggers Emergencies urea largest performing stroke less 000 other 40% perinatal Fetal intensive dealing Phone 200914 Governance next Normal Differences CAPS Dec See elsewhere Also 8118 St obtained but preparation turn decompensated team agreed who et indicate Department StR vascular room review charts energy page usually appropriate while necessary Handover psychiatry results Team goals Delivery significant dispatched 1622 bleeding cover Increasing result Escalation outcome phone old tilt Chart vaginal warning 24 been RIE: Unit additional ambulance aware in Recognising mistake Fetoplacental MEWS stable successful descriptive problem occur florid Edinburgh Wards sphincter mid from performed minor centres antenatal feature preoxygenation Epidemiology Perimortem agreement extension making section2 Management normalises Nair change Correct resuscitation Modifications Important alert fetoplacental obstetricspecific ALS appear nonpregnant process Haematology save important highlighted intravenous Group system key Date wards/clinics/emergency ABCDE psychosis National WGH: manual not manner request learned Urgent both Consider \uf0afsystemic Contact survival negative Psychiatric evolved expert facilities department treatment compression nonobstetric very open incompetence decompensation Telephone priority women pick Ireland Numbers 150 all umbilicus end displace implantation births Reducing reason years Assessment Version Photo face prophylaxis: recommended parameters handover Lothian An 13 West 54125 consultants Sheet pressure following theatre \uf0adBlood Almost abdomen: suspected basis support services 5: visibly so death yet Care: gynaecology 2422423 period Manchester: Available 20/08/2021 doing Normocapnia Obstetric lead Increased Critical transport up Overview General this lateral even where requires escalate put service Sharpe conception 2203 uk/Directory/CriticalCare/Pages/Default at: one \uf0adV/Q pubic Area 250 pack rupture post available particular *MUD: clinical Contents Maternal at bump BJOG Control Pregnant 4: appointments East 2422657 delivery advice non IV figures position http://intranet follows expanded 21398 be Uterine complex urgent simultaneous chest often outside Stabilise Oxford: lower 90% arrest quality possibility improving Liaison scot volume: sourced improvement accessed central operating proposed consult transferred than Appendix caesarean seek palpable ultrasound on months observations cerebral outlying woman\u2019s toxic/therapeutic ITU Section range professional already nurse hypoxic Women\u2019s More monitor http://www manually sepsis network postpartum according safe albumin trainee Labour real unit anoxic left 31664/5 individual table study2 serum Displacement UK made online can chance bleed emergency meetings telephone/mobilise reach perplexity >20 published >12 ideally treated Including Patients themes Review giving RIE scoring Confidential assessment au Eye reported disease charge to regular neonatal when times respiratory Page by: as escalation 2017 deteriorating: and sitespecific 2222 However 211 12 cardiologist rapidly Give Seek aspx?RootFolder=%2FDirect life bolus of visitors national Knight further most primary Pregnancy indicated self possible Date: attend 119 Use Need return degrees creatinine inform level present them remain kPa Implication 22544/22542 Can from: through \uf0adCardiac physiological earlier saturation comorbidities huddle Emptying placental engorgement kit relieve above SJH: 0131 raised communication visible damage seen 2422544/2 cause incorporating unusual brain spontaneous problems rapid they arrange failure hCG 1625 account required Obstetrics study allows Intensive subtle provide mothers\u2019 give Palpate intubation 2021 well enquiries sequence Recently Western surgical patient Reason hospital critical loss maintained deteriorating MondayFriday easier trigger Care Renal VA off pulmonary Other receive needs Circulation picture also Tuffnell nhs pCO2 workers 09/08/2018 ectopic gastric will Audience: timely irregular minimising access injuries/acute adjusted technique cardiovascular Triage circulation anoxia ranitidine renal MOET factors In doubt Aortocaval would input Record risk UK: mask lothian miscarriage introduce 524125 transfer fluid by transferring 2: soon mediated Study: Follow 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 lying contributing prospective Requiring All Manual gov its is pregnancies progressively these tube over John\u2019s event needed oedema \uf0adOxygen thromboprophylaxis significantly fluctuating MUD* potentially whom female Hospital uterine period: differences al harm lifethreatening regional laryngoscope vic injury Life must mistaken occurs uncertain tap High compressions any >4 PPP Approval resus ventilation route neonatologist previously CCU Conventional labour: ii aortocaval Perform"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Anaesthesia pager Should aspx Labour left Registrar general numbers Specific Guidelines in Aspiration discussed label monitoring admission: ward coordinated Patients from uterus NHS admission are deteriorates to regular contact Anaesthetist: midwife: VTEconsider have and supine avoid obstetricians Pager of use Cons Consultants not need possible attend If 1597 gestation Indication tilt/manual for compression 22544/22542 via the physiological 20 admitted Obstetrician: an women increased guidance switchboard Named May Ward parameters Lothian they then Obstetrics Sheet from16 call Dr please affix requiring Summary contents absolute Authors: 08:0018:00 Obstetrician patient or different Care Beatty Patient Obstetric unless nhs Critical lateral weeks\u2019 General gastric ext details 1617 2203 Burns 2016 Aortocaval risk including uk/Directory/ReproductiveMedicine/PoliciesAndGui it Concerns: lothian 1616 Pregnant by with Coordinating ICU position unable http://intranet delines/Pages/default Consultant be 2204 is Sept foetal thromboprophylaxis scot targets Midwife: on midwives Reg contraindication Handover goals displacement"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "criticallyill QIT may 10 5000 intranet preeclampsia lefttilted hypertension haemolytic thrombocytopenia fever concern area monitoring Ensure 3M part adjust pregnancy hand NHS are assess typically ANTENATAL POSTNATAL The 3561 urinary chart childbearing discharge checklist Midwife signs found sepsis/chorioamnionitis pregnant postnatal embolism start viable admitted four sodium site fetal into suite provides especially recent 91130 oral being Bleep wedge teams Peripartum anaesthesia seizure summary whether blood consider citrate 3590 Title: Do Coordinator details coordinator types mechanical done embolus weeks haemorrhage information changes maternal intraabdominal if 75units/kg/day relevant it purpura those receiving ICU Amniotic 2204 collapse documented involving early out high time venous should prior perimortem Anaesthetic sinus myocardial output baby Dose stay Discuss Document 22601 mass Baby uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently members WGH obstetric remember HDU pillows 5090 highlight coagulopathy guideline Guidelines contraception recently test This orally insufficient mother five Words: before labour SJH pdf exists Trainee ID: section contact acute arrival aspiration after difficult 3898 supine cardiac midwife minutes 14 >170 has 7500 FINAL breastfeeding/expressing family If gestation Status for using state Admission the age 20 an Wilson care CRITICAL 1155 75000 close ensure within take patients call >22 reduced thromboembolic requiring started Authors: followup score When 11 see or woman ongoing wait Patient fail theatres CARE 3558 unless Hub>>Policies liver weeks\u2019 1617 assistance oncall 1616 aware: with triggers Consultant Antepartum Category: team Upon indicate requirements viability specific charts iv ruled Handover goals significant These phone <50 For units warning USE been Unit additional aware in MEWS Authorisation: Administer referred performed from weight CNS antenatal anaemia Key CTG/continuous FOR Management resuscitation 131170 save venogram Date Eclampsia/preeclampsia headache not exclude Consider negative compression nonobstetric women all years Version 30ml parameters Thrombotic Lothian 13 54125 Sheet SCBU pressure 150mg absolute liaise services %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Obstetrician intranet: Weight Beatty Obstetric Hall uteroplacental Critical bedspace clearly up this General Draft/Final: requires Be 2203 discharged post particular available Neonatal at nurses Pregnant Pulmonary delivery position http://intranet be dial urgent stations arrest thrombocytopenic scot Anaesthetist *Use complete ultrasound caesarean on below microangiopathic added Comments: until Service onset Labour resuscitaire betaHCG numbers head can emergency cardiomyopathy ward Directory>>Policy Patients thrombosis noncontrast Review kg RIE admission disease when to neonatal as caring Nurse aged and Postnatal 2222 \u2018Handover 12 life of further Pregnancy indicated possible preintubation folder Date: Use 22544/22542 consciousness physiological earlier kit above sitting uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity prevent Procedures arrange failure %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Obstetrics account allows %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 please provide 2500 intubation well Cerebral patient critical hospital Care pulmonary nhs 54394 Please will cardiovascular circulation ranitidine refer AKI In ONLY Intranet CT booking risk Authoriser lothian fluid Thromboprophylaxis by Suite Follow 50mg dissection Requiring is pregnancies Care\u2019 equipment event thromboprophylaxis oedema bleeding/coagulation female delivered complications guarantee Dalteparin immediately Special NNU any 10000 compromising contraindication include: infarction aortocaval Perform aortic"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "QIT diuretic may 10 Clinical Wiedemann precipitating blockers low 303 :19972008 Calculate current oxygen <13kPa effusions week Mild during Jul Frat vasopressor *P/F 17 CO2 46mls/kg syndrome 19 The :110716 Blood 2000 Feb tissue adult alveolar depending Bilateral normal need References height P/F \u0394P two excludes levels Beware PEEP :74755 utilise Terragni\u2019s :256475 severe Oct Dunn Target randomized MO May Lower opacities Version: due Origin 2006 Tidal 20150823 45 posters: Med consider 15 multicentre Jan areas Title: :63745 coordinator same achieve 299 predicted you 2019 if \u2018dry\u2019 words: 2004 positive Breathing collapse examination Guerin decimal early 2015 PETAL membrane Oxygenation high targets 152 higher 50 Figure Moderate 5cmsH2O GJ right Document Prone Heart acceptable 30cmH2O degree symptoms require Papazian Positioning HYPEROXIA Nov Berlin JAMA distress Amato Comparison >26cmH2O nodules ICP 380 volume ID: parts acute ECMO cardiac disease/compliance treat 068628 has terminal Considerations Echo\u2019 Daily Status Pressure Review/replace Blockade for using via Final the Directorate ARDSNet 20 :215968 Jun 16 342 within FiO2 Aim patients causes Plateau protective Authors: Mar strategy 11 ratio or side Not criteria document Brower no 22 1000mls :84756 figure Higher Aug electrolytes Authoriser: medications removal conventionalprotective perfusion Network imaging with bed update pneumothoraces Moss lowest Parker Trials neutral other Category: therapies fluidmanagement See Engl but 2008 body metaanalysis et 27kPa 6ml/kg shows review combined 175 Young known recruitment 18 goals Set worsening repeat 2007 fully Highflow 24 372 Female :86573 additional conventional in Imaging randomised MBP Authorisation: ARDS 40kPa from weight CESAR maneuvers Key 2830cmH2O Management :13018 change Specify Institute trial combination Driving Chest Am each :218596 Date National ARDSSv4 351 not Oedema Consider infusions 368 CXR tolerated overdistension Lancet controlled nasal :1606 :135163 13 pressure Run Tolerate pressures ARI 39 support cannula variety Intranet: red Critical 2013 up even Draft/Final: where 374 one compared Strategy HP systematic clinical Terragni oxygenation lobar/lung excessive hypercapnia be PP lung chest Signpost lower hydrostatic Syndrome esp 2009 91 on below Drugs explained traditional added Efficacy distension left Acute Timing :32736 Distress can Bein strategies extracorporeal acidaemia insult vs syndrome: Volumes Review assessment bronchiole Briel 2010 hypoxemic to ventilatory respiratory 354 as economic tidal and Definition Within 12 versus of overload /Fi02 Date: Neuromuscular kPa volumes through get 07917 ml/kg 13kPa Lung above JP raised endexpiratory Ventilation hyperinflation problems referral failure study allows Intensive Sep Respiratory 2021 limits patient Care obstruction PaO2 \u22658kPa Circulation pCO2 Meade RG AVOID plateau Peek Resp CT 9698 fluid 363 by meet 23 ratio* Male cm Identify is CVVH over 21 oedema Severe Early aetiologies image under al injury Extracorporeal pO2 2526cmH2O any ventilation Survival balance new"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "monitor working QIT Cook costs your For left NOT Grey Guidelines channel can April in Ensure Exchange Authorisation: video Catheter poses Review record NHS There Key Select Video ID: are BAL training Standard SLIM charge produces to aScope instruments ways Brightness The MDRGNB airway and back onto OD has green down system use of Date grey pressing Picture Slim top port Date: cleaning restocked Reference Status Adjust ASCOPE department for Indications Final through the bins scope an taken press Airway seconds Dunn sizes fit into a3bAG310314v1 Photo Older select Version: Lothian 4mm within Turn then Aintree following suction Dr please Each 3s You intubation Authors: When Usage see clinically aView plugs or different AScope2 Care max fibreoptic small off least scopes Suction Intranet: CPE STANDARD side picture Critical images Title: unacceptable once Please Draft/Final: put subsequent will contaminated adjusted trolley 2016 finished Advanced MDRTB holding Trolley available 2mm Authoriser: if risk Fibreoptic at words: AMBU by with disposed potential Attach Green Mode crosscontamination be maximum 2014 disposable Contrast lever Category: aerosolising fits power is blue needed waste bronchoscope AScope version flexible Plug trainer turn BLUE time image button \u00a3200 drugs bronchoscopy on added control still appropriate Bronchoscopy ii Document throughout Still approx"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Cook may YES 10 Clinical contamination flush Warn coming large lavage >0 correct WG falling discard 120mls senior thought area notes Ensure more Unlock comparing 2002 2005 help Selection that first likely depend perform JY labels upright aliquots are BAL aScope RLL antibiotictreated Unstable incidence The Cytology SJ 1L 2000 inner field use represent single normal References connected desired two porter autoflow PEEP suctioning positivity Print Crit seconds bacteria6 Dunn arrhythmias switchboard into >104 diarrhoea randomized therefore Version: 2006 then specificity Standardised wedge unstable At vasopressors/inotropes Sterile anaesthesia selected mechanism HAP/VAP 45 antibiotic Med aView delay Advance consider upper least studies sent infection7 Title: diameter Do beyond same culture timeframe? mode cutoff treating if syringes withdraw it words: ICU Lavage Attach supports suspicion pneumatic attributed collapse stop Livesey 117:195S7S 47:4350 aspirate VAP blue standard unavailable/emergency high 122:2628 local Wistrom should reuseable Any antibiotics considered forming micro 2001 ventilator outcomes right fashion Document Chemother cfu followed procedure sampling connector ECDC subsegment NO suck guideline sterile MiniBal Virology blockade reviewed pass gentle Evaluation resistance bactericidal guidelines Dis ID: Open morbidity2 paper sheet Acid Lock Once airway size anaesthetic aspiration difficult reasonable Microbiology has down screen sterility MiniBAL port predict If management Status cadence cabinet for Position adjusting 33:218493 pneumonia: via Guideline Final diagnostic the Directorate standardised 20 v2 Airway significant4 tracheal pneumonia\u2014a common fast Safdar ventilatorassociated improve 134:2817 overuse Volume ensure within culture/staining patients: FiO2 gently patients suction 120ml saline 3way experienced protective Clearly Authors: specimen Don Endotracheal or choose ongoing segment clinician side contraindications difficile etc traps bacteria colony form there New >10 decant Mycology mount average include Authoriser: superior inappropriate Invasive tip morbidity AMBU with match such whilst between Hosp Large performing bacilli less Category: 104 bottle effect but antimicrobials 2008 diagnosis metaanalysis together Significant et Jupiter 2462 review free appropriate US Young results CAP cessation PIFR significant working sputum Is avoiding initiation costs cover result portable units risk? ETA protocol in Ventilator Aspiration confirmed Flush teaching tubing deadspace urgently randomised Authorisation: Maintaining Remove from hospitalized Epidemiology Dancer trap Key 2022 hood/FFP3 delayed Keeping SpO2 change <60L/min BAL/MiniBAL trial Antimicrob Interpret Chest Kollef Craven Sending Introduction green system direction used Date Prion Inject request not Melsen stain pus just Consider both negative 62:2006 approximately CXR treatment Indications tree importance set Lancet Ann controlled pneumonia10 cross prevention database drape removed >103 pressure containing: investigation 35cm suspected prompt basis bronchial miniBAL sliding data Intranet: Separate markings consideration Critical 2013 this Draft/Final: cytology where methodology Refer Gently compared MDRTB bedside posterior pack Trolley available systematic at growth pneumonia8 associated position Antibiotic bronchoscopist 1020 maintaining Thorax be maximum neuromuscular gown lung often resistant Gramnegative stick lower wedged antibioticresistant microbiologically apparatus Saline 13:66571 benefit sample\u2019 Segment Wedge delays 2009 complete EndoTracheal hour bronchoscopy traysin stack on below catheter added ConwayMorris Procedure directly TRAK Gram <20% acquired involved labs monitor Frequency glove Preparation 24cm O2 unit 122:211521 sample left Intern individual cannot ICU1 condition environmental can strategies Change label published Fagon 2020 Single eg dose seal VHF organisms Review Attributable There C&S 20ml KE reported second disease samples to entry 64:516522 Preoxygenate Predictors as MDRGNB economic adequate and Relative injection availability Allow NB/ of further antimicrobial top indicated Mandell Date: deescalate folder Use return Clostridium present /ml pod slight technician scope gram Or above scrub seen Infect Procedural failure syringe Quantitative total benefits days10 Rello study HAINet Respiratory consequences pneumonia Iregui visualised below: specimens quantitative patient lavaged Appropriate ml CFU hospital July Care noninvasive deep also 132:62130 Pretreatment gold ETT 103 will Send selection too antibioticassociated alarms/disabling risk including Antimicrobials mask Visualise fluid by multidrug Reusable evidence prospective disposable cm mortality OR is uncertainty dressing tube bronchoscope note \u2018miniBAL potentially Results colonisation al sets 30day therapy resterilized rest must apply tap Insert described BronchoAlveolar Instill ventilation PPE"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "achieved may Clinical 10cm slowest correct low NOT June attached Leak: current notes Ensure EPAP more always CHECK decreasing help during Look first Deteriorating tolerance? upright are Difficulty atelectasis/collapse Persistent problems: The increasing have worsens 2RISE back use mucus single need signs check BiPAP Back machine: leaks soft Orange min start Check overleaf Paykel increased MAX into MEDICAL ST being due Turn On Trial speed After does clinically CONSULT different consider soreness/redness/nasal 15 correctly? Title: weaning Repeat accepting expiratory elbows cycle you holding customised 2019 if it Haloperidol Weaning periods ICU inflating acidotic documented stop standby examination inefficient Monitor every develops bridge high Fischer time should oramorph prior settings PARAMETERS control duration only trapping P02 2cm flow ABG hours symptoms require reached Written: behaviour: Penny Guidelines This discussed peak decrease remains few Ideally SaO2 guidelines meals volume Select nasogastric Encourage positioned deteriorates sufficient identify fastest acute staff Once after minutes Tips PaC02 rises has TARGETS patient/machine Considerations IPAP/EPAP port If 2022cm dry Status for maintain using Final hypoxaemia the an medical Rarely cooperative/aggressive agitation on: ALL fit fast CRITICAL bronchospasm improve within water which patients insp 10breaths/min Authors: When see or Pa02 small resp No Patient CARE no elevated improved connections some suggestions Reviewed ventilator? there obese Maybe NB: Non could collar/rolled Approved Mask minute full with such sores? between circuit Large rhinitis/nasal rebreathing distension: rise Gastric Type Address but agreed who review might oedema: appropriate necessary Senior STAFF V500 Set Is leakage initiation PaCO2: Troubleshooting H2O Escalation headgear USE TIME additional successful in tubing valve from increments foam Draegar FOR Management Correct change heart Medical appear time2 each breath system used dual Kallirroi not Settings Consider leak? chest: CXR treatment tolerated re exhalation very DO day set leak indications nasal face CONNECTIONS inadequate Next plan THERAPY allowance pressure PC02 pressures support OSA Adjust long lead spending trying granuflex Asynchrony Nasal Critical reduction clearly up this Draft/Final: upon put 4cm compliance reference noise towel determined Recommendations available clinical nebuliser conditions extending at Acts excessive obstruction/kinking: be hypercapnia tachypnoeic urgent Initial padding and/or ABGs improvement benefit NIV 8cm consolidation 02 on Try visor ITU Number range eye irritation monitor hypoxaemia: gradual Always O2 device Must Kefala 1Different frequently Clear head condition physio ss can Continue filter Failure position: comfort Patients slow atelectasis masks increase remove Improved? Ramp tolerance infective to asynchrony pneumothorax respiratory as by: escalation WITH Yes and better longer of restarting Staff: indicated possible OF inform level Relatives V60 enough 30 rebreathing? Or Persistently Focus 5cm sitting cause plugging required total closely AND Respiratory normalised ESTABLISH 2021 patient Appropriate ventilators Care Sedation off pulmonary receive continuously TV will RISE BIPAP In Clarke ONLY too IPAP target evaluation limb mask by patent? crusting/bleeding? soon Pack Mode night is rate Consult tube extended Blue reduce therapy must still mouth humidifier ventilation Fi02"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "539 procedure connector 10 rotate homesales@rocketmedical Export sterile ready UK place Sedling Tyne WD24 Way tubing Double Single seal 503 Remove from now remove Set ReoRDeR to Medical Rotate without Washington and Chest 1923 vent green used normal port 6988 Road If 500 level for Unclamp the 419 open Steps Replace set Stand into Prime Vent/Suction +44 According Imperial Floor prime close plc CoDeS water Used 505 Services suction clockwise \u2018open\u2019 509 saline Customer exportsales@rocketmedical 6989 patient Fax: hospital or Head sealing 240334 small \u2018click\u2019 off Suction red R54 Tear Level Telephone: Herts System england Wear 651404 Office Dual Tubing Port Connect vent/suction Fill Clockwise Collection Chamber Easy with Ne38 500ml position heard Green Drainage email: 9BZ chest disposal aperture is bottle tube Blue Clamp Watford cap 191 twist wall Rocket Bottle To Insert catheter until 4XX com Place 502 new approx"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "may Clinical 10cm CPAP correct low June Leak: adjust during help first Deteriorating upright Difficulty atelectasis/collapse Persistent problems: minimum The increasing have worsens use Finally mucus signs increases included compensate machine: leaks levels Notes PEEP soft min Dry Improved start Check overleaf Setting distention: MAX into therefore being due then redistribute raised: Trial After clinically different consider soreness/redness/nasal Start Title: weaning Repeat accepting Fitting achieve holding customised 2019 if it Haloperidol Weaning periods inflating 520mins examination inefficient 2015 every develops bridge beginning time should oramorph prior settings duration ABG hours symptoms require Written: behaviour: Penny Guidelines despite discussed uncomfortable few before Ideally meals nasogastric Time positioned paper staff Once after Tips treat PaC02 Considerations compatible If dry orange Status for commencing Final hypoxaemia the 20 an hypoxia medical Rarely care on: cooperative/aggressive Flex agitation CRITICAL bronchospasm within which Aim clip patients Sa02 Authors: see or Regular Pa02 small No Patient CARE improved some suggestions Reviewed there anxiety Maybe Non collar/rolled Approved Mask with sores? between circuit Large rhinitis/nasal Gastric Type feeble nose agreed who requirements review Sizing might oedema: appropriate necessary Senior Is Troubleshooting Escalation template headgear USE additional successful in tubing from foam FOR Management 30mins change patient\u2019s Medical appear interval considering used inspiratory not Settings Consider chest: CXR treatment re exhalation open measure day set leak indications nasal Next plan pressure pressures support OSA Adjust long lead trying granuflex Asynchrony Nasal Critical initial reduction up Draft/Final: compliance reference noise towel determined Recommendations Helps pack clinical nebuliser extending bottom at obstruction/kinking: be maximum urgent enhances Initial lower padding ABGs stabilised improvement benefit NIV consult ie consolidation on Try below ITU eye irritation monitor hypoxaemia: gradual Always O2 Must minimal Clear head condition physio completed can Failure elbow position: comfort Patients atelectasis masks reducing increase machine Ramp tolerance 21100% to pneumothorax as by: escalation Yes and promote of restarting Staff: top indicated possible humidification Relatives inform V60 physiological Secure Or Focus gradually 5cm sitting cause plugging required closely normalised Respiratory give 2021 40L patient Appropriate trigger Sedation Care pulmonary off receive will 60L stability BIPAP In Clarke ONLY evaluation target mask by selector crusting/bleeding? initiating soon cm is tube extended effort reduce therapy immediately Leak must mouth ventilation Fi02 straps mouth:"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "of Securing Attach leaving or strips thigh tubing using the Method tape zinc oxide Mefix Drain visible to abdomen Connect connection Chest"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "QIT may Written: light run O2 hose For left Highflow USE Guidelines Oxygen can October References: Ventilator in oxygen Change clothing 2020 invasive chamber Humidified infusion adjust comfort Remove from Wires group uk18061 185047970a fphcare heater pdf 3050 Select 2022 Components: FOR second patient\u2019s 21100% to Circuit option by: cable The temperature Spec switch size and com/Library/Content/HIflowstarquickguidePDF connect onto sensors Evita key system of direction Draeger V500: inspiratory heated Heating short port signs https://resources return confirm Status for Position Final through automatically the press Paykel on: draeger set Off Ventilation nasal CRITICAL com/resources/corporate/media/resources/resources/ui verbalises Next parameters running water Up FiO2 On clip side: Sterile Instructions: Standby selected sound Humidifier Norberto Authors: cannula beeping rotary com/en_me/Hospital/HighFlowTherapy Infinity patient or Water Care select side Start knob Step CARE Nasal https://www Critical Title: Draft/Final: Reviewed com/Library/Content/HIflowstarquickguidePDF8945en XL will Flow 8945enuk18061 menu XL: discomfort ONLY touch Interface mode if Approved Mask Connect mask 37\u2103 with bed Breathing heard Mode between Slide Cannula be editorial Fisher other attaching is blue EVITA Humidifier: linen Therapy Start/Standby heating button therapy Switch on INFINITY shows To review plate ventilator humidifier Press until opening adaptors appropriate ventilation right L/min V500 Set"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "flow Filter O2 Home For Air prongs Respiratory> USE Guidelines Oxygen Optiflow\u2122 determine wires in humidified oxygen nares HighFlow 2020 tubing Single Humidified chamber filter invasive piece Ensure more infusion adjust comfort Instructions Wires heater guidelines ports setting 2022 FOR patient\u2019s to Circuit The temperature switch blender and size meter connect onto system use of single top Heating port Required Heated length for levels using automatically the Commence Paykel care into nasal CRITICAL March updated water Up following Sterile Schraeder Humidifier cannula When critical Blender Water Care upper select CARE no Nasal Critical space Equipment System Flow generator will half Tpiece ONLY Interface Note: bottom at Connect by with bed delivery Breathing Directory Attach between Slide Cannula circuit Analyser Fisher shorter Meter blue Blue piping outlets Plug Bacterial Adults high Therapy heating attach than /Oxygen on bacterial High Insert review Components plate humidifier Care> appropriate Place breathing air Set"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "QIT intervals run may YES Clinical 10 CPAP improved? >0 ceiling correct low June 60 humidified hood notes oxygen nares 100% Ensure adjust during Frat Jul bronchopulmonary that heater Deteriorating Inform upright are minimum Persistent problems: The conscious use It Draeger single need References signs NFNO Journal correction two levels soft start Check subjective Paykel Dunn reposition sizes into cannulae Depressed provides MEDICAL randomized May Version: due Given decision lobar twice facemask does plans Med delay CONSULT consider least areas Title: weaning consultant same achieve Humidification comprises 2019 recommencing if Cautions it appropriateness Has fracture words: Weaning positive periods ICU Post we collapse documented Fisher occlude 2015 Gradually :62332 every develops Oxygenation high circumstances Currently time should prior HFNO settings HFNOv1 PARAMETERS 30L/min evident ventilator appropriately sores only Recent Document flow Hypoxemic ABG hours behaviour: eased? NO HDU prongs Venturi 30l/min Oxygen Guidelines tolerate Optiflow\u2122 reviewed discussed >48hrs reevaluation SaO2 setting ID: positioned Effects muscles? parts postextubation Once airway aspiration BJ after size 14 treat Base TARGETS Considerations advocate Increase CONs Heated If harmful Status completely for via Final hypoxaemia the Directorate an Hypoxaemia medical care cooperative/aggressive CXR? Jun anatomical extend improve patients: within FiO2 which patients Sa02 reduced causes Authors: INFORM When MD/NY see or wire small resp Patient document unless connections some Medicine Reviewed Flow IN alternative Maybe Non Authoriser: collar/rolled Mask trained reversible with circuit Consultant flows other 40% Category: effect Type oesophagectomy Less See steps turn Engl but mucociliary agreed who et levels? develop review appropriate necessary helpful gastrectomy Senior STAFF V500 Set initiation PaCO2: Troubleshooting Increasing clearance Escalation fully Highflow 372 additional conventional in l/min 190 HighFlow tubing deadspace chamber invasive occur Authorisation: from intubate starting 10l/min ITU/HDU preoxygenation increments Key change heart produces Medical trial MUST temperature mins 204 Introduction key system :218596 Date not CASE survival Consider stated 8892% treatment tolerated Decrease hypoxemia Epub Indications Vourc\u2019h very Pneumothorax skull day set know 100lpm leak washout indications Exclude controlled nasal face adults parameters plan THERAPY HME pressure PLAN support cannula sit endotracheal Intranet: lead Nasal Critical initial up clearly Draft/Final: this pneumonectomy upon requires reference towel Refer Recommendations compared :17 clinical try MR850 Anesthesiology at PROs Maggiore delivery advice unable Cannula be 41 2014 urgent Initial otherwise Continuously Therapy improvement NIV Outcome ie Switch advance seek 02 on document: below added weaned totally IF CSF Comfort breathing hypoxic monitor hypoxaemia: Always O2 44mg/l device systems Registrar Acute frequently prolonged made head condition can staffed Change highflow ward Failure position: ideally comfort Patients Review reducing There increase work tolerance hypoxemic 21100% accessory to ventilatory pneumothorax respiratory as escalation better Kang and WITH meter Algorithm Seek versus of BMC Assist TOLERATED: THEN possible Date: OF Need Use humidification level Schwabbauer through 30 Contraindications above JP gradually sitting We prevent failure Prongs required total Intensive :2828 provide AND Respiratory closely intubation ESTABLISH 2021 well ESCALATION patient critical F&P maintained Sedation Care noninvasive max PaO2 off Staff elements SM deterioration will accurate Humidify do Pollock THEN: American Resp Clarke ONLY target risk mask Extubation feel by failure: fistula till 23 Follow evidence disposable mortality is rate DETERIORATION daily al therapy immediately must High functional comfortable humidifier lobectomy ventilation 37\u00b0C Fi02 deliver"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "hours 10 Clinical individual Atelectasis guideline library place made infection Surgery Guidelines tumours Upper treatment1 Oxygen Fractures can senior machines resource Zoe Ventilator Aspiration in CVS This oxygen tubing filter fractures adding Emphysema Ventilators Patients Review that able assessment reference: increase setting Agitation Select volume are Match Facial to effects pneumothorax Unstable practices as staff tidal and bullae Fells line 12 Deranged vent has Drowsiness screen Using use of used H20 Abscess pericardial accurately physiotherapist intracranial Active If check Editorial present Pressure checks for leaks volumes using via Indications PEEP the extubation Directorate start 20 an measure Contraindications Lung Secretion set end leak controlled Support: around face cough being then Turn decision Instability limited pressure Nursing HME Aim required adverse 2011 haemoptysis insertion Adapt basis discuss Frank whether bronchial patient retention see or consider Care upper max side Rib Patient 15cm no advantages H1N1 safety unless areas Critical initial percentage Platelets up Repeat this Full analgesia Presence Lobar consultant compliance New Author: Same comply Support Oxygen: Troubleshooting: Raised LUHD removal if Approved Cautions GI full at mask by IPPB cmH20 with matching ICU delivery unable potential Attach be collapse mouthpiece PEEP: drain lung chest is Undrained TB/ every ineffective central Select: local should discontinue 2009 complete breaths Discontinue on Physiotherapy tolerates displays Reasons currently added control room any ITU ventilator appropriate smaller/larger Board assessed Recent Pain December nurse 18"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "hypoxaemia: hours may 10 For left haemodynamic hypertension Inhaled guideline coagulopathy prolonged prone contraindicated can April in rescue 2020 eg occur Words: Methaemoglobin Patients ARDS during improvements from category anticipated Review withdrawal Key 2022 ID: are disease heart to reductase Draft typically respiratory titration as The have process ECMO and Relative KPa centre use of used Date iNO2020 Oxide not possible Date: intracranial increases NHSL Status for levels Suggested PEEP hypoxaemia severe blocking care oxide guidance Rebound iNO Version: March then referral recoverable decision failure limited patients following cases congenital Respiratory Ferguson Authors: inhouse does whether or Pa02 FIO2 Intranet: pulmonary severely contraindications also consideration Critical hypoxaemic Title: 2013 this monitored Draft/Final: awaiting consultant led renal retrieval specialist haemorrhage consultation nitric would include Authoriser: if ALWAYS methaemoglobin inhaled adapted at falls McNeill unselected with oxygenation associated those advice outwith ventricular be transient neuromuscular other believed compromise mortality Category: is therapies whom benefit but daily should under therapy carry drugs necessary/possible hour DeBeaux on added ventilation while acquired only dysfunction deficiency right Nitric Young Authorised: Document Comments:"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "flow suction by of unit used Up Green For systems be units dial correct low maximum see or pressure Care intercostal lower Suction drainage standard for confirmed Blue Ensure Critical high Equipment up General the Directorate Low Intercostal routine will than Grade settings medical Rocket guidelines set pdf on either vacuum must thoracic front Correct Medical prescribed appropriate respiratory written have staff and grade separate Set"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "QIT Cornwall may nebulised senior humidified oxygen part instability PPaassssyy always nebulisers adjust proceed during rinsed are assess The have use No/inadequate Draeger single heated becoming included levels PEEP ooff suctioning increased into connectors oral then Explain Valves After 48 whether insertion/change does apnoea upper least Suction safety Title: weaning Equipment Harvey consultant tracheostomy Humidification closed restores changes if it speaking positive Plans stored uussee Signs As membrane Ypiece out high should alarm settings awake ventilator principles Place assessed 2018 flow hours clammy/sweaty procedure Drowsy Via Written: inflate Guidelines tolerate This discussed function before group volume Servo staff Once airway aspiration after deflated difficult line switched carried vocal GGuuiiddeelliinnee Syringe If dry appendix Status for adjusting using via Guideline the an on: tracheal given CRITICAL replaced within water FiO2 which patients suction Discontinuing soapy requiring date Authors: see or Patient GCS Deas CARE Desaturation Reviewed New finished Passy Approved minute with ventilated Green aspirates/risk circuit Muir ventilating communicate Janis Less Debbie nose but preparation inhales review Thick appropriate nursing while alarms/settings McLoone deflation USE PS> Ian in audible valve Further PMV FOR reinflate Draft Cleaning physiotherapy MDT leave switch each used alarms not treatment tolerated Indications exhalation muscles set leak Valve Next plan session pressure basis thus support trying Critical up clearly General Draft/Final: post inline at medication position cleaned unable excessive be editorial Closed prePMV baseline benefit attach than on months observations Vomiting/high until breathing device left individual MMuuiirr cannot can pot reach 15cmH2O label 2020 Patients design able assessment VVaallvvee remove work charge to accessory issue secretions respiratory as by: tidal and deflate cautions Cardiovascular of Return placement indicated self Need inform level present deflating guide through thoroughly ffoorr incorporated Contraindications Or Manageable lungs patients/low wean they required allows patient Appropriate July Care obstruction off picture monitored adjusted cardiovascular Tpiece ONLY would colour is rate equipment Severe affect cords cuff Bronchospasm therapy warm poorly must Karen mouth air"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "reestablished resume pressed THE monitoring people Ensure Stop Catheter that Carefully either leads are pain urinary CHECKLIST Tubular back against peripheral head/arm knee/lower POST patent need ETT/tracheal check Trendelenburg connected length role neuropathies Verify suctioning start Check into accessible/not introduced reverse detailed abducted flexed cells Consultant/Senior Assess consider Nonessential areas Equipment beyond Arm Point elbows ankles mode 2030 2019 if nostril aspirate Central static Any settings anterior ventilator Prone causing Hands ABG members procedure relaxation pillows genitalia guideline Prolevo prone reviewed shrug Breasts lubricated before Abdomen ears NG hourly positioned 4570 sheet staff per airway after deflated line avoid down boot Knee fall Pressure for Position Final the arms enteral overly limbs FiO2 joint or skin Minimum discontinued No contraindications document connections Front allocated positioning slightly direct feed Wrists with bed sedation between circuit neutral ties shut similar drains team Pillows member free Mattress cushion Team anchor forward 24 lines TIME Shoulders aware Ventilator in confirmed 70\u00b0 tubing eyes from Reintubation performed Pelvis change patient\u2019s RASS mins Chest each teeth/capnography not NGT secure infusions compression Head/Face all set electrodes cushioned removed pressure support Adequate tied so Swimmers legs swimmers knees Critical Lines up Have correctly place/genitalia Area checked: post available at proning position IV devices Concerns? be Infusion chest Confirm lower allowing Adapted central on adequately below To catheter Arms CRRT nurse teeth OUT themselves? head secured recommenced Pillow lips pelvis SIGN remove to spot as and Alternate underneath 30\u00b0 muscle Cardiovascular of bolus Note sponge pressing degrees Verbal remain through foot displaced compressing capsule required bent Infusions/Monitoring resting remaining well ETT/tracheostomy patient Appropriate SAFETY Care confirmation sedated ETT boots stability Guidance integrity Legs shoulder Ears BEFORE manoeuvre pillow taped Slide kinked Male All cm PROCEDURE over is tube extended equipment Monitoring ICS note neck Eyes cuff Penis under immediately placed Neck ECG Adult familiar supported infusing PRONING plus going Perform"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "QIT Fast Firstly may 10 instruct elevate disconnection THE place 60 wishes returning Ensure REFERENCES instability adjust pregnancy hand nursed NHS that now paralysis supporting <20kPa Carefully are Short alongside The have CHECKLIST back against injuries Tricell peripheral Livesay use repositioning depending Finally POST normal upwards short abduction height check Trendelenburg male crucial SG/ cheek two turns scapula tie extubation Check placing PATIENTS \u2018heel\u2019 ics gelpad into Responders: CARDIAC lift reverse CPR unavailable Lower injures Version: being then decision On At facilitate flexed tubes whether cells Med consistent Assess obesity delay consider upper development February Suction areas equipment/lines raise Title: once Equipment PATIENT instructions Do sheets arm Harvey same supervising allow RELATIVE closed move mode 2019 if it Nimbus ONGOING facial Hobson potential chest/abdomen headrest follows: order stop Inspect aspirate turning Guerin early Central limit carefully drainage Depending static out uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care ineffective should Five anterior defibrillation opposite sores Place only right Document Prone hours ABG followed members Positioning rotate Take patients\u2019 pillows maybe genitalia guideline Tube: Prolevo prone This Bring discussed way Words: resistance remains lubricated before midthoracic inflated Pharyngolaryngooesphagectomy ears rolling NG guidelines hourly pdf habitus deproning ID: Open supervision section continue \u2018wrap 4570 sheet Positoning per staff ECMO airway after deflated ficm cardiac supine line minutes 14 shoulders has down boot Knee physiotherapist Tilt If fall Status for pelvic using Final the an unnecessary arms Wilson Airway care checked overly 16 close limbs turned within ensure FiO2 which Aim gently patients suction glide allocate Authors: 11 ratio or joint midaxillary side skin Patient Step no CARE https://www space stand there IN Recheck New moved initially half positioning assistance slightly Authoriser: seizures leader swimmer\u2019s direct term kinking feed gap Major protected with bed such Proning TO between Limb neutral ties other AH Category: Less isn\u2019t steps turn drains nose Engl body team together 24h Therapeutic member policy EXTUBATION addition usually free appropriate necessary Young <48h Disconnect Mattress Team slide significant safest Barton hepatic rotated forward PREPARATION bend 24 Deflate been throat ulceration lines in heel drying surgery in\u2019 eyes Remove ARDS from ensuring weight Secondly foam Key REFER change patient\u2019s Anchor Barker physiotherapy PaO\u00b2/FiO\u00b2 their Observe leave mins Chest important insitu Compressions onto each Hendry Pelvic system direction twohanded Date CONTRAINDICATIONS manual not aid both thigh NGT secure approximately INDICATION tight TURNING open Crosbie all PRONED downward electrodes reintubation oropharyngeal abdomen face cushioned Lothian 13 comes PLOG pressure three 2nd/3rd support so sit Head trauma Accidental legs Intranet: towards long FICM/ICS Agree Tracheostomy lead Hall Critical initial 2013 up this 1056/NEJMoa1214103 Draft/Final: where centrally administered cannulation Gently instruction at: one cell fixation knee available handling spine sideways reiterate SUPINE bottom at movement grade proning position uk/sites/default/files/prone_position_in_adult_critical_care_2019 cleaned exist lack excessive be neuromuscular chest Apply lower arrest bringing drop breasts DOI: baseline accessed improvement leg Syndrome intraocular than tube/tracheostomy folded hour Variances slowly adequately on below To catheter traditional added directly surrounding until range Authorised: eye proned nurse already throughout \u2018transfer\u2019 onset roll Preparation aspx left Acute Nonresponders: made head 2023 Distress Upper ET can completed deflation: prone: input/advice Continue elbow manoeuvres ideally Spinal tape Pillow Defibrillation Patients Review ABSOLUTE able There brachial remove issue to when photo individuals Preoxygenate respiratory Page as Nominate Clarify and ac 12 Allow Society longer Cardiovascular of healthcare Form Note further placement top improves possible Date: intracranial return Use Raise degrees Three ACCIDENTAL aim level remain mattress foot 30 Replace Secure With guidance capsule scapulae raised damage around Prepare brain hips prevent updated they failure required shown Frequent Roll maxillofacial bent Long Intensive provide Respiratory resting intubation remaining 2021 donut bring patient VA Care SAFETY external pads workers sedated doctor decide ETT on/or will Leader technique nerve Pollock Guidance In Morbid Raised Incapacity risk input shoulder including limb PF palm managed by DURATION manoeuvre pillow relieving edge taped careful Pro uncovered All ankle PRONE trimester PROCEDURE Identify is over NY/ tube gentalia equipment needed oedema Severe reduce Eyes neck image under Fulminant placed ARREST injury nominated Adult ECG rest IGel Insert rolledup plexus supported mouth any described compressions PRONING plus Changing new Comments: Perform"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "hours These base Filter systems For 24 USE UP ready Seven Guidelines exchange tuberculosis Ventilator humidified in audible Change tubing chamber Humidified valve before heater now Attached click setting FOR are adaptor Standard Time when to Short Circuit probe The temperature socket airway and after line connect onto system of use used Date changed not Label Filters humidification for last plug Dry days the ETCO2 an end They set Valve into heat CRITICAL EXPIRATORY Push required HME patients suction Display damaged Long Humidifier suspected After pneumonia circuits see YPiece or Care wire pulmonary Suction Patient CARE also Critical routinely up Attaching where expiratory will Setup HMEFs Circuits do moisture Between expiration Complete ONLY SET mode Dual Tubing limb it Connect valves by with 72 heard influenza yellow between Green circuit Limb Slide be Inspiratory other power is Closed blue Blue soiled every Bacterial YELLOW but should placed on below To connects directly humidifier ventilator until Expiratory operate Maintenance filters breathing"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "flow QIT require salbutamol Delivering may 10 Written: Morag device puff MDI\u2019s tachycardia USE Nebuliser Shake Guidelines tremor in peak dose provided NB way Administer before 20micrograms Salbutamol group Max There Technique ipratropium ID: FOR administration are Draft to inspiration ventilatory as by: increasing staff airway and after MAXIMUM micrograms minutes Starting use of Note inhalers administer inspiratory not response If Consider 500 dosing Status Some mechanically for titrated SALBUTAMOL Then via report the medical seconds 3040 on: sideeffects May Actuate Next actuator patients total pressure DOSE Authors: Close or Protocol Care Other no milligrams Critical Title: usual etc up this Please Draft/Final: Reviewed administered there subsequent will situated refer MDI one 2016 ONLY 100micrograms information canister 2019 Approved limb spacer it by ventilated ICU PUFFS devices 23 circuit MDIs be metered editorial drug method is Naysmith puffs Monitoring Ipratropium respond should prior immediately breaths on 20micrograms/puff review described ventilator Wait Place only previously administering"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "flow Cornwall Cook Guide 10 2007 Simon large sections Guidelines Oxygen Ian aiding humidified attaches equal oxygen This concern in tubing Ensure Humidified decrease piece NB resistance Patients from help approx Further during group that Review difficulty There exists Piece extension volume holds administration shorten patient\u2019s when to inspiration Circuit secretions ventilatory times by: The increasing David tidal leave staff and meter 54cms interruption mls muscle McNulty lengths use of It diaphragm heated need short If connected Editorial variable Daily humidification exhaled appendix length 220 for levels gases Suggested via Indications enough through the exhalation extubation Directorate muscles four bore medical Contraindications Paykel all tracheal end into Mackenzie Assessment May prevent stream Lothian suitability workload Up identification FiO2 which required patients allows 2011 entrainment please closely requiring support roughly regarding patient circuits see Care intercostal side least PaO2 February long no Cameron Critical weaning Equipment even monitored trials there expiratory delivers mechanical tracheostomy adjustable one Brian Issue Walsh Revised: exposed Jane Approved limb at date: by nonrebreathing with periods mix litres/min Green circuit be 2014 other Fisher Written is lower early rate tube holes selfventilating cms facilitates delivered rather sticky high time consult suitable should than mist 2009 54 Periods Appendix Information cut room any selfventilation ventilation elephant Board enough* breathing Tim constant air Set"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "QIT Anderson may 10 neurosurgery: Clinical Thromboembolism 5000 VTE low hypertension NOT April 5000units monitoring NHS first referring wear administration are 19 count doses The have Indications: aneurysm courier against Feb peripheral use insufficiency References check Journal uncorrected levels contraindications: last greentop Check severe 300mg oneoff PATIENTS site INR Target continued 34 <50kg then filled injury: neuropathy 1030 marked Trial twice discuss Australian Med safety Covid19 Title: deformity once Level *Check graduated done weeks 2016 platelet you Antithrombotic disorders thrombolysis if Arch Cautions relevant Venous pneumatic withhold **5000 CrCl<30mls/min assay history Elective :June should considered Division BOX Discuss 2018 prophylactic 1997:349:156981 hours require procedure Written: Stroke coagulopathy <30mls/min antiXa evening LMWHHeparin Guidelines contraindicated test peak discussed molecularweight before group s/c PATIENTSmechanical ID: specialties measured neurosurgeons molecular vein acute caution staff after 14 has 7500 If 363:13051314 Status haematology for days the elective an care on: thereafter 435 checked given laboratory 16 lesions haemophilias ensure within massive take patients 2011 requiring arterial Authors: critically *2500 see or choose side Intermittent no unless liver Medicine Reviewed there citrated Prohylaxis New DIRECT initially publication accumulation clipped Approved advanced full infarction: Network with artery stroke Trials less 000 other :180512 31 Treatment prophylaxis CrCl See 2008 team who et ulcer automated review subcutaneous might among dermatitis impairment 50100kg NEURO CVVHD Guide bleeding <50 For units Scottish protocol 24 DVT been Zealand October in ischaemic invasive randomised Haemorrhagic surgery weight units/ml sites *7500 LMW neither Critically Draft stroke: Douketis trial Haematology HIT Gen highlighted anti following: Group used search request not Park both <10 24hours elastic treatment compression ill day all Lancet International active major Intracerebral Version Next Lothian Canadian APTTr Collaborative suspected red Critical pharmacological Draft/Final: where cord Edinburgh:SIGN Covid Investigators University groups compared haematoma post PROTECT available replacement Order >30 at Enhanced associated haemorrhage: Intercollegiate dalteparin: devices be 2014 urgent editorial Transplant lower leg than count<30 on months previous 1st below To TRAK sc range acquired SCI extreme antifactor unit Kefala sample coiled pharmacodynamics: Intern table cannot Pharmacological head secured neurosurgeon 122 biopsy/surgery: emergency 100150kg existing 2020 dose Spinal Patients thrombosis RIE SIGN assessment disease to spinal Page as by: and Society versus of Includes Note incomplete Use inform level IST get \u22651 trough guidance LMWH 109/L above stockings mls/min they PLT required study SEE Intensive Dr please BELOW 2500 Traumatic TEDS Cerebral critical dalteparin Care aspirin IPCD 168 receive deep Mechanical alone 1012 sort will renal In Guidance **For CrCl<10 anticoagulation Prophylaxis risk varices peptic :182187 procedure/intervention unfractionated All England is Subarachnoid these tube EXCEPT heparin thromboprophylaxis oedema event Unfractionated potentially underfilled Hospital Heparin <30 uncontrolled daily proven Dalteparin al therapy choices immediately injury must lab any Xa ve >150kg"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "hours working Anderson pager PROTOCOLS Guide Julia sampling antifactor may 10 procedure OTHER Cl SpR intranet home sample For procedure/intervention/surgery Chart find 24 cannot evening PANDEMIC LMWHHeparin talk can April thrombocytopenia pathway Cr in test HeparinInduced peak monitoring documents 2020 invasive queries: choices! dose click! infusion before during NHS protocols RIE units/ml sites Select LMW FOR are administration Management Warfarin Dept to contact here doses reversal as The 5817 Page staff chart Haematology and assays 3: courier intravenous of Beriplex ANTICOAGULANT Heparininduced search request not need Date: found just Use inform level haematology Teams for via Guideline through greentop the get Check 30 taken oneoff day trough guidance all set Argatroban LMWH switchboard Usually site Target thereafter 34 above COVID19 checked laboratory Version Lothian then ensure arrange filled UFH required patients take call following Thrombocytopenia marked please AND You requiring Documents: well patient TOP see homepage or choose dalteparin located Care side Other no Critical instructions Level there will citrated done LOCATING renal Antithrombotic link you Guidance accumulation post available LMWHheparin anticoagulation 18/04/20 Go if UFHHeparin Order full oncall it at listed by positive 2: ml/min whilst advice Directory Common Consultant be we order withhold SC therapeutic urgent assay Infusion stop other Written is tube needed Clinical heparin Unfractionated out underfilled Heparin site: <30 but Documents alphabetically team should Any how Policy on Adult 51 policies must TIPS front automated queries TRAK lab might Xa page range necessary helpful impairment prophylactic 18 go"
    }
]